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Abstract 
Chao Wang, Ph.D. 
Department of Chemistry, June 2008 
University of Kansas 
 
 Our group has a long-standing interest in Pd or Ru-catalyzed decarboxylative 
coupling reactions. It has been shown that allyl β-ketoesters, upon treatment with 
palladium or ruthenium, generate freely diffusing enolates and π-allyl electrophiles. 
Consequently, we were curious about whether appropriate reactants (such as Michael 
acceptors) could be used to intercept these intermediates during the reaction. It has 
been since shown that a [Cp*RuCl]4/bipyridyl catalyst effectively induces a 
regioselective tandem Michael addition-allylation reaction. This protocol works well 
with a variety of allyl β-ketoesters and Michael acceptors. Interestingly, ruthenium 
complexes behave as bifunctional catalysts, which activate the electrophilic allyl 
fragment and catalyze the decarboxylative formation of enolate nucleophiles. In 
addition, we have shown that cyclic carbamates diastereoselectively produce vinyl 
azetidines in good yields via a decarboxylative ring contraction. The 
diastereoselectivity is facilitated by rapid epimerization of the C5 stereocenter through 
π-σ-π allyl interconversion. This allows the synthesis of highly diastereoenriched 
azetidines from diastereomeric mixtures of cyclic allylic carbamates. Furthermore, in 
 iv 
the presence of Michael acceptors, the cyclic carbamates undergo tandem Michael 
addition-allylation to produce highly substituted piperidines with good 
diastereoselectivity. Moreover, we have demonstrated that vinyl benzoxazinones 
undergo decarboxylative allylation to generate a series of dihydroquinoline 
derivatives. Once again, reaction in the presence of Michael acceptors led to a formal 
decarboxylative [4+2] cycloaddition.  The analogous reaction in the presence of 
nonracemic palladium catalysts led to a highly enantioselective reaction. Lastly, a 
selenium-catalyzed oxidative halogenation of carbonyl compounds was developed. 
Interestingly, phenylselenides were found to be efficient and selective catalysts that 
enhance the electrophilicity of oxidized halogen sources such as NCS toward 
α–halogenation of carbonyl containing compounds such as ketones, β-ketoesters, and 
even α,β-unsaturated ketones. In most cases, monohalogenated products were 
generated exclusively. 
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Chapter 1 
 
Ruthenium-Catalyzed Decarboxylative Insertion of Michael Acceptors into Allyl 
Ketoesters 
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1.1 Overview of Ruthenium-Catalyzed Allylation Reactions 
 New methodologies for C-C bond formation have been driving progress in 
synthetic organic chemistry. Transition metals were introduced as reagents and 
catalysts in this scenario because they often allow reactions to proceed under mild 
conditions and with high functional group compatibility. Furthermore, transition 
metal complex-catalyzed reactions are often highly chemoselective, regioelective and 
stereoselective, so they have found wide applications in modern synthesis.1 Also of 
note here is that transition metal functions by either activating the reactants or by 
stabilizing the high energy transition state and product through coordination.2  
 Palladium and ruthenium-catalyzed allylic alkylations have attracted many 
research groups’ interest across the world. Possibly one of the most remarkable 
examples is the Tsuji-Trost allylation reaction,3, 4 which has been extensively explored 
and generated thousands of references since its discovery in 1965. The general 
reaction scheme and mechanism are shown in Scheme 1. The reaction starts by 
coordination of the Pd(0) catalyst to the allylic substrate 1a, followed by nucleophilic 
displacement of the leaving group to generate a π-allylpalladium complex 1c, which 
undergoes nucleophilic substitution to generate the allylation product 1f. Trost 
proposed two different mechanisms, depending on the nature of the nucleophiles.5 
With hard nucleophiles, the reaction was thought to proceed by ligand exchanging 
 3 
first, followed by reductive elimination to give the product 1h with reversed 
stereochemistry; while the soft nucleophiles attack the π-allyl unit directly in the 
sense of SN2 reaction, during which double inversion generates the product 1i with 
overall retention stereochemistry. 
Scheme 1 Tsuji-Trost allylation reaction 
X X=OAc, Br, OCO2MeNuc Pd(0)Ln NucR R
Nuc
1b
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XR
XR
Pd(0)Ln
Pd(0)Ln 1a
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Pd(II)
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oxidative
addition
L
X
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NucR
Pd(0)Ln
NucR
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R2R1
1i Nuc
R2R1
1h Nuc
soft Nuchard Nuc
R2
hard Nuc : RMgBr, RLi etc
soft Nuc-H : CH2(CO2R)2 etc
 
 
 Palladium-catalyzed allylic alkylations normally generate linear products as 
compared to ruthenium catalysts, which afford branched products.5 Tsuji reported the 
first ruthenium catalyzed allylic alkylation in 1985 as illustrated in Scheme 2.6 The 
combination of RhH(PPh3)4 with n-butyl phosphine favored the branched product 2d, 
while the palladium catalyst generated a mixture of linear 2c and branched product 2d 
in a ratio of 73:27. 
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Scheme 2 Ruthenium-catalyzed regioselctive allylation 
OCO2CH3
CO2CH3
O
RuH2(PPh3)4
CO2CH3
O
CO2CH3
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Cat.
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61 32:68
RhH(PPh3)4/PnBu3 81 14:86
Cat Yield Ratio 2c:2d
linear 2c branched 2d2a 2b
 
 
Much early work in the field of ruthenium-catalyzed allylic alkylations was done 
by Watanabe et al. In 1993, Watanabe published their results on different ruthenium 
complex-catalyzed allylations of β-ketoesters with allylic carbonates (Scheme 3).7 A 
Ru(COD)(COT) complex was found to favor the addition of nucleophiles to the more 
substituted terminus of the Ru-allyl complex as shown in Scheme 3. The addition of 
ethyl acetoacetate 3a to cinnamyl methyl carbonate 3b is quite regioselective, 
affording exclusively the branched product. Also included are other ruthenium 
complexes, such as Ru3(CO)3, RuH2(PPh3)4, RuCl2((PPh3)2 and RuCl3; however those 
catalysts showed little or no reactivity toward allylation reaction. It was proposed that 
the regioselectivity depends on the structure of the substrates and ligands that 
coordinate to the ruthenium catalyst. For instance, the ratio of linear to branched 
product dropped to 50:50 when dimethyl or diethyl malonate were used as 
nuceleophiles instead of the ketoester.  
 5 
Scheme 3 Ru(COD)(COT) catalyzed regioselctive allylation of β-ketoesters 
O
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OEt
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Along this line, various Ru(II) catalysts were developed in order to incorporate 
heteroatom nucleophiles rather than carbon nucleophiles. For example, Cp*RuCl(cod) 
was found to catalyze allylic amination of cinnamyl methyl carbonate 3b, which 
generated the branched product 4b and linear product 4c in a ratio of 84:16 (Scheme 
4).8 
Scheme 4 [Cp*RuCl(cod)] catalyzed allylic amination 
[Ru]
84
OCO2CH3
THF, 0oC, 1h
4b 4c
Ph
N
Ph N
[Ru]= Cp*RuCl(cod)
Cp*RuBr(cod)
[Cp*RuOMe]2
[Cp*RuCl2]2
16:
84 16:
83 17:
83 17:
overall yield
99%
99%
99%
99%
NH
4a
3b
 
 
In 1999, the same Cp*RuCl(cod) catalyst was used for the allylation of thiols,9 
which were generally thought to poison transition metal catalysts due to their strong 
coordinating ability.10 This reaction was relatively regioselective and favored the 
linear allylic thioether (Scheme 5). Interestingly, under mild reaction conditions, two 
 6 
regioisomers 5a and 5b gave an identical mixture of products 5c and 5d in a ratio of 
78:22 and 95% and 77% yield respectivly. Thus, it was logically proposed that a 
π-allylruthenium complex was involved as the reactive intermediate. [CpRu(PPh3)2Cl] 
was also shown to catalyze allylation of phenols and thiols, however the 
regioselectivity was only 50:50.11 
Scheme 5 Regioselective thiol allylation 
OCO2CH3
RSH
Cp*RuCl(cod)
CH3CN, rt, 1h
SR SR
OCO2CH3
5a
5b
5c 5d
5c:5d=78 : 22R=n-C5H11
 
 
In 2002, Trost reported a stereospecific allylic alkylation with 
[Cp*Ru(NCCH3)3]PF6.12 This Ru-catalyzed allylation proved to be highly 
regioselective, favoring the branched product 6a over linear product 6b as illustrated 
in Scheme 6. The reaction conditions were generally mild, however a general solvent 
and temperature that was effective for all substrates was not found. 
Scheme 6 [Cp*Ru(NCCH3)3]PF6- catalyzed regioselecitive allylation 
LG
NaCH(CO2Me)2
LG=OCO2tBu
OCO2Me
Cl
1m% [Cp*Ru(NCCH3)3]PF6
Sol. temp
Ph
MeO2C CO2Me
Ph
CO2Me
CO2Me
acetone rt 99%
yiled
19 1:
DMF 99%rt 14 1:
DMF 99%
-40oC 110 1:
6a 6b
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 The general reaction mechanism is thought to proceed by formation of ruthenium 
π-allyl complex 7c, followed by nucleophilic attack at the more substituted allyl 
terminus to generate 7d. Decomplexation then produces allylic alkylation product 7e 
and regenerates the catalyst 7a.13 
Scheme 7 Proposed catalytic cycle 
Ru
Ru OR
OR
Ru Nuc
Ru
OR
Nuc
OR
Nuc
7a
7b
7c
7d
7e
 
 
 To investigate the stereochemical course of the Ru-catalyzed allylation, two 
diastereoisomers 8a and 8b were synthesized and allowed to react with piperidine 8c 
in the presence of 5 mol% of [CpRuCl(cod)] and 5 mol% of NH4PF6.14 The 
cis-carbonate 8a gave primarily cis-product 8d; whereas in the case of 
trans-carbonate 8b, trans-product 8e was produced predominately over 8d in a ratio 
of 98:2. This result indicates a double inversion mechanism giving rise to overall 
retention of stereochemistry, which is consistent with the stereochemical course of 
 8 
related Pd-catalyzed allylic substitutions.15 
Scheme 8 Stereochemical course of Ru-catalyzed allylation 
CO2Me
OCO2Me NH
CpRuCl(cod)
NH4PF6
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CO2Me
N
CO2Me
N
95 5
67%
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N
CO2Me
N
98%
8a 8d 8e
:
2 98:
8b 8d 8e
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Our research group has been interested in extending the utility of the above 
transformations to the use of ketone enolates using transition metal-catalyzed 
decarboxylative allylation. For instance, Erin showed that allyl β-ketoesters 9a 
combined with a [Cp*Ru(bpy)Cl] catalyst undergo regioselective allylation to form 
γ,δ-unsaturated ketones 9b under neutral conditions (Scheme 9).16 To be noted here is 
that non-stabilized ketone enolates were formed under extremely mild reaction 
conditions compared to the traditional methods of generating ketone enolates using 
strong bases such as lithium diisopropylamide. As expected, Ru-catalyzed allylic 
alkylation favors the branched products 9b, and in most cases, the regioselectivity 
was over 19:1. 
 
 9 
Scheme 9 Synthesis of γ,δ-unsaturated ketones from allyl β-ketoesters 
R1 O
O O
R2
10m% [Cp*Ru(bpy)Cl]
CH2Cl2, rt
-CO2
R1
O
R2
81-96% yield
9a 9b
 
 
1.2 Palladium-Catalyzed Decarboxylative Generation of Enolate Nucleophiles 
1.2.1 Palladium-Catalyzed Decarboxylative Generation of Enolate Nucleophiles 
 The concept of differing reactivity of “hard” and “soft” nucleophiles with 
palladium π-allyl complexes was introduced in 1996 by Trost et al.5 “Soft” 
nucleophiles refer to those resulting from conjugated acids with a pKa less than 25; 
whereas “hard” nucleophiles are defined as those, whose conjugated acids have a pKa 
that is greater than 25. Those nucleophiles are also called non-stabilized nucleophiles. 
The two types of nucleophiles react differently with non-stabilized nucleophiles 
coordinating to the metals before nucleophilic attack, while stabilized nucleophiles 
attack the π-allyl species directly. 
 Allylation of non-stabilized nucleophiles, for example ketone enolates, was 
traditionally carried out in the presence of a strong base, which limits its synthetic 
utility if the substrate contains base-labile functional groups or multiple enolizable 
hydrogens. As such, methodology performed under non-basic conditions would be 
highly desirable. Interestingly, allyl β-ketoesters, upon treatment with palladium 
 10 
generate ketone enolates under extremely mild conditions. Pioneering work in this 
field was done by Tsuji and Saegusa.17-20 
 In 1980, Saegusa reported a facile Pd-catalyzed decarboxylative allylation with 
allyl cyclohexanone-2-carboxylate 10a as shown in Scheme 10.17 A Pd(II) enolate 
intermediate 10c was thought to be involved in the course of this reaction. 
Scheme 10 Pd-catalyzed decarboxylative allylation with cyclic allyl β-ketoesters 
O
O
O
5 mol% Pd(PPh3)4
DMF, rt
O
CO2
96%10a 10b
OPd
10c
 
 
 Following that, Tsuji further investigated the ligand effects and reported a 
Pd-catalyzed decarboxylation-dehydrogenation to produce various α,β-unsaturated 
ketones 11c (Scheme 11).18 A bidentate phosphine ligand, diphenylphosphino 
ferrocene (dppf), combined with a Pd catalyst precursor produced mainly enone 
products 11c in refluxing acetonitrile. In contrast, triphenylphosphine ligand gave the 
decarboxylative allylation product 11b. Protonated product 11d was formed in the 
presence of ammonium formate, which further enriched the synthetic utility of allyl 
β-ketoesters. Noteworthy is that solvents also play a key role here and it has been 
shown that aprotic solvents such as DMF and acetonitrile favor the formation of 
enones. On the other hand, allylation occurred in t-butyl alcohol. Interestingly, the 
 11 
presence of an α-substituent R is crucial for the formation of 11c. For example, 
allylation product 11b was formed in almost equal amount as well as double 
allylation products when R equals to hydrogen. 
Scheme 11 Pd-catalyzed decarboxylation-dehydrogenation 
O
O
ORO R
Pd-PPh3 Pd-dppf
CH3CN
O
R
PdCl2(PPh3)2
O
R
HCO2NH4
Dioxane
11a11b 11c
11d
DMF
 
 
 Furthermore, acyclic allyl β-ketoesters 12a have been shown to undergo a 
regioselective decarboxylative allylation smoothly, producing the γ,δ-unsaturated 
ketone products 12e through nucleophilic attack at the less substituted terminus of the 
Pd-allyl complex 12d (Scheme 12).19 Also of note is that regioisomeric reactant, 12b, 
gave the identical linear olefin products 12e as expected for a reaction involving a 
π-allylpalladium intermediate 12d. 
 
 
 
 
 12 
 Scheme 12 Acyclic substrates for decarboxylative allylation 
R
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 In addition to ketoesters, starting materials with other electron-withdrawing 
groups (EWG), such as ester, nitrile, and nitro were also investigated (Scheme 12),20 
however, malonate and cyanoacetate substrates were somewhat less reactive than the 
corresponding carbonyl substrates 12a, and consequently higher temperatures were 
required. For instance, when the EWG was CO2Me, decarboxylative allylation was 
carried out in refluxing dioxane or DMF, affording product 12g in 75% yield. 
Scheme 13 Asymmetric allylic alkylation (AAA) 
5 mol% Pd2(dba)3
10 mol% Trost ligand
O
O O
R
CH2Cl2, 25 oC
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O
R
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R R
R O
O O
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R
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H
N
H
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13a
13b
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 In 2004, Burger and Tunge reported an asymmetric allylic alkylation (AAA) of 
non-stabilized ketone enolates catalyzed by a combination of 5 mol% Pd2(dba)3 and 
10 mol% Trost ligand 13e as illustrated in Scheme 13.21 The allylation products 13c 
and 13d were obtained in excellent enantioselectivity. Also included in this report was 
a crossover experiment, conducted to investigate whether the decarboxylative 
allylation occurred intra- or intermolecularly (Scheme 14). Treatment of a mixture of 
substrates 14a and 14b with the standard reaction conditions afforded almost equal 
quantities of all four possible products. This result seems to indicate that freely 
diffusing enolates (or enolate precursors) and π-allylpalladium species 14c were 
generated during the course of the reaction. This phenomenon was also noted by 
others, consequently intramolecular trapping of the generated enolates with aldehydes 
was reported.22 
Scheme 14 Crossover experiment 
Et O
O O
Me O
O O
36%
64%
5 mol% Pd2(dba)3
10 mol% 15e
C6D6
Et
O
Me
O
Et
O
Me
O
19% 97:3 er17%
19% 45% 99:1 er
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14b
R
O Pd
R
14c
 
 
1.2.2 Multiple Transformations Via Palladium Enolate Chemistry 
 Palladium enolates have been postulated as important intermediates in the 
 14 
decarboxylative allylic alkylation of β-ketoesters (Scheme 15).17 In their subsequent 
study, Tsuji reported the first intramolecular aldol reaction of palladium enolates with 
aldehydes under non-basic conditions.22 Oxidative addition of allyl β-ketoesters 15a 
to Pd(0), followed by decarboxylation generated a Pd(II) enolate 15c, which 
underwent an intramolecular aldol reaction to smoothly produce 15d. Aldol products 
15b were obtained in good to excellent yield. The regeneration of the palladium 
catalyst from intermediate 15d was unfortunately not addressed by this report. 
Scheme 15 Intramolecular aldol reaction with allyl β-ketoesters 
n
n=1,2,4,8
O
O
O
CHO
5 mol% Pd(OAc)2
10 mol% PPh3
CH3CN, rt to 65 oC
O
n
OH
n
O
CHO
Pd
O
n
O Pd
15a 15b
15c 15d
yield 69-90%
 
 Various α, β-unsaturated ketones tethered to allyl β-ketoesters were also shown to 
react with palladium enolates, generated by decarboxylation of allyl β-ketoesters to 
produce cyclic Michael adducts 16d (Scheme 16).23 Also included in this report was a 
brief screening of reaction conditions to optimize the yield of Michael adducts 16d. It 
was found that treatment of 16a with catalytic amount of Pd(PPh3)4 in CH3CN at 
room temperature generated exclusively the Michael product 16d by protonation of  
intermediate 16c, while the Michael addition/allylation product 16e and the Michael 
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addition/β-hydride elimination product 16f were formed as minor products under 
other conditions. This reaction was proposed to go through a similar pathway as the 
intramolecular aldol reaction shown in Scheme 15. 
Scheme 16 Intramolecular Michael Addition with allyl β-ketoesters 
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 Even though those Pd-enolates have been shown to undergo intramolecular 
nucleophilic additions to aldehydes and enones, the intermolecular version is 
problematic due to the competitive decarboxylative allylic alkylations.24 In this regard, 
a hetero-bimetallic catalyst complex was shown to efficiently catalyze the 
intermolecular decarboxylative aldol reaction of allyl β–ketoesters with aldehydes as 
shown in Scheme 17.25 The incorporation of a metal salt YbCl3 was thought to 
promote either the formation of metal enolates or nucleophilic additions by increasing 
the eletrophilicity of aldehydes. Interestingly, it was necessary to adopt two 
equivalents of allyl β–ketoesters 17a to aldehydes 17b in order to achieve high yield 
of aldol products. Based on their results, Schaus suggested that the second equivalent 
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allyl β–ketoester reacted with intermediate 17d to give aldol product 17c and a metal 
enolate 17e, which undergoes allylation to regenerate the Pd(0) catalyst. This 
hypothesis was supported by separation of a stoichiometric amount allylic alkylation 
product 17g. 
Scheme 17 Heterobimetallic-catalyzed decarboxylative aldol reaction 
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 In addition, electron-poor olefins were also compatible with the above reaction 
protocol. It has been shown that electron poor olefins such as benzylidene 
malononitrile 18c, react with allyl β–ketoester 18a in the presence of Pd(PPh3)4 to 
generate 18d in high yield (Scheme 18).26 Michael addition of an oxygen-bonded 
palladium enolate 18d to activated olefin 18c produce an intermediate 18d, which, 
upon allylation finishes this cascade reaction.27, 28 However, the substrate scope was 
not well addressed in this paper, and allyl β–ketoester 18a with an unsubstituted 
alkene unit was the only one used in their reactions. 
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Scheme 18 Pd-catalyzed intermolecular Michael addition with activated olefins 
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 In conclusion, transition metal-catalyzed allylic alkylation has proven to be an 
important and convenient tool for organic synthesis, which is still a “hot” topic, and 
finds many applications in natural products synthesis.29-33 Yet, despite the significant 
attention directed toward catalytic allylic alkylation, many challenges still exist. 
 
1.3 Ruthenium-Catalyzed Tandem Michael Addition-Allylation 
 The desire to rapidly generate complex molecules has driven the search for new 
catalytic processes that effect multiple transformations in one pot. Notable recent 
examples include tandem cyclization-arylation,34 allyllation/Pauson-Khand,35 and 
olefin metathesis-hydrogenation.36 All those transformations rely on the ability of a 
transition metal to catalyze two distinct sequential transformations. On the other hand, 
a bifunctional catalyst that can simultaneously activate two components of a reaction 
mixture toward reaction with a third should facilitate multiple concurrent 
bond-forming reaction with high atomic economy.37 
 During our investigation on transition metal-catalyzed decarboxylative allylation 
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of allyl β–ketoesters, namely the Carroll rearrangement, we and other have shown 
that transition metals play two functions, catalyzing the decarboxylative formation of 
enolate nucleophiles and activating the electrophilic allyl fragment toward 
nucleophilic substitution.16, 38, 39 In this regard, a [Cp*Ru(bpy)Cl] complex was 
shown to catalyze the decarboxylative allylation regioselectively, favoring the 
branched product (Scheme 9).16 A crossover experiment was carried out to elucidate 
the reaction mechanism. Allyl β-ketoesters 19a and 19b were prepared and upon 
treatment with 10 mol% [Cp*Ru(bpy)Cl], all four possible products were formed in a 
statistical yield (Scheme 19). This result seems to suggest that allyl β-ketoesters are 
sources of freely diffusing enolates and allylic cations. 
Scheme 19 Cross-over experiment 
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 Consequently, we were curious whether those enolate intermediates could be 
trapped by appropriate reactant. As mentioned above, the enolates generated by 
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Pd-catalyzed decarboxylation have been intramolecularly intercepted by aldehydes 
and Michael acceptors.22, 23 However, the intermolecular version seems to be 
problematic due to the competing allylation. Recent focus has been directed toward 
this end. To recap, Schaus reported an intermolecular aldol reaction using a 
hetero-bimetallic catalyst system (Scheme 17)25 and Yamamoto found that 
electron-poor olefins such as benzylidene malononitrile can intercept palladium 
enolates and undergo intermolecular Michael addition reactions.26 
1.3.1 Transition-metal Directed Aldol Reaction 
 Based on those precedents with Pd-enolates chemistry, we decided to investigate 
the tandem Michael addition-allylation of pronucleophiles under the conditions for 
Ru-catalyzed decarboxylative allylation.16 First, different aldehydes were studied 
since the aldol adducts are synthetically useful. It has been found that 
α,α-disubstitution of the β-ketoester starting materials slows the Carroll 
rearrangement and consequently, the rearrangement requires higher temperature.40 
The hypothesis here is that, if the competing allylic alkylation is slow, then the 
generated Pd-enolates could be possibly trapped by aldehydes.  To test this 
hypothesis, disubstituted β-ketoester 20a was prepared and treated with a catalytic 
amount of Pd(PPh3)4 in the presence of five equivalents of benzaldehyde (Scheme 20). 
However, neither the decarboxylative allylation product nor the aldol adducts formed. 
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Instead, the competing elimination product 20b and protonated enolate 20c were 
formed exclusively. 
Scheme 20 Pd-enolate directed aldol reaction 
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 Following that, starting material 19a was synthesized and allowed to react with 
benzaldehyde in the presence of palladium catalyst. Unfortunately, the linear 
decarboxylative allylic alkylation product 21b was produced. Similarly, when a 
ruthenium complex was employed as the catalyst, the branched allylation product 21c 
was formed and no aldol reaction products were observed (Scheme 21). 
Scheme 21 Pd-enolate directed aldol reaction 
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 In the light of Schaus’ strategy,25 Lewis acids were also incorporated as a 
cocatalyst in an attempt to activate aldehydes toward nucleophilic addition. However 
both ZnCl2 and YbCl3, which were shown to be the most effective Lewis acids by 
Schaus, failed in our case and only decarboxylative allylation products, such as 21c, 
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24a-b were produced as shown in Scheme 22. The possible reason could be either 
that the Lewis acids were not compatible with the ruthenium catalyst complex or that 
the Lewis acids did not activate the aldehyde enough to be trapped by the enolate 
intermediates. Besides, other solvents, such as THF, CH3CN and CH2Cl2 were used, 
and it was found that solvent effects were negligible. In most case, decarboxylative 
allylation products were formed as the major products, even though in some cases, 
trace amounts of aldol adducts were generated. As to substrate 22a, a combination of 
palladium with different phosphine ligands and Lewis acids were also studied. 
Surprisingly, no reaction occurred and the starting material stayed intact over the 
course of the reaction. 
Scheme 22 Attempted use of Lewis acids to facilitate a directed aldol reaction 
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 Even though standard allyl β-ketoesters did not undergo intermolecular aldol 
reactions, silyl β-ketoester 25a showed interesting reactivity toward benzaldehyde 
(Scheme23). With the ruthenium complex, only 65% of the starting material 25a 
underwent decarboxylation after 48 hours and small amount of the aldol product 25b 
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was formed along with by-products; whereas Pd(PPh3)4 has shown super catalytic 
activity, the decarboxylation completed in 10 minutes and the aldol adduct 25b was 
generated cleanly in one hour (95% NMR yield). 
Scheme 23 Pd-enolate directed aldol reaction with silyl β-ketoester 
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 The successful aldol reaction can be rationalized as follows. The expected 
oxidative addition reaction would produce π-allylpalladium complex 26a which 
undergoes a desilylation reaction to generate 1,3-butadiene and intermediate 26b, 
which was supported by the formation of a new proton signal at 3.5 ppm in the 1H 
NMR spectrum of the reaction mixture. Aldol reaction generates intermediate 26c, 
which then undergoes intramolecular silyl transfter, followed by decarboxylation to 
furnish product 25b as shown in Scheme 24. 
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Scheme 24 Possible pathways 
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1.3.2 Transition Metal-Catalyzed Michael Addition-Allylation Reactions 
 It has been shown that Michael additions to electron-poor olefins (RCH=CZ2) 
generate stabilized nucleophiles, which are well known to undergo transition metal 
facilitated allylic alkylation. Thus, we expected that ruthenium would be a competent 
catalyst for a tandem Michael addition-allylation reaction.  Fortunately, benzylidene 
malononitrile smoothly reacted with the unsubstituted allyl β–ketoesters 22a under 
the condition of previously developed for catalytic Carroll-type rearrangement, 
affording the desired product 27a in high yield as shown in Scheme 25.41 Thus, 
activated Michael acceptors are ideally set up to undergo tandem enolate addition and 
allylation. Furthermore, it was envisioned the regiochemistry of allylation could be 
controlled by the appropriate choice of the transition metal catalyst.12, 42 
Scheme 25 Reaction conditions for decarboxylative olefin insertion 
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 To begin, a range of Michael acceptors were investigated to test their 
compatibility with the above reaction conditions. Based on the screening results, it 
was found that the electrophilicity of the Michael acceptors/electrophile is crucial for 
the successful decarboxylative olefin insertion. The unsuccessful Michael acceptors 
28b are shown in Scheme 26. Except for DMAD, a strong π-acid known to 
deactivating the transition metal catalysts through coordination, all other Michael 
acceptors did not undergo the tandem Michael addition-allylation reactions and the 
Carroll rearrangement products 28c were formed exclusively. 
Scheme 26 Unsuccessful Michael acceptors 
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 After that, our attention was focused on the benzylidene malononitrile derivatives, 
which have been shown to efficiently trap the Pd-enolates as illustrated previously in 
Scheme 27. Various β-ketoesters and malononitriles were prepared. Interestingly, the 
electronics of the malononitrile are crucial to the success of the decarboxylative 
insertion. When p-hydroxybenzylidene malononitrile (electrophilicity, E= -10.8)43 
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was employed as the electrophile, Michael addition-allylation product 29a was 
obtained in <5% yield, in which the decarboxylation-allylation product was formed 
exclusively (Scheme 27). This issue was addressed by simply acylation of the 
hydroxyl group and in that case, Michael addition-allylation product 27b was 
obtained in 97% isolated yield.43 
Scheme 27 Effects of the electrophilicity of Michael acceptors 
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 The most successful reactions achieved were those with olefins containing two 
electron-withdrawing groups, which is consistent with their electrophilicity 
parameters (18c, Ar=Ph, E= -9.42).43 Also shown in Scheme 27 is a Meldrum’s acid 
derivative 29b that is an effective Michael acceptor, showing that activated diesters 
are also viable reaction partners. Yamamoto has shown that Michael acceptors with 
acyclic diesters do not undergo tandem Michael addition-allylation reactions under 
palladium catalysis, which was attributed to lack of coplanarity of the two esters due 
to the sterics.26 Whereas in the case of Meldrum’s acid derivative 29b, the 
six-membered ring helps to lock the coplanarity of the ester groups, enhancing the 
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electrophilicity of the olefin. 
 Next, we turned our attention to developing the first regioselective tandem 
Michael addition-allylic alkylation of activated Michael acceptors. It was gratifying to 
find that treatment of 30a with benzylidene malononitrile, 2.5 mol % [Cp*RuCl]4, 
and 10 mol % bipyridine at room temperature in methylene chloride produced 27c in 
high yield (89%) and over 19:1 regioselectivity (dr = 1.9:1) (Scheme 28). The 
analogous palladium-catalyzed reaction produced the opposite regioisomer 30b in 
80% yield. The regioselectivities for ruthenium and palladium catalysts are consistent 
with those observed for other allylation reactions.5, 12, 26 
Scheme 28 Catalyst-dependent regioselectivity 
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 A variety of allyl β-ketoesters undergo smooth decarboxylative coupling with 
Michael acceptors (Table 1). Variation of the R1 group shows that the reaction is 
typified by regiospecific formation of enolates (Scheme 28). Of note here is that the 
diastereoselectivity of products 27c and 27i, formed from the unsubstituted allyl 
partners are generally higher than those synthesized from the other regioisomers. This 
observation is interesting and deserves further attention. It is noteworthy that 
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equilibration of the kinetic enolate does not occur even when R1 is benzyl and there is 
a large thermodynamic driving force favoring the formation of the stabilized enolate. 
In fact, previous attempts to generate the terminal enolate of phenylacetone by 
deprotonation have failed.44, 45 
Table 1 Yields of tandem ruthenium-catalyzed Michael addition-allylations 
R1 R2 Time (h)a % Yield
(dr)b
Me 2 84
Me 5 97
Me 12 89(1.9:1)
Me 6 85(3.5:1)
Bn 4.5 87
Me 18 62(1.6:1)
Me 19 62(1.8:1)
48
Prod.
27a
27b
27c
27c
27d
27g
27h
R1 O
O O
R4
CN
CN
R2
27c
R3
R1
O R4
R3 R2
CN
CN
CH2Cl2, rt
10 mol% Cp*Ru(bpy)Cl
H
H
Ph
H
H
H
H
R3
H
H
H
Ph
H
p-C6H4OMe
p-C6H4OCl
R4
Ph
p-C6H4OAc
Ph
Ph
Ph
Ph
Ph
Ph 5.5 6427eH H Ph
Et 22 93(1.8:1)27fPh H Ph
Me Ph H p-C6H4OAc 27i 92(2.7:1)
16Me H p-C6H4OAc 27i 76(4.5:1)Ph
R1
O R4
R2 R3
CN
CNor
 
 
a
 Unless otherwise mentioned, the reaction was carried out with allyl β-ketoester (0.2 M), 
Michael acceptor (0.2 M), [Cp*RuCl]4 (0.005 M), and bpy (0.02 M) in CH2Cl2 at room 
temperature. b Isolated yield after column chromatography. c The branched product was formed 
exclusively, with references to the size of substituent s R2 and R3. 
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 For the reason of comparison, two allyl β-ketoesters were treated with 10 mol% 
Pd(PPh3)4 in the presence of one equivalent Michael acceptors, affording the opposite 
regioisomers 30b, 30c in high yield (Table 2). 
Table 2 Yields of Pd-catalyzed tandem Michael addition-allylation 
R1 O
O O
R4
CN
CN
R2
30
R1
O R4
R2
CN
CN
CH2Cl2, rt
10 mol%Pd(PPh3)4
R1 R2 Prod.R4
13Me Ph Ph 30b 80
17Et Ph Ph 30c 88
Time (h)a % Yieldb
 
 
a
 Unless otherwise mentioned, the reaction was carried out with allyl β-ketoester (0.2 M), 
Michael acceptor (0.2 M) and Pd(PPh3)4 (0.02 M) in CH2Cl2 at room temperature. b Isolated yield 
after column chromatography. 
 
 One application of the tandem Michael addition-allylation reaction protocol was 
found in the modification of coumarin derivatives, and product 31b was obtained in 
45% yield; however the product was formed cleanly based on 1H NMR spectrum. 
This could serve as a rapid way for modifying coumarin, which is the core structure 
of many biologically active compounds.46, 47 Also shown in Table 3 is a Meldrum’s 
acid derivative, which functions as efficient Michael acceptors to furnish products 
31a and 31c in good yields. Of note here is that the formation of product 31c was 
catalyzed by Pd(PPh3)4; whereas when [Cp*Ru(bpy)Cl] was employed as the catalyst, 
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the Carroll rearrangement product was produced as the major one. This is possibly 
due to the steric hindrance of cyclopentene ring but it illustrates the trend that 
palladium catalysts are generally more active toward tandem Michael 
addition-allylation than the corresponding ruthenium catalysts. This hypothesis was 
further supported by the longer reaction times when [Cp*Ru(bpy)Cl] catalyst was 
adopted as the catalyst, comparing with that of Pd catalyst. For example, product 31c 
was formed in 12 hours with Pd(PPh3)4; while with [Cp*Ru(bpy)Cl] catalyst, the 
reaction did not go to completion even after 180 hours. It is noteworthy that the 
diastereoselectivity of addition to the cyclic Michael acceptor is much higher than 
that observed for benzylidene malononitrile derivatives, in which a less constrained 
transition state is involved (Table 1). 
Table 3 Yields of tandem Michael addition-allylation of other Michael acceptors 
R1 O
O O
R
Z
Z
31
R1
O R
Z
Z
CH2Cl2, rt
R1 Time (h)a % Yield
(dr)b
Me 1.5 51
Prod.
31a
10 mol% Cp*Ru(bpy)Cl
Michael
acceptor
O O
CN
Me 2 45
(12:1)
31b
O
O
O
O
Ph
R2
H
R3
H
R3R2 R3R2
H H
Me 1.5 65
(5.5:1)
31cc
O
O
O
O
Ph
 
a
 Unless otherwise mentioned, the reaction was carried out with allyl β-ketoester (0.2 M), 
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Michael acceptor (0.2 M) and [Cp*RuCl]4 (0.005 M), and bpy (0.02 M) in CH2Cl2 at room 
temperature. b Isolated yield after column chromatography. c using 10 mol% Pd(PPh3)4. 
 
 Following that, more diesters and β-ketoester derivatives were investigated and 
the results are summarized in Scheme 29. In the presence of a [Cp*Ru(bpy)Cl] 
catalyst, allyl β–ketoesters 30a reacted with three equivalents of Meldrum’s acid 
derivative 29b, affording a mixture of Michael addition-allylation product 32a and 
Carroll rearrangement product 32b in a ratio of 1.2:1. We propose that the bulky 
styrene unit accounts for the lower selectivity, similar to cyclopentene derivative 
mentioned above. Since cyanocoumarin has shown to be effective Michael acceptors, 
3-acetyl coumarin 32c was also examined as a partner for decarboxylative olefin 
insertion; however the Carroll rearrangement products were formed instead. 
Scheme 29 Tandem Michael addition-allylation with lower chemoselectivity 
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 While we expected that the above reactions involved π-allyl ruthenium 
intermediates, this was confirmed by the reactions of regioisomeric allyl β-ketoesters 
33a and 30a which give the same product 27c (Scheme 30). Thus the reaction 
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regiospecifically generates enolates followed by regioselective allylation. 
Interestingly, the less substituted olefin reactant 33a provides product more rapidly. 
Consistent with this trend, the unsubstituted allyl partners generally react most 
quickly. This implies that coordination of the alkene to ruthenium may be important 
prior to, or in, the rate-limiting step. 
Scheme 30 Regioselective allylation 
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 Our group has a long-standing interest in decarboxylative allylation reactions. In 
2005, Dinesh reported a decarboxylative allyl-acetylide coupling of 34a to form 
1,4-enyne product 34b, in which a palladium-allyl-acetylide intermediate 34f was 
thought to be involved as shown in Scheme 31.48 Consequently, we were curious 
whether the Pd-acetylide intermediate can be trapped by Michael acceptors. However, 
treatment of the propiolate ester 34a with benzylidene malononitrile 18c yielded a 
mixture of products 34c and 34b in almost 1:1 ratio. Phenyl propiolic acid 34d was 
also studied in this context, in which palladium acetate was employed as the catalyst 
to facilitate the generation of a Pd-acetylide intermediate 34g. Surprisingly, reductive 
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elimination occurred predominantly over insertion reaction, and Pd black was formed 
along with acetic acid which in turn supported the formation of proposed intermediate 
34g. The product structure was tentatively assigned as 34e. 
Scheme 31 Tandem Michael addition-allylation with Pd-acetylide intermediate 
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 To further expand our tandem Michael addition-allylation, a three-component 
coupling reaction was investigated (Scheme 32).  Here toluene was chosen as the 
solvent because of the need for in situ formation of allyl β–ketoester 35b. Interesting, 
the linear product 35c was produced with a pair of diastereotopic protons signal at 2.6 
and 2.7 ppm, along with unreacted starting material 35b in a ratio of 0.6:1. The 
reaction was also carried out with Pd(PPh3)4 as the catalyst, in which a messy mixture 
was generated with recovery of cinnamyl alcohol.  
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Scheme 32 Three components coupling reactions 
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 Finally, to illustrate the utility of the benzylidene diester electrophiles, we 
performed a simple hydrolysis and decarboxylation of 31a (Scheme 33). Products like 
the resulting γ,δ-unsaturated acid 36a, are particularly useful substrates for 
halolactonizations.49 
Scheme 33 Utility of the benzylidene Meldrum’s derivatives 
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 Another noteworthy application could be found in the rapid synthesis of 
polycyclic tropane alkaloid precursor 37d. Michael acceptor 37a bearing a nitro 
group was prepared and reacted with allyl-β-ketoester 22a to form the insertion 
product 37b, which was partially reduced to hydroxyl amine followed by cyclization 
to generate nitrone product 37c. Upon refluxing in toluene, intramolecular [3+2] 
cycloaddition afforded the polycyclic ring system.50, 51 The efficient ring construction 
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strategy was not followed up due to time constraints. 
Scheme 34 Tropane alkaloid ring synthesis 
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 The tandem Michael addition-allylic alkylations involved in all of the above 
reactions are thought to start by oxidative addition the allylic ester, followed by 
decarboxylation to generate freely diffusing enolates 38b and π-allyl species 38c 
(Scheme 35). The addition enolates to activated Michael acceptors (RCH=C(EWG)2) 
produces stabilized enolates 38d, which are well-known nucleophiles for 
metal-catalyzed allylic substitution to produce product 38e and regenerate the 
catalyst.5 
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Scheme 35 Catalytic cycle of Tandem Michael addition-allylation 
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 In conclusion, we have developed a regioselective, catalytic coupling of enolates, 
Michael acceptors, and allyl electrophiles. The tandem Michael addition-allylation is 
made possible by the decarboxylative activation of allyl β-ketoesters to produce 
enolates and π-allyl metal electrophiles. We are currently exploring similar reactions 
that exploit our ability to regiospecifically generate enolates from β-keto esters at 
room temperature under base-free conditions. 
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General Experimental  
 
THF was dried over sodium metal. Toluene, methylene chloride and diethyl 
ether were dried over activated alumina on a solvent system purchased from 
Innovative Technology, Inc.1 Acetonitrile and 1,4-dioxane were dried and stored over 
activated molecular sieves. Commercially available reagents were used without 
additional purification unless otherwise stated. Products were purified on silica gel 
from Sorbent Technologies (230x400 mesh, 60 Å porosity, pH 6.5-7.5). Ruthenium 
and palladium compounds were obtained from Strem. Thin layer chromatography 
was performed on silica gel 60F254 plates (EM-5715-7, EMD chemicals). UV lamp 
(254 nm) or KMnO4 stain were used for monitoring TLC plates. 
1H and 13C NMR spectra were obtained on a Bruker Avance 400 or Bruker 
Avance 500 DRX spectrometer and referenced to residual protio solvent signals.  
Structural assignments are based on 1H, 13C, DEPT-135, COSY, and HMQC 
spectroscopies and X-ray data. High resolution mass spectrometry was performed on 
an AUTOSPEC-Q tandem hybrid mass spectrometer (VG Analytical Ltd, 
Manchester, UK). High resolution mass spectrometry was performed on a LCT 
Premier (Waters Corp., Milford MA) time of flight mass spectrometer. FTIR spectra 
were acquired on a Shimadzu FTIR-8400S spectrometer. HPLC analysis was 
performed on a Shimadzu SCL-10A VP instrument. 
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 Preparation of Starting Materials 
Generally, allyl β-ketoesters were synthesized by the DMAP catalyzed 
coupling reaction between commercially available allylic alcohols with diketene, 
followed by purification via flash column chromatography when R1 equals to methyl 
group. (SiO2, 7:1 hexane: ethyl acetate).2 
O
O OH
R1
R2
R3
O
O
O
R2
R310 mol% DMAP
Et2O, rt+
 
 
For silyl allyl β-ketoester 25a, the allylic alcohol was prepared,3 followed by 
coupling with diketene.2 To a solution of propargyl triethylsilane (500 mg, 4.4 mmol) 
in 5 mL THF at -78 oC under argon was added n-butyl lithium (4.9 mmol, 1.1 eq.) 
dropwise, and the reaction mixture was stirred at -78 oC for 0.5 hour before adding 
paraformaldehyde  (4.9 mmol, 1.1 eq.) portion wise. The mixture was warmed to 
room temperature and kept stirring overnight. The reaction was quenched with sat. 
NH4Cl solution, extracted with EtOAc. The organic phase was washed with brine, 
dried over MgSO4 and concentrated to give the crude product, which was taken to the 
next step without further purification. 
To a solution of LAH (340 mg, 8.8 mmol, 2.0 eq.) in 15 mL THF under argon 
was slowly added a solution of crude alkyne (4.4 mmol) in 5 mL THF via cannulation. 
The reaction mixture was then heated to reflux for 1hr, followed by quenching with 
water which was monitored by the release of hydrogen. The resulting mixture was 
filtered over a celite pad, dried over MgSO4 and the solvent was removed to afford 
the corresponding allylic alcohol. 
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To a solution of the allylic alcohol (225 mg, 1.6 mmol) in 10 mL ether under 
argon was added diketene in one protion (1.8 mmol, 1.1 eq.), followed by DMAP 
(17.6 mg, 0.16 mmol, 0.1 eq). The reation mixture was kept stirring until reaction 
completion indicated by TLC (generally 1.5 hr). The reaction was quenched with sat. 
NH4Cl solution, extracted with ether. The organic phase was washed with brine, dried 
over MgSO4 and concentrated to give the crude product, which was purified by flash 
column chromatography (SiO2, 10:1 hexane: ethyl acetate). 
25a
TMS BuLi, (CHO)n TMS
HO
LAH
HO
TMS
HO
TMS O
O DMAP, ether
rt
O
O O
TMS
THF, -78 oC THF, rt
96% yield
 
If R1 is a group other than methyl, then the allyl β-ketoesters were synthesized 
by the condensation of the corresponding acid chloride with Meldrum’s acid,4 
followed by addition of the appropriate allylic alcohol.5 
To a solution of the Meldrum’s acid (1.5 g, 10.4 mmol) in 20 mL 
dichloromethane at 0 oC under argon was added pyridine (26.0 mmol, 2.5 eq.) over 5 
mins, followed by propionyl chloride (10.4 mmol, 1.0 eq.) over 20 mins. The 
resulting orange mixture was kept stirring until reaction completion indicated by TLC 
(generally 12 hrs). The reaction mixture was poured to a mixture of  ice and HCl (2 
M/L), extracted with dichloromethane, dried over MgSO4 and concentrated to give 
the crude product, which was purified by flash column chromatography (SiO2, 8:1 
hexane: ethyl acetate). 
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O O
OO
R1 Cl
O
+
O
O
O
O
HO
R1
HO Ph
Toluene, reflux, 12 hrs
R1= Et, Bn, Ph
pyridine
0 °C to RT, 12 hr
R1 O
O O
Ph
 
 
General procedure for ruthenium-catalyzed tandem Michael-allylation: 
 
In a Schlenk tube under argon, [Cp*RuCl]4 (2.5 mol %), bipyridine (10 mol 
%), allyl β-ketoester (1 mmol) and malonitrile (1 equiv.) were dissolved in 5 mL of 
methylene chloride. The resulting deep purple solution was stirred at room 
temperature under Ar. The reaction was monitored by TLC. Following solvent 
evaporation the crude product was purified via flash chromatography (SiO2, 6:1 
hexane: ethyl acetate), providing the products in > 95% purity as determined by 1H 
NMR spectroscopy. 
General procedure for the palladium-catalyzed tandem Michael-allylation: 
 
In a Schlenk tube under argon, Pd(PPh3)4 (10 mol %), allyl β-ketoester (1 
mmol) and malonitrile (1 equiv.) were dissolved in 5 mL of methylene chloride. The 
resulting yellow solution was stirred at room temperature under Ar. The reaction was 
monitored by TLC. Following solvent evaporation the crude product was purified via 
flash chromatography (SiO2, 6:1 hexane: ethyl acetate), providing the products in > 
95% purity as determined by 1H NMR spectroscopy 
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Spectroscopic Data  
O
O O
TMS
(E)-4-(trimethylsilyl)but-2-enyl 3-oxobutanoate
 
27a (cw1067) 
colorless oil 
 
1H NMR (400 MHz, CDCl3) δ ppm 12.08 (0.1 H, br. S.: CH(OH)=), 5.85 (1H, ddd, 
J=15.2, 8.3, 8.2 Hz: TMSCH2CH=), 5.45 (1H, m: CH=), 4.57 (2H, d, J=6.8 Hz: 
CH2CO), 3.46 (s, 2H: C(O)CH2), 2.26 (3H, s: C(O)CH3), 1.56 (2H, dd, J=8.2, 0.5 Hz: 
CH2TMS), 0.04 (s, 9H: CH3(TMS)). 
 
13C NMR (100 MHz, CDCl3) δ ppm 203.95 (C=O), 167.5 (CO2), 135.20 (CH=), 
122.05 (TMSCH2CH=), 66.97 (OCH2), 50.68 (CH2CO), 30.52 (CH3CO), 23.49 
(TMSCH2), -1.86 (CH3(TMS)). 
 
Ph
O O TMS
4-phenyl-4-(trimethylsilyloxy)butan-2-one
 
25b (cw1070) 
Pd(PPh3)4: 95% NMR yield 
 
1H NMR (400 MHz, CDCl3) δ ppm 7.36 (m, 4H: arom H), 7.28 (m, 1H: arom H), 
5.18 (dd, 1H, J=8.8, 4.0 Hz: CHPh), 2.93 (dd, 1H, J=15.2, 8.8 Hz: C(O)CH2), 2.61 
(dd, 1H, J =15.3, 4.0 Hz: C(O)CH2), 2.15 (s, 3H: C(O)CH3), 0.03 (s, 9H: CH3(TMS)). 
 
O
O O
allyl 3-oxobutanoate
 
22a (cw1083) 
colorless oil 
 
1H NMR (400 MHz, CDCl3) δ ppm 12.05 (0.1 H, br. S.: CH(OH)=), 5.95 (1H, m: 
CH=), 5.37 (1H, d, J=17.2 Hz: CH=CH(H)E), 5.28 (1H, d, J=11.7 Hz: CH=CH(H)Z), 
4.65 (2H, d, J=6.8 Hz: CH2O), 3.51 (s, 2H: C(O)CH2), 2.27 (3H, s: C(O)CH3). 
 
13C NMR (100 MHz, CDCl3) δ ppm 201.0 (C=O), 167.3 (CO2), 132.4 (CH=), 118.8 
(=CH2), 66.3 (OCH2), 50.5 (CH2CO), 30.6 (CH3CO). 
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O Ph
NC CN
2-allyl-2-(3-oxo-1-phenylbutyl)malononitrile
 
27a6 (cw1110) 
colorless oil 
[Cp*Ru(bpy)Cl]: 84% yield 
 
1H NMR (400 MHz, CDCl3) δ 7.44 (m, 5H: arom H), 5.98-5.88 (m, 1H, J = 10.1, 
6.8, 7.3, 7.1 Hz: =CH), 5.43 (d, 1H, J = 10.1 Hz: CH=CH(H)Z), 5.23 (d, 1H, J = 6.8 
Hz: CH=CH(H)E), 3.78 (dd, 1H, J =10.4, 3.5 Hz: C(O)CH2CHPh), 3.44 (dd, J =10.4, 
17.4 Hz, 1H: C(O)CH2), 3.22 (dd, J =3.5, 17.4 Hz, 1H: C(O)CH2), 2.56(dd, J =7.3, 
14.1 Hz, 1H: CH2CH=), 2.42(dd, J =7.1, 14.1 Hz, 1H: CH2CH=), 2.13(s, 3H: 
C(O)CH3); 
 
13C NMR (100 MHz, CDCl3) δ 203.95 (C=O), 136.15 (Quat.), 129.54 (=CH), 129.54 
(Arom. CH), 123.36 (=CH2), 115.66 (CN), 114.91 (CN), 46.25 (CHPh), 46.10 
(C(O)CH2), 43.52 (C(CN)2), 40.73 (CH2CH=), 30.86 (CH3). The assignments of the 
1H and 13C were based on DEPT, COSY, and HMQC spectroscopies.  
 
O
NC CN
OAc
 
2-[1-[4-(acetyloxy)phenyl]-3-oxobutyl]-2-(2-propen-1-yl)-propanedinitrile 
27b (cw1126) 
colorless oil 
[Cp*Ru(bpy)Cl]: 97% yield 
 
1H NMR (400 MHz, CDCl3) δ 7.42 (m, J = 8.6, 2H: arom H), 7.14 (m, J = 8.6, 2H: 
arom H) 5.93-5.83 (m, 1H, J = 10.1, 17.4, 7.6, 5.8 Hz: =CH), 5.43 (d, 1H, J = 10.1 
Hz: CH=CH(H)E), 5.34 (d, 1H, J = 17.4 Hz: CH=CH(H)Z), 3.80 (dd, 1H, J =3.5, 9.8 
Hz: C(O)CH2CH), 3.36 (dd, J =9.8, 17.7 Hz, 1H: C(O)CH2), 3.20 (dd, J =3.5, 17.7 
Hz, 1H: C(O)CH2), 2.47(dd, J =7.6, 13.9 Hz, 1H: CH2CH=), 2.39(dd, J =5.8, 13.9 
Hz, 1H: CH2CH=), 2.32(s, 3H: OC(O)CH3), 2.15(s, 3H: C(O)CH3). 
 
13C NMR (100 MHz, CDCl3) δ 203.40 (C=O), 169.27 (OC=O), 151.24 (Quat.), 
132.95 (Quat.), 130.05 (Arom. CH), 128.56 (=CH), 123.66 (=CH2), 122.53 (Arom. 
CH), 115.17 (CN), 114.44 (CN), 46.32 (C(O)CH2), 45.30 (CHAr), 42.98 (C(CN)2), 
40.37 (CH2CH=), 30.75 (CH3), 21.35 (OC(O)CH3).  
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FTIR (CDCl3): νmax 3062, 2252, 1770, 1724, 1425, 989, 914.  
HRMS calcd for C18H18N2O3Na [M+Na] 333.1215, found 333.1208. 
 
O
O O
Ph
cinnamyl 3-oxobutanoate
 
20a7 (cw1098) 
colorless oil 
 
1H NMR (400 MHz, CDCl3) δ ppm 12.07 (0.1 H, s: CH(OH)=), 7.42 (2H, m: arom 
H), 7.35 (2H, t, J=7.3 Hz: arom H), 7.30 (1H, d, J=7.0 Hz: arom H), 6.70 (1H, d, 
J=15.9 Hz: PhCH=), 6.30 (1H, dt, J=15.8, 6.7 Hz: CH), 4.83 (2H, d, J=6.5 Hz: 
CH2O), 3.53 (s, 2H: C(O)CH2), 2.31 (3H, s: C(O)CH3). 
 
O
O O Ph
1-phenylallyl 3-oxobutanoate
 
33a (cw1133) 
colorless oil 
 
1H NMR (400 MHz, CDCl3) δ ppm 7.36 (5H, m: arom H), 6.33 (1H, dt, J=6.0, 1.2 
Hz: PhCH), 6.04 (1H, ddd, J=17.0, 10.6, 5.9 Hz: CH=), 5.33 (2H, m: =CH2), 3.53 
(2H, s: C(O)CH2), 2.26 (3H, s: C(O)CH3). 
 
13C NMR (100 MHz, CDCl3) δ ppm 200.8 (C=O), 138.6 (Quat. arom. C), 166.5 
(CO2), 136.0 (CH=), 129.0 (Arom. CH), 128.9 (Arom. CH), 128.9 (Arom. CH), 
127.6 (Arom. CH), 118.1 (=CH2), 77.7 (OCH), 50.7 (CH2CO), 30.6 (CH3CO). 
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O
O OO Ph
CN
CN
Ph
2-(3-oxo-1-phenylbutyl)-2-(1-phenylallyl)malononitrile
Ph
 
27c (cw1104) 
colorless oil 
[Cp*Ru(bpy)Cl]: 89% yield, dr = 1.9 
 
O
O O
Ph
O Ph
CN
CN
Ph
2-(3-oxo-1-phenylbutyl)-2-(1-phenylallyl)malononitrile
 
27c (cw1138) 
colorless oil 
[Cp*Ru(bpy)Cl]: 85% yield, dr = 3.5 
 
1H NMR (400 MHz, CDCl3) Major diastereoisomer: δ 7.50-7.28 (m, 10H: arom H), 
6.41-6.32 (m, 1H, J = 16.9, 10.4, 9.1 Hz: =CH), 5.53 (d, 1H, J = 10.4 Hz: 
CH=CH(H)E), 5.23 (d, 1H, J = 16.9 Hz: CH=CH(H)Z), 3.87 (dd, 1H, J =10.6, 3.3 Hz: 
C(O)CH2CHPh), 3.45-3.38 (m, 2H: overlapping CHPh, C(O)CH2), 3.22 (dd, J =17.4, 
3.3 Hz, 1H: C(O)CH2), 2.09 (s, 3H: C(O)CH3). 
 
Minor diastereoisomer: δ 7.50-7.28 (m, 10H: arom H, overlapping minor/major 
isomers), 6.44-6.30 (m, 1H, overlapping minor/major isomer: =CH), 5.47 (d, 1H, J = 
10.1 Hz: CH=CH(H)E), 5.36-5.26 (d, 1H, overlapping minor/major isomer: 
CH=CH(H)Z), 3.76 (dd, 1H, J =10.6, 3.0 Hz: C(O)CH2CHPh), 3.45-3.38 (m, 2H: 
overlapping CHPh, C(O)CH2), 3.08 (dd, J =17.2, 3.0 Hz, 1H: C(O)CH2), 2.06 (s, 3H: 
C(O)CH3); 
 
 
13C NMR (100 MHz, CDCl3) Major diastereoisomer: δ 203.76 (C=O), 137.10 
(Quat.), 135.52 (Quat.), 132.40 (=CH), 129.34 (Arom. CH), 129.35 (Arom. CH), 
128.73 (Arom. CH), 122.90 (=CH2), 115.13 (CN), 114.21 (CN), 52.90 (CHPh), 
48.65 (C(CN)2), 46.85 (C(O)CH2), 44.68 (C(O)CH2CHPh), 30.94 (CH3). 
 
Minor diastereoisomer: δ 203.76 (overlapping C=O), 136.65 (Quat.), 135.20 (Quat.), 
133.84 (=CH), 129.58-128.91 (overlapping minor/major isomer: Arom. CH), 121.88 
(=CH2), 115.09 (CN), 114.63 (CN), 53.09 (overlapping with solvent: CHPh), 48.84 
(overlapping minor/major isomer: C(CN)2), 45.76 (C(O)CH2), 44.71 (overlapping 
minor/major isomer: C(O)CH2CHPh), 30.85 (overlapping minor/major isomer: CH3).  
 
FTIR (CDCl3): νmax 3053, 2304, 1724, 1421, 991, 895. 
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HRMS calcd for C22H20N2ONa [M+Na] 351.1473, found 351.1468. 
 
O
O O
Ph
allyl 3-oxo-4-phenylbutanoate
 
cw1150 
colorless oil 
 
1H NMR (400 MHz, CDCl3) δ ppm 12.06 (0.1H, s: CH(OH)=), 7.36 (2H, q, J=7.1 
Hz: arom H), 7.32 (1H, d, J=7.5 Hz: arom H), 7.23 (2H, d, J=7.5 Hz: arom H), 5.92 
(1H, m: CH=), 5.35 (1H, d, J=17.2 Hz: CH=CH(H)E), 5.28 (1H, d, J=10.4 Hz: 
CH=CH(H)Z), 4.63 (2H, d, J=7.0 Hz: CH2O), 3.86 (2H, s: PhCH2), 3.51 (2H, s: 
C(O)CH2),. 
 
13C NMR (100 MHz, CDCl3) δ ppm 200.7 (C=O), 167.2 (CO2), 133.5 (Quat. arom. 
C), 131.9 (CH=), 130.0 (Arom. CH), 129.3 (Arom. CH), 127.8 (Arom. CH), 119.4 
(=CH2), 66.5 (OCH2), 50.5 (PhCH2), 48.6 (CH2CO). 
 
O Ph
CN
CN
Ph
2-allyl-2-(3-oxo-1,4-diphenylbutyl)malononitrile
 
27d (cw1153) 
colorless oil 
[Cp*Ru(bpy)Cl]: 87% yield 
 
1H NMR (400 MHz, CDCl3) δ 7.32 (m, 8H: arom H), 7.05 (m, 2H: arom H), 5.87 (m, 
1H, J = 10.1, 16.9, 7.6, 7.1 Hz: =CH), 5.41 (d, 1H, J = 10.1 Hz: CH=CH(H)
 E), 5.31 
(d, 1H, J = 16.9 Hz: CH=CH(H)
 Z), 3.77 (dd, 1H, J =10.4, 3.3 Hz: C(O)CH2CHPh), 
3.66 (AB, 2H: PhCH2C(O) ), 3.45 (dd, J =10.6, 17.4 Hz, 1H: C(O)CH2), 3.22 (dd, J 
=3.5, 17.2 Hz, 1H: C(O)CH2), 2.46(dd, J =7.6, 14.1 Hz, 1H: CH2CH=), 2.42(dd, J 
=7.1, 13.9 Hz, 1H: CH2CH=). 
 
13C NMR (100 MHz, CDCl3) δ 203.68 (C=O), 135.35 (Quat.), 133.17 (Quat.), 
129.77-127.78 (Arom. CH; =CH), 123.75 (=CH2), 115.46 (CN), 114.67 (CN), 51.03 
(PhCH2C(O)), 46.37 (CHPh), 44.35 (C(O)CH2), 43.23 (C(CN)2), 40.68 (CH2CH=). 
 
FTIR (CDCl3): νmax 12251, 1720, 1454, 989. 
 
HRMS calcd for C22H20N2ONa [M+Na] 351.1473, found 351.1481. 
 
 51 
Ph O
O O
allyl 3-oxo-3-phenylpropanoate
Ph O
OH O
 
cw11598 (4:1) 
colorless oil 
 
1H NMR (400 MHz, CDCl3) δ ppm 7.97 (2H, d, J=8.0 Hz: arom H), 7.62 (1H, t, 
J=7.4 Hz: arom H), 7.51 (2H, t, J=7.0 Hz: arom H), 5.92 (1H, m: CH=), 5.33 (1H, d, 
J=17.2 Hz: CH=CH(H)E), 5.25 (1H, d, J=10.4 Hz: CH=CH(H)Z), 4.69 (2H, dd, J=5.7, 
1.4 Hz: CH2O), 4.06 (2H, d, J=1.8 Hz: C(O)CH2) . 
 
Enol form: 12.51 (1 H, s:OH), 7.80 (2H, d, J=6.9 Hz: arom H), 7.45 (2H, m: arom H), 
6.02 (1H, m: CH=), 5.74 (1H, d, J=1.8 Hz: PhC(OH)=CH), 5.40 (1H, d, J=17.2 Hz: 
CH=CH(H)E), 4.74 (2H, dd, J=5.7, 1.4 Hz: CH2O). 
 
Ph
O Ph
CN
CN
2-allyl-2-(3-oxo-1,3-diphenylpropyl)malononitrile
 
27e (cw1162) 
colorless oil 
[Cp*Ru(bpy)Cl]: 64% yield 
 
1H NMR (400 MHz, CDCl3) δ 7.96-7.38 (10H: arom H), 5.95 (m, 1H, J = 10.1, 16.9, 
7.1, 7.3 Hz: =CH), 5.44 (d, 1H, J = 10.1 Hz: CH=CH(H)E), 5.36 (d, 1H, J = 16.9 Hz: 
CH=CH(H)Z), 4.10-4.01 (m, 2H: overlapping C(O)CH2CHPh, C(O)CH2), 3.70 (d, 
1H, J = 14.4 Hz: C(O)CH2 ), 2.55 (dd, J =7.3, 13.9 Hz, 1H: CH2CH=), 2.43 (dd, J 
=7.1, 13.9 Hz, 1H: CH2CH=). 
 
13C NMR (100 MHz, CDCl3) δ 195.46 (C=O), 136.46 (Quat.), 135.92 (Quat.), 
129.57-128.51 (overlapping Arom. CH; =CH), 123.80 (=CH2), 115.69 (CN), 114.92 
(CN), 46.53 (CHPh), 43.53 (C(CN)2), 41.66 (C(O)CH2), 40.83 (CH2CH=).  
 
FTIR (CDCl3): νmax 3053, 2308, 1689, 1421, 989, 895. 
 
HRMS calcd for C21H19N2O [M+H] 315.1497, found 315.1493. 
 
 
 
 52 
Et O
O O
Ph
cinnamyl 3-oxopentanoate
 
19a (cw1114)9 
colorless oil 
 
1H NMR (400 MHz, CDCl3) δ ppm 12.09 (0.06 H, s: CH(OH)=), 7.24 - 7.58 (5H, m: 
arom H), 6.71 (1H, d, J=16.0 Hz: PhCH=), 6.33(1H, m: =CH), 4.81 (2H, m: CH2O), 
3.52 (s, 2H: C(O)CH2), 2.60 (2H, q, J=7.2 Hz: CH2C(O)), 1.09 (3H, t, J=7.3 Hz: 
CH3). 
 
Et
O Ph
CN
CN
Ph
2-(3-oxo-1-phenylpentyl)-2-(1-phenylallyl)malononitrile
 
27f (cw1119) 
colorless oil 
[Cp*Ru(bpy)Cl]: 93% yield, dr = 1.8 
 
1H NMR (400 MHz, CDCl3) Major diastereoisomer: δ 7.50-7.28 (m, 10H: arom H), 
6.42-6.33 (m, 1H, J = 16.9, 10.4, Hz: =CH), 5.53 (d, 1H, J = 10.4 Hz: CH=CH(H)E), 
5.23 (d, 1H, J = 16.9 Hz: CH=CH(H)Z), 3.90 (dd, 1H, J =10.6, 3.3 Hz: 
C(O)CH2CHPh), 3.53-3.29 (m, 2H: overlapping CHPh, C(O)CH2), 3.18 (dd, J =13.9, 
3.3 Hz, 1H: C(O)CH2), 2.45 (m, 1H: C(O)CH2), 2.21 (m, 1H: C(O)CH2), 0.95(app. t, 
3H: C(O)CH2CH3). 
 
Minor diastereoisomer: δ 7.50-7.28 (m, 10H, arom H: overlapping minor/major 
isomer), 6.34-6.25 (m, 1H, =CH: overlapping minor/major isomer), 5.43 (d, 1H, J = 
10.4 Hz: CH=CH(H)E), 5.28 (d, 1H, J = 16.9 Hz: CH=CH(H)Z), 3.76 (dd, 1H, J 
=10.6, 3.3 Hz: C(O)CH2CHPh), 3.53-3.29 (m, 2H: overlapping minor/major isomer 
CHPh, C(O)CH2), 3.05 (dd, J =13.9, 3.3 Hz, 1H: C(O)CH2), 2.45 (m, 1H: 
overlapping minor/major isomer C(O)CH2), 2.21 (m, 1H: overlapping minor/major 
isomer C(O)CH2), 0.95(app. t, 3H: overlapping minor/major isomer C(O)CH2CH3); 
 
13C NMR (100 MHz, CDCl3) Major diastereoisomer: δ 206.84 (C=O), 137.30 
(Quat.), 135.61 (Quat.), 132.61 (=CH), 129.51-128.92 (Arom. CH), 123.30 (=CH2), 
115.32 (CN), 114.42 (CN), 53.09 (CHPh), 48.84 (C(CN)2), 45.85 (C(O)CH2), 44.94 
(C(O)CH2CHPh), 37.22 (CH3CH2), 7.82 (CH3). 
 
Minor diastereoisomer: δ 206.84 (C=O: overlapping minor/major isomer), 136.22 
(Quat.), 135.61 (Quat.), 134.09 (=CH), 129.51-128.92 (Arom. CH), 121.99 (=CH2), 
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114.89(CN), 114.42 (CN), 54.35 (CHPh), 48.35 (C(CN)2), 45.47 (C(O)CH2), 44.65 
(C(O)CH2CHPh), 37.29 (CH3CH2), 7. 77 (CH3).  
 
FTIR (CDCl3): νmax 2252, 1720, 1456, 991.   
 
HRMS calcd for C23H22N2O1Na1 [M+Na] 365.2, found365.1. 
 
Me O
O O
MeO
(E)-3-(4-methoxyphenyl)allyl 3-oxobutanoate
 
cw114410 
colorless oil 
 
1H NMR (400 MHz, CDCl3) δ ppm 7.35 (2H, d, J=8.8 Hz: arom H), 6.88 (2H, d, 
J=8.8 Hz: arom H), 6.64 (1H, d, J=16.0 Hz: =CHAr), 6.17 (1H, dt, J=15.8, 6.7 Hz: 
CH=), 4.80 (2H, dd, J=6.7, 1.3 Hz: CH2O), 3.83 (2H, s: C(O)CH2), 2.30 (3H, s: CH3). 
 
O Ph
CN
CN
OMe
2-(1-(4-methoxyphenyl)allyl)-2-(3-oxo-1-phenylbutyl)malononitrile
 
27g (cw1149) 
colorless oil 
[Cp*Ru(bpy)Cl]: 62% yield, dr = 1.6 
 
1H NMR (400 MHz, CDCl3) Major diastereoisomer: δ 7.50-7.21 (m, 5H: arom H), 
6.94-6.88 (m, 4H: Arom. H), 6.38-6.23 (m, 1H, J = 16.9, 10.1, 9.1 Hz: =CH), 5.51 (d, 
1H, J = 10.1 Hz: CH=CH(H)E), 5.23 (d, 1H, J = 16.9 Hz: CH=CH(H)Z), 3.81 (s, 3H: 
OCH3), 3.81-3.85(dd, 1H: overlapping C(O)CH2CHPh, OCH3), 3.48-3.31 (m, 2H: 
overlapping CHAr, C(O)CH2), 3.20 (dd, J =17.2, 3.0 Hz, 1H: C(O)CH2), 2.09(s, 3H: 
C(O)CH3). 
 
Minor diastereoisomer: δ 7.50-7.21 (m, 5H: arom H, overlapping minor/major 
isomer), 6.94-6.88 (m, 4H: Arom. H, overlapping minor/major isomer), 6.38-6.23 (m, 
1H: =CH, overlapping minor/major isomer), 5.41 (d, 1H, J = 10.1 Hz: CH=CH(H)E), 
5.23 (d, 1H: CH=CH(H)Z, overlapping minor/major isomer), 3.85 (s, 3H: OCH3), 
3.71(dd, 1H, J =10.9, 3.0 Hz: C(O)CH2CHPh), 3.48-3.31 (m, 2H: overlapping 
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minor/major isomer: CHAr, C(O)CH2), 3.08 (dd, J =17.2, 3.0 Hz, 1H: C(O)CH2), 
2.05(s, 3H: C(O)CH3). 
 
13C NMR (100 MHz, CDCl3) Major diastereoisomer: δ 203.96 (C=O), 160.27 
(Quat.), 135.74 (Quat.), 132.79 (=CH), 130.52-129.22 (Arom. CH), 122.67 (=CH2), 
114.82 (Arom. CH), 115.38 (CN), 114.82 (CN), 55.73 (OCH3), 52.40 (CHAr), 49.17 
(C(CN)2), 47.01 (C(O)CH2), 44.74 (CHPh), 31.12 (CH3). 
 
Minor diastereoisomer: δ 203.96 (C=O, overlapping minor/major isomer), 136.20 
(Quat.), 134.26 (=CH), 130.52-129.22 (Arom. CH, overlapping minor/major isomer), 
127.41 (Quat.), 121.59 (=CH2), 114.82 (Arom. CH, overlapping minor/major 
isomer), 114.94 (CN), 114.50 (CN), 55.67 (OCH3), 53.61 (CHAr), 48.58 (C(CN)2), 
46.58 (C(O)CH2), 44.51 (CHPh), 31.17 (CH3). The assignments of the 1H and 13C 
were based on DEPT, COSY, HMQC etc. 
 
FTIR (CDCl3): νmax 2247, 1724, 1253. 
 
HRMS calcd for C23H22N2O2Na [M+Na] 381.1579, found 381.1556. 
 
Me O
O O
Cl
(E)-3-(4-chlorophenyl)allyl 3-oxobutanoate
 
19b (cw1145)11 
colorless oil 
 
1H NMR (400 MHz, CDCl3) δ ppm 12.04 (0.1 H, s: CH(OH)=), 7.32 (4H, m: arom 
H), 6.63 (3 H, d, J=15.9, 1.1 Hz: =CHAr), 6.27 (5 H, dt, J=15.9, 6.5 Hz: CH=), 4.81 
(2H, dd, J=6.4, 1.3 Hz: CH2O), 3.53 (2H, s: C(O)CH2), 2.31 (3H, s: CH3). 
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O Ph
CN
CN
Cl
2-(1-(4-chlorophenyl)allyl)-2-(3-oxo-1-phenylbutyl)malononitrile
 
27h (cw1155) 
colorless oil 
[Cp*Ru(bpy)Cl]: 62% yield, dr = 1.8 
 
1H NMR (400 MHz, CDCl3) Major diastereoisomer: δ 7.50-7.22 (m, 9H: arom H), 
6.31 (m, 1H, J = 16.7, 10.4, 9.1 Hz: =CH), 5.55 (d, 1H, J = 10.4 Hz: CH=CH(H)E), 
5.21 (d, 1H, J = 16.7 Hz: CH=CH(H)Z), 3.88 (dd, J =10.6, 3.0 Hz, 1H: 
C(O)CH2CHPh), 3.44-3.34 (m, 2H: overlapping CHAr, C(O)CH2), 3.21 (dd, J =17.4, 
3.3 Hz, 1H: C(O)CH2), 2.10 (s, 3H: C(O)CH3). 
 
Minor diastereoisomer: δ 7.43-7.22 (m, 9H: arom H), 6.24 (m, 1H, J = 16.7, 10.4, 9.1 
Hz: =CH), 5.44 (d, 1H, J = 10.4 Hz: CH=CH(H)E), 5.26 (d, 1H, J = 16.7 Hz: 
CH=CH(H)Z), 3.69 (dd, J =10.6, 3.0 Hz, 1H: C(O)CH2CHPh), 3.49 (d, 1H, J = 8.8 
Hz: CHAr), 3.35 (dd, J =17.2, 10.4 Hz, 1H: C(O)CH2), 3.10 (dd, J =16.9, 3.0 Hz, 1H: 
C(O)CH2), 2.07 (s, 3H: C(O)CH3). 
 
13C NMR (100 MHz, CDCl3) Major diastereoisomer: δ 203.83 (C=O), 135.86 
(Quat.), 135.42 (Quat.), 131.98 (=CH), 130.30 (Arom. CH), 129.54 (Arom. CH), 
123.56  (=CH2), 115.06 (CN), 114.25 (CN), 52.29 (CHAr), 48.65 (C(CN)2), 47.17 
(C(O)CH2), 44.79 (CHPh), 31.12 (CH3). 
 
Minor diastereoisomer: δ 203.78 (C=O), 135.91 (Quat.), 135.39 (Quat.), 133.56 
(=CH), 130.70-128.22 (Arom. CH), 122.39  (=CH2), 115.14 (CN), 114.63 (CN), 
53.57 (CHAr), 48.21 (C(CN)2), 46.62 (C(O)CH2), 44.53 (CHPh), 31.19 (CH3). 
  
FTIR (CDCl3): νmax 2253, 1726, 1425, 990, 912. 
 
HRMS calcd for C21H20NOCl [M+H-HCN] 337.1, found 337.0. 
 
 
 
 
 
 
 
 
 
 56 
O
NC CN
OAc
Ph
4-(5',5''-dicyano-2-oxo-6-phenyloct-7-en-4-yl)phenyl
acetate
O
O O
Ph
 
27i (cw1111) 
colorless oil 
[Cp*Ru(bpy)Cl]: 92% yield, dr = 2.7 
 
O
NC CN
OAc
Ph
4-(5',5''-dicyano-2-oxo-6-phenyloct-7-en-4-yl)phenyl
acetate
O
O O
Ph
 
27i (cw1139) 
colorless oil 
[Cp*Ru(bpy)Cl]: 76% yield, dr = 4.5 
 
1H NMR (400 MHz, CDCl3) Major diastereoisomer: δ 7.51-7.09 (10H: arom H), 
6.40-6.23 (m, 1H, J = 10.4, 17.4 Hz: =CH), 5.53 (d, 1H, J = 10.4 Hz: CH=CH(H)E), 
5.25 (d, 1H, J = 17.4 Hz: CH=CH(H)Z), 3.89 (dd, 1H, J =3.0, 10.4 Hz: C(O)CH2CH), 
3.49-3.27 (m, 2H: overlapping CHPh, C(O)CH2), 3.22 (dd, J =3.0, 17.4 Hz, 1H: 
C(O)CH2), 2.34 (s, 3H: OC(O)CH3), 2.11(s, 3H: C(O)CH3). 
 
Minor diastereoisomer: δ 7.51-7.09 (10H: arom H, overlapping minor/major isomer), 
6.40-6.23 (m, 1H: =CH, overlapping minor/major isomer), 5.42 (d, 1H, J = 10.4 Hz: 
CH=CH(H)E), 5.25 (d, 1H, J = 17.4 Hz: CH=CH(H)Z, overlapping minor/major 
isomer), 3.74 (dd, 1H, J =3.0, 10.4 Hz: C(O)CH2CH), 3.49-3.27 (m, 2H: overlapping 
minor/major isomer CHPh, C(O)CH2), 3.11 (dd, J =3.0, 17.4 Hz, 1H: C(O)CH2), 
2.32 (s, 3H: OC(O)CH3), 2.07 (s, 3H: C(O)CH3); 
 
13C NMR (100 MHz, CDCl3) Major diastereoisomer: δ 203.05 (C=O), 169.46 
(OC=O), 151.49 (Quat.), 137.12 (Quat.), 132.45 (=CH), 133.11 (Quat.), 129.57-
129.91 (Arom. CH), 122.59 (overlapping =CH2, Arom. CH), 115.17 (CN), 114.30 
(CN), 53.07 (CHPh), 48.77 (C(CN)2), 47.16 (C(O)CH2), 44.15 (CHAr), 31.02 
(CH3C(O)), 21.62 (OC(O)CH3). 
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Minor diastereoisomer: δ 203.05 (C=O, overlapping minor/major isomer), 169.46 
(OC=O, overlapping minor/major isomer), 135.40 (Quat.), 134.06 (=CH), 133.52 
(Quat.), 133.11 (Quat.), 130.63 (Arom. CH), 129.57-129.91 (Arom. CH, overlapping 
minor/major isomer), 122.59 (=CH2, Arom. CH, overlapping minor/major isomer), 
115.17/114.30 (CN, overlapping minor/major isomer), 54.27 (CHPh), 48.16 
(C(CN)2), 46.87 (C(O)CH2), 43.82 (CHAr), 31.07 (CH3C(O)), 21.62 (OC(O)CH3, 
overlapping minor/major isomer). 
 
FTIR (CDCl3): νmax 3053, 2305, 1769, 1724, 1421, 1205, 895. 
 
HRMS calcd for C24H22N2O3Na [M+Na] 409.1528, found 409.1523. 
 
O Ph
CN
CN
Ph
2-cinnamyl-2-(3-oxo-1-phenylbutyl)malononitrile
 
30b (cw1124) 
colorless oil 
Pd(PPh3)4: 80% yield 
 
1H NMR (400 MHz, CDCl3) δ 7.48-7.33 (m, 10H: arom H), 6.65 (d, 1H, J = 15.7 Hz: 
=CHPh), 6.26 (m, 1H, J = 15.7, 7.6, 7.3 Hz: CH2CH=), 3.85 (dd, 1H, J =10.4, 3.5 
Hz: C(O)CH2CHPh), 3.48 (dd, J = 17.4, 10.4 Hz, 1H: C(O)CH2), 3.26 (dd, J = 17.4, 
3.5 Hz, 1H: C(O)CH2), 2.73 (dd, J = 7.6, 13.9 Hz, 1H: CH2CH=), 2.60 (dd, J = 7.3, 
13.9 Hz, 1H: CH2CH=), 2.15 (s, 3H: C(O)CH3); 
 
13C NMR (100 MHz, CDCl3) δ 203.96 (C=O), 137.99 (=CHPh), 136.19 (Quat.), 
136.19 (Quat.), 129.57 (Arom. CH), 129.50 (Arom. CH), 129.46 (Arom. CH), 129.17 
(Arom. CH), 128.90 (Arom. CH), 127.14 (Arom. CH), 122.07 (CH2CH=), 115.78 
(CN), 115.00 (CN), 46.35 (CHPh), 46.20 (C(O)CH2CHPh), 43.88 (C(CN)2), 40.26 
(CH2CH=), 30.87 (CH3). 
 
FTIR (CDCl3): νmax 2248, 1724, 1456, 968. 
 
HRMS calcd for C44H40N4O2Na [2M+Na] 679.3049, found 679.3074. 
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Et
O Ph
CN
CN
Ph
2-cinnamyl-2-(3-oxo-1-phenylpentyl)malononitrile
 
30c (cw1156) 
colorless oil 
Pd(PPh3)4: 88% yield 
 
1H NMR (400 MHz, CDCl3) δ 7.44-7.31 (m, 10H: arom H), 6.60 (d, 1H, J = 15.7 Hz: 
=CHPh), 6.21 (m, 1H, J = 15.7,7.8,7.3 Hz: CH=CHPh), 3.86 (dd, 1H, J =10.1, 3.5 
Hz: C(O)CH2CHPh), 3.42 (dd, 1H, J =10.1, 17.1 Hz: EtC(O)CH2), 3.20 (dd, 1H, J 
=3.5, 17.1 Hz: EtC(O)CH2), 2.66 (dd, J =13.9, 7.8 Hz, 1H:CH2CH=), 2.58-2.47 (m, 
2H: overlapping CH2CH=, CH2C(O)), 2.31 (q, 1H, J =7.3 Hz: CH2C(O)), 0.95 (t, 3H, 
J =7.3 Hz: C(O)CH2CH3). 
 
13C NMR (100 MHz, CDCl3) δ 206.77 (C=O), 138.27 (=CHPh), 136.15 (Quat.), 
135.82 (Quat.), 129.64-128.87 (Arom. CH), 127.12 (Arom. CH), 119.53 
(CH=CHPh), 115.67 (CN), 114.90 (CN), 46.47 (CHPh), 45.30 (EtC(O)CH2) 43.68 
(C(CN)2), 40.22 (CH2CH=), 37.20 (CH2C(O)), 7.87 (CH3).  
 
FTIR (CDCl3): νmax 2249, 1720, 1456, 968.   
 
HRMS calcd for C23H23N2O [M+H] 343.1810, found 343.1830. 
 
O Ph
O
O
O
O
5-allyl-2',2''-dimethyl-5-(3-oxo-1-phenylbutyl)-1,3-dioxane-4,6-
dione
 
31a (cw1120) 
colorless oil 
[Cp*Ru(bpy)Cl]: 51% yield 
 
1H NMR (400 MHz, CDCl3) δ 7.31 (m, 3H: arom H), 7.19 (d, J = 6.8 Hz, 2H: arom 
H), 5.74-5.64 (m, 1H, J = 12.9, 5.1, 12.6 Hz: =CH), 5.25 (d, 1H, J = 12.9 Hz: 
CH=CH(H)Z), 5.22 (d, 1H, J = 5.1 Hz: CH=CH(H)E), 4.05 (dd, 1H, J =8.8, 5.3 Hz: 
C(O)CH2CHPh), 3.35 (app t, 2H: C(O)CH2), 2.89 (dd, J =7.8, 12.6 Hz, 1H: 
CH2CH=), 2.77 (dd, J =7.3, 12.6 Hz, 1H: CH2CH=), 2.10 (s, 3H: C(O)CH3), 1.52 (s, 
3H: CH3), 0.71 (s, 3H: CH3). 
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13C NMR (100 MHz, CDCl3) δ 206.01 (C=O), 168.46 (OC=O) 167.80 (OC=O) 
139.41 (Quat.), 131.70 (=CH), 129.59 (Arom. CH), 129.38 (Arom. CH), 128.57 
(Arom. CH), 121.99 (=CH2), 106.64 (C(CH3)2), 59.89 (C(CO2R)2), 47.89 (CHPh), 
43.91 (C(O)CH2), 41.42 (CH2CH=), 30.91/30.82 (overlapping C(O)CH3 with CH3), 
28.26 (CH3).  
 
FTIR (CDCl3): νmax 3063, 1765, 1732, 1456.  
 
HRMS calcd for C19H22O5Na [M+Na] 353.1365, found 353.1347. 
 
O
NC
O
O
3-allyl-2-oxo-4-(2-oxopropyl)chroman-3-carbonitrile
 
31b (cw1193) 
colorless oil 
[Cp*Ru(bpy)Cl]: 45% yield, dr = 12 
 
1H NMR (400 MHz, CDCl3) δ 7.35 (m, 2H: arom H), 7.18 (app. t, 1H: arom H), 7.09 
(app. d, 1H: arom H), 5.85 (m, 1H, J = 10.1, 16.9 Hz: =CH), 5.33 (d, 1H, J = 10.1 Hz, 
CH=CH(H)E), 5.10 (d, 1H, J = 16.9 Hz: CH=CH(H)Z), 3.80 (dd, 1H, J = 6.6, 3.0 Hz: 
CH), 3.16 (dd, 1H, J =17.9, 2.8 Hz: C(O)CH2), 2.83 (dd, 1H, J =17.9, 9.6 Hz,: 
C(O)CH2), 2.59 (dd, J =6.6, 14.1 Hz, 1H: CH2CH=), 2.38 (dd, 1H, J =8.1, 13.9 Hz: 
CH2CH=), 2.11 (3H: C(O)CH3). 
 
13C NMR (100 MHz, CDCl3) δ 206.35 (C=O), 162.95 (OC=O), 149.94 (Quat.), 
130.31 (Arom. CH), 129.04 (=CH), 126.11 (Arom. CH), 123.16 (=CH2), 121.51 
(Quat.), 117.25 (Arom. CH), 116.84 (CN), 49.70 (t-C(CN)(CO2)), 47.03 (C(O)CH2), 
38.38 (overlapping CH2CH=, CHCH2CO), 30.83 (CH3).  
 
FTIR (CDCl3): νmax 2250, 1780, 1726, 912. 
 
HRMS calcd for C16H15NO3Na [M+Na] 292.0950, found 292.0946. 
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O
O O
cyclopent-2-enyl 3-oxobutanoate
 
cw1135 
colorless oil 
 
1H NMR (400 MHz, CDCl3) δ ppm 6.15 (1H, m: OCH), 5.85 (1H, dd, J=3.3, 2.2 Hz: 
CH=), 5.78 (1H, m: =CHCH2), 3.44 (2H, s: C(O)CH2), 2.53 (1H, m: CH2), 2.33 (4H, 
m: overlapping CH3, CH2), 1.87 (1H, m: CH2), 1.73 (1H, m: CH2). 
 
O Ph
O
O
O
O
5-(cyclopent-2-enyl)-2,2-dimethyl-5-(3-oxo-1-phenylbutyl)-1,3-dioxane-4,6-dione
 
31c (cw1123) 
colorless oil 
[Cp*Ru(bpy)Cl]: 65% yield, dr = 5.5 
 
1H NMR (400 MHz, CDCl3) Major diastereoisomer: δ 7.31 (m, 2H: arom H), 7.25 
(m, 2H: arom H), 7.24 (m, 1H: arom H), 5.97 (m, 1H, =CH), 5.51 (m, 1H, =CH), 
4.26 (dd, 1H, J =11.6, 3.0 Hz: CHPh), 3.77-3.63 (m, 2H: overlapping CHCH=CH, 
C(O)CH2), 3.14 (dd, J =2.0, 17.4 Hz ,1H: C(O)CH2), 2.56 (m,  1H: CH2CHCH=CH), 
2.46 (m, 1H: CH2CH=), 2.37 (m, 1H: CH2CH=), 2.08 (m, 1H: CH2CHCH=CH), 2.08 
(s, 3H: C(O)CH3), 1.54 (s, 3H: CH3), 0.50 (s, 3H: CH3);   
 
Minor diastereoisomer: δ 7.31-7.24 (m, 5H: arom H), 5.97 (m, 1H: =CH, overlapping 
minor/major isomer), 5.36 (m, 1H, =CH), 4.26 (dd, 1H: CHPh, overlapping 
minor/major isomer), 3.77-3.63 (m, 2H: overlapping minor/major isomer 
CHCH=CH, C(O)CH2), 3.14 (1H: C(O)CH2, overlapping minor/major isomer), 2.56 
(1H: CH2CHCH=CH, overlapping minor/major isomer), 2.46 (1H: CH2CH=, 
overlapping minor/major isomer), 2.37 (1H: CH2CH=, overlapping minor/major 
isomer), 2.08 (1H: CH2CHCH=CH, overlapping minor/major isomer), 2.08 (s, 3H: 
C(O)CH3, overlapping minor/major isomer), 1.54 (s, 3H: CH3, overlapping 
minor/major isomer), 0.50 (s, 3H: CH3, overlapping minor/major isomer). 
 
13C NMR (100 MHz, CDCl3) Major diastereoisomer: δ 206.31 (C=O), 169.40 
(OC=O) 167.72 (OC=O), 139.78 (Quat.), 136.36 (=CH: δ=5.97ppm), 130.14 (Arom. 
CH), 129.46 (Arom. CH), 128.37 (=CH: δ=5.51ppm), 106.27 (C(CH3)2), 62.11 
(C(CO2R)2), 55.19 (CHCH=CH), 44.27 (CHPh), 43.87(C(O)CH2), 32.73 (CH2CH=: 
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δ= 2.37ppm), 29.61 (CH3), 29.37 (CH3), 29.16 (CH3), 23.85 (CH2CHCH=CH: δ= 
2.08ppm).  
 
Minor diastereoisomer: δ 206.31 (C=O, overlapping minor/major isomer), 168.65 
(OC=O) 166.77 (OC=O), 140.70 (Quat.), 134.36 (=CH: δ=5.97ppm), 130.14, 129.46 
(Arom. CH, overlapping minor/major isomer), 128.37 (=CH: δ=5.51ppm, 
overlapping minor/major isomer), 106.51 (C(CH3)2), 62.48 (C(CO2R)2), 55.19 
(CHCH=CH, overlapping minor/major isomer), 44.78 (CHPh), 43.69 (C(O)CH2), 
32.09 (CH2CH=: δ=2.46 ppm), 29.61, 29.37, 29.16 (CH3, overlapping minor/major 
isomer), 27.63 (CH2CHCH=CH, δ=2.56 ppm).  
 
FTIR (CDCl3): νmax 3063, 1765, 1732, 1456, 945. 
 
HRMS calcd for C21H24N2O5Na [M+Na] 379.1521, found 379.1511. 
 
Ph Ph
(E)-pent-1-en-4-yne-1,5-diyldibenzene
 
34b13 (cw1212) 
colorless oil 
40% yield 
 
1H NMR (400 MHz, CDCl3) δ 7.33-7.51 (m, 5H: arom H), 6.75 (d, 1 H, J=15.7 Hz: 
=CHPh), 6.29 (dt, 1 H, J =6.0, 16.0 Hz: CHCH2), 3.41 (d, 2 H, J=4.0 Hz: CH2). 
 
Ph
Ph
CN
CN
Ph
2-cinnamyl-2-(1,3-diphenylprop-2-ynyl)malononitrile
 
34c (cw1212) 
colorless oil 
40% yield 
 
1H NMR (400 MHz, CDCl3) δ 7.37-7.66 (m, 10H: arom H), 6.80 (d, 1 H, J=15.7 Hz: 
=CHPh), 6.29 (ddd, 1 H, J =15.4, 7.6, 7.5 Hz: CHCH2), 4.39 (s, 1 H: CHPh), 3.14 (t, 
1H, J=8.1 Hz: CH2). 
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O Ph
CO2H
2-allyl-5-oxo-3-phenylhexanoic acid
 
36a (cw1177) 
colorless oil 
80% yield, dr = 1.5 
 
1H NMR (400 MHz, CDCl3) Major diastereoisomer: δ 7.33 (m, 2H: arom H), δ 7.26 
(m, 3H: arom H), δ 5.70 (m, 1H, J = 7.3 Hz: =CH), 4.97 (app s, 1H, CH=CH(H)Z), 
4.94 (d, 1H, J = 7.3 Hz: CH=CH(H)E), 3.33 (td, 1H, J =10.4, 3.8 Hz: 
C(O)CH2CHPh), 2.98 (dd, 1H, J =10.4, 16.4Hz: C(O)CH2), 2.77 (dd, 1H, J =3.8, 
16.4 Hz: C(O)CH2), 2.67 (td, J =4.1, 1H, 10.1 Hz: CHCO2H), 2.10 (m, 1H: 
overlapping H2O, CH2CH=), 1.97 (3H: overlapping CD3CN, CH2CH=), 1.97 (3H: 
overlapping CD3CN, C(O)CH3). 
 
Minor diastereoisomer: δ 7.35-7.23 (m, 5H: arom H, overlapping minor/major 
isomer), δ 5.80 (m, 1H, J = 17.2, 9.9 Hz: =CH), 5.06 (d, 1H, J = 17.2 Hz, 
CH=CH(H)Z), 5.04 (d, 1H, J = 9.9 Hz: CH=CH(H)E), 3.42 (td, 1H, J =9.2, 4.8 Hz: 
C(O)CH2CHPh), 3.03-2.88 (m, 1H: C(O)CH2, overlapping minor/major isomer), 
2.80-2.65 (m, 2H: overlapping minor/major isomer C(O)CH2, CHCO2H), 2.32 (m, 
2H: overlapping H2O, CH2CH=), 1.97 (3H: overlapping minor/major isomer CD3CN, 
C(O)CH3). 
 
13C NMR (100 MHz, CDCl3) Major diastereoisomer: δ 206.26 (C=O), 174.34 
(HOC=O), 141.41 (Quat.), 135.03 (=CH), 128.07 (Arom. CH), 126.47 (Arom. CH), 
115.82 (=CH2), 50.31 (CHCO2H), 46.96 (C(O)CH2), 42.52 (CHPh), 34.20 
(CH2CH=), 29.26 (CH3). 
 
Minor diastereoisomer: δ 206.85 (C=O), 174.97 (HOC=O), 142.01 (Quat.), 135.59 
(=CH), 128.22 (Arom. CH, overlapping minor/major isomer), 126.62 (Arom. CH), 
116.24 (=CH2, overlapping minor/major isomer), 50.29 (CHCO2H), 45.98 
(C(O)CH2), 42.12 (CHPh), 33.85 (CH2CH=), 29.53 (CH3, overlapping minor/major 
isomer).   
 
FTIR (CDCl3): νmax 1745, 1711. 
 
HRMS calcd for C15H18O3Na [M+Na] 269.1154, found 269.1154.  
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O Ph
CN
NO2
2-allyl-2-nitro-5-oxo-3-phenylhexanenitrile
 
37b (cw2064) 
colorless oil 
Pd(PPh3)4, 56% yield 
 
1H NMR (400 MHz, CDCl3) δ ppm 7.34 (m, 5H: arom H), 5.78 (m, 1H: =CH), 5.35 
(dd, 1H, J=5.0, 0.7 Hz: CH=CH(H)Z), 5.35 (dd, 1H, J=11.8, 0.9 Hz: CH=CH(H)E), 
4.16 (dd, 1H, J=8.9, 4.3 Hz: C(O)CH2CHPh), 3.29 (dd, 1H, J=17.7, 8.9 Hz: 
C(O)CH2), 3.09 (m, 2H: overlapping CH2CH=, C(O)CH2), 2.83 (dd, 1H, J=14.5, 6.5 
Hz: CH2CH=), 2.14 (s, 3H: C(O)CH3). 
 
13C NMR (100 MHz, CDCl3) δ 203.95 (C=O), 136.15 (Quat.), 129.54 (=CH), 129.54 
(Arom. CH), 123.36 (=CH2), 115.66 (CN), 114.91 (CN), 46.25 (CHPh), 46.10 
(C(O)CH2), 43.52 (C(CN)2), 40.73 (CH2CH=), 30.86 (CH3). 
 
CN
Ph
N
O
Me
2-allyl-2-cyano-5-methyl-3-phenyl-3,4-dihydro-2H-pyrrole 1-oxide
 
37c (cw2083) 
colorless oil 
79% yield 
 
1H NMR (400 MHz, CDCl3) δ ppm 7.42 (m, 3H: arom H), 7.34 (d, 2H, J=8.0 Hz: 
arom H), 5.76 (m, 1H: =CH), 5.42 (m, 2H: CH2=), 3.74 (t, 1H, J=8.0 Hz: CH2), 3.11 
(m, 3H: overlapping CH2CH=, CHPh and CH2), 2.87 (dd, 1H, J=14.2, 8.1 Hz: 
CH2CH=), 2.23 (s, 3H: CH3). 
 
13C NMR (101MHz, CDCl3) δ ppm 145.7 (C=N), 136.2 (Quat. arom C), 129.8 
(=CH), 129.6 (Arom. CH), 129.3 (Arom. CH), 128.9 (Arom. CH), 123.3 (=CH2), 
116.0 (CN), 79.0 (Quat. C), 44.6 (CH2), 39.7 (CHPh), 37.9 (CH2CH=), 13.8 (CH3). 
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N
Ph
CN
Me
O
 
37d (cw2097) 
brown solid 
35% yield 
 
1H NMR (400 MHz, CDCl3) δ ppm 7.39-7.40 (m, 4H: arom H), 7.33 (ddd, 1H, J=4.9, 
3.4, 2.4 Hz: arom H), 4.98 (t, 1H, J=4.9 Hz: OCH), 3.57 (dd, 1H, J=10.1, 5.6 Hz: 
CHPh), 2.73 (m, 2H: overlapping CH2CH, CH2CHPh), 2.08 (dd, 1H, J=14.2, 5.6 Hz: 
CH2CHPh), 1.97 (m, 2H: overlapping CH2C(CN)N, CH2CH), 1.64 (d, 1H, J=11.9 Hz: 
CH2C(CN)N), 1.47 (s, 3H: CH3). 
 
13C NMR (101MHz, CDCl3) δ ppm 142.8 (Quat. C), 129.3 (Arom. CH), 128.6 
(Arom. CH), 128.2 (Arom. CH), 120.7 (CN), 81.0 (OCH), 72.9 (Quat. CN(CN)), 
71.5 (Quat. CN(OCH)), 50.5 (CHPh), 49.8 (CH2CH), 48.4 (CH2C(CN)N), 44.4 
(CH2CHPh), 28.2 (CH3). The assignments of the 1H and 13C were based on DEPT, 
COSY, HMQC etc. 
 
FTIR (CDCl3): νmax 3067, 2976, 2241, 1495, 1456, 1292, 883. 
 
HRMS calcd for C15H17N2O [M+] 241.1341, found 241.1341. 
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Chapter 2 
 
The Synthesis of Nitrogen-Containing Heterocycles via the Palladium-Catalyzed 
Decarboxylative Allylation 
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2.1 Importance of Nitrogen Heterocycles in the Pharmaceutical Industry 
Heterocycles are structural motifs found in 68% of drugs in the clinical stage or 
on the market, and seven of the top ten selling drugs are N-heterocycles (Figure 1).1, 2 
These structural components are also found in biologically active natural products.1 
To match the increasing interest in N-containing heterocycles, many methods have 
been developed for efficient synthesis of those important heterocycles, on gram to ton 
scale for industrial production.2, 3 
Figure 1 Structures of top-selling drugs 
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An interesting subclass of N-heterocycles is the four-membered azetidine 
alkaloids, which have not drawn a lot of attention as compared to the analogous 
aziridine, pyrrolidine and piperidine alkaloids. The reason partially resides in the fact 
that there are not many natural products reported to include the azetidine ring 
structure. Nevertheless, azetidine rings do show up as the structural motifs of some 
pharmaceuticals and agrochemicals due to their interesting biological activities. For 
example, sphingosine derivatives penaresidin A and B isolated from a marine sponge 
exhibit potent actomyosin ATPase-activating activity, while penazetidin A is found to 
be a protein kinase C inhibitor (Figure 2).4, 5 All these compounds feature a hydroxyl 
azetidine ring and their syntheses have been achieved by several synthetic groups.6-11 
Figure 2 Sphingosine type azetidine alkaloids isolated from marine sponge 
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 Some other representative examples are shown in Figure 3. Enantiopure 
L-azetidine carboxylic acid (L-Aze) 1a was isolated from convallaria majalis plants 
and serves an potential building block for a variety of molecules.12 Mugineic acid 
(1b), excreted from the roof of barley, is a typical phytosiderophore, promoting the 
absorption and transportation of iron in plants.13 Nicotianamine 1c, present in “soy 
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sauce” was identified as an inhibitor of angiotensin I-converting enzyme (ACE).14 
Vioporlide A 1d, isolated from cystobaxter violoceus displays interesting antifungal 
activity.15 Due to its complex and challenging ring structure, gelsemoxonie 1e has 
been a synthetic target ever since it was separated from gelemium elegants.16 
Furthermore, gelsemoxonie 1e has shown potent analgesic and antispasmodic 
activity.17 Another interesting family of azetidine alkaloids are the polyxins 2a-2d, 
which are present in cultures of streptomyces cacaoi var. asoenisis and exhibits 
antifungal activity.18 
Figure 3 Natural products bearing an azetidine ring 
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 In addition, azetidine alkaloids could become the target of medicinal chemistry 
studies in which N-heterocycles are frequently studied. For example, a neuronal 
nicotinic acetylcholine receptor (nAChR) inhibitor ABT-594 was identified in the 
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SAR study of morphine-related non-opioid drug (-)-epibatidine with similar potency 
(Figure 4).19, 20 More importantly, ABT-594 did not appear to cause opioid-related 
physical dependence or opioid analgesic activity, which should motivate further 
studies of azetidine analogs. 
Figure 4 Synthetic azetidine ABT-594 as analog of natural (-)-epibatidine 
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2.2 Overview of Azetidine Synthesis 
2.2.1 Azetidine Ring Syntheses from 1,3 –Amino Halides 
 A traditional way for azetidine ring synthesis is intramolecular cyclization of 
amines bearing a good leaving group at the γ-position, for example γ–chloroamines 
3a, as shown in Scheme 1.21, 22 Other leaving groups were also tested in this context, 
including: bromo, iodo, tosylate, mesylate and triflate groups. It was found that, due 
to slow kinetics (unfavorable enthalpy of activation) of four-membered ring closure, 
those transformations were generally very slow even when treated with a strong base 
at higher temperatures.23 The best combination was shown by Shioiri, in which 
tosylamide 3c with a tosylate leaving group was utilized as the reactant.24 The 
intramolecular SN2 substitution yields the azetidine product 3d and 3e in combined 
93% yield with the correct stereochemistry. 
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Scheme 1 Intramolecular Ring closure of 1,3–amino halides 
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2.2.2 Azetidine Ring Syntheses from 1,3–Amino Alcohols 
 Azetidine rings can also be synthesized from 1,3–amino alcohols under 
Mitsunobu-type reaction conditions, in which stoichiometric amount of PPh3 is used 
in the presence of an oxidant such as DEAD, Br2 or CBr4 (Scheme 2).25, 26 Even 
though the reactions can be carried out under mild conditions, the yields of azetidine 
products 4b and 4d are moderate.27, 28 Furthermore, in addition to the poor atom 
economy of these reactions, the phosphine oxide byproducts are notorious for 
complicating product purification. 
Scheme 2 Intramolecular Ring closure of 1,3–amino alcohols 
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2.2.3 One Pot Azetidine Ring Syntheses from via 1,3-Dielectrophiles 
 For the intramolecular azetidine ring closure reactions, secondary amines are 
used to avoid the byproducts of competitive dialkylation. However, by carefully 
controlling the reaction conditions, the cyclized azetidine ring product 5c was 
produced via dialkylation of primary amine 5b in 75% yield as shown in Scheme 3.29 
One thing to note here is that this transformation could be carried out on kilogram 
scale. Dibromoelectrophile 5d was also used to synthesize the azetidine product 5f.  
However the reaction conditions need to be carefully controlled to avoid competing 
reactions.30 
Scheme 3 Intramolecular ring closure of 1,3-dielectrophiles with primary amines 
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2.2.4 Azetidine Ring Syntheses via Ring Contraction 
 Lastly, decarboxylative ring contraction of carbamate 6a yielded azetidine 6b in 
85% yield at high temperature and pressure (Scheme 4).31 Similarly, the 
four-membered ring product 6d was produced via a metal facilitated ring contraction 
of urea derivative 6c. 
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Scheme 4 Ring synthesis via six-membered ring contractions 
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2.3 Pd-Catalyzed Azetidine Synthesis via Decarboxylative Ring Contraction 
Our group has shown that cyclohexenyl pyrazoyl carboxylate 7a undergoes a 
similar decarboxylative amination to furnish product 7b in good yield as shown in 
Scheme 5.32  It is also known that 6-vinyl-1,3-oxazinanones undergo ring opening 
and decarboxylation in the presence of palladium catalysts, and the intermediate 
palladium allyl complexes have been trapped by pendant nucleophiles and CO to 
yield oxazine 7d and pyrrolidinone 7f respectively.33, 34 
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Scheme 5 Nitrogen nucleophiles in Pd-catalyzed allylation reactions 
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On the basis of this precedent, we hypothesized that vinyl oxazinanones 8 would 
undergo decarboxylative ring contractions and allow facile generation of vinyl 
azetidines 13 (Scheme 6). 
Scheme 6 Decarboxylative ring contraction 
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To begin, free allylic carbamates 9a and 9b were allowed to react under our 
standard conditions as shown in Scheme 7. However, substrate 9a did not react even 
at 77 oC in toluene.  This is possibly due to the steric hinderance of geminal 
dimethyl substituents or the difficulty of generating an unstabilized amide nucleophile 
by decarboxylation. That decarboxylation can take place under these conditions is 
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shown by the formation of butadiene product 9d from exclusive β-hydride elimination 
from vinyl oxazinanone 9b. This suggested that the amide anion generated was too 
basic, which promoted elimination. Also showed here is a scheme for preparing the 
vinyl oxazinanone 9b. 
Scheme 7 Decarboxylative ring contractions with N-unprotected carbamates 
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With the goal of reducing the basicity of nitrogen, we turned to the reaction of 
tosyl-protected carbamates. Thus, 10a was prepared from the corresponding 
1,3-amino alcohol by treatment with carbonyl diimidazole.33, 35 Indeed, allowing 
trans-10a (>19:1 dr) to react in the presence of 5 mol% of Pd(PPh3)4 in CH2Cl2 at 25 
oC led to rapid evolution of CO2 and formation of the vinyl azetidine 13a in 74% yield 
with no observable formation of the tetrahydropyridine 10b (Scheme 8).36, 37 
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Scheme 8 Diastereoselective decarboxylative azetidine synthesis 
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 Next, several control experiments were conducted to probe the effect of the 
palladium catalyst (Scheme 9). No reaction occurred without catalyst and starting 
material 10a was recovered. Similarly, amino alcohol 11a was treated with our 
standard reaction conditions, in which azetidiene product 13a was not formed and 
reactant 11a remained intact. Lastly, treatment of compound 11b with 5 mol% of 
Pd(PPh3)4 afforded a messy polymeric mixture, which further demonstrated that 
6-vinyl-1,3-oxazinanones are the best substrates for diastereoselective, 
decarboxylative ring contractions. 
Scheme 9 Control experiments 
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Turning back to the successful ring contraction, we noted that the ratio of 
diastereomers in the product azetidine (16:1) was slightly smaller than that of the 
starting material (>19:1). This suggested that the diastereomers were interconverting 
on the time scale of the cyclization. To test this hypothesis, cis-10a was prepared and 
subjected to the same reaction conditions (Scheme 10). Although the rate of the 
reaction with cis-10b was somewhat slower than that with trans-10a, the product was 
identical. Thus, epimerization through pi-σ-pi allyl interconversion is faster than 
cyclization (Scheme 10).38 This is an important observation because it allows the 
synthesis of highly diastereoenriched azetidines from diastereomixtures of the cyclic 
allylic carbamates. 
Scheme 10 Diastereoselective decarboxylative azetidine synthesis 
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As further proof, two diastereoisomers 12a and 12b produced identical vinyl 
azetidine product 13e in 78% yield (Scheme 11). More importantly, highly 
diastereoenriched azetidines 13g and 13h were synthesized from 1:1 
diastereomixtures of the cyclic allylic carbamates 12c and 12d. 
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Scheme 11 Diastereoenriched azetidine syntheses 
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Rapid formation of the vinyl azetidine can be explained by one of two possible 
mechanisms (Scheme 12). First, nitrogen may coordinate to palladium to form a 
five-membered metallacycle A that would give rise to the azetidine upon reductive 
elimination.39, 40 Second, a free nitrogen anion might preferentially undergo backside 
attack at the 4-carbon of π-allyl complex B. The two mechanisms are readily 
distinguished by the stereochemistry of the cyclization. Reductive elimination from a 
five-membered metallacycle should give overall inversion of stereochemistry, and 
backside attack by an amide anion should result in overall retention of 
stereochemistry.41 
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Scheme 12 Two possible mechanisms of the vinyl azetidines formation 
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The stereochemical analysis of the ring contraction can only be performed if the 
substrate does not epimerize. Therefore, substrate 14a was chosen for study because 
the initial stereochemistry of the allyl alcohol cannot be lost by a π-σ-π epimerization 
mechanism that is common for terminally unsubstituted π-allyl complexes. The 
azetidine formed from 14a under our standard reaction conditions was shown to be 
the trans isomer by nOe experiments, indicating that the reaction proceeds with 
overall retention of stereochemistry. Thus, the reaction likely proceeds by backside 
attack of the amide anion on the π-allyl ligand via B. 
Regarding the preferential four-member cyclization, Rutjes and Hiemstra have 
suggested a stereoelectronic origin for the regioselectivity of related cyclizations of 
β-aminoallenes.36 Monosubstituted palladium π-allyl complexes can adopt two 
conformations, and the syn conformation is thermodynamically favored because it 
avoids A1,3-strain (Scheme 13). Although the syn conformation can readily give rise 
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to the vinyl azetidine, the anti conformation is required for formation of the 
tetrahydropyridine derivative. 
Scheme 13 Stereoelectronic origin for the preferential four-membered cyclization 
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To probe this mechanistic hypothesis, a 6-phenyl vinyloxazinanone 15a was 
prepared. Such a substrate should prefer to place the sterically smaller amino alkyl 
fragment in the anti position and would be expected to preferentially form the 
tetrahydropyridine isomer (Scheme 14) if the Rutjes mechanism is correct. Indeed, 
treatment of 15a under standard reaction conditions produced tetrahydropyridine 15b 
in quantitative yield. Furthermore, scrutiny of the reaction progression by 1H NMR 
spectroscopy showed no evidence for intermediate azetidine formation, indicating 
that tetrahydropyridine 15b is the kinetic product. A similar 6-methyl-substituted 
derivative 15c was prepared and allowed to react with 5 mol% of Pd(PPh3)4 in 
CH2Cl2. In this case, deprotonation is favored, and diene 15d is the only observable 
product of the reaction. Bicyclic vinyl oxazinanone 15e was also tested, in which 
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deprotonation occurred exclusively to produce diene product 15f in a quantitative 
yield. 
Scheme 14 Stereoelectronic effects on the ring cyclizations 
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Although the above considerations eliminate the possibility of formation of 
tertiary C-N bonds via decarboxylative ring contraction, other substitution patterns 
are allowed. For example, both 5-alkyl- and 5-aryl-substituted 1,3-oxazinanones 
provide good yields and selectivities for trans-1,2-vinyl azetidines (Table 1). The 
4-substituted vinyl oxazinanones react similarly, but they provide the syn-1,3-vinyl 
azetidines with good diastereoselectivity. The stereochemical outcome for either case 
can be rationalized on the basis of the preference for substituents to occupy the 
pseudoequatorial positions of the four-membered transition state 16a for cyclization 
as shown in Scheme 15. 
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Table 1 Yields and diastereoselectivities for decarboxylative ring contractions 
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a
 Yield and dr of isolated product via column chromatography. b Prepared from ca. 1:1 
syn/anti-1. 
 
Scheme 15 Transition state for the decarboxylative ring contraction 
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On the basis of literature reports, the formation of vinyl azetidines is expected to 
be reversible.36, 42-45 In accord, treatment of 17a for 10 min at room temperature 
provided the vinyl azetidine 13i; however, prolonged standing in the presence of the 
Pd(0) catalyst resulted in complete conversion to the thermodynamically more stable 
tetrahydropyridine isomer 17b (Scheme 16). A diatereomixture 17a was treated with 
the standard reaction conditions. As expected, diastereoenriched azetidine product 13i 
was formed at comparable rates. Also to be noted here is that lower catalyst loading 
(0.8 mol% of Pd(PPh3)4) completely shut the isomerization off and the 
thermodynamic tetrahydropyridine isomer 17b was not formed even after three days. 
Thus, the rapid reaction rate and mild conditions of azetidine formation are important 
because they allow one to avoid isomerization which can be significant at elevated 
temperatures and/or catalyst loadings.36 
Scheme 16 Isomerization of azetidines to thermodynamically stable pyridines 
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2.3.1 Other observations 
Unsubstituted vinyl oxazinanone 18a was prepared and treated with 5 mol% of 
Pd(PPh3)4 in CH2Cl2 (Scheme 17). In this case a (presumably) polymeric mixture was 
formed within 10 minutes at room temperature, even though a small amount of 
twelve-membered dimer 18c was separated via column chromatography (26% yield).  
This product was confirmed by two triplet double 1H signal (1:1 ratio) at 5.4 and 5.6 
ppm respectively in the 1H NMR spectrum. 
Scheme 17 Investigation on reaction scope 
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 Benzoyl-protected substrate 19a was prepared and allowed to react with 
Pd(PPh3)4 in CH2Cl2 at room temperature (Scheme 18). Instead of the four-membered 
azetidine product, a six-membered oxazine 19b was produced as a 1.7:1 
diastereomixture in 72% yield. Presumably, a zwitterionic intermediate A was 
generated upon decarboxylation, which was in resonance with intermediate B. This 
intermediate is perfectly set up for the oxazine ring closure which is consistent with 
the related reaction discovered by Cook.34 We were also curious whether the oxazine 
product isomerizes at higher temperature. In that regard, compound 19b was treated 
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with 5 mol % of Pd(PPh3)4 in toluene at 80 oC and a diene product 19c was formed 
cleanly in 96% NMR yield. 
Scheme 18 Substrate with a different N-protection group 
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In summary, we have developed a unique ring contraction of cyclic carbamates 
that diastereoselectively produces vinyl azetidines. Importantly, the reaction proceeds 
under mild conditions and produces CO2 as the only byproduct. 
 
2.4 The Importance of Bioactive Quinolines and Their Derivatives 
Other well-known N-heterocycles are quinolines and their derivatives such as 
1,2-dihydroquinoline, isoquinoline and tetrahydroquinoline. These compounds occur 
widely in nature and find many applications including their use as building blocks for 
organic synthesis, and as potential candidates for pharmaceuticals, antioxidants, 
agrochemicals and dyes. 
The 1,2-dihydroquinoline alkaloids are an interesting type of compounds, which 
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can be converted to quinolines by oxidation and in that regard, two dihydroquinoline 
derivatives 20a and 20b have been used in rubber production as antioxidants (Figure 
5).46 Substituted 1,2-dihydroquinoline derivative 20c has shown potent antibacterial 
activity and high inhibition of Escherichia coli dihydrofolate reductase.47 In other 
cases, reduction48 or electrophilic addition49, 50 to the double bond of 
1,2-dihydroquinoline generates 1,2,3,4-tetrahydroquinoline derivatives. 
Figure 5 1,2-Dihydroquinoline alkaloids 
N
H
F
Me
OMe
Me
CH2F
N
N
NH2
H2NNH
Me
Me 11
N
H
Me
EtO
20a 20b 20c
 
 
2.5 Overview of 1,2-Dihydroquinoline Synthesis 
 Even though 1,2-dihydroquinolines have not drawn a lot of attention, possibly 
due to their inherent instability and the scarcity of natural products bearing a 
1,2-dihydroquinoline structure element, they are a potential building block for 
quinoline and tetrahydroquinolin alkaloids.51 For example, Taguchi recently reported 
a convenient synthesis of fluorinated 1,2-dihydroquinolines synthesis from 
substituted anilines (Scheme 19).52 Dihydroquinoline 21a was smoothly converted to 
quinoline 21b or tetrahydroquinoline 21c by either air oxidation or reduction 
respectively. 
 88 
Scheme 19 Modification of 1,2-dihydroquinoline derivatives 
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2.5.1 Skraup and Skraup/Doebner-Miller procedures starting with aniline derivatives 
Quinoline derivative synthesis has drawn a lot of attention due to their biological 
activities (Chapter 2.4). Traditionally, quinolines were synthesized from the 
corresponding aniline derivatives via the Skraup procedure shown in Scheme 20.53 
Glycerol was used as the synthetic equivalent of acrolien, which cyclized with aniline 
to generate a 1,2-dihydroquinoline intermediate 22a, followed by oxidation to give 
quinoline product 22b. The related Skraup/Doebner-Miller procedure involves a 
reaction of aniline with α,β-unsaturated aldehydes or ketones in the presence of HCl 
or Lewis acids. Air oxidation of intermediate 22c produced the quinoline product 22d. 
However, those transformations require a large amount of sulfuric acid or strong 
Lewis acid combined with harsh reaction conditions. Thus, the products were 
generally obtained in low to moderate yields. 
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Scheme 20 Skraup and Skraup/Doebner-Miller Procedures 
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 A modified Skraup/Doebner-Miller procedure has been adopted for 
1,2-dihydroquinoline synthesis, in which disubstituted mesityl oxide derivatives were 
employed instead (Scheme 21).23,24 Compounds 23a and 23b were synthesized by 
treatment of anilines with mesityl oxide derivatives catalyzed by iodine. As such, the 
aromatization of the 1,2-dihydroquinolines would require losing one molecule of 
methane (Riehm quinoline synthesis), which is more difficult than losing a molecule 
of hydrogen. 
Scheme 21 Modified Skraup/Doebner-Miller type reactions 
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 The major drawback of this procedure is the low yield of dihydroquinoline 
product due to the competing polymerization. Recently solvent-free Skraup Doebner- 
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Miller reactions have been developed with microwave radiation.54 For example, a 
series of dihydroquioline products were synthesized in moderate yields by treatment 
of aniline with enones in the presence of silica gel charged with indium trichloride 
under microwave conditions. 
2.5.2 Transition-metal catalyzed 1,2-dihydroquinoline synthesis 
There are several drawbacks of traditional methods for 1,2-dihydroquinoline or 
quinoline synthesis. For example most reactions need high temperature in the 
presence of a strong Bronsted or Lewis acids. Functional group compatibility, 
decomposition of products, and competing side reactions are always the concerns 
under those harsh conditions. To potentially alleviate these problems, transition metal 
catalysts have been introduced into this scenario. 
 Transition metal-catalyzed heteroannulation reactions have been extensively 
studied due to the potential biological and pharmaceutical activity of those 
heterocyclic compounds. For example, substituted 2-iodoanilines have been shown to 
undergo a Heck reaction with cis-dimethyl maleate to generate trans-olefin 
intermediate 24a, which upon cyclization produced quinolone 24b in moderate yields 
(Scheme 22). Larock reported a similar procedure with allylic alcohols, in which 
β-hydride eliminations afforded enol intermediates 24c, followed by intramolecular 
condensations and oxidations to furnish quinolines 24e.55 
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Scheme 22 Heck- type coupling reaction 
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Another procedure involves intramolecular amination of substituted 
2-allylanilines 25a and 25c produced dihydroqinoline 25b and indole 25d 
respectively in the presence of catalytic amount of PdCl2(CH3CN)2 (Scheme 23). 
Interestingly, different chemoselectivity displayed with simple allyl side chain in 
which a 5-exo-trig was favored over 6-endo-trig, whereas the dimethyl substituted 
allylaniline 25a predominantly generated the 6-endo-trig product. The reason possibly 
resides in the stability of a tertiary carbocation. 
Scheme 23 Intramolecular amination of olefines 
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 Gold and silver have been used for the functionalization of alkynes based on their 
unique Lewis acidity. In 2005, Li reported their results on hydroamination of alkynes 
with a silver catalyst toward the synthesis of highly substituted 
1,2-dihydroquinolines.56 A possible mechanism was also postulated as shown in 
Scheme 24. Silver-catalyzed hydroamination generates an enamine intermediate 26c 
in tautomerization with ketimine 26d, and reaction of ketimine with another molecule 
of alkynes yields propargylamine 26e, followed by intramolecular cyclization and 
further addition to give highly functionalized 1,2-dihydroquinoline product 26b. 
Scheme 24 Silver-catalyzed 1,2-dihydroquinoline synthesis 
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 Gold complexes were also found to catalyze similar transformations. Recently, an 
efficient synthesis of quinolines and dihydroquinolines catalyzed by Au(I) was 
disclosed by Che under microwave radiation (Scheme 25).57 Product 27e was 
prepared by a Au-catalyzed tandem hydroamination-hydroarylation of phenyl 
acetylene in 91% yield. 
Scheme 25 Gold-catalyzed 1,2-dihydroquinoline synthesis 
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 Finally, ring-closing metathesis strategies have also been employed in 
1,2-dihydroquionline synthesis (Scheme 26). For example, 2-vinyl allylamines 28b 
underwent ring-closing metathesis smoothly in the presence of Grubbs’ catalyst A or 
B to generate the dihydroquinoline product 28c in high yield.58 Dihydroquinolines 
with acidic sensitive N–protecting groups 28d were subsequently deprotected and 
air-oxidized to give quinoline product 28e during silica gel chromatography in good 
to excellent yield. 
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Scheme 26 RCM (Ring-closing metathesis) for 1,2-dihydroquinoline synthesis 
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 Evans reported an efficient synthesis of 1,2-dihydroquionline rings using a 
regioselective allylic amination combined with ring-closing metathesis in the 
presence of rhodium catalysts as shown in Scheme 27. Vinyl aniline 29a reacted with 
enatiopure allylic carbonate 29b to produce the RCM reaction precursor 29c in 
excellent reigoselctivity (36:1). Upon treatment with Grubbs’s catalyst A, 
1,2-dihydroquionline product 29e was furnished in 92% yield. 
Scheme 27 Allylic amination combined with RCM for 1,2-dihydroquinoline synthesis 
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Other transition metals such as copper,59, 60 manganese61 and iron62 etc have also 
shown catalytic activity toward the synthesis of dihydroquinolines. However, due to 
their similarity with the transition metals mentioned above, those catalysts are not 
covered in this dissertation. 
2.5.3 1,2-dihydroquinolines synthesis via modification of quinoline rings 
 It has been shown that nucleophilic addition to quinoline derivatives furnishes 
1,2-dihydroquinoline products, which were then transformed to tetrahydroquinolines 
through reduction (Scheme 28). For example, treatment of quinoline 30a with n-butyl 
lithium or ethyl magnesium bromide produces 1,2-dihydroquinolines 30b and 30d in 
97% and 57% yield respectively.48, 63, 64 Interestingly, activation of quinoline 30a by 
converting it to iminium salt 30f allowed the nucleophilic attack of weaker 
nucleophiles, and in fact compound 30g was obtained in 66% yield.65 
Scheme 28 Conversion of quinolines to 1,2-dihydroquinolines 
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2.6 Decarboxylative Dihydroquinoline Synthesis via Aza-ortho-xylylene 
Intermediates 
 
 Even though there are many reported procedures for 1,2-dihydroquinoline 
synthesis, the current methods still have some limitations in regard to the cost and 
availability of substrates, prolonged reaction times at high temperature, strongly 
acidic conditions and functional group compatibility. As such, a mild and efficient 
method for dihydroquinoline syntheis is still highly desirable. 
We have previously reported that vinyl oxazinanones 31a underwent catalytic 
diastereoselective decarboxylative ring contraction to form vinyl azetidines under 
mild conditions in good yield.66 A zwitterionic π-allyl palladium complex 31b was 
proposed as the intermediate (Scheme 29). We reasoned that conjugation of the two 
charges would allow mild catalytic generation of aza-ortho-xylene intermediates.67  
Such a scenario creates two possibilities. The zwitterionic intermediate can 
potentially expel Pd(0) to produce a free aza-o-xylylene 31e. Alternatively, if Pd 
remains coordinated, then a polarized aza-o-xylylene intermediate 31d will result.68 
Then substituted 1,2-dihydroquinolines could be formed via either a cyclization of the 
π-allyl intermediate 31d or a electrocyclization of the free aza-o-xylenene 31e.69 
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Scheme 29 Zwitterionic π-allyl palladium intermediates 
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 To begin, the parent vinyl benzoxazinanone 32a was prepared and subjected to 
Pd(PPh3)4 in CH2Cl2 at room temperature. In contrast to the saturated analogs which 
undergo ring contraction to azetidines, 32a produced the hydroquinoline 33a in 65% 
yield (Scheme 30). Interestingly, conducting the same reaction in toluene solvent 
produces the 12-membered dimer 34a exclusively. Even though the dimer product 
34a was obtained in 36% isolated yield, this compound was formed cleanly as shown 
by 1H NMR spectroscopy. Since it is improbable that such a dimer could arise from 
concerted [6+6] cycloaddition, it seems likely that Pd-polarized aza-o-xylylene 32b is 
the intermediate in these reactions. 
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Scheme 30 Solvent effects on the chemoselectivity 
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Next we turned our attention to investigating the reaction scope. It since has been 
shown that various vinyl benzoxazinanones undergo smooth intramolecular 
decarboxylative allylic aminations and the dihydroquinoline products were obtained 
in good to excellent yield (Table 2). 
Table 2 Yields of dihydroquinolines via intramolecular decarboxylative allylations 
N
O
O
Ts
R2
N
R2
Ts
5 mol % Pd(PPh3)4
rt, CH2Cl2
R1 R2 Yield% a
H 65b
H 77
p-Me 50b
p-Me 94
p-MeO 80b
p-MeO 92
Product
33a
33b
33c
33d
33g
32h
H
Me
H
Me
H
Me
p-F 51b33eH
p-F 8233fMe
CO2
33
R1R1
 
 
a
 Yield of isolated product via column chromatography. b The by-products were dimers or 
polymers, which were somehow suppressed by performing the reaction in dilute solution with 
lower catalyst loading. 
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The clean formation of dimer products was also interesting to us and treatment of 
different vinyl benzoxazinanones with a catalytic amount of Pd(PPh3)4 in toluene 
gave the 12-membered ring products 34 in good to excellent yield at room 
temperature as shown in Table 3. The coupling constants of olefins suggested a 
trans-geometry in compounds 34a, 34b and 34c (J = 16.2 Hz); while compound 34d 
(J = 9.8 Hz) was formed with a cis-olefin geometry. At this point, we don’t have a 
reasonable explanation for this stereoselectivity. 
Table 3. Yields of dimer products via intermolecular decarboxylative cycloaddition 
N
O
O
Ts
5 mol % Pd(PPh3)4
rt, Tol
R Yield%
H 36 c
Me 87
OMe 94
F 92 d
Product
34a a
34b a
34c a
34d b
-CO2
34
2
N
N
Ts
Ts
R
R
R
 
a
 Dimer products with a trans-olefin geometry. b Dimer product with a cis-olefin geometry. c 
Yield of isolated product via column chromatography and 34a was formed cleanly as shown by 
1HNMR spectroscopy. d This reaction was carried out in dichloroethane at 60 oC. 
 
To further shed light on the reaction mechanism, vinyl benzoxazinanone 32a was 
allowed to react with vinyl butyl ether in the presence of 5 mol% Pd(PPh3)4 in toluene 
as shown in Scheme 31. If a free aza-o-xylylene is indeed being formed, then one 
would predict that it would undergo [4+2] cycloaddition with vinyl butyl ether.70 
 100 
However, the dimer product 34a was formed smoothly in the presence of a dienophile 
and no [4+2] cycloaddition reaction occurred. Interestingly, if the reaction was heated 
to 100 oC, dimer product 34a cleanly isomerized to the thermodynamically more 
stable dihydroquinoline product 33a. This reaction was also performed in 
dichloromethane, in which dihydroquinoline 33a was formed along with the dimer 
34a in a ratio of 4:1. These observations suggest that palladium catalyzes the 
equilibration of dimers 34 and dihydroquinolines 33. To test this hypothesis, isolated 
dimer products 34a and 34c were treated with catalytic amount of Pd(PPh3)4 in 
toluene at 100 oC; however no equilibration occurred and the reactant kept intact over 
the course of the reaction. One thing to note here is that palladium black precipitated 
out the reaction solution at high temperatures. 
Scheme 31 Kinetic vs thermodynamic product 
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General observations related to dihydroquinoline synthesis 
 
 Vinyl benzoxazinanone 35a, with a terminal disubstituted olefin, was prepared 
and treated with our standard reaction conditions. No reaction occurred and starting 
material was recovered either at room temperature or 110 oC, which suggests that the 
coordination between olefin and catalyst must occur first for the reaction to proceed 
(Scheme 32). Also of note is that dihydroquinolines 35d were produced in high yield 
with no observation of dimer formation. Actually when we tried to synthesize dimer 
35i, the intramolecular cyclization was much faster and dihydroquinoline 33d was 
generated exclusively. 
Scheme 32 Intramolecular vs intermolecular cyclization 
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 An interesting observation was found with substrate 36a with two electron 
donating groups on the phenyl ring as illustrated in Scheme 33. Treatment of 36a with 
5 mol% Pd(PPh3)4 in methylene chloride did not generate the dihydroquinoline 
product 36b, even though decarboxylation did occur and a new product was formed, 
whose structure is yet to be determined. However this compound was not stable under 
the reaction conditions and polymeric products were formed if the reaction mixture 
was allowed to stand overnight. Similarly, the Ts-protection of carbamate 36a was 
problematic due to the generation of a polymer-like mixture. This result seems to 
indicate that under basic conditions, carbamate 36a generates a free aza-o-xylylene 
upon losing CO2. 
Scheme 33 Problematic reactions 
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 Vinyl benzoxazinanones with different protecting groups were also prepared and 
subjected to the decarboxylative allylic amination under our standard reaction 
conditions (Scheme 34). It was found that benzyl-protected benzoxazinanone 37a was 
not reactive, as expected considering that the decarboxylation is not favorable since 
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the pKa of the secondary amine is relatively high. The reaction only afforded a small 
amount of quinoline product 37b (3% conversion), while most of starting material 
was recovered. When N-nosyl benzoxazinanone 37c was allowed to react with 5 
mol% Pd(PPh3)4, dihydroquinoline 37d did form along with large amount of 
polymer-like byproduct. Benzoyl protected benzoxazinanone 37e was also prepared 
and treated with the standard condition to generate the oxazine product 37f in 96% 
NMR yield. 
Scheme 34 Vinyl benzoxazinanones with different protecting groups 
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 The formation of dihydroquinoline ring was thought to start by oxidative addition, 
followed by decarboxylation to generate a palladium-polarized aza-ortho-xylylene 
intermediate 38b, followed by intramolecular allylic amination to product 38d and 
regenerate the catalyst (Scheme 35). Due to unfavorable enthalpy of 4-membered ring 
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closure and bond angles, the 6-memered ring was favored as compared to the 
decarboxylative ring contraction of unsaturated analogues. 
Scheme 35 Catalytic cycle for decarboxylative dihydroquinoline synthesis via 
aza-ortho-xylylene intermediates 
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In conclusion, we have developed a unique and efficient way for 
dihydroquinoline synthesis through palladium-polarized aza-ortho-xylylene 
intermediates. Interestingly, carrying out the same reactions in less polar solvents 
such as toluene produced a 12-membered dimer product cleanly, while reactions in 
more polar dichloromethane selectively produced dihydroquinolines. Importantly, the 
reactions proceed under mild conditions and produce CO2 as the only byproduct. 
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General Experimental  
 
THF was dried over sodium metal. Toluene, methylene chloride and diethyl 
ether were dried over activated alumina on a solvent system purchased from 
Innovative Technology, Inc. Acetonitrile and 1,4-dioxane were dried and stored over 
activated molecular sieves. Commercially available reagents were used without 
additional purification unless otherwise stated. Products were purified on silica gel 
from Sorbent Technologies (230x400 mesh, 60 Å porosity, pH 6.5-7.5). Ruthenium 
and palladium compounds were obtained from Strem. Thin layer chromatography 
was performed on silica gel 60F254 plates (EM-5715-7, EMD chemicals). UV lamp 
(254 nm) or KMnO4 stain were used for monitoring TLC plates. 
1H and 13C NMR spectra were obtained on a Bruker Avance 400 or Bruker 
Avance 500 DRX spectrometer and referenced to residual protio solvent signals.  
Structural assignments are based on 1H, 13C, DEPT-135, COSY, and HMQC 
spectroscopies and X-ray data. High resolution mass spectrometry was performed on 
an AUTOSPEC-Q tandem hybrid mass spectrometer (VG Analytical Ltd, 
Manchester, UK). High resolution mass spectrometry was performed on a LCT 
Premier (Waters Corp., Milford MA) time of flight mass spectrometer. FTIR spectra 
were acquired on a Shimadzu FTIR-8400S spectrometer. HPLC analysis was 
performed on a Shimadzu SCL-10A VP instrument. 
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Preparation of Starting Materials 
 
Vinyl oxazinanone 9a, in which R1=H were prepared from the corresponding 
amino alcohols, which were synthesized by reduction of β-hydroxy nitriles with 
LAH.1 β-Hydroxy nitriles were prepared by treatment of substituted nitriles with n-
butyl lithium, followed by aldol reaction with the aldehydes. To increase the yield of 
aldol reaction, a modified procedure was used and 1.5 eq. of chloro trimethylsilane 
was added to trap the generated enolates, followed by methanol quenched.2 
To a solution of n-butyl lithium (9.6 mmol, 1.1 eq.) in THF at -78 oC under 
argon was added benzyl cyanide (1.0 g, 8.7 mmol) dropwise, and the reaction mixture 
was stirred at -78 oC for 0.5 hour before adding a solution of acrolein (486 mg, 8.7 
mmol, 1.0 eq.) in THF via cannulation. The reaction mixture turned pale yellow color 
upon addition and kept stirring at -78 oC until reaction completion indicated by TLC 
(generally 0.5 hr-1.5h). The reaction was quenched by chloro trimethylsilane (1.5 g, 
13.1 mmol, 1.5 eq.), followed by adding methanol (2.0 ml). The reaction mixture was 
extracted by ethyl acetate, washed with brine, dried over magnesium sulfate and 
concentrated to give the crude product, which was purified by flash column 
chromatography (SiO2, 5:1 Hexane: Ethyl acetate).2 
NC
OH
Ph
NC
OPh
1) n-BuLi, THF
-78oC, 0.5hr
2)
1.5 hr
3) TMSCl
H
4) MeOH
N O
O
Ts
R1
R2
R4
R3
9a
 
 
To a solution of LAH (290 mg, 7.6 mmol, 1.2 eq.) in THF under argon at 0 oC 
was slowly added a solution of cyano alcohol (1.1 g, 6.4 mmol) in THF via 
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cannulation. The resulting yellow mixture was kept stirring until reaction completion 
indicated by TLC (generally 0.5 hr). Because amino alcohols were very polar with a 
higher solubility in water, a slightly different work-up procedure was used. Small 
amount of water was added dropwise to the reaction mixture to quench the excess 
amount of LAH, which was monitored by the release of hydrogen, followed by 
adding ethyl acetate and filtration over a celite pad, dried over magnesium sulfate and 
the solvent was removed to afford the crude product which was taken to the next step 
without further purification. (One thing to note here is that the reduction step is very 
sensitive to water, and the solvent was dried over sodium metal before use.) 
The preparation of carbamates was achieved by treatment of amino alcohols 
with CDI (carbonyl diimidazole) reagent.3 The coupling step could also be performed 
stepwise by reacting with chloroformate, followed by an intramolecular cyclization 
under basic conditions.4 To a solution of amino alcohol (1.1g, 5.2 mmol) in THF at 
room temperature was added carbonyl diimidazole (CDI, 923 mg, 5.7 mmol, 1.1 eq). 
The mixture was kept stirring at room temperature until reaction completion indicated 
by TLC (generally 12 hr). Most of the THF was removed, and the residue was taken 
up with ethyl acetate, washed with dilute hydrochloric acid, brined and dried over 
magnesium sulfate and concentrated to give the crude product, which was purified by 
flash column chromatography (SiO2, 1:2 Hexane: Ethyl acetate). 
NC
OH
Ph
1.2 eq LAH OH
Ph
NH2
THF, 0 oC to rt
CDI
THF
O
Ph
HN
O
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Finally, N-protected carbamates were prepared according to literature 
procedure.5 Sodium hydride and n-butyl lithium were both used for deprotonation, 
though the latter one gave the product in better yield. To a solution of carbamate (300 
mg, 2.1 mmol) in THF at -78 oC under argon was added n-BuLi (2.3 mmol, 1.1 eq.) 
dropwise, and stirred for 1.5 hr before the addition of TsCl (486 mg, 2.6 mmol, 1.2 
eq.) in one portion. The yellow solution turned colorless upon addition of TsCl and 
monitored by TLC analysis. The reaction was quenched with sat. NH4Cl solution 
after 0.5 hr, extracted with ethyl acetate. The organic phase was washed with brined, 
dried over magnesium sulfate and concentrated to give the crude product, which was 
purified by flash column chromatography (SiO2, 1:5 Hexane: Ethyl acetate). 
O
Ph
HN
O
n-BuLi, TsCl
THF, -78oC to rt
O
Ph
N
O
Ts
 
This method was not successful when R2, R3 are both aromatic rings, in which 
1,4-addition was favored due to steric reasons. 
MeO
HO
CN
Ph
O
MeO
CN
BuLi
O
MeO
Ph
CN
N O
O
Ts
R1
R2
R4
R3
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In the case of R1=Ph, amino alcohol was efficiently synthesized from the 
corresponding adol adduct by a reductive amination protocol developed by 
Yamazaki.6 
Ph
O OH
Ph O NH3 Cl
Ph
N OHBnO LAH
Ph
NH2 OH
PhCOCH3
LDA
H
O
 
General procedure for catalytic decarboxylative ring contraction of vinyl 
oxazinanoes: 
 
In a Schlenk tube under argon, Pd(PPh3)4 (0.05 mmol) and carbamate (1 mmol) were 
dissolved in 5 mL of methylene chloride. The resulting yellow solution was stirred at 
ambient temperature under Ar until reaction completion was indicated by TLC 
(generally 10 min.-2h). Following solvent evaporation, the crude product was purified 
via flash chromatography (SiO2, 7:1 Hexane: Ethyl acetate). 
Spectroscopic Data  
 
N O
O
Ts
Ph
5-phenyl-3-tosyl-6-vinyl-1,3-oxazinan-2-one
 
10a (cw1293) 
Colorless oil 
 
1H NMR (400 MHz, CDCl3) δ ppm 7.90 (d, 2H, J = 8.3 Hz: arom H), 7.31 - 7.43 (m, 
4H: arom H), 7.21 (dd, 2H, J=7.7, 1.6 Hz: arom H), 5.62 (ddd, 1H, J=17.1, 10.7, 5.9 
Hz: CH=), 5.27 (dt, 1H, J=17.1, 1.1 Hz: CH=CH(H)E), 5.19 (dt, 1H, J=10.6, 1.0 Hz: 
CH=CH(H)Z), 4.95 (dd, 1H, J=9.4, 5.8 Hz: OCH), 4.28 (dd, 1H, J=12.2, 5.2 Hz: 
diastereotopic CH2NTs), 3.98 (dd, 1H, J=12.2, 10.5 Hz: diastereotopic CH2NTs), 
3.12 (td, 1H, J=9.9, 5.2 Hz: PhCH), 2.46 (s, 3H: CH3). 
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Ph
N
Ts
3-phenyl-1-tosyl-2-vinylazetidine
 
13a(cw2028) 
White solid 
Pd(PPh3)4: 74% yield, dr = 16 
 
1H NMR (400 MHz, CDCl3) δ 7.81 (d, 2H, J = 8.3 Hz: arom H), 7.43 (d, 2H, J = 7.8 
Hz: arom H), 7.22 (m, 3H: arom H), 6.88 (m, 3H: arom H), 6.06 (m, 1H: =CH),  5.35 
(d, 1H, J = 17.2 Hz: CH=CH(H)E), 5.24 (d, 1H, J = 10.4 Hz: CH=CH(H)Z), 4.35 (t, 
1H, J =7.6 Hz: CHNTs), 4.06 (t, 1H, J =7.8 Hz: CH2), 3.77 (t, 1H, J =8.1Hz: CH2), 
3.52 (q, 1H, J = 8.3, 16.4 Hz: PhCH), 2.51 (s, 3H: CH3). 
 
13C NMR (100 MHz, CDCl3) δ 144.52 (Quat.), 139.33 (Quat.), 136.96 (=CH), 
132.92 (Quat.), 130.14 (Arom. CH), 129.05 (Arom. CH), 128.95 (Arom. CH), 127.63 
(Arom. CH), 127.38 (Arom. CH), 118.24 (=CH2), 72.74 (CHNTs), 54.44 (CH2), 
41.96 (CHPh), 21.95 (CH3). The assignments of the 1H and 13C were based on DEPT, 
COSY, HMQC etc.  
 
FTIR (CDCl3): νmax 3088, 3065, 3032, 1599, 1495, 1346, 1165, 818, 669.  
 
HRMS calcd for C18H20NO2S [M+H] 314.1215, found 314.1201. 
 
N O
O
Ts
Ph
Ph
5-phenyl-6-styryl-3-tosyl-1,3-oxazinan-2-one
 
14a (cw2117) 
Colorless oil 
 
1H NMR (400 MHz, CDCl3) δ ppm 7.92 (d, 1H, J=8.4 Hz: arom H), 7.34 (m, 6H: 
arom H), 7.22 (m, 6H: arom H), 6.54 (d, 1H, J=16.0 Hz: =CHPh), 5.92 (dd, 1H, 
J=15.9, 6.3 Hz: CH=), 5.12 (ddd, 1H, J=9.5, 6.3, 1.2 Hz: OCH), 4.32 (dd, 1H, J=12.2, 
5.2 Hz: diastereotopic CH2NTs), 4.01 (dd, 1H, J=12.2, 10.6 Hz: diastereotopic 
CH2NTs), 3.21 (td, 1H, J=10.0, 5.1 Hz: CHPh), 2.46 (s, 3H: CH3). 
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Ph
N
Ts
Ph
3-phenyl-2-styryl-1-tosylazetidine
 
13b (cw2121) 
White solid 
Pd(PPh3)4: 62% yield, dr = >19:1 
 
1H NMR (400 MHz, CDCl3) δ 7.86 (d, 2H, J = 8.3 Hz: arom H), 7.44 (d, 2H, J = 7.8 
Hz: arom H), 7.34 (m, 4.6H: arom H), 7.25 (m, 3.4H: arom H),  6.90 (m, 2H: arom 
H), 6.59 (d, 1H, J = 15.9 Hz: =CHPh), 6.39 (dd, 1H, J = 7.1, 15.9 Hz: =CH), 4.50 (t, 
1H, J =7.3 Hz: CHNTs), 4.12 (t, 1H, J =8.3 Hz,: CH2), 3.83 (t, 1H, J =8.3Hz: CH2), 
3.61 (q, 1H, J = 8.3, 16.2 Hz: PhCH), 2.49 (s, 3H: CH3). 
 
13C NMR (100 MHz, CDCl3) δ 144.74 (Quat.), 139.26 (Quat.), 136.44 (Quat.), 
133.31 (=CHPh), 132.61 (Quat.), 130.27-127.19 (overlapping Arom. CH, =CH), 
72.94 (CHNTs), 54.37 (CH2), 42.56 (CHPh), 22.05 (CH3). The assignments of the 1H 
and 13C were based on DEPT, COSY, HMQC etc. 
 
FTIR (CDCl3): νmax 3084, 3065, 3032, 1599, 1495, 1346, 1163, 966, 816, 750, 669.   
 
HRMS calcd for C24H24NO2S [M+H] 390.1528, found 390.1547. 
 
N O
O
Ts
Cl
5-(4-chlorophenyl)-3-tosyl-6-vinyl-1,3-oxazinan-2-one
 
12a (cw2098) 
Colorless oil 
 
1H NMR (400 MHz, CDCl3) δ ppm 7.88 (d, 2H, J=8.3 Hz: arom H), 7.34 (t, 4H, 
J=7.0 Hz: arom H), 7.14 (m, 2H: arom H), 5.61 (ddd, 1H, J=17.0, 10.7, 5.9 Hz: CH=), 
5.27 (d, 1H, J=17.2 Hz: CH=CH(H)E), 5.22 (d, 1H, J=10.5 Hz: CH=CH(H)Z), 4.91 
(m, 1H: OCH), 4.25 (dd, 1H, J=12.3, 5.1 Hz: diastereotopic CH2NTs), 3.95 (m, 1H: 
diastereotopic CH2NTs), 3.12 (ddd, 1H, J=9.5, 4.9, 4.8 Hz: ArCH), 2.47 (s, 3H: CH3). 
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13C NMR (100 MHz, CDCl3) δ ppm 148.5 (NCO2), 145.8 (Quat.), 135.2 (Quat.), 
134.6 (Quat.), 133.6 (Quat.), 130.8 (CH=), 129.9 (Arom. CH), 129.8 (Arom. CH), 
129.6 (Arom. CH), 129.3 (Arom. CH), 120.5 (=CH2), 81.2 (OCH), 47.8 (CH2NTs), 
41.0 (ArCH), 22.2 (CH3). 
 
N
Ts
Cl
3-(4-chlorophenyl)-1-tosyl-2-vinylazetidine
 
13e (cw2100) 
colorless oil 
Pd(PPh3)4: 78% yield, dr >19:1 
 
1H NMR (400 MHz, CDCl3) δ 7.78 (d, 2H, J = 8.3 Hz: arom H), 7.44 (d, 2H, J = 8.1 
Hz: arom H), 7.20 (d, 2H, J = 8.6Hz: arom H), 6.76 (d, 2H, J = 8.6Hz: arom H), 6.03 
(m, 1H: =CH),  5.32 (d, 1H, J = 17.2 Hz: CH=CH(H)E), 5.23 (d, 1H, J = 10.4 Hz: 
CH=CH(H)Z), 4.25 (t, 1H, J =7.1 Hz: CHNTs), 4.05 (t, 1H, J =8.1 Hz: CH2), 3.69 (t, 
1H, J =8.4Hz: CH2), 3.48 (q, 1H, J =8.3, 16.4 Hz: ArCH), 2.52 (s, 3H: CH3). 
 
 
13C NMR (100 MHz, CDCl3) δ 144.36 (Quat.), 137.35 (Quat.), 136.24 (=CH), 
133.28 (Quat.), 131.97 (Quat.), 129.86-128.37 (Arom. CH), 118.27 (=CH2), 72.47 
(CHNTs), 53.97 (CH2), 40.91 (CHAr), 21.68 (CH3). The assignments of the 1H and 
13C were based on DEPT, COSY, HMQC etc. 
 
FTIR (CDCl3): νmax  3087, 3031, 1600, 1495, 1348, 1165, 1094, 820, 669. 
 
HRMS calcd for C18H19ClNO2S [M+H] 348.0825, found 348.0820. 
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N O
O
Ts
OMe
5-(4-methoxyphenyl)-3-tosyl-6-vinyl-1,3-oxazinan-2-one
 
cw2136 
White solid 
 
1H NMR (400 MHz, CDCl3) δ ppm 7.91 (d, 1H, J=8.5 Hz: arom H), 7.34 (d, 1H, 
J=8.1Hz: arom H), 7.12 (d, 1H, J=8.8 Hz: arom H), 6.91 (d, 1H, J=8.7 Hz: arom H), 
5.61 (ddd, 1H, J=16.9, 10.7, 5.8 Hz: CH=), 5.27 (d, 1H, J=17.2 Hz: CH=CH(H)E), 
5.19 (d, 1H, J=10.6 Hz: CH=CH(H)Z), 4.90 (dd, 1H, J=9.5, 5.8 Hz: OCH), 4.25 (dd, 
1H, J=12.2, 5.3 Hz: diastereotopic CH2NTs), 3.93 (dd, 1H, J=12.2, 10.7 Hz: 
diastereotopic CH2NTs), 3.83 (s, 3H: OCH3), 3.07 (td, 1H, J=10.0, 5.2 Hz: ArCH), 
2.47 (s, 3H: CH3). 
 
MeO
N
Ts
3-(4-methoxyphenyl)-1-tosyl-2-vinylazetidine
 
13f (cw2140) 
White solid  
Pd(PPh3)4: 84% yield, dr = 14:1 
 
1H NMR (400 MHz, CDCl3) δ 7.81 (d, 2H, J = 8.3 Hz: arom H), 7.42 (d, 2H, J = 8.6 
Hz: arom H), 7.22 (m, 3H: arom H), 6.75 (s, 4H: arom H), 6.04 (m, 1H: =CH),  5.26 
(dd, 2H, J = 10.4, 16.9 Hz: =CH2), 4.24 (t, 1H, J =7.1 Hz: CHNTs), 4.04 (t, 1H, J 
=7.8 Hz: CH2), 3.77 (s, 3H: OCH3), 3.68 (t, 1H, J =7.8Hz: CH2), 3.46 (q, 1H: ArCH), 
2.52 (s, 3H: CH3). 
 
13C NMR (100 MHz, CDCl3) δ 159.25 (Quat.), 144.60 (Quat.), 136.91 (=CH), 
132.41 (Quat.), 131.26 (Quat.), 130.22-128.56 (Arom. CH), 118.26 (=CH2), 114.42 
(Arom. CH), 73.26 (CHNTs), 55.68 (OCH3), 54.89 (CH2), 41.42 (CHAr), 22.07 
(CH3). The assignments of the 1H and 13C were based on DEPT, COSY, HMQC etc. 
 
FTIR (CDCl3): νmax 3065, 3005, 1516, 1466, 1346, 1250, 1165, 829, 818. 
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HRMS calcd for C19H22NO3S [M+H] 344.1320, found 344.1315. 
 
N O
O
Ts
Ph
5-benzyl-3-tosyl-6-vinyl-1,3-oxazinan-2-one
 
12c (cw2164) 
White solid, dr = 1:1 
 
1H NMR (400 MHz, CDCl3) δ ppm 7.90 (t, 4H, J=8.4 Hz: arom H (cis/trans)), 7.34 
(m, 10H: arom H (cis/trans)), 7.15 (dd, 4H, J=16.9, 7.0 Hz: arom H (cis/trans)), 5.91 
(td, 1H, J=11.3, 5.4 Hz: =CH (cis/trans)), 5.81 (ddd, 1H, J=17.0, 10.8, 5.9 Hz: =CH 
(cis/trans)), 5.38 (m, 4H: =CH2 (cis/trans)), 4.61 (t, 1H: OCH (cis/trans)), 4.83 (br. s., 
1H: OCH (cis/trans)), 3.88 (dd, 1H, J=12.2, 4.8 Hz: CH2NTs (cis/trans)), 3.69 (ddd, 
1H, J=11.9, 7.5, 7.4 Hz: CH2NTs (cis/trans)), 2.90 (dd, 1H, J=14.0, 5.9 Hz: CH2Ph 
(cis/trans)), 2.78 (d, 1H, J=7.8 Hz: CH2Ph (cis/trans)), 2.56 (m, 3H: overlapping 
CH2Ph, BnCH (cis/trans)), 2.47 (s, 3H: CH3 (cis/trans)), 2.46 (s, 3H: CH3 (cis/trans)), 
2.28 (m, 1H: BnCH (cis/trans)). 
 
N
Ts
Ph
3-benzyl-1-tosyl-2-vinylazetidine
 
13g (cw2170) 
White solid 
Pd(PPh3)4: 60% yield, dr = 8.5 
 
1H NMR (400 MHz, CDCl3) δ 7.74 (d, J = 8.3 Hz, 2H: arom H), 7.37 (d, J =8.6 Hz, 
2H: arom H), 7.23 (m, 3H: arom H), 7.25 (d, J = 7.1 Hz, 2H: arom H), 5.85 (m, 1H: 
=CH), 5.14 (dd, J = 9.8, 17.7 Hz, 1H: =CH2), 4.04 (t, 1H, J =6.8 Hz: CHNTs), 3.78 
(t, J =7.8 Hz, 1H: CH2NTs), 3.36 (t, J =7.6Hz, 1H: CH2NTs), 2.62 (m, 1H: BnCH), 
2.50 (m, 5H: overlapping CH2, CH3). 
 
13C NMR (100 MHz, CDCl3) δ 144.42 (Quat.), 138.26 (Quat.), 137.02 (=CH), 
132.62 (Quat.), 130.07-126.93 (Arom. CH), 117.74 (=CH2), 70.47 (CHNTs), 53.45 
(CH2NTs), 38.97 (CH2Ph), 38.31 (CHBn), 22.08 (CH3). The assignments of the 1H 
and 13C were based on DEPT, COSY, HMQC etc. 
 
FTIR (CDCl3): νmax 3086, 3065, 3030, 1599, 1497, 1344, 1165, 816, 669. 
 
HRMS calcd for C19H22NO2S [M+H] 328.1371, found 328.1360. 
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N O
O
Ts
5-isopropyl-3-tosyl-6-vinyl-1,3-oxazinan-2-one
 
12d (cw3099) 
White solid, dr = 1:1 
 
1H NMR (400 MHz, CDCl3) δ ppm 7.93 (t, 4H, J=7.8 Hz: arom H (cis/trans)), 7.35 
(d, 4H: arom H (cis/trans)), 5.81 (m, 2H: =CH (cis/trans)), 5.34 (m, 4H: =CH2 
(cis/trans)), 4.93 (br. s., 1H: OCH (cis/trans)), 4.72 (t, 1H, J=6.5 Hz: OCH (cis/trans)), 
4.12 (ddd, 1H, J=11.7, 5.3, 1.6 Hz: CH2NTs (cis/trans)), 3.93 (m, 1H: CH2NTs 
(cis/trans)), 3.84 (m, 1H: CH2NTs (cis/trans)), 3.48 (t, 1H, J=11.9 Hz: CH2NTs 
(cis/trans)), 2.46 (s, 6H: CH3Ts (cis/trans)), 1.91 (m, 2H: overlapping CH(CH3)2, 
CHCH2NTs (cis/trans)), 1.78 (m, 1H: overlapping CH(CH3)2, CHCH2NTs (cis/trans)), 
1.59 (m, 1H: overlapping CH(CH3)2, CHCH2 (cis/trans)), 1.06 (m, 8H: CH3 
(cis/trans)), 0.99 (d, 4H, J = 6.8 Hz: CH3 (cis/trans)). 
 
N
Ts
3-isopropyl-1-tosyl-2-vinylazetidine
 
13h (cw2239) 
colorless oil 
Pd(PPh3)4: 93% yield, dr >19:1 
 
1H NMR (400 MHz, CDCl3) δ 7.73 (d, J = 8.3 Hz, 2H: arom H), 7.38 (d, J =8.1 Hz, 
2H: arom H), 5.85 (m, 1H: =CH), 5.33 (d, J = 16.9 Hz, 1H: =CH2(H)E), 5.18 (d, J = 
10.4 Hz, 1H: =CH2(H)Z), 3.95 (t, 1H, J =7.1 Hz: CHNTs), 3.74 (t, J =7.8 Hz, 1H: 
CH2NTs), 3.24 (t, J =7.8Hz, 1H: CH2NTs), 2.46 (s, 3H: CH3(Ts)), 2.01 (m, 1H: CH), 
1.29 (m, 1H: CH(CH3)2), 0.72 (d, J =6.6Hz, 3H: CH3), 0.68 (d, J =6.6Hz, 3H: CH3). 
 
13C NMR (100 MHz, CDCl3) δ 144.31 (Quat.), 137.99 (=CH), 130.03 (Quat.), 
130.03 (Arom. CH), 128.75 (Arom. CH), 117.68 (=CH2), 70.12 (CHNTs), 52.51 
(CH2NTs), 44.20 (CH), 32.51 (CH(CH3)2), 22.03 (CH3(Ts)), 19.71/19.59 (CH3). The 
assignments of the 1H and 13C were based on DEPT, COSY, HMQC, NOESY etc. 
 
FTIR (CDCl3): νmax 3053, 1599, 1495, 1344, 1163, 818, 671.   
 
HRMS calcd for C15H21NO2SNa [M+Na] 302.1191, found 302.1191. 
 
 125 
N O
O
Ts
Ph
4-phenyl-3-tosyl-6-vinyl-1,3-oxazinan-2-one
 
17a (cw2212) 
White solid 
 
1H NMR (400 MHz, CDCl3) δ ppm 7.23 - 7.37 (m, 5H: arom H), 7.15 (d, 2H, J=7.8 
Hz: arom H), 7.04 (d, 2H, J=8.6 Hz: arom H), 5.84 (ddd, 1H, J=17.1, 10.8, 5.9 Hz: 
CH=), 5.47 (m, 2H: overlapping CH=CH(H)E and CHPh), 5.32 (d, 1H, J=10.6 Hz: 
CH=CH(H)Z), 4.91 (dd, 1H, J=11.3, 5.9 Hz: OCH), 2.63 (ddd, 1H, J=14.4, 8.1, 1.9 
Hz: diastereotopic CH2), 2.36 (s, 3H: CH3), 2.04 (dt, 1H, J=14.4, 11.0 Hz: 
diastereotopic CH2). 
 
N
TsPh
2-phenyl-1-tosyl-4-vinylazetidine
 
13i (cw2221) 
colorless oil 
Pd(PPh3)4: 92% yield, dr >19:1 
 
1H NMR (400 MHz, CDCl3) δ 7.68 (d, J = 8.3 Hz, 2H: arom H), 7.42 (d, J = 7.1 Hz, 
2H: arom H), 7.33 (m, 5H: arom H), 6.06 (m, 1H: =CH), 5.38 (d, 1H, J = 17.2 Hz: 
CH=CH(H)E), 5.25 (d, 1H, J = 10.4 Hz: CH=CH(H)Z), 4.81 (t, 1H, J =8.3 Hz: 
PhCH), 4.41 (q, J =8.1, 4.9 Hz, 1H: CHCH=CH2), 2.61 (d t, J =8.3, 10.9 Hz, 1H: 
CH2), 2.45(s, 3H: CH3), 1.99(d t, J =8.3, 10.9 Hz, 1H: CH2). 
 
13C NMR (100 MHz, CDCl3) δ 141.05 (Quat.), 141.05 (Quat.), 137.92 (=CH), 
133.46 (Quat.), 130.02-126.96 (Arom. CH), 117.71 (=CH2), 62.66 (PhCH), 66.19 
(CHCH=CH2), 33.68 (CH2), 22.02 (CH3). The assignments of the 1H and 13C were 
based on DEPT, COSY, HMQC, NOESY etc. 
 
FTIR (CDCl3): νmax 3087, 3066, 3031, 1599, 1495, 1346, 1163, 816, 748, 665. 
 
HRMS calcd for C18H20NO2S [M+H] 314.1215, found 314.1216; C18H19NO2SNa 
[M+Na] 336.1034, found 336.1048. 
 
 126 
N O
O
Ts
4-methyl-3-tosyl-6-vinyl-1,3-oxazinan-2-one
 
cw2243 
colorless oil 
 
1H NMR (400 MHz, CDCl3) δ ppm 7.99 (d, 2H, J=8.7 Hz: arom H), 7.33 (dd, 2H, 
J=8.1, 0.6 Hz: arom H), 5.84 (ddd, 1H, J=17.2, 10.7, 5.6 Hz: CH=), 5.40 (dd, 1H, 
J=17.2, 0.9 Hz: CH=CH(H)E), 5.29 (d, 1H, J=10.7 Hz: CH=CH(H)Z), 4.66 (m, 2H: 
overlapping CHCH3 and OCH), 2.45 (m, 4H: overlapping CH3NTs and 
diastereotopic CH2), 1.77 (dt, 1H, J=14.1, 9.7 Hz: diastereotopic CH2), 1.49 (s, 3H: 
CH3). 
 
N
Ts
2-methyl-1-tosyl-4-vinylazetidine
 
13j (cw2247) 
White solid 
Pd(PPh3)4: 78% yield, dr = 8:1 
 
1H NMR (400 MHz, CDCl3) δ 7.71 (d, J = 8.1 Hz, 2H: arom H), 7.36 (d, J =7.8 Hz, 
2H: arom H), 5.95 (m, 1H: =CH), 5.26 (td, J = 1.3, 17.2 Hz, 1H: =CH2(H)E), 5.14 (d, 
J =1.3, 10.4 Hz, 1H: =CH2(H)Z), 4.11 (q, 1H, J =8.1, 15.2 Hz: CHNTs), 3.82 (m, 1H: 
CHCH3), 2.46 (s, 3H: CH3(Ts)), 2.26 (m, 1H: CH2), 1.68 (m, 1H: CH2), 1.40 (d, J 
=6.3 Hz, 3H: CH3). 
 
13C NMR (100 MHz, CDCl3) δ 143.85 (Quat.), 137.94 (=CH), 132.66 (Quat.), 
129.65 (Arom. CH), 128.34 (Arom. CH), 116.91 (=CH2), 61.47 (CHNTs), 56.68 
(CHCH3), 31.68 (CH2), 22.56 (CH3), 21.61 (CH3(Ts)),. The assignments of the 1H 
and 13C were based on DEPT, COSY, HMQC, NOESY etc. 
 
FTIR (CDCl3): νmax 3055, 1600, 1495, 1342, 1163, 818. 
 
HRMS calcd for C13H18NO2S [M+H] 252.1058, found 252.1056. 
 
 127 
N O
O
Ts
Ph
6-phenyl-3-tosyl-6-vinyl-1,3-oxazinan-2-one
 
15a (cw2223) 
White solid 
 
1H NMR (400 MHz, CDCl3) δ ppm 7.80 (dd, 2H, J=8.3, 1.5 Hz: arom H), 7.31 (m, 
7H: arom H), 6.02 (ddd, 1H, J=17.2, 10.8, 1.4 Hz: CH=), 5.26 (dd, 1H, J=7.4, 1.4 Hz: 
CH=CH(H)Z), 5.24 (dd, 1H, J=13.9, 1.3 Hz: CH=CH(H)E), 3.96 (dddd, 1H, J=12.0, 
6.8, 5.2, 1.2 Hz: diastereotopic CH2NTs), 3.75 (m, 1H: diastereotopic CH2NTs), 2.47 
(m, 5H: overlapping: CH3 and CH2). 
 
N
Ts
Ph
4-phenyl-1-tosyl-1,2,3,6-tetrahydropyridine
 
15b (cw2226) 
White solid 
Pd(PPh3)4: 99% yield 
 
1H NMR (400 MHz, CDCl3) δ 7.75 (d, J = 8.1 Hz, 2H: arom H), 7.34 (m, 7H: arom 
H), 5.98 (broad s, 1H: =CH), 3.78 (broad s, 2H: =HCCH2NTs), 3.34 (t, 2H, J =5.6 
Hz: TsNCH2), 2.64 (broad s, 2H: CH2), 2.46 (s, 3H: CH3). 
 
13C NMR (100 MHz, CDCl3) δ 144.10 (Quat.), 140.50 (Quat.), 135.76 (Quat.), 
133.42 (Quat.), 130.12-125.40 (Arom. CH), 119.40 (=CH), 45.69 (=HCCH2NTs) 
43.45 (CH2NTs), 27.96 (CH2), 21.98 (CH3). The assignments of the 1H and 13C were 
based on DEPT, COSY, HMQC etc. 
 
FTIR (CDCl3): νmax 3065, 3033, 1597, 1495, 1342, 1167, 816, 673. 
 
HRMS calcd for C18H20NO2S [M+H] 314.1215, found 314.1212. 
 
 
 128 
N O
O
Ts
6-methyl-3-tosyl-6-vinyl-1,3-oxazinan-2-one
 
15c (cw2189) 
colorless oil 
 
1H NMR (400 MHz, CDCl3) δ ppm 7.85 (d, 2H, J=8.1 Hz: arom H), 7.38 (d, 2H, 
J=8.4 Hz: arom H), 5.82 (ddd, 1H, J=17.2, 10.9, 0.8 Hz: CH=), 5.21 (d, 1H, J=10.9 
Hz: CH=CH(H)Z), 5.08 (d, 1H, J=17.2 Hz: CH=CH(H)E), 4.07 (dt, 1H, J=11.9, 4.6 
Hz: diastereotopic CH2NTs), 3.73 (td, 1H, J=11.8, 5.0 Hz: diastereotopic CH2NTs), 
2.48 (s, 3H: CH3Ts), 2.07 (m, 2H: CH2), 1.45 (s, 3H: CH3). 
 
NH
Ts
4-methyl-N -(3-methylenepent-4-enyl)benzenesulfonamide
 
15d (cw2201) 
colorless oil 
Pd(PPh3)4: 40% yield 
 
1H NMR (400 MHz, CDCl3) δ 7.76 (d, J = 8.3 Hz, 2H: arom H), 7.33 (d, J = 8.5 Hz, 
2H: arom H), 6.29 (dd, 1H, J=17.7, 10.8 Hz: CH=CH2), 4.92-5.19 (m, 4H: 
overlapping =CH2), 4.50 (s, 1H: NHTs), 3.12 (q, J=6.7 Hz, 2H: CH2NHTs), 2.45 (s, 
3H: CH3Ts). 2.41 (t, 2H, J=6.9 Hz: CH2) 
 
13C NMR (100 MHz, CDCl3) δ ppm 143.85 (Quat.), 142.57 (Quat.), 138.10 (CH=), 
137.37 (Quat.), 130.13 (Arom. CH), 127.53 (Arom. CH), 118.57 (overlapping 
=CH2), 114.65 (overlapping =CH2), 41.82 (CH2NHTs), 21.98 (CH3), 31.93 (CH2). 
 
N
O
O
Ts
3-tosyl-1-oxa-3-azaspiro[5.5]undec-7-en-2-one
 
15e (cw2122) 
colorless oil 
 
1H NMR (400 MHz, CDCl3) δ ppm 7.95 (d, 2 H, J=8.3 Hz: arom H), 7.34 (dt, 2H, 
J=8.0, 0.7 Hz: arom H), 6.02 (ddd, 1H, J=10.1, 4.2, 3.2 Hz: =CHCH2), 5.62 (d, 1 H, 
J=10.2 Hz: =CH), 4.02 (ddd, 2H, J=6.8, 6.0, 1.2 Hz: CH2NHTs), 2.45 (s, 3 H: CH3), 
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2.05 (m, 5H: overlapping CH2), 1.87 (m, 1H: overlapping CH2), 1.67 (m, 2H: 
overlapping CH2). 
 
NHTs
N-(2-(cyclohexa-1,3-dienyl)ethyl)-4-methylbenzenesulfonamide
 
15f (cw2129) 
colorless oil 
Pd(PPh3)4: 99% yield 
 
1H NMR (400 MHz, CDCl3) δ ppm 7.75 (d, 2H, J=8.3 Hz: arom H), 7.32 (d, 2H, 
J=8.6 Hz: arom H), 5.82 (m, 1H: =CHCH2), 5.65 (d, 1H, J=9.6 Hz: CH=), 5.47 (br. s., 
1H: CH=C(Quat.)), 4.46 (s, 1H: NHTs), 3.02 (q, 2H, J=6.1 Hz: CH2NHTs), 2.45 (s, 
3H, overlapping CH2), 2.16 (t, 3H, J=6.7 Hz: overlapping CH2), 2.08 (s, 3H: CH3). 
 
13C NMR (100 MHz, CDCl3) δ ppm 143.80 (Quat.), 137.27 (Quat.), 132.00 (Quat.), 
130.11 (Arom. CH), 128.52 (CH=), 127.54 (Arom. CH), 126.02 (CH=), 123.89 
(CH=), 41.74 (CH2NHTs), 35.55 (CH2), 22.62 (CH2), 22.58 (CH2), 21.98 (CH3). 
  
N
Ts
Ph
2-phenyl-1-tosyl-1,2,3,6-tetrahydropyridine
 
17b (cw2222) 
White solid 
Pd(PPh3)4: 68% yield 
 
1H NMR (400 MHz, CDCl3) δ 7.71 (d, J = 7.8, 2H: arom H), 7.38 (d, J = 8.3, 2H: 
arom H), 7.29 (m, 5H: arom H), 5.81 (m, 1H: PhCHCH2=CH), 5.61 (m, 1H, =CH), 
5.32 (br d, 1H, J =5.6 Hz: PhCH), 4.14 (br d , J =17.7 Hz, 1H: CH2NTs), 3.42 (br d, J 
=19.7 Hz, 1H: CH2NTs), 2.43 (5H: overlapping CH2CHPh, CH3). 
 
13C NMR (100 MHz, CDCl3) δ 134.51 (Quat.), 139.58 (Quat.), 138.12 (Quat.), 
129.95-127.43 (Arom. CH), 124.32 (PhCHCH2=CH), 124.13 (=CH), 53.21 (PhCH) 
41.21 (CH2NTs), 26.76 (CH2), 21.95 (CH3). The assignments of the 1H and 13C were 
based on DEPT, COSY, HMQC etc. 
 
FTIR (CDCl3): νmax 3065, 3040, 1599, 1494, 1344, 1161, 816, 654. 
 
HRMS calcd for C18H20NO2S [M+H] 314.1215, found 314.1219; C18H19NO2SNa 
[M+Na] 336.1034, found 336.1038. 
 
 130 
N O
O
Ts
3-tosyl-6-vinyl-1,3-oxazinan-2-one
 
18a (cw2152) 
colorless oil 
 
1H NMR (400 MHz, CDCl3) δ ppm 7.04 (d, 1H, J=8.4 Hz: arom H), 7.36 (d, 1H, 
J=8.0 Hz: arom H), 5.83 (ddd, 1H, J=17.2, 10.7, 5.3 Hz: CH=), 5.32 (m, 1H: =CH2), 
4.84 (m, 1H: OCH), 4.08 (dt, 1H, J =12.0, 5.3 Hz: CH2NTs), 3.91 (d, 1H, J=12.0, 9.5, 
4.9 Hz: CH2NTs), 2.46 (s, 3H: CH3), 2.25 (m, 1H: CH2), 1.98 (m, 1H: CH2). 
 
N
Ts
N
Ts
(4E ,10E)-1,7-ditosyl-1,7-diazacyclododeca-4,10-diene
 
18c (cw2180) 
White solid 
Pd(PPh3)4: 26% yield 
 
1H NMR (400 MHz, CDCl3) δ ppm 7.72 (d, 4H, J=8.3 Hz: arom H), 7.72 (d, 4H, 
J=8.6 Hz: arom H), 5.62 (dt, 1H, J =15.6, 6.8 Hz: CH=), 5.45 (dt, 1H, J =15.4, 5.8 Hz: 
CH=), 3.58 (d, 4H, J=5.8 Hz: CH2NTs), 3.20 (m, 4H: CH2=), 2.45 (s, 6H: CH3), 2.41 
(m, 4H: CH2). 
 
N O
OO
Ph
Bn
3-benzoyl-5-benzyl-6-vinyl-1,3-oxazinan-2-one
 
19a (cw2166) 
White solid, dr = 1:1 
 
1H NMR (400 MHz, CDCl3) δ ppm 7.20 - 7.59 (m, 10H: arom H (cis/trans)), 6.10 (m, 
1H: =CH (cis/trans)), 5.97 (m, 1H: =CH (cis/trans)), 5.55 (m, 4H: =CH2 (cis/trans)), 
4.95 (br. s., 1H: OCH (cis/trans)), 4.74 (br. s., 1H: OCH (cis/trans)), 3.96 (d, 1H, 
J=13.3 Hz: CH2NTs (cis/trans)), 3.88 (ddd, 1H, J=12.8, 5.4, 4.2 Hz: CH2NTs 
(cis/trans)), 3.59 (m, 2H: CH2NTs (cis/trans)), 3.02 (ddd, 1H, J=13.9, 4.5, 4.3 Hz: 
overlapping CH2Ph, CHBn (cis/trans)), 2.83 (m, 1H: overlapping CH2Ph, CHBn 
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(cis/trans)), 2.66 (m, 3H: overlapping CH2Ph, CHBn (cis/trans)), 2.39 (m, 1H: 
overlapping CH2Ph, CHBn (cis/trans)). 
 
 
N O
Ph
Bn
5-benzyl-2-phenyl-6-vinyl-5,6-dihydro-4H-1,3-oxazine
 
19b (cw2179) 
White solid 
Pd(PPh3)4: 60% yield, dr = 1.5:1 
 
1H NMR (400 MHz, CDCl3) Major diastereoisomer: δ ppm 8.00 (m, 2 H: arom H, 
overlapping minor/major isomers), 7.44 (m, 3 H: arom H, overlapping minor/major 
isomers), 7.33 (m, 2 H: arom H, overlapping minor/major isomers), 7.26 (m, 3 H: 
arom H, overlapping minor/major isomers), 6.00 (m,1 H, overlapping minor/major 
isomer: CH=), 5.40 (m, 2 H: =CH2), 4.60 (t, 1 H, J=5.9 Hz: OCH), 3.59 (dd, 1 H, d, 
J=16.8, 4.9 Hz: CH2N), 3.37 (td, 1 H, J=16.6, 8.1 Hz: CH2N), 2.94 (dd, 1 H, J=13.6, 
6.3 Hz: CH2Ph), 2.58 (m, 1 H: CH2Ph), 2.08 (m, 1 H: CHBn). 
 
Minor diastereoisomer: δ ppm 8.00 (m, 2 H: arom H, overlapping minor/major 
isomers), 7.44 (m, 3 H: arom H, overlapping minor/major isomers), 7.33 (m, 2 H: 
arom H, overlapping minor/major isomers), 7.26 (m, 3 H: arom H, overlapping 
minor/major isomers), 6.00 (m,1 H, overlapping minor/major isomer: CH=), 5.40 (m, 
2 H: =CH2), 4.87 (t, 1 H, J=3.7 Hz: OCH), 3.59 (dd, 1 H, d, J=16.8, 4.9 Hz: CH2N), 
3.37 (td, 1 H, J=16.6, 8.1 Hz: CH2N), 2.68 - 2.73 (m, 1 H: CH2Ph), 2.58 (m, 1 H: 
CH2Ph), 2.43 (m, 1 H: CHBn). 
 
13C NMR (100 MHz, CDCl3) δ ppm 155.14 (C=N), 139.55 (C=N), 139.40 (Quat.), 
136.43 (CH=), 134.15 (Quat.), 133.60 (CH=), 126.81-130.85 (Arom. CH), 118.75 
(=CH2), 118.30 (=CH2), 78.94 (OCH), 77.67 (OCH), 46.29 (CH2N), 37.37 (CHBn), 
37.26 (CHBn), 37.05 (CH2Ph), 34.66 (CH2Ph) (1.5:1 diastereomixture). The 
assignments of the 1H and 13C were based on DEPT, COSY, HMQC etc. 
 
FTIR (CDCl3): νmax 3062, 3030, 2926, 1657, 1581, 1495, 1117. 
 
HRMS calcd for C19H20NO [M+H] 278.1545, found 278.1527. 
 
 132 
NH
O
Ph
Bn
N-(2-benzylpenta-2,4-dienyl)benzamide
 
19c (cw2182) 
colorless oil 
Pd(PPh3)4: 96% NMR yield, dr =1.1:1 
 
1H NMR (400 MHz, CDCl3) Major diastereoisomer: δ ppm 7.72 (m, 3H: arom H), 
7.53 (m, 4H: arom H), 6.98 - 7.19 (m, 3 H: arom H), 6.66 (m, 1H: CH=), 6.01 (d, 1H, 
J=11.1 Hz: BnC=CH), 5.68 (br. s., 1H: NH), 5.15 (m, 2H; =CH2), 3.99 (d, 2H, J=5.6 
Hz: CH2NH), 3.42 (s, 2H: CH2Ph). 
 
Minor diastereoisomer: δ ppm 7.72 (m, 3H: arom H), 7.53 (m, 4H: arom H), 6.98 - 
7.19 (m, 3 H: arom H), 6.77 (m, 1H: CH=), 6.14 (d, 1H, J=11.1 Hz: BnC=CH), 5.68 
(br. s., 1H: NH), 5.15 (m, 2 H; =CH2), 4.18 (d, 2H, J=5.6 Hz: CH2N), 3.99 (s, 2H: 
CH2Ph). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 133 
General procedure for synthesizing starting vinyl benzoxazinanones: 
Amino benzalehydes were synthesized by oxidation of the corresponding 
amino alcohols except commercially available ones. N-protected carbamates were 
prepared from amino aldehydes by literature methods, followed by tosylation. 1H 
NMR spectra were referenced to residual protio solvent signals. Structural 
assignments are based on 1H, 13C, DEPT-135, COSY, HMQC. 
Substituted ortho-amino benzyl alcohols were treated with chloroformate to 
synthesize the corresponding carbamates,7 which were oxidized to aldehydes with 
PCC (pyridinium chlorochromate).8 Grinard Reaction of the aldehydes,9 followed by 
intramolecular cyclization upon treatment with potassium carbonate,10 generated the 
desired vinyl benzoxazinanones in high yield. Finally, N-tosylation gave the starting 
material according to literature procedure.11 One thing to note here is that all the 
above procedures generate the desired products in high yield and purity. 
Consequently, the only necessary flash column separation was the tosylation step, just 
to ensure the high purity of the starting material for Pd-catalyzed decarboxylative 
dihydroquinoline syntheses and asymmetric cycloadditions. 
To a solution of amino alcohol (2.9 g, 23 mmol) in 14 ml 1,4-dioxane, 14 ml 
saturated NaHCO3 and 5 ml of water at 0 oC, was added dropwise methyl 
chloroformate (2.2 ml, 1.2 eq.), and the reaction mixture was warmed up slowly to 
room temperature and stirred overnight. The reaction was quenched by brine, 
extracted by ethyl acetate, dried over magnesium sulfate and concentrated to give the 
crude product, which was purified by flash column chromatography (SiO2, 2:1 
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Hexane: Ethyl acetate).2 The oxidiation was carried out with PCC (pyridinium 
chlorochromate) preabsorbed on Al2O3. To a solution of carbamate (1.0 g, 5.5 mmol) 
in 30 ml dichloromethane at rt was added PCC/Al2O3 (8.3 mmol, 1.2 eq.) in one 
portion. The reaction mixture was kept stirring until reaction completion indicated by 
TLC (generally 2 hr). 50 ml of ether was poured in the reaction mixture and the 
resulting solution was filter through a pad of Florisil. The reaction flask was rinse 
three times and the organic phase was combined and the solvent was removed to give 
the amino aldehyde in 94% yield, which is pure enough for the next step reaction. 
(One thing to note here is that longer oxidation time lowers the yield) 
NH2
OH
Cl OMe
O sat. NaHCO3
NHCO2Me
OH PCC/Al2O3
NHCO2Me
O
dioxane/H2O
0 oC to rt
DCM, rt
 
 
To a solution of amino aldehyde (450 mg, 2.5 mmol) in THF under argon at -
78 oC was slowly added Grinard reagent (5.5 mmol, 2.2 eq.). The resulting yellow 
mixture was kept stirring at -78 oC for 2hrs before quenched with saturated NH4Cl 
solution. The crude product was extracted with ethyl acetate three times, dried over 
magnesium sulfate and the solvent was removed to afford the crude product, which 
was taken to the next step without further purification. To a solution of allylic 
alchohol (520 mg, 2.5 mmol) in 7 ml MeOH was added dropwise 10% K3CO3 
solution (3.3 mmol, 1.3 eq.). The reaction mixture was stirred at rt for 10 hrs until 
reaction completion indicated by TLC. The reaction was dilute with water, 
neutralized with 10% HCl solution, followed by extraction with ethyl acetate. The 
organic phase was washed with dilute hydrochloric acid, brined and dried over 
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magnesium sulfate and concentrated to give the crude product, which was purified by 
flash column chromatography (SiO2, 4:1 Hexane: Ethyl acetate). 
NHCO2Me
O MgBr2.2 eq
THF, -78C NHCO2Me
OH 10% K2CO3
N
H
O
OMeOH, rt
 
Finally, N-protected carbamates were prepared according to literature 
procedure.11 Sodium hydride was used as the base for deprotonation. To a solution of 
carbamate (430 mg, 2.5 mmol) in THF at 0 oC under argon was added NaH (5.0 
mmol, 2.0 eq) in one portion and reaction was stirred for 1hr before TsCl (3.0 mmol, 
1.2 eq) was added. The reaction was allowed to warm up to room temperature and 
kept stirring till reaction completion indicated by TLC (generally 1 hr). The reaction 
was quenched with sat. NH4Cl solution after 0.5 hr, extracted with ethyl acetate. The 
organic phase was washed with brined, dried over magnesium sulfate and 
concentrated to give the crude product, which was purified by flash column 
chromatography (SiO2, 5:1 Hexane: Ethyl acetate). 
N
H
O
O
NaH, TsCl O
N O
Ts
THF-DMF, rt
 
 
General procedure for catalytic decarboxylative dihydroquinoline synthesis 
from vinyl benzoxazinanones: 
 
  In a Schlenk tube under argon, Pd(PPh3)4 (0.05 mmol) and vinyl 
benzoxazinanone 1a (1 mmol) were dissolved in 5 mL of methylene chloride. The 
resulting yellow solution was stirred at ambient temperature under Ar until the 
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completion of the reaction was indicated by TLC (generally 1h-4h). Following 
solvent evaporation under reduced pressure, the crude product was purified via flash 
chromatography (SiO2, 7:1 Hexane: Ethyl acetate). 
General procedure for catalytic decarboxylative dimer synthesis from vinyl 
benzoxazinanones: 
 
In a Schlenk tube under argon, Pd(PPh3)4 (0.05 mmol) and vinyl 
benzoxazinanone 1 (1 mmol) were dissolved in 5 mL of toluene. The resulting yellow 
solution was stirred at ambient temperature under Ar until reaction completion was 
indicated by TLC (ca. 10 min). Following solvent evaporation under reduced 
pressure, the crude product was purified via flash chromatography (SiO2, 2:1 Hexane: 
Ethyl acetate). 
 
O
N O
Ts
1-tosyl-4-vinyl-1H-benzo[d][1,3]oxazin-2(4H)-one
 
32a (cw3124) 
White solid 
 
1H NMR (400 MHz, CDCl3) δ ppm 8.10 (2H, d, J=8.3 Hz: Ar CH), 7.62 (1H, d, 
J=8.2 Hz: Ar CH), 7.40 (3H, m: Ar CH), 7.24 (3H, m: Ar CH), 6.04 (1H, ddd, J=17.0, 
10.6, 6.1 Hz: =CH), 5.64 (1H, d, J=6.0 Hz: CHCH=), 5.46 (1H, dd, J=10.5, 0.6 Hz: 
CH=CH(H)Z), 5.38 (1H, dd, J=17.2, 0.6 Hz: CH=CH(H)E), 2.46 (3H, s: CH3Ts). 
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N
Ts
1-tosyl-1,2-dihydroquinoline
 
38a (cw3154) 
White solid 
Pd(PPh3)4: 65% yield 
 
1H NMR (400 MHz, CDCl3) δ ppm 7.67 (1H, d, J=8.08 Hz: Ar CH), 7.26 (2H, d, 
J=8.08 Hz: Ar CH), 7.23 (1H, dd, J=8.08, 1.77 Hz: Ar CH), 7.14 (1H, td, J=7.45, 
1.26 Hz: Ar CH), 7.04 (2H, d, J=8.59 Hz: Ar CH), 6.90 (1H, dd, J=7.33, 1.52 Hz: Ar 
CH), 5.99 (1H, d, J=9.60 Hz: =CH), 5.55 (1H, dt, J=9.60, 4.17 Hz: =CHCH2), 4.41 
(2H, dd, J=4.17, 1.64 Hz: CH2), 2.31 (3H, s: CH3Ts). 
 
13C NMR (100 MHz, CDCl3) δ ppm 143.40 (quat. Ar C), 136.32 (quat. Ar C), 134.97 
(quat. Ar C), 129.55 (quat. Ar C), 129.06 (Ar CH), 127.98 (Ar CH), 127.30 (Ar CH), 
126.86 (Ar CH), 126.68 (Ar CH), 126.48 (Ar CH), 125.89 (=CH), 123.98 (=CHCH2), 
45.4 (CH2), 21.6 (CH3Ts). The assignments of the 1H and 13C were based on DEPT, 
COSY, HMQC etc. 
 
FTIR (CH2Cl2): νmax 3053, 2986, 1421, 1262, 895 
 
HRMS calcd for C16H15NO2SNa [M+Na] 308.0721, found 308.0729. 
 
O
N O
Ts
4-(prop-1-en-2-yl)-1-tosyl-1H-benzo[d][1,3]oxazin-2(4H)-one
 
32a (cw3248) 
White solid 
 
1H NMR (400 MHz, CDCl3) δ ppm 8.09 (2H, d, J=8.4 Hz: Ar CH), 7.62 (1H, d, 
J=8.1 Hz: Ar CH), 7.39 (3H, m: Ar CH), 7.25 (1H, m: Ar CH), 7.15 (1H, m: Ar CH), 
5.59 (1H, s: OCH), 5.17 (1H, s: =CH), 4.97 (1H, s: =CH), 2.46 (3H, s: CH3Ts), 1.78 
(3H, s: CH3). 
 
 138 
N
Ts
3-methyl-1-tosyl-1,2-dihydroquinoline
 
38b (cw3261) 
White solid 
Pd(PPh3)4: 77% yield 
 
1H NMR (400 MHz, CDCl3) δ ppm 7.66 (1H, d, J=7.83 Hz: Ar CH), 7.24 (2H, d, 
J=8.08 Hz: Ar CH), 7.19 (1H, dd, J=7.83, 1.52 Hz: Ar CH), 7.15 (1H, dd, J=7.45, 
1.39 Hz: Ar CH), 7.05 (2H, d, J=8.34 Hz: Ar CH), 6.85 (1H, d, J=7.33 Hz: Ar CH), 
5.71 (1 H, s: =CH), 4.24 (2 H, s: CH2), 2.32 (3H, s: CH3Ts), 1.64 (3H, s: CH3). 
 
13C NMR (100 MHz, CDCl3) δ ppm 143.43 (quat. Ar C), 135.98 (quat. Ar C), 133.77 
(quat. Ar C), 133.6 (=C), 130.6 (quat. Ar C), 128.9 (Ar CH), 126.9 (Ar CH), 126.9 
(Ar CH), 126.8 (Ar CH), 125.7 (Ar CH), 120.9 (=CH), 49.4 (CH2), 21.6 (CH3Ts), 
20.7 (CH3). The assignments of the 1H and 13C were based on DEPT, COSY, HMQC 
etc. 
 
FTIR (CH2Cl2): νmax 3053, 2985, 1421, 1261, 895. 
 
HRMS calcd for C17H17NO2SNa [M+Na] 322.0878, found 322.0879. 
 
O
N O
Ts
4-(2-methylprop-1-enyl)-1-tosyl-1H-benzo[d][1,3]oxazin-2(4H)-one
 
35a (cw3249) 
White solid 
 
1H NMR (400 MHz, CDCl3) δ ppm 7.66 (1H, d, J=7.9 Hz: Ar CH), 7.28 (2H, m: Ar 
CH), 7.21 (2H, d, J=8.5 Hz: Ar CH), 7.07 (2H, d, J=8.0 Hz: Ar CH), 6.99 (1H, dd, 
J=7.4, 1.7 Hz: Ar CH), 5.98 (1H, d, J=9.3 Hz: OCH), 5.38 (1H, d, J=9.4 Hz: 
CH=),2.35 (3H, s: CH3Ts), 1.46 (6H, s: CH3). 
 
 139 
O
N O
Ts
6-methyl-1-tosyl-4-vinyl-1H-benzo[d][1,3]oxazin-2(4H)-one
 
cw3257 
colorless oil 
 
1H NMR (400 MHz, CDCl3) δ ppm 8.07 (2H, d, J=8.4 Hz: Ar CH), 7.49 (1H, d, 
J=8.3 Hz: Ar CH), 7.37 (2H, d, J=8.7 Hz: Ar CH), 7.20 (1H, d, J=8.3 Hz: Ar CH), 
6.97 (1H, s: Ar CH), 6.02 (1H, ddd, J=17.1, 10.5, 6.1 Hz: =CH), 5.58 (1H, d, J=6.1 
Hz: CHCH=), 5.44 (1H, dd, J=10.4, 0.8 Hz: CH=CH(H)Z), 5.35 (1H, d, J=17.2 Hz: 
CH=CH(H)E), 2.45 (3H, s: overlapping CH3Ts, CH3), 2.35 (3H, s: overlapping CH3Ts, 
CH3). 
 
N
Ts
6-methyl-1-tosyl-1,2-dihydroquinoline
 
38c (cw3262) 
White solid 
Pd(PPh3)4: 50% yield 
 
1H NMR (400 MHz, CDCl3) δ ppm 7.59 (1 H, d, J=8.15 Hz: Ar CH), 7.31 (2 H, d, 
J=8.27 Hz: Ar CH), 7.08 (3 H, d, J=8.02 Hz: Ar CH), 6.75 (1 H, s: Ar CH), 5.98 (1 
H, d, J=9.60 Hz: =CH), 5.56 (1 H, dt, J=9.60, 4.17 Hz: =CHCH2), 4.41 (2 H, dd, 
J=4.04, 1.64 Hz: CH2), 2.35 (3 H, s: overlapping CH3Ts, CH3), 2.32 (3 H, s: 
overlapping CH3Ts, CH3). 
 
13C NMR (100 MHz, CDCl3) δ ppm 143.26 (quat. Ar C), 136.46 (quat. Ar C), 136.39 
(quat. Ar C), 132.41 (quat. Ar C), 129.31 (quat. Ar C), 129.03 (Ar CH), 128.67 (Ar 
CH), 127.34 (Ar CH), 126.99 (Ar CH), 126.71 (Ar CH), 125.95 (=CH), 123.84 
(=CHCH2), 45.46 (CH2), 21.55 (overlapping CH3, CH3Ts), 21.03 (overlapping CH3, 
CH3Ts). The assignments of the 1H and 13C were based on DEPT, COSY, HMQC etc. 
 
FTIR (CH2Cl2): νmax 3053, 2986, 1489, 1421, 1271, 1258, 895 
 
HRMS calcd for C17H18NO2S [M+] 300.1058, found 300.1059. 
 
 140 
O
N O
Ts
6-methyl-4-(prop-1-en-2-yl)-1-tosyl-1H-benzo[d][1,3]oxazin-2(4H)-one
 
35g (cw4204) 
White solid 
 
1H NMR (400 MHz, CDCl3) δ ppm 8.10 (2H, d, J=8.3 Hz: Ar CH), 7.52 (1H, d, 
J=8.4 Hz: Ar CH), 7.39 (2H, d, J=8.0 Hz: Ar CH), 7.23 (1H, d, J=8.4 Hz: Ar CH), 
6.97 (1H, s: Ar CH), 5.57 (1H, s: OCH), 5.18 (1H, s: =CH), 4.99 (1H, s: =CH), 2.48 
(3H, s: overlapping CH3Ts, CH3), 2.38 (3H, s: overlapping CH3Ts, CH3), 1.80 (3H, s: 
CH3C=). 
 
N
Ts
3,6-dimethyl-1-tosyl-1,2-dihydroquinoline
 
38d (cw4207) 
White solid 
Pd(PPh3)4: 94% yield 
 
1H NMR (400 MHz, CDCl3) δ ppm 7.56 (1 H, d, J=8.15 Hz: Ar CH), 7.26 (2 H, d, 
J=8.21 Hz: Ar CH), 7.07 (2 H, d, J=8.27 Hz: Ar CH), 7.03 (1 H, dd, J=8.08, 1.52 Hz: 
Ar CH), 6.68 (1 H, s: Ar CH), 5.67 (1 H, s: =CH), 4.23 (2 H, s: CH2), 2.35 (3 H, s: 
overlapping CH3Ts, CH3), 2.31 (3 H, s: overlapping CH3Ts, CH3), 1.63 (3 H, s: =CCH3). 
 
13C NMR (100 MHz, CDCl3) δ ppm 143.32 (quat. Ar C), 136.51 (quat. Ar C), 135.98 
(quat. Ar C), 133.58 (=C), 131.02 (quat. Ar C), 130.34 (quat. Ar C), 128.96 (Ar CH), 
127.67 (Ar CH), 126.88 (Ar CH), 126.64 (Ar CH), 126.22 (Ar CH), 121.00 (=CH), 
49.48 (CH2), 21.57 (overlapping CH3Ts, CH3), 21.08 (overlapping CH3Ts, CH3), 20.78 
(=CCH3). The assignments of the 1H and 13C were based on DEPT, COSY, HMQC 
etc. 
 
FTIR (CH2Cl2): νmax 3054, 2926, 1493, 1346, 1271. 
 
HRMS calcd for C18H23N2O2S [M+NH4] 331.1480, found 331.1479. 
 
 141 
O
N O
Ts
F
6-f luoro-1-tosyl-4-vinyl-1H-benzo[d][1,3]oxazin-2(4H)-one
 
cw3288 
colorless oil 
 
1H NMR (400 MHz, CDCl3) δ ppm 8.08 (2H, d, J=8.4 Hz: Ar CH), 7.60 (1H, dd, 
J=9.1, 4.5 Hz: Ar CH), 7.39 (2H, dd, J=8.1, 0.6 Hz: Ar CH), 7.13 (1H, td, J=8.5, 2.9 
Hz: Ar CH), 6.92 (1H, dd, J=7.7, 2.8 Hz: Ar CH), 6.01 (1H, ddd, J=17.0, 10.6, 6.2 Hz: 
=CH), 5.60 (1H, d, J=6.2 Hz: CHCH=), 5.50 (1H, d, J=10.4 Hz: CH=CH(H)Z), 5.40 
(1H, d, J=17.6 Hz: CH=CH(H)E), 2.47 (3H, s: CH3Ts). 
 
F
N
Ts
6-fluoro-1-tosyl-1,2-dihydroquinoline
 
38e (cw3298) 
White solid 
Pd(PPh3)4: 51% yield 
 
1H NMR (400 MHz, CDCl3) δ ppm 7.66 (1 H, dd, J=8.72, 5.05 Hz: Ar CH), 7.28 (2 
H, d, J=8.34 Hz: Ar CH), 7.08 (2 H, d, J=8.46 Hz: Ar CH), 6.96 (1 H, td, J=8.57, 
2.94 Hz: Ar CH), 6.63 (1 H, dd, J=8.59, 2.91 Hz: Ar CH), 5.95 (1 H, d, J=9.66 Hz: 
=CH), 5.63 (1 H, dt, J=9.19, 4.20 Hz: =CHCH2), 4.42 (2 H, dd, J=4.11, 1.71 Hz: 
CH2), 2.35 (3 H, s: CH3Ts). 
 
13C NMR (100 MHz, CDCl3) δ ppm 143.6 quat. Ar C), 136.0 (quat. Ar C), 129.1 (Ar 
CH), 128.9 (quat. Ar C), 128.8 (quat. Ar C), 127.8 (quat. Ar C), 127.3 (Ar CH), 125.5 
(=CHCH2), 125.2 (=CH), 114.4 Ar CH), 112.9 (Ar CH), 112.7 (Ar CH), 45.4 (CH2), 
21.5 (CH3Ts). 
 
FTIR (CH2Cl2): νmax 3063, 2926, 1713, 1487, 1352, 1167. 
 
HRMS calcd for C16H18FN2O2S [M+NH4] 321.1073, found 321.1074. 
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O
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F
6-fluoro-4-(prop-1-en-2-yl)-1-tosyl-1H -benzo[d][1,3]oxazin-2(4H )-one
 
cw3289 
colorless oil 
 
1H NMR (400 MHz, CDCl3) δ ppm 8.07 (2H, d, J=8.3 Hz: Ar CH), 7.60 (1H, dd, 
J=9.0, 4.5 Hz: Ar CH), 7.38 (2H, d, J=8.0 Hz: Ar CH), 7.12 (1H, td, J=8.2, 2.5 Hz: 
Ar CH), 6.88 (1H, dd, J=7.7, 2.8 Hz: Ar CH), 5.56 (1H, s: OCH), 5.20 (1H, s: =CH), 
4.99 (1H, s: =CH), 2.47 (3H, s: CH3Ts), 1.78 (3H, s: CH3). 
 
F
N
Ts
6-fluoro-3-methyl-1-tosyl-1,2-dihydroquinoline
 
38f (cw3293) 
White solid 
Pd(PPh3)4: 82% yield 
 
1H NMR (400 MHz, CDCl3) δ ppm 7.64 (1 H, dd, J=8.81, 5.21 Hz: Ar CH), 7.25 (2 
H, d, J=8.34 Hz: Ar CH), 7.09 (2 H, d, J=8.46 Hz: Ar CH), 6.91 (1 H, td, J=8.59, 
2.91 Hz: Ar CH), 6.56 (1 H, dd, J=8.75, 2.87 Hz: Ar CH), 5.66 (1 H, s: =CH), 4.25 (2 
H, s: CH2), 2.35 (3 H, s: CH3Ts), 1.66 (3 H, s: CH3). 
. 
 
13C NMR (100 MHz, CDCl3) δ ppm 160.01 (quat. Ar C), 143.63 (quat. Ar C), 135.69 
(quat. Ar C), 135.53 (quat. Ar C), 132.40 (=C), 129.35 (quat. Ar C), 129.05 (Ar CH), 
128.56 (Ar CH), 126.86 (Ar CH), 120.36 (=CH), 113.39 (Ar CH), 111.83 (Ar CH), 
49.46 (CH2), 21.54 (CH3Ts), 20.72 (CH3). The assignments of the 1H and 13C were 
based on DEPT, COSY, HMQC etc. 
 
FTIR (CH2Cl2): νmax 3053, 2986, 1480, 1348, 1166. 
 
HRMS calcd for C17H16FNO2S [M+] 317.0886, found 317.0887. 
 
 143 
O
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MeO
6-methoxy-1-tosyl-4-vinyl-1H-benzo[d][1,3]oxazin-2(4H)-one
 
cw4142 
White solid 
 
1H NMR (400 MHz, CDCl3) δ ppm 8.06 (2H, d, J=8.5 Hz: Ar CH), 7.52 (1H, d, 
J=9.0 Hz: Ar CH), 7.37 (2H, d, J=8.5 Hz: Ar CH), 6.93 (1H, dd, J=9.0, 2.8 Hz: Ar 
CH), 6.69 (1H, d, J=2.8 Hz: Ar CH), 6.01 (1H, ddd, J=17.0, 10.6, 6.1 Hz: =CH), 5.58 
(1H, d, J=6.0 Hz: CHCH=), 5.45 (1H, d, J=11.1 Hz: CH=CH(H)Z), 5.37 (1H, d, 
J=17.2 Hz: CH=CH(H)E), 3.81 (3H, s: OCH3), 2.46 (3H, s: CH3Ts). 
 
MeO
N
Ts
6-methoxy-1-tosyl-1,2-dihydroquinoline
 
38g (cw4194) 
White solid 
Pd(PPh3)4: 80% yield 
 
1H NMR (400 MHz, CDCl3) δ ppm 7.62 (1 H, d, J=8.84 Hz: Ar CH), 7.28 (2 H, d, 
J=8.34 Hz: Ar CH), 7.09 (1 H, d, J=8.53 Hz: Ar CH), 6.82 (1 H, dd, J=8.81, 2.94 Hz: 
Ar CH), 6.47 (1 H, d, J=2.91 Hz: Ar CH), 5.95 (1 H, d, J=9.60 Hz: =CH), 5.56 (1 H, 
dt, J=9.60, 4.04 Hz: =CHCH2), 4.40 (2 H, dd, J=4.07, 1.67 Hz: CH2), 3.81 (3 H, s: 
OCH3), 2.35 (3 H, s: CH3Ts). 
 
13C NMR (100 MHz, CDCl3) δ ppm 158.20 (quat. Ar C), 143.30 (quat. Ar C), 136.14 
(quat. Ar C), 130.69 (quat. Ar C), 129.03 (Ar CH), 128.35 (Ar CH), 127.78 (quat. Ar 
C), 127.39 (Ar CH), 125.84 (=C), 124.60 (=CHCH2), 113.02 (Ar CH), 111.53 (Ar 
CH), 55.48 (OCH3), 45.54 (CH2), 21.57 (CH3Ts). The assignments of the 1H and 13C 
were based on DEPT, COSY, HMQC etc. 
 
FTIR (CH2Cl2): νmax 3050, 2923, 1491, 1350, 1271. 
 
HRMS calcd for C17H17NO3SNa [M+Na] 338.0827, found 338.0828. 
 
 144 
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MeO
6-methoxy-4-(prop-1-en-2-yl)-1-tosyl-1H-benzo[d][1,3]oxazin-2(4H)-one
 
cw4196 
White solid 
 
1H NMR (400 MHz, CDCl3) δ ppm 8.08 (2H, d, J=8.4 Hz: Ar CH), 7.55 (1H, d, 
J=9.0 Hz: Ar CH), 7.39 (2H, d, J=8.5 Hz: Ar CH), 6.95 (1H, dd, J=9.0, 2.8 Hz: Ar 
CH), 6.69 (1H, d, J=2.7 Hz: Ar CH), 5.55 (1H, s: OCH), 5.17 (1H, s: =CH), 4.99 (1H, 
s: =CH), 3.83 (3H, s: OCH3), 2.48 (3H, s: CH3Ts), 1.79 (3H, s: CH3). 
 
13C NMR (100 MHz, CDCl3) δ ppm 157.4 (CONTS), 149.4 (quat. Ar C), 145.5 (=C), 
139.5 (quat. Ar C), 135.8 (quat. Ar C), 129.6 (Ar CH), 129.0 (Ar CH), 127.6 (quat. 
Ar C), 127.2 (quat. Ar C), 122.2 (Ar CH), 117.2 (Ar CH), 114.0 (Ar CH), 111.2 
(=CH), 82.2 (OCH), 55.7 (OCH3), 21.7 (CH3Ts), 18.4 (CH3). 
 
MeO
N
Ts
6-methoxy-3-methyl-1-tosyl-1,2-dihydroquinoline
 
38h (cw4200) 
White solid 
Pd(PPh3)4: 92% yield 
 
1H NMR (400 MHz, CDCl3) δ ppm  7.61 (1 H, d, J=8.78 Hz: Ar CH), 7.25 (2 H, d, 
J=8.27 Hz: Ar CH), 7.09 (2 H, d, J=8.08 Hz: Ar CH), 6.79 (1 H, dd, J=8.78, 2.91 Hz: 
Ar CH), 6.41 (1 H, d, J=2.84 Hz: Ar CH), 5.66 (1 H, s: =CH), 4.23 (2 H, s: CH2), 
3.81 (3 H, s: OCH3), 2.36 (3 H, s: CH3Ts), 1.65 (3 H, s: CH3). 
 
13C NMR (100 MHz, CDCl3) δ ppm 158.28 (quat. Ar C), 143.34 (quat. Ar C), 135.77 
(quat. Ar C), 134.41 (=C), 131.76 (quat. Ar C), 128.94 (Ar CH), 128.16 (Ar CH), 
126.91 (Ar CH), 126.46 (quat. Ar C), 120.97 (=CH), 111.97 (Ar CH), 110.77 (Ar 
CH), 55.45 (OCH3), 49.58 (CH2), 21.57 (CH3Ts), 20.78 (CH3). The assignments of 
the 1H and 13C were based on DEPT, COSY, HMQC etc. 
 
FTIR (CH2Cl2): νmax 3052, 2929, 1346, 1259, 1165 
 
HRMS calcd for C18H19NO3SNa [M+Na] 352.0984, found 352.0982. 
 
 145 
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MeO
MeO
6,7-dimethoxy-4-vinyl-1H-benzo[d][1,3]oxazin-2(4H)-one
 
36a (cw4060) 
White solid 
 
1H NMR (400 MHz, CDCl3) δ ppm 7.48 (1H, br. s.: NH), 6.60 (1H, s: Ar CH), 6.35 
(1H, s: Ar CH), 6.05 (1H, ddd, J=17.0, 10.4, 6.5 Hz: =CH), 5.74 (1H, d, J=6.6 Hz: 
CHCH=), 5.41 (1H, d, J=10.4 Hz: CH=CH(H)Z), 5.36 (1H, d, J=17.4 Hz: 
CH=CH(H)E), 3.87 (3H, s: OCH3), 3.84 (3H, s: OCH3). 
 
(7E,15E)-5,13-ditosyl-5,6,13,14-tetrahydrodibenzo[b,h][1,7]diazacyclododecine
N
N
Ts
Ts
 
39a (cw4017) 
White solid 
Pd(PPh3)4: 36% yield, dr = 8:1 
 
1H NMR (400 MHz, CDCl3) δ ppm 7.83 (4 H, d, J=8.1 Hz: Ar CH), 7.50 (2 H, d, 
J=16.4 Hz: =CH), 7.41 (4 H, d, J=8.6 Hz: Ar CH), 7.28 (2 H, d, J=8.7 Hz: Ar CH), 
7.15-7.25 (4 H, m: Ar CH), 6.94 (2 H, d, J=7.8 Hz: Ar CH), 5.46 (2 H, dt, J=16.1, 5.9 
Hz: =CHCH2), 4.66 (2 H, ddd, J=13.2, 5.9, 1.3 Hz: CH2), 3.73 (6 H, s: CH3), 3.62 (2 
H, dd, J=13.2, 5.9 Hz: CH2), 2.47 (6 H, s: CH3Ts). 
 
13C NMR (100 MHz, CDCl3) δ ppm 143.9 (quat. Ar C), 139.0 (quat. Ar C), 137.3 
(=CH), 136.0 (quat. Ar C), 130.0 (Ar CH), 129.6 (quat. Ar C), 129.0 (Ar CH), 128.5 
(Ar CH), 128.4 (Ar CH), 128.2 (Ar CH), 127.0 (Ar CH), 124.6 (=CHCH2), 50.9 
(CH2), 21.7 (CH3Ts). The assignments of the 1H and 13C were based on DEPT, 
COSY, HMQC etc. 
 
FTIR (CH2Cl2): νmax 30513, 2926, 1346, 1271, 1161, 760. 
 
HRMS calcd for C32H34N3O4S2 [M+NH4] 588.1991, found 588.1990. 
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Me
Me
(7E,15E)-2,10-dimethyl-5,13-ditosyl-5,6,13,14-tetrahydrodibenzo[b,h][1,7]diazacyclododecine
39b (cw4223) 
White solid 
Pd(PPh3)4: 87% yield, dr =5.5:1 
 
1H NMR (400 MHz, CDCl3) δ ppm 7.83 (4H, d, J=8.2 Hz: Ar CH), 7.42 (6H, m: 
overlapping Ar CH, =CH), 7.07 (1H, s: Ar CH), 6.97 (2H, d, J=8.3 Hz: Ar CH), 6.81 
(2H, d, J=8.1 Hz: Ar CH), 5.44 (2H, dt, J=16.2, 6.0 Hz: =CHCH2), 4.63 (2H, ddd, 
J=13.1, 6.0, 1.5 Hz: CH2), 3.63 (2H, dd, J=13.1, 5.9 Hz: CH2), 2.48 (6 H, s: CH3Ts), 
2.25 (6 H, s: CH3). 
 
13C NMR (126 MHz, CDCl3) δ ppm 138.8 (quat. Ar C), 143.8 (quat. Ar C), 138.6 
(quat. Ar C), 137.4 (=CH), 136.1 (quat. Ar C), 134.7 (quat. Ar C), 129.9 (Ar CH), 
129.3 (Ar CH), 128.2 (Ar CH), 128.1 (Ar CH), 127.6 (Ar CH), 124.3 (=CHCH2), 
50.8 (CH2), 21.7 (CH3Ts), 21.2 (CH3). The assignments of the 1H and 13C were based 
on DEPT, COSY, HMQC etc. 
 
FTIR (CH2Cl2): νmax 2924, 1599, 1491, 1346, 1163. 
 
HRMS calcd for C34H38N3O4S2 [NH4] 616.2304, found 616.2302. 
 
N
N
Ts
Ts
MeO
OMe
(7E,15E)-2,10-dimethoxy-5,13-ditosyl-5,6,13,14-tetrahydrodibenzo[b,h][1,7]diazacyclododecine
 
39c (cw4205) 
White solid 
Pd(PPh3)4: 94% yield, dr = 6.7:1 
 
1H NMR (400 MHz, CDCl3) δ ppm 7.81 (4 H, d, J=8.21 Hz: Ar CH), 7.35 - 7.54 (6 
H, m: overlapping Ar CH, =CH ), 6.82 (2 H, d, J=8.72 Hz: Ar CH), 6.76 (2 H, d, 
J=2.91 Hz: Ar CH), 6.69 (2 H, dd, J=8.72, 2.84 Hz: Ar CH), 5.46 (2 H, dt, J=16.14, 
5.89 Hz: =CHCH2), 4.66 (2 H, ddd, J=13.17, 5.87, 1.29 Hz: CH2), 3.73 (6 H, s: CH3), 
3.62 (2 H, dd, J=13.17, 5.91 Hz: CH2), 2.47 (6 H, s: CH3Ts). 
 147 
13C NMR (100 MHz, CDCl3) δ ppm 159.5 (quat. Ar C), 143.8 quat. Ar C), 140.1 
(quat. Ar C), 137.2 (=CH), 136.1 (quat. Ar C), 129.9 (Ar CH), 129.4 (Ar CH), 128.1 
(Ar CH), 124.9 (=CHCH2), 114.1 (Ar CH), 111.7 (Ar CH), 55.4 (OCH3), 50.8 (CH2), 
21.7 (CH3Ts); Note: one quat. Ar carbon is not found. The assignments of the 1H and 
13C were based on DEPT, COSY, HMQC etc. 
 
FTIR (CH2Cl2): νmax 3065, 2926, 1599, 1570, 1493, 1258, 1161. 
 
HRMS calcd for C34H34N2O6S2Na [M+Na] 653.1756, found 653.1762. 
 
N
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F
(7Z,15Z)-2,10-difluoro-5,13-ditosyl-5,6,13,14-tetrahydrodibenzo[b,h][1,7]diazacyclododecine
 
39d (cw4210) 
Colorless oil 
Pd(PPh3)4: 92% yield 
 
1H NMR (400 MHz, CDCl3) δ ppm 7.53 (2 H, d, J=8.15 Hz: Ar CH), 7.33 (4 H, d, 
J=8.21 Hz: Ar CH), 7.19 - 7.26 (2 H, m: Ar CH), 7.11 (4 H, d, J=7.89 Hz: Ar CH), 
6.91 (2 H, t, J=8.75 Hz: Ar CH), 6.29 (2 H, d, J=9.73 Hz: =CH), 5.67 (2 H, dt, 
J=9.79, 4.26 Hz: =CHCH2), 4.46 (4 H, dd, J=3.73, 1.39 Hz: CH2), 2.36 (6 H, s: 
CH3Ts), 
 
13C NMR (100 MHz, CDCl3) δ ppm 158.80 (quat. Ar C), 156.82 (quat. Ar C), 143.78 
(quat. Ar C), 136.15 (quat. Ar C), 129.25 (Ar CH), 128.20 (Ar CH), 127.23 (Ar CH), 
124.33 (=CH), 122.33 (Ar CH), 118.55 (=CHCH2), 117.84 (quat. Ar C), 113.03 (Ar 
CH), 45.14 (CH2), 21.59 (CH3Ts). The assignments of the 1H and 13C were based on 
DEPT, COSY, HMQC etc. 
 
FTIR (CH2Cl2): νmax 3065, 2926, 1612, 1472, 1263, 1167, 750. 
 
HRMS calcd for C32H28F2N2O4S2Na [M+Na] 629.1356, found 629.1359. 
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O
N O
OPh
1-benzoyl-4-vinyl-1H-benzo[d][1,3]oxazin-2(4H)-one
 
37e (cw3159) 
Colorless oil 
 
1H NMR (400 MHz, CDCl3) δ ppm 7.90 (2H, d, J=8.1 Hz: Ar CH), 7.62 (1H, t, 
J=7.5 Hz: Ar CH), 7.55 (1H, d, J=8.1 Hz: Ar CH), 7.49 (2H, t, J=7.8 Hz: Ar CH), 
7.36 (1H, m: Ar CH), 7.26 (2H, d, J=15.2 Hz: Ar CH), 6.27 (1H, td, J=11.2, 5.2 Hz: 
=CH), 5.93 (1H, d, J=5.6 Hz: CHCH=),5.59 (1H, dd, J=10.4, 0.6 Hz: CH=CH(H)Z), 
5.46 (6 H, d, J=17.2 Hz: CH=CH(H)E)). 
 
O
N Ph
2-phenyl-4-vinyl-4H-benzo[d][1,3]oxazine
 
42f (cw3164) 
White solid 
Pd(PPh3)4: 96% NMR yield 
 
1H NMR (400 MHz, CDCl3) δ ppm  8.17 (2H, dd, J=8.3, 1.4 Hz: Ar CH), 7.68 
(4H,m: Ar CH), 7.33 (3H, m: Ar CH), 6.11 (1H, m: =CH), 5.88 (1H, d, J=6.3 Hz: 
OCH), 5.33 (2H, m: =CH2). 
 
O
N O
Ph
1-benzyl-4-vinyl-1H-benzo[d][1,3]oxazin-2(4H)-one
 
37a (cw3191) 
colorless oil 
 
1H NMR (400 MHz, CDCl3) δ ppm 7.37 (5H, m: Ar CH), 7.28 (1H, dd, J=15.6, 1.7 
Hz: Ar CH), 7.19 (1H, d, J=6.4 Hz: Ar CH), 7.14 (1H, d, J=7.4 Hz: Ar CH), 6.92 (1H, 
d, J=8.2 Hz: Ar CH), 6.18 (1H, ddd, J=17.1, 10.4, 5.9 Hz: =CH), 5.85 (1H, d, J=6.0 
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Hz: CHCH=), 5.51 (1H, d, J=10.4 Hz: CH=CH(H)Z), 5.42 (1H, d, J=17.1 Hz: 
CH=CH(H)E), 5.24 (2H, m: CH2Ph). 
 
O
N O
Ts
1-tosyl-1H-benzo[d][1,3]oxazin-2(4H)-one
 
cw4161 
colorless oil 
 
1H NMR (400 MHz, CDCl3) δ ppm 8.14 (2H, d, J=8.4 Hz: Ar CH), 7.60 (1H, d, 
J=8.4 Hz: Ar CH), 7.40 (3H, d, J=8.1 Hz: Ar CH), 7.24 (2H, d, J=6.4 Hz: Ar CH), 
5.13 (2H, s: CH2), 2.47 (3H, s: CH3Ts). 
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3.1 Introduction 
 Substituted piperidines are frequently encountered structural motifs of alkaloids 
that are abundant in nature and have attracted much attention due to their significant 
biological activities.1, 2 Statistics indicate that more that 12,000 piperidine derivatives 
have been claimed to be in clinical or preclinical studies.3 
 The industrial preparation of piperidines has largely relied on nickel-catalyzed 
hydrogenation of pyridine. The routine synthesis of piperdine in the laboratory is also 
achieved with resort to the reduction of the corresponding pyridines. For example, 
sodium in alcohol solvent has been employed to reduce pyridines. Transition 
metal-catalyzed hydrogenation is also used due to the mild reaction conditions and 
functional group compatibility. For instance, piperdine 1d was prepared by selective 
reduction by resorting to different transition metals as shown in Scheme 1.4 
Scheme 1 Piperidines synthesis via transition metal-catalyzed reduction of pyridines 
N
CN
H2 , Ni(0)
60-70 oC
N
NH2
H2 , PtO2
AcOH
NH2
H
N
1d1c1a
50% 67%
 
 
 Intramolecular N-cyclizations have also been widely used for piperidine ring 
preparation from precursors such as 1,5-amino halides, 1,5-diamino alcohols, 
1,5-diamines and 1,5-dihalides.5 For example, piperidines 2b and 2d were 
synthesized from the corresponding 1,5-aminohalides in good yields (Scheme 2).6, 7 
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However, secondary amines with an electron withdrawing group were used to avoid 
competing side reactions such as dialkylation and intermolecular N-alkylation. 
Scheme 2 Piperidine synthesized from 1,5-aminohalides 
Me
H
N
Ph
O
Cl NaH, Et2O MeN
Ph
O
92%
2b2a
N
F
O
Ph
Me
O
F
HN
Br
Ph
Me
NaH, THF
85%
reflux, 20 hrs
2c 2d
 
 
Intramolecular ring closure of 1,5-amino alcohols is another classical way for 
piperidine preparation (Scheme 3). In the late 1940’s, Woods reported the synthesis of 
piperidine 3d from a free 1,5-amino alcohol 3b.8 Conversion of 3b to its sulfate salt 
3c was achieved by treatment with sulfuric acid and piperidine 3d was formed by 
refluxing with hydrobromide acid. Similarly, piperidines 3g and 3j were prepared 
from their corresponding 1,5-aminoalcohols.9, 10 
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Scheme 3 Piperidine synthesized from 1,5-aminoalcohols 
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Pseudoconhydrine 4c isolated along with coniine from Poison Hemlock, conium 
maculatum was synthesized via an intramolecular reductive amination of intermediate 
4b (Scheme 4).9 Alkaloid solenopsine 4h，a subcategory of ant venoms, displays 
potent antifungal, insecticide and repellent activity.14,15 The synthesis featured a 
intermolecular double condensations of (-)-phenylglycinol 4d and glutaraldehyde 4e 
to form an iminium intermediate 4f, which was trapped by KCN to furnish 
cyanopiperidine 4g. Further elaborations provided the alkaloid product 4h.10 
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Scheme 4 Piperidines synthesis via an imine intermediate 
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Ph OH
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N
Ph OH
N ONC
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H
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NH2
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O
N
HO
N
H
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4b4a 4c
H3O H2 /Raney Ni
 
 
 Transition metal-mediated piperidine synthesis has drawn a lot of attention. 
In 2000, Trost reported a ruthenium-catalyzed piperidine synthesis from allene 5a and 
enone 5b (Scheme 5).11 A ruthenacycle 5d was thought to be involved, and 
subsequent intramolecular nucleophilic attack to furnish the piperdine product 5c in 
53% yield. 
Scheme 5 Piperidines synthesis via a ruthenacycle 
H3CO
H
N •
O
H3CO
N
O
10% CpRu(CH3CN)3 PF6
15% CH3AlCl2
DMF, 40oC, 1hr
53%Ru
ONH
H3CO
4
5b5a 5c
5d
 
 
 Ring closing methathesis (RCM) has also been applied in piperidine synthesis as 
shown in Scheme 6.14 Tetrahydropyridine 6b was prepared by treatment of compound 
6a with 10 mol% Grubbs’ catalyst A, and (R)-coniine 6c was obtained upon further 
 156 
elaboration. Coniine 6c is a poisonous alkaloid, which is found in poison hemlock 
and the yellow pitcher plant.12 
Scheme 6 Piperidines synthesis via Ring closing methathesis (RCM) 
N
Cbz
10 mol% A
N
Cbz
Ru
Cl
Cl
PCy3
PCy3
Ph
A
CH2Cl2, reflux, 88%
Pd/C, H2
MeOH, rt, 1.5 hr
76%
N
H
6b6a 6c
 
 
An intramolecular aminomercuration protocol was developed by Harding and 
applied in the synthesis of alkaloid (±)-Pseudoconhydrine 7d (Scheme 7).13, 14 
Aziridine 7c was formed from iodo compound 7b upon treatment of hydrobromide in 
acetic acid. Electrophilic ring opening followed by hydrolysis yield the alkaloid 
product 7d in 50% yield. 
Scheme 7 Piperidines synthesis via intramolecular aminomercuration 
H N CO2Bn
N
CO2BnI
N
H
N
H
HO
Hg(OAc)2, THF1)
2) NaI
HBr, AcOH
TFA1)
2) Na2CO3
7c7b7a
7c
7d
 
 
 Palladium catalysts have also been used for the synthesis of piperidine alkaloids 
(Scheme 8). For example, Hirai reported an efficient Pd-catalyzed intramolecular 
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N-alkylation to yield a mixture of diastereoisomers 8b and 8c in a ratio of 8:1.15 In 
2005, Harrity reported a stepwise [3+3] cycloaddtion for constructing the piperidine 
ring system.16 Aziridine 8d was allowed to react with allylic alcohol 8e under strong 
basic conditions to yield the corresponding amine product 8f, which, upon 
intramolecular cyclization generated piperdine alkaloid 8g in the presence of 
Pd(OAc)2 and a cocatalytic Ti(OiPr)4. A Pd π-allyl intermediate was generated during 
the course of this reaction, and ring closure of carbamates with free allylic alcohols 
has been catalyzed by Pd(II) catalysts.17 
Scheme 8 Piperidines synthesis from Pd-catalyzed intramolecular N-annulations 
NH
BnO
Boc
OH
N
BnO
Boc
N
BnO
Boc
30 mol% PdCl2(CH3CN)2
81%
8 : 1
N
Ts OH
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MgBr2
Et2O, 25 oC OH
Ph
NHTs
Ph 10% Pd(OAc)2, 40% PPh3
N
Ts
Ph
62%
25% Ti(OiPr)4, 4A MS
Toluene, 110oC
8b8a 8c
8g8f8e8d
 
 
 Even though there are many synthetic methods for piperdine ring preparation, 
the substrates availability, harsh reaction conditions and functional group tolerance 
are some limitations of the current methods. Therefore, the need for a novel and 
efficient method for substituted piperidine synthesis, especially highly-substituted 
piperidines still exists. 
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3.2 Synthesis of Highly-substituted Piperidines  
In 2002, Yamamoto reported an efficient synthesis of pyrrolidine derivative 9b 
via Pd-catalyzed ring expansion of vinyl azetidine 9a in the presence of electron-poor 
olefin; however, the pyrrolidine product was formed in very low diastereoselectivity 
(dr = 1.2). The reaction was thought to proceed by forming a zwitterionic π-allyl 
palladium intermediate 9c from vinyl azetidine in the presence of Pd catalyst.18 
Scheme 9 Nitrogen nucleophiles in Pd-catalyzed allylation reactions 
N
Ph
CN
CN 5 mol% Pd(PPh3)4
N
Ph
CN
CN
CH2Cl2, rt
9a 9b
Ts Ts
N
Pd
Ts
99%
9ccis/tran: 1.2
 
 
We have previously shown that vinyl oxazinanones 10a underwent catalytic 
diastereoselective decarboxylative ring contraction to form vinyl azetidines 10b under 
mild conditions in good yield (Scheme 11).19 In addition to the decarboxylative ring 
contractions, it was envisioned that performing the decarboxylation in the presence of 
Michael acceptors would result in decarboxylative olefin insertion to provide 
highly-substituted vinyl piperidines 11a. 
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Scheme 10 Decarboxylative olefin insertion reactions with vinyl oxazinanones 
N O
O
Ts
R1
R2
N
Ts
R2R1
R4
R3 R3
R4
5 mol% Pd(PPh3)4
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-CO2
N
R5
Ts
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Upon Pd-facilitated decarboxylation, zwitterionic π-allyl intermediates 12c 
should lend themselves to decarboxylative olefin insertion if the intermediate amide 
anion could be intercepted by a suitably electrophilic Michael acceptor (Scheme 
11).21-23 The resulting stabilized carbanion 12d could undergo addition to the π-allyl 
palladium fragment which would give rise to 4-vinyl piperidines. Indeed, treatment of 
rac-12a with benzylidenemalononitrile and Pd(PPh3)4 produced the vinyl piperidine 
13a as a single diastereoisomer in excellent yield. The reaction is rapid, and vinyl 
azetidines are not observed as intermediates when the reaction is monitored by 1H 
NMR spectroscopy. Once again, cis-12a provides the same product as trans-12a, 
indicating that π-allyl epimerization is faster than cyclization. 
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Scheme 11 Decarboxylative olefin insertion reactions with vinyl oxazinanones 
N O
O
Ts
Ph
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Ph
CN
CN 5 mol% Pd(PPh3)4
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 Other Michael acceptors were also tried with our standard reaction conditions as 
shown in Scheme 12. It turned out that the electronics of the Michael acceptors are 
crucial to the success of the decarboxylative cycloaddition reactions. The same 
phenomenon has been observed in the Ru-catalyzed tandem Michael 
addition-allylation reactions.20 Not surprisingly, when Michael acceptor such as 14a 
or dipolarphile 14c was employed, no cycloaddition product was observed and the 
decarboxylative ring contraction product was formed exclusively. In the case of ethyl 
cyanobutenoate 14d, azetidine 14b was generated first and later transformed to a 
messy polymeric mixture. Of note here is that when p-hydroxybenzylidene 
malononitrile was employed as the electrophile, the O-allylation product 14g was 
formed exclusively in 90% NMR yield, which in turn supported that a zwitterionic 
π-allyl intermediate was formed first then subsequently quenched by the nucleophile 
present. 
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Scheme 12 Problematic Michael acceptors 
N O
O
Ts
Ph
CN
CN
5 mol% Pd(PPh3)4
rt, CH2Cl2
NH
Ts
Ph
12a
14f 14g
HO
O
NC CN
N O
O
Ts
Ph
N
CN
CN
5 mol% Pd(PPh3)4
rt, CH2Cl214a
N
Ts
Ph14b
N O
O
Ts
Ph
5 mol% Pd(PPh3)4
rt, CH2Cl2
14c
N
Ts
Ph
14b
N O
O
Ts
Ph
CO2Et
CN
5 mol% Pd(PPh3)4
rt, CH2Cl2
14d
N
Ts
Ph
CO2Et
CN
N C
14e
90% NMR yield
 
 
 Interesting chemoselectivity was observed when a sterically-hindered Michael 
acceptor 15a was used (Scheme 13). Treatment of vinyl oxazinanone 12a with 5 
mol% Pd(PPh3)4 in the presence of 15a at rt yielded the unexpected 
tetrahydropyridine ring product 15b exclusively in 10 mins. Interestingly, the scale-up 
reaction gave a 1:1 mixture of products 15b and cycloaddition adduct 15f in 99% 
combined yield. This chemoselectivity was interesting since it has been shown that, in 
the absence of benzylidenemalononitrile, the four-membered vinyl azetidine product 
is favored over the tetrahydropyridine due to stereoelectronic effects. We reasoned 
that cycloaddition could be favored if the substrate was less sterically demanding so 
the unsubstituted vinyl oxazinanone 12b was prepared in that regard. Treatment of 
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12b under our standard reaction conditions produced the six-membered cycloaddition 
product in 38% isolated yield with no observation of piperidine product. The lower 
yield was attributed to the formation of a polymer-type byproduct, which has been 
observed when the decarboxylative ring contraction was performed with vinyl 
oxazinanone 12b in the absence of Michael acceptor. As expected, this 
chemoselectivity was switched back when vinyl oxazinanone 12c was used, and the 
six-membered ring product 15e was generated exclusively in 80% NMR yield. 
Scheme 13 Interesting chemoselectivity 
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 Ultimately, if the Michael acceptors are properly chosen, a variety of vinyl 
oxazinanones undergo smooth decarboxylative cycloaddition reactions (Table 1). 
Although the stereocontrol is good when the vinyl oxazinanone is substituted at C4, 
C5, or C6, the stereocontrol is not high when the vinyl oxazinanone is unsubstituted 
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(i.e., 13j,k trans/cis~3:1, Table 1) or with a small substituent (i.e., 13l,m trans/cis=2:1, 
Table 1). 
Table 1 Yields and diastereoselectivities of decarboxylative olefin insertions 
R1 R2 Yield (dr)b
Ph 94 (>19:1)c
p-MeOC6H4 88 (>19:1)
p-MeOC6H4 81 (>19:1)
p-ClC6H4 87 (>19:1)
Ph 54 (10:1)
Ph 53 (>19:1)
Producta
13a
13b
13c
13d
13g
13h
H
H
H
H
H
H
R3
H
H
H
H
Ph
Ph
R4
Ph
Ph
p-AcOC6H4
Ph
Ph
p-AcOC6H4
p-ClC6H4 96 (>19:1)13eH H p-AcOC6H4
Ph 76 (>19:1)13fH H p-AcOC6H4
Bn H H Ph 13i 66 (8.3:1)
N O
O
Ts
R1
R3
R2
H H H Ph 13j 85 (1:3)
N
R4
Ts
R1
R3
R2
2,4-cis
CNCN N
R4
Ts
R1
R3
R2
CNCNR4
CN
CN
cat . Pd(PPh3)4
2,4-tr ans
H H H p-AcOC6H4 13k 99 (1:2.8)
H CH3 H Ph 13l 99 (1:2)
H Ph H Ph 13n 87 (1:>19)
H CH3 H p-AcOC6H4 13m 92 (1:2)
 
 
a
 Unless otherwise mentioned, the reaction was carried out with vinyl oxazinanone (1 mmol), 
Michael acceptor (1 mmol), Pd(PPh3)4 (0.05 mmol) in CH2Cl2 at room temperature. b yield and 
syn/anti ratio of isolated product. c >19:1 indicates that the minor diastereomer was not detected 
by 1H NMR spectroscopy. 
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Although the preference for formation of 2,4-trans products, as determined by 
nOe experiments, from unsubstituted vinyl oxazinanones is difficult to explain, the 
diastereoselectivity of the substituted derivatives is straightforward. In these cases, 
the product is the result of cyclization through a conformation A or B that places the 
larger groups in equatorial positions as shown in Scheme 14. Such an interpretation 
requires that the Michael addition is reversible, allowing the diastereoselectivity to be 
controlled by the relative barriers for cyclization. 
Scheme 14 Preferred six-membered transition state 
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Z
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H RL2Pd
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Z
Z
Ar
Ts
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Furthermore, the above cycloaddition can be applied to an annulation of 
cyanocoumarins, which are frequently encountered structural motifs of many 
biologically active compounds (Table 2).21, 22 Although product 16a was isolated in 
lower yield than other substrates, investigation of the reaction by 1H NMR 
spectroscopy shows clean formation of 16a. Furthermore, the annulation sets three 
contiguous stereocenters with high diastereoselectivity for syn addition to the 
coumarin. Unlike entry 1 and 2, when R2 equals to a phenyl group, decarboxylative 
cycloaddition product 16c was produced along with the four-membered azetidine 
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product in a ratio of 2.5:1. The reason was partially attributed to the sterically bulkier 
vinyloxazinanone, which slows down the intermolecular cycloaddition reaction. For 
example, the reaction with unsubstituted vinyl oxazinanone took less than 10 minutes, 
whereas substituted ones need days to complete as shown in Table 2. 
Table 2 Yields and diastereoselectivities with cyanocoumarin Michael acceptor 
R1 R2 Yield (dr)
H 49 (>19:1)b
H 88 (1:1)
Ph
Producta
16a
16b
16c
H
CH3
H
Michael acceptor
N O
O
Ts
R1
R2
cat. Pd(PPh3)4O O
CN
O
O
NTs
H CN
R2
R1
O O
CN
71 (>19:1)c
entry
1
2
3
time
10min
36 hr
3 days
 
 
a
 Unless otherwise mentioned, the reaction was carried out with vinyl oxazinanone (1 mmol), 
Michael acceptor (1 mmol), Pd(PPh3)4 (0.05 mmol) in CH2Cl2 at room temperature. b 1H NMR 
yield are very high. c 1H NMR yield and the reaction time is 3 days. 
 
 Spiro vinyl oxazinanone 17a was treated with 5 mol% Pd(PPh3)4 in the presence 
of one equivalent of Michael acceptor; however, cycloaddition did not occurr and  
β-hydride elimination product 17b was formed exclusively (Scheme 15). Interestingly, 
decarboxylative ring contraction product 17d was yielded when cis-oxazinanone 17c 
was employed under our standard reaction conditions. Noteworthy here is that the 
four-membered azetidine 17d did not isomerize to the thermodynamically more stable 
tetrahydropyridine, which occurred smoothly without benzylidene malononitrile 
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present. We have no reasonable explanation for why cycloaddition reaction did not 
occur with compound 17c; however it may reside in steric effects brought by the 
cis-geometry of 4,6-substituents. 
Scheme 15 Substrates with no reactivity toward cycloadditions 
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O
N
O
Ts
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Ph Ph
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 While 17c is an extreme example, the decarboxylative ring contractions often 
competed with the cycloaddition reaction pathway as shown in Table 3. The lower 
yields of vinyl piperidines 13g and 13h were due to the formation of azetidine 
products (Table 1). In addition, a 1:1 mixture of 13o and 18b was formed with a 
bulky isopropyl substituted oxazinanone (entry 3). 
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Table 3 Lower chemoselectivity with sterically hindered vinyl oxazinanones 
N O
O
Ts
R1
R3
R2 N
R4
Ts
R1
R3
R2
CN
CN
cat. Pd(PPh3)4
R1 R2 ratio
Ph 2.3:1
Ph 1.7:1
Producta
13g:18a
13h:18a
H
H
R3
Ph
Ph
N
Ts
R1
R2
R3
R4
CN
CN
R4
Ph
p-AcOC6H4
13 18
N
Ts
R2
19
H Ph H Ph 13n:19ab 7.5:1c
CH(CH3)2 H H Ph 13n:18b 1:1
entry
1
2
3
4
or
R3
R1
 
a
 Except for 3o, 2,4-cis vinylpiperidine was the major diastereoisomer. b 6-membered 
decarboxlylative ring product 9a was formed as the by-product. c the product ratio of scale-up 
reaction, while 1HNMR reaction ratio was 2.5:1. 
 
A benzoyl protected vinyl oxazinanone 20a (1:1 cis/trans) was also employed in 
the decarboxylative cycloaddition reaction, which produced a mixture of 
cycloaddition product 20b and decarboxylative allylation product 20c (~1:1 ratio) as 
illustrated in Scheme 16. However, when compound 20c was treated with a palladium 
catalyst in toluene at 80 0C in the presence of a Michael acceptor, β-hydride 
elimination product 20d was generated formed without the formation of cycloaddition 
product 20b. 
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Scheme 16 Cycloaddition with Bz-protected vinyl oxazinanone 
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 As a further extension of the above decarboxylative cycloadditions, we would 
like to develop an asymmetric version of this reaction protocol. Toward that end, 
vinyl oxazinanone 12a was allowed to react with isocyanate 21a and carbodiimide 
21c in the presence of 5 mol% Pd(PPh3)4 in dichloromethane at room temperature, in 
which cycloaddition product 21b and ring contraction product 14b were produced 
respectively as shown in Scheme 17. Other oxazinanones were also used and 
cycloaddtion products 21e and 21g were obtained in 72% and 70% yield respectively. 
Of note here is that the reactions with isocyanate were very sensitive to water and the 
solvent needed to be dried over basic anhydrous alumina to ensure the clean 
formation of cycloaddition products. 
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Scheme 17 Cycloadditions of heterocumulenes 
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The decarboxylative cycloadditions were also carried out in the presence of 5 
mol% Pd2(dba)3 combined with 10 mol% of the Trost ligand (Scheme 18). With the 
Trost ligand, cycloaddition reactions were generally faster and cleaner than those 
catalyzed by Pd(PPh3)4. However, we had a hard time in separating compound 21e 
and 21g on chiral stationary phase HPLC (Diacel Chiralpak AD-H and OD-H) and the 
stereoselectivity of these reactions deserve further attention. 
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Scheme 18 Asymmetric cycloadditions 
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 Finally, to investigate the utility of the malonotrile-containing products, we 
performed a hydrolysis and decarboxylation of 13j to the mono cyano-substituted 
piperidine product as shown in Scheme 19. Acidic condition gave a mixture of 
starting material along with an unidentified new product; however the reaction did not 
go to completion, even at high temperature.26, 27 An analogue, 1,1-cyclohexane 
dicarbonitrile 22b, was then prepared and used as the standard substance for 
comparison. Treatment of 22b with concentrated sodium hydroxide solution afforded 
the corresponding carboxylic acid 22c, which upon decarboxylation gave 22d in 
quantitative yield.23 However, a messy mixture formed when 13j was treated under 
the same reaction conditions.  
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Scheme 19 Acid and base hydrolysis of nitriles 
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 Platinum complexes A and B have been shown to catalyze the partial hydrolysis 
of nitriles to amides.24 Treatment of 1,1-cyclohexanedicarbonitrile 22b with 0.5 mol% 
catalyst A and B provided the amide product 23d (Scheme 20). According to 
literature report, complex B was catalytically more active than A; however only one 
of the nitrile function group was selectively hydrolyzed in both cases to generate the 
corresponding cyanoamide product 23d, which was further hydrolyzed to the 
dicarboxylacid 22c. 
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Scheme 20 Platinium complexes catalyzed nitriles hydrolysis 
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 Piperdine drivatives 24a and 24c were also subjected to the Pt-catalyzed nitrile 
hydrolysis, in which amide products 24b and 24d were formed smoothly as shown in 
Scheme 21. It is worthy to note that in both cases, a diastereoisomeric mixture was 
obtained cleanly. 
Scheme 21 Pt- catalyzed nitriles hydrolysis with piperdine derivatives 
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 A radical process has previously been used to decyanate germinal dinitriles 
(Scheme 22).25 Interestingly, treatment of piperdine 25a with AIBN and t-butyl tin 
hydride generated the deacetylated product 25b while the cyano groups remained 
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intact. Strong bases such as n-butyl lithium induced a β-elimination reaction to form 
diene product 25d along with another product, whose structure was temporarily 
signed to be 25e. 
Scheme 22 Other reaction conditions 
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In summary, we have reported that decarboxylation of the vinyl oxazinanones in 
the presence of Michael acceptors results in cycloaddition to form highly substituted 
piperidines with good diastereoselectivity. Importantly, those reactions proceed under 
mild conditions and produce CO2 as the only byproduct. We further demonstrated that 
the resulting geminal dinitriles can be transformed to the corresponding amides with 
resort to Pt-catalyzed nitrile hydrolysis. 
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3.3 Palladium-Catalyzed Asymmetric, Diastereoselective Cycloadditions in 
Hydroquinoline Synthesis  
 
3.3.1 Methods for generating aza-ortho-xylylenes and applications in synthesis 
Aza-ortho-xylylenes like 26a are highly reactive intermediates that have been 
used to construct nitrogen heterocycles ever since Smolinsky proposed the structure 
of aza-ortho-xylylene for the first time in 1961.31, 32 Other xylyene analogues, such as 
the oxy- and thio-xylyenes are also known and have found many applications in 
heterocyclic ring syntheses (Scheme 23).26, 27 Aza-o-xylylene 26a could isomerize to 
benzoazetidine 26b, during which the driving force is the rearomatization; however 
theoretical calculations at the MP2 level showed that isomer 26a is more stable.28 
Scheme 23 Aza-ortho-xylylene and its analogues 
O S NH
NH NH
26a 26b
 
 
 Preparation of aza-ortho-xylylene 27c was achieved by treatment of benzoazetine 
27b with either thermal or photochemical conditions, followed by intermolecular 
Diels-Alder reaction with N-phenylmaleimide (NPMI) or 1,4-naphthoquinone (NQ) 
to give quinoline products 27d and 27f respectively as illustrated in Scheme 24.29, 30 
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Scheme 24 Reactions of Aza-ortho-xylylenes prepared from benzoazetine 
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Another convenient strategy for generating aza-ortho-xylylenes is 1,4-emlination 
reactions of various 1,4-amino benzyl derivatives as illustrated in Scheme 27. Upon 
losing one molecule of ethanol and CO2, aza-ortho-xylylene 30b was formed from 
1,4-amino benzyl carbonate 30a, followed by a intramolecular 6π eletrocyclization 
reaction to furnish a benzoxazine derivative 30c in 58% yield. In the presence of a 
dienophile, Diels-Alder adduct 30d was obtained, albeit in low yield.31 In 1986, 
Saegusa showed that a TMS-protected ammonium salt 30e reacted with cesium 
fluoride to generate xylyene intermediate 30f under mild reaction conditions, during 
which one molecule of trimethylamine was extruded. Cycloaddition with diethyl 
maleate generated the quinoline products 30g and 30h in combined 50% yield.32 
1,4-Elimination of HCl from o-(chloromethyl)aniline derivatives has also been used 
for generating xylyenes. For instance, treatment of 30i and 30j with cesium carbonate 
produced aza-ortho-xylylenes intermediates, which then underwent cycloadditions 
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with vinyl ethyl ether to give quinoline products 30k and 30l in good yields.40, 41 
Scheme 27 Aza-ortho-xylylenes preparation via 1,4-emlimation reactions 
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Benzosultams have also served as the precursor to aza-ortho-xylylenes upon 
losing one molecule of SO2 as shown in Scheme 25. For instance, intermediate 28b 
reacted with a dienophile NPMI to produce the corresponding [4+2] cycloaddition 
product 28c, while a dimeric eight-membered diazocine 28f was formed through a 
formal [4+4] cycloaddition in the absence of dienophiles.33-35 The intramolecular 
Diels-Alder reactions of xylylene intermediates 28h and 28k were also investigated, 
in which the corresponding tetrahydroquinolines were synthesized in good yields. 
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Scheme 25 Reactions of Aza-ortho-xylylenes generated from benzosultams 
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 Finally, and most relevant to this chapter, thermal decarboxylation of 
benzoxazinanones 29a also results in the formation of aza-ortho-xylylenes such as 
29b; the aza-o-xylylene was trapped with different dienophiles to give the related 
Diels-Alder adducts 29c and 29e in moderate yields (Scheme 26). Similarly, treatment 
of benzoxazinanones 29f with flash vacuum pyrolysis (FVP) at 180 oC produced 
aza-ortho-xylylene intermediates 29g, which underwent an intramolecuar [4+2] 
cycloaddition to produce quinoline derivatives 29h in moderate to low yield.36 
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Scheme 26 Reactions of Aza-ortho-xylylenes prepared from benzoxazinanones 
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3.3.2 Palladium-facilitated aza-ortho-xylylene generation and its application in 
hydroquinoline synthesis 
 
Recently, we have shown that catalytic decarboxylative cycloadditions of 
aza-ortho-xylenes occurs under mild conditions via zwitterionic π-allyl palladium 
intermediates (Scheme 28). This was discussed in chapter 2.19 Two possible 
intermediates 31d and 31e were proposed to form from the decarboxylation of 31a 
and our experimental results supported that palladium-polarized aza-o-xylylenes 31d 
are likely the intermediates, considering the formation of dimer product 31c. Next we 
wanted to develop a diastereoselective, asymmetric [4+2] cycloaddition of 
palladium-polarized aza-o-xylylenes with electron deficient olefins. 
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Scheme 28 Zwitterionic π-allyl palladium intermediates 
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If zwitterionic Pd-allyl intermediates are indeed being formed, then one would 
also predict that they would undergo [4+2] cycloadditions with electron deficient 
olefins as shown in Scheme 29.18, 37 Indeed, upon treatment of the benzoxazinanone 
31a with Pd(PPh3)4 in the presence of one equivalent of benzylidene malononitrile 
32a, cycloaddition occurs to produce the highly substituted dihydroquinoline 33a 
with good diastereoselectivity. This reaction was also carried out in non-polar 
solvents such as toluene and cycloaddition adduct 33a was afforded smoothly with no 
observation of the dimer formation. 
Scheme 29 [4+2] cycloaddition with electron deficient olefin 
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 To exclude the possibility that the free aza-o-xylenene intermediate is involved in 
the above [4+2] cycloaddition, different dienophiles 34a and 34c were allowed to 
react with vinyl benzoxazinanone 31a catalyzed by 5 mol% Pd(PPh3)4 in either 
methylene
 
chloride or toluene as shown in Scheme 30. Either of these electrophiles 
would be expected to react with a free aza-o-xylylene intermediate.  The 
cycloaddition adducts such as 34b were not formed in those reactions, which further 
confirmed that palladium-polarized aza-o-xylylenes are likely the relevant 
intermediates. 
Scheme 30 Other dienophiles do not undergo [4+2] cycloadditions 
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Next, we turned our attention toward the development of an asymmetric version 
of this cycloaddition. Standard ligand screening quickly revealed that the 
Trost-ligands are superior ligands for the asymmetric cycloaddition (Table 4).38 While 
the diphenyldiamine-based ligand 35e provided the highest enantioselectivity, the 
ligand based on the anthracenyl diamine 35g provided high enantioselectivity as well 
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as superior diastereoselectivity.  A single recrystallization of the product derived 
from 35g provided an 87% yield of highly enantio- and diastereoenriched 
hydroquinoline (97% ee, 50:1 dr). 
Table 4 Ligand and solvent screening results 
Ligand Sovlent
35a
35b
35c
35d
35f
35f
dr
-
7:1
6:1
>19:1
CD2Cl2
CD2Cl2
CD2Cl2
CD2Cl2
CH2Cl2
THF
33a:31b
NR
>19:1
0.85:1
5.5:1
ee 33a
-
78
69
69
35e 9:1CD2Cl2 >19:1 92
35f 9.4:1C6D6 1.7:1 78
2.5mol% Pd2(dba)3O
N O
Ts
N
Ts
Ph
CN
CN
Ligand
33a31a
N
Ts
31b
NC CN
Ph
PPh2
PPh2
N
H
N
H
O O
PPh2 Ph2P
R R
N
H
N
H
O O
PPh2Ph2P
N
H
N
H
O O
PPh2 Ph2P
35f
35d: R=(CH2)4
35e: R=Ph35a
35b
35c 35g
-NR -
-NR -
35g
35g
32:1
21:1
THF
dioxane
>19:1
>19:1
89
87
35g 15:1C6D6 10.6:1 88
35g 19:1aCH2Cl2 >19:1 89a
Ph2P
H
N
Ph
Fe
H
Ph
N PPh2
Fe
PPh2
H
PPh2
CH3
 
a
 97% ee and 50:1 dr after a single recrystallization. 
Using these as standard reaction conditions, we briefly explored the effect of 
electronics on the reaction. If the benzylidene malononitrile was too electron rich [i.e. 
p-MeOC6H4CHC(CN2)] then the intermolecular cycloaddition did not compete with 
the intramolecular cyclization to form dihydroquinolines.39, 40 However, if the olefin 
was sufficiently electron deficient, then the cycloaddition proceeded with both high 
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enantioselectivity and diastereoselectivity; the ee’s and dr’s of the product 
dihydroquinolines before recrystallization are shown in Table 5. Highly 
electron-deficient olefins slowed the reaction substantially, presumably due to 
favorable binding to the Pd(0) catalyst.41 For example, in contrast to most reactions 
which were facile at room temperature, the nitro-containing benzylidene 
malononitrile (33b-33d, Table 5) required 80 oC for the reaction to proceed.  It is 
noteworthy that the reaction selectivity was largely unaffected by the increased 
reaction temperature.  
Table 5 Asymmetric decarboxylative cycloaddition of vinyl oxazinanones.a 
5 mol%
Pd(Anth-Trost)
N
Ts
X
Ar
CN
CN
N
O
O
Ts
X
ee dr
p-Me o-CF3 98 >99:1
NC CN
Y
+
X Y Yield
85
p-Me p-CO2Me 98 37:197
p-Me p-CF3 86 56:188
p-Me p-NO2 99 >99:190
p-Me p-OAc 90 70:173
92 >99:177H
96 25:176p-CO2Me
91 45:190p-CF3
89 36:178o-CF3
91 92:152p-OAc
p-Me
H
H
H
H
96 >99:178p-NO2H
87 87:175Hp-F
87 >99:160p-OAcp-F
86 54:192Hp-OMe
80 50:190p-OAcp-OMe
92 25:199p-CO2Mep-OMe
99 25:191p-NO2p-OMe
84 37:193p-CF3p-OMe
86 29:197o-CF3p-OMe
33i
33f
33l
33cb
33o
33s
33g
33m
33j
33p
33dc
33t
33q
33r
33n
33e
33bb
33k
33h
Product
33
4-6 hrs
31
 
a
 1.0 mmol substrate was treated with Pd2(dba)3 (0.025 mmol) and 35g (0.055 mmol) in 
CH2Cl2 at room temperature. b run in CH2Cl2 at 40 oC for 25 h. c run in toluene at 80 oC for 6 h. 
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The origin of the stereoselectivity in this reaction is not known, however the 
reaction likely proceeds through aza-Michael addition of intermediate 36a to the 
activated olefin (Scheme 31).  The resulting stabilized carbanionic intermediate can 
then undergo intramolecular cyclization. The two potential stereochemistry- 
-determining steps in such a transformation are 1) the aza-Michael addition or 2) the 
cyclization. Since it is difficult to imagine that the chirality of the ligands could effect 
a highly enantioselective aza-Michael addition, our working hypothesis is that 
reversible conjugate addition is followed by stereochemistry-determining cyclization.  
This hypothesis is consistent with the pKa values for malononitrile (11.2) and the 
arylsulfonamide (9-10).42  
Scheme 31 The origin of the reaction’s stereoselectivity 
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Curtin-Hammett analysis of the resulting kinetic scenario indicates that the major 
product of the reaction will result from the most favorable cyclization.43 Elegant 
studies have allowed Lloyd-Jones to develop a model for the binding of Trost ligands 
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to palladium.44 These studies suggest that Trost ligand binds to produce a complex of 
C1-symmetry where the ligand bulk is concentrated in the upper right-hand and lower 
left-hand quadrants. Superimposing our intermediate onto Lloyd-Jones’ model gives 
four potential transition states for cyclization; three are shown in Scheme 32.  The 
favored transition state results from placing the benzylidene malononitrile fragment in 
the least hindered quadrant and the phenyl group is directed away from the bulky 
ligand in back. Such a prediction is confirmed by an X-ray crystal structure of the 
product that is of sufficient quality to allow determination of the relative and absolute 
configuration of the product. 
Scheme 32 Possible transition states for cyclizations 
 
Other electron deficient olefins were also tested to check their compatibility. 
Meldrum’s acid derivative 37a has been shown to be a suitable reactant for both 
X -ray conf irms
stereochemistr y
NTs
Ph
Z
Z
N
Ts Z
Z
Ph
N
Ph
Ts CN
CN
f avored
disf avored
NTs
Ph
Z
Z
disf avored
 185 
Ru-catalyzed tandem Michael addition-allylic alkylations and Pd-catalyzed 
decarboxylative olefin insertions with vinyl oxazinanones.19, 20 Interestingly, when 
compound 37a was allowed to react with different vinyl benzoxazinanones, a mixture 
of six- and eight-membered ring products was generated in different ratios (Scheme 
33). Of note here is that Meldrum’s acid derivative 37a is very reactive and those 
reactions were done in less than 10 minutes without observing any dihydroquinoline 
formation. However cycloaddition reactions became much slower with Pd2(dba)3 and 
anthracenyl diamine Trost ligand and a polymer-like product was generated. Since the 
asymmetric decarboxylative cycloaddition reactions were only realized during the 
formation of terminal olefins, that research was not further carried on. 
Scheme 33 Six-membered vs eight-membered cycloaddition products 
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 In addition, the above cycloadditions can be applied to the annulation of 
cyanocoumarins, which are frequently encountered structural motifs of many 
biologically active compounds.21, 22 For example, vinyl benzoxazinanone 31a reacted 
with three equivalents of cyanocourmarin 38a in the presence of Pd(PPh3)4 to yield a 
mixture of cycloadducts and dihydroquinolines in a ratio of 1.5:1, which can be 
improved to 7:1 by carrying out the reaction at higher concentration as shown in 
Scheme 34. Varying the electronics of the benzoxazinanones did not produce 
significant beneficial effects plus polymer-like byproducts were always formed along 
with dihydroquinolines. The optimization of those reaction conditions was not 
performed but could warrant further attention. 
Scheme 34 [4+2] cycloadditions with cyanocoumarin 
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 Regarding to the substrate scope, electron deficient olefin 39b was allowed the 
react with benzoxazinanone 39a
 
(Scheme 35). Even though racemic cycloaddition 
products were formed smoothly in two hours at room temperature, dihydroquinolines 
along with polymer byproducts were formed when the same reaction were catalyzed 
by Pd2(dba)3 and different Trost ligands in a much slower rate. Even though we are 
not exactly sure about the reason, it could reside in two factors. First, it is known that 
phenylsulfonyl group is bulkier than the corresponding cyano group and thus slow 
down the cycloaddition step. Secondly, phenylsulfonyl has been shown to function as 
a ligand for palladium catalysts. Consequently, the competition of ligand binding 
between Trost ligands and 39b may favor the intramolecular cyclization.45, 46 
Scheme 35 [4+2] cycloadditions with other electron deficient olefins 
Ph
SO2Ph
CN 5 mol % Pd(PPh3)4
CH2Cl2, rt
Ph SO2Ph
CN Pd2(dba)3
Trost ligands
39a 39b
O
N O
Ts
R
N
Ts
Ph
SO2Ph
CN
R
39c R=H, 80% NMR yield
39d R=Me, 75% yield
N
Ts
R
39a
O
N
Ts
R
39e
O
 
 
Vinyl benzoxazinanones 40a with a methyl substituent on the olefin were 
allowed to react with electron deficient olefins, generating a mixture of cycloaddition 
product 40b and dihydroquinoline 31b with poor chemoselectivity, even though 
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generally those reactions were clean with no occurrence of dimer by-products 
(Scheme 36). Vinyl benzoxazinanones 40d yielded dihydroquinoline 40e exclusively, 
while compound 40h was obtained as the major product from 40f. 
Scheme 36 [4+2] cycloadditions with substitute vinyl benzoxazinanones 
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 Cycloadditions of vinyl benzoxazinanones with different N-protecting groups 
were also performed (Scheme 37). For example, nosyl-protected substrate formed 
product 41b smoothly at the cost of requiring excess of olefin 32a. The analogous 
[4+2] cycloadditions of benzoyl-protected benzoxazinanone 41b did not afford the 
corresponding cycloadducts and intramolecular cyclization occurred to give product 
41d. 
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Scheme 37 Vinyl benzoxazinanones with different N-protecting groups 
5 mol % Pd(PPh3)4
CD2Cl2, rtN
O
O
Ns
41a 32a 41b
Ph CN
CN
5eq
N
Ns
Ph
CN
CN
Ph CN
CN
O
N O
PhO
CD2Cl2, rt
O
N PhEt
O
or
5 mol % Pd(PPh3)4
41c 41d
92% NMR yield
 
 
 The generation of aza-ortho-xylylene intermediate was proven to be very difficult 
with substrate 42a, which remained intact in most cases (Scheme 38). Interestingly, 
when benzoxazinanone 42a was allowed to react with benzylidene malononitrile 
under microwave irridation in DMF at 180 oC, a diamine product 42b was generated 
in high yield with or without the palladium catalyst. Other solvents would have been 
planned but the Microwave reactor broke down. Trapping the aza-o-xylylene 
intermediates with amines was also tried and starting material was recovered. 
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Scheme 38 Reactions of traditional benzoxazinanone 
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Et
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N O
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N O
Ts Ts
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42a
42b
62% yield
 
 
Trapping aza-o-xylenene intermediates with good nucleophiles has been 
reported.47-49 Similarly, secondary amines have been used in our experiments as 
shown in Scheme 39. The secondary amines 43a and 43d turned out to be so reactive 
that those reactions were finished in less than 10 minutes and a control experiment 
without palladium catalyst was also performed to generate product 43e in less than an 
hour. Such reactivity was later proven to be problematic when benzoxazinanone 31a 
was allowed to react with piperidine 43d in the presence of Pd2(dba)3 and Trost ligand 
35e, which produced product 43e as a racemic mixture. Interestingly, those reactions 
displayed different regioselectivity from traditional Pd-catalyzed allylic alkylations. 
In our case, the terminal olefins 43b and 43e were formed exclusively, and at higher 
 191 
temperature, terminal olefin product 43b isomerized to the more thermodynamically 
stable product 43c. 
Scheme 39 Allylic aminations via Aza-o-xylenene intermediates 
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N
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 Aniline derivatives were allowed to reacted with benzoxazinanone 31a in the 
presence of Pd(PPh3)4 and addition products 44b and 44d were obtained in less than 
20 minutes (Scheme 40); however the products were not stable and transformed into 
polymer-like by-products upon standing overnight. This reaction did not occur 
without palladium catalyst and was very sluggish in toluene. 
Scheme 40 Allylic aminations via Aza-o-xylenene intermediates 
O
N O
Ts
PhNH2
Pd(PPh3)4
NH
Ts
NHPh
CD2Cl2, 10 mins
O
N O
Ts
PhNHCH3
NPhCH3
NH
Ts
Pd(PPh3)4
CD2Cl2, 2 mins
31a 44a 44b
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 A racemic diamine product 45b was prepared by treatment of benzylamine with 
benzoxazinanone 31a in the presence of 5 mol% Pd(PPh3)4 as shown in Scheme 41. 
With anthracenyl diamine Trost ligand 35g, enantioenriched product 45b was 
obtained (55% and 50% ee at 0 oC and 25 oC respectively), while the ee of aniline 
derivative 45d was very low. We reasoned that electron-poor amines such as 
cyanopyrrole could potentially give a better enantioselectivity because of its lower 
nucleophilicity, which deserves further attention. 
Scheme 41 Asymmetric allylic aminations 
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O
N O
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Ts45dee 18%
0 oC, ee 55%
rt, ee 50%
CD2Cl2
 
 
 To further expand the scope of asymmetric [4+2] cycloadditions, tosyl isocyanate 
was allowed to react with treated vinyl benzoxazinanone 31a as shown in Scheme 42. 
Even though racemic mixture 46b was formed cleanly in 55% isolated yield, the 
asymmetric reaction gave the cycloaddition product in 24% ee at higher temperature. 
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Other Trost ligands combined with Pd2(dba)3 generated a messy mixture of 
dihydroquinoline and polymer byproducts. 
Scheme 42 [4+2] cycloadditions with tosyl isocyanate 
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In conclusion, we have developed an asymmetric decarboxylative cycloaddition 
that proceeds through intermediates that may be viewed as palladium-polarized 
aza-ortho-xylylenes.  Formal [4+2] cycloaddition of these intermediates produces 
enantioenriched hydroquinolines with high diastereoselectivity. The implied 
stabilization of aza-o-xylylenes by palladium is expected to translate to other reactive 
intermediates. 
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Appendix C
Experimental Procedures and Data for Chapter 3
200
General Experimental
THF was dried over sodium metal. Toluene, methylene chloride and diethyl
ether were dried over activated alumina on a solvent system purchased from
Innovative Technology, Inc.1 Acetonitrile and 1,4-dioxane were dried and stored over
activated molecular sieves. Commercially available reagents were used without
additional purification unless otherwise stated. Products were purified on silica gel
from Sorbent Technologies (230x400 mesh, 60 Å porosity, pH 6.5-7.5). Ruthenium
and palladium compounds were obtained from Strem. Thin layer chromatography
was performed on silica gel 60F254 plates (EM-5715-7, EMD chemicals). UV lamp
(254 nm) or KMnO4 stain were used for monitoring TLC plates.
1H and 13C NMR spectra were obtained on a Bruker Avance 400 or Bruker
Avance 500 DRX spectrometer and referenced to residual protio solvent signals.
Structural assignments are based on 1H, 13C, DEPT-135, COSY, and HMQC
spectroscopies and X-ray data. High resolution mass spectrometry was performed on
an AUTOSPEC-Q tandem hybrid mass spectrometer (VG Analytical Ltd,
Manchester, UK). High resolution mass spectrometry was performed on a LCT
Premier (Waters Corp., Milford MA) time of flight mass spectrometer. FTIR spectra
were acquired on a Shimadzu FTIR-8400S spectrometer. HPLC analysis was
performed on a Shimadzu SCL-10A VP instrument.
 Preparation of Starting Materials
Vinyl oxazinanones were prepared as reported in Chapter 2 of this thesis.
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General procedure for catalytic decarboxylative olefin insertions:
In a Schlenk tube under argon, Pd(PPh3)4 (0.05 mmol) and carbamate 1 (1
mmol), and different Michael acceptors (1 mmol) were dissolved in 5 mL of
methylene chloride. The resulting yellow solution was stirred at ambient temperature
under Ar until reaction completion was indicated by TLC. Following solvent
evaporation, the crude product was purified via flash chromatography (SiO2, 5:1
Hexane: Ethyl acetate).
Spectroscopic Data
N
Ph
Ts
Ph
CN
CN
2,5-diphenyl-1-tosyl-4-vinylpiperidine-3,3-dicarbonitrile
13a(cw2027)
colorless oil
Pd(PPh3)4: 94% yield, dr >19:1
1H NMR (400 MHz, CDCl3) δ 7.47 (m, 3H: arom H), 7.38 (m, 7H: arom H), 7.18 (d,
2H, J =6.8 Hz: arom H), 7.06 (d, 2H, J =8.6 Hz: arom H), 5.93 (s, 1H: PhCHNTs),
5.62 (m, 1H: CH2=CH), 5.20 (dd, 2H, J =10.4, 16.9 Hz: =CH2), 3.99 (dd, 1H, J =4.5,
13.4 Hz: CH 2NTs), 3.39 (m, 1H: CH 2NTs), 3.25 (m, 2H: overlapping PhCH ,
CHCH=CH2), 2.35 (s, 3H: CH3Ts).
13C NMR (75 MHz, CDCl3) δ 144.36 (Quat.), 137.84 (Quat), 135.27 (Quat.), 133.91
(Quat.), 132.12 (=CH), 130.26-127.81 (Arom.CH), 124.47 (=CH2), 113.79 (CN),
113.31 (CN), 61.54 (PhCHNTs), 47.51 (CH2), 45.80/43.83 (overlapping PhCH,
CHCH=CH2), 45.07 (CCN2), 21.91 (CH3Ts). The assignments of the 
1H and 13C
were based on DEPT, COSY, HMQC etc.
FTIR (CDCl3): νmax  3090, 3065, 3034, 2251, 1599, 1497, 1354, 1167, 806, 758, 663.
HRMS calcd for C28H26N3O2S [M+H] 468.1746, found 468.1737.
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N
Ts
CN
CN
MeO Ph
5-(4-methoxyphenyl)-2-phenyl-1-tosyl-4-vinylpiperidine-3,3-
dicarbonitrile
13b(cw2139)
colorless oil
Pd(PPh3)4: 88% yield, dr >19:1
1H NMR (400 MHz, CDCl3) δ 7.45 (m, 4H: arom H), 7.38 (t, 4H, J =8.3 Hz: arom
H), 7.09 (m, 4H: arom H), 6.90 (d, 2H, J =8.6 Hz: arom H), 5.92 (s, 1H: PhCHNTs),
5.61 (m, 1H: CH2=CH), 5.21 (dd, 2H, J =10.4, 17.2 Hz: =CH2), 3.97 (dd, 1H, J = 4.5,
12.6 Hz: CH2NTs), 3.82 (s, 3H: OCH3), 3.35 (dd, 1H, J =5.8, 12.9 Hz: CH2NTs),
3.19 (m, 2H: overlapping ArCH, CHCH=CH2), 2.35 (s, 3H: CH3Ts).
13C NMR (75 MHz, CDCl3) δ 159.71 (Quat.), 144.32 (Quat), 135.26 (Quat.), 132.93
(Quat.), 132.26 (=C H), 130.24-127.81 (Arom.CH), 124.38 (=CH2), 114.94
(Arom.CH), 113.81 (CN), 113.34 (CN), 61.53 (PhCHNTs), 55.72 (OCH3), 47.66
(CH2), 45.96/43.00 (overlapping ArCH, CHCH=CH2), 45.12 (CCN2), 21.91
(CH3Ts). The assignments of the 
1H and 13C were based on DEPT, COSY, HMQC
etc.
FTIR (CDCl3): νmax 3092, 3061, 3035, 2253, 1514, 1456, 1354, 1167, 814, 762, 660.
HRMS calcd for C29H27N3O3SNa [M+Na] 520.1671, found 520.1652.
N
Ts
NC CN
MeO OAc
4-(3,3-dicyano-5-(4-methoxyphenyl)-1-tosyl-4-vinylpiperidin-2-yl)phenyl acetate
13c(cw2143)
colorless oil
Pd(PPh3)4: 81% yield, dr >19:1
1H NMR (400 MHz, CDCl3) δ 7.44 (d, 2H, J =8.6 Hz: arom H), 7.37 (d, 2H, J =6.8
Hz: arom H), 7.10 (m, 6H: arom H), 6.91 (d, 2H, J =8.6 Hz: arom H), 5.92 (s, 1H:
PhCHNTs), 5.60 (m, 1H: CH2=CH), 5.22 (dd, 2H, J =10.4, 16.9 Hz: =CH2), 3.96 (dd,
1H, J =4.3, 12.6 Hz: CH2NTs), 3.82 (s, 3H: OCH3), 3.20 (m, 3H: overlapping
CH2NTs, ArCH, CHCH=CH2), 2.36 (s, 6H: overlapping CH3Ts, OCOCH3).
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 13C NMR (75 MHz, CDCl3) δ 169.14 (OCOCH3), δ 159.72 (Quat.), 152.04 (Quat),
144.59 (Quat.), 135.03 (Quat.), 132.12 (=CH), 131.22-127.72 (Arom.CH), 124.49
(=CH2), 122.76 (Arom.CH), 114.94 (Arom.CH), 113.68 (CN), 113.29 (CN), 60.89
(PhCHNTs), 55.72 ((OCH3), 47.62 (C H 2), 45.85/42.95 (overlapping PhCH,
CHCH=CH2), 45.10 (CCN2), 21.90/21.61 (overlapping CH3Ts, OCOCH3). The
assignments of the 1H and 13C were based on DEPT, COSY, HMQC etc.
FTIR (CDCl3): νmax 3089, 3034, 2251, 1769, 1610, 1514, 1354, 1167, 833, 660.
HRMS calcd for C31H29N3O5SNa [M+Na] 578.1726, found 578.1730.
N
Ts
Ph
CN
CN
Cl
5-(4-chlorophenyl)-2-phenyl-1-tosyl-4-vinylpiperidine-3,3-dicarbonitrile
13d(cw2091)
colorless oil
Pd(PPh3)4: 87% yield, dr >19:1
1H NMR (400 MHz, CDCl3) δ 7.45-7.35 (m, 9H: arom H), 7.13-7.06 (m, 4H: arom
H), 5.93 (s, 1H: PhCHNTs), 5.60 (m, 1H: CH2=CH), 5.27 (d, 1H, J =10.4 Hz: =CH2),
5.16 (d, 1H, J =16.9 Hz: =CH2), 3.97 (dd, 1H, J = 4.3, 12.9 Hz: CH2NTs), 3.24 (m,
3H: overlapping CH2NTs, ArCH, CHCH=CH2), 2.35 (s, 3H: CH3(Ts)).
13C NMR (75 MHz, CDCl3) δ 144.47 (Quat.), 136.32 (Quat), 135.20 (Quat.), 134.50
(Quat.), 133.77 (Quat.), 131.84 (=CH), 130.31-127.78 (Arom.CH), 124.78 (=CH2),
113.67 (CN), 113.15 (CN), 61.48 (PhCHNTs), 47.36 (CH2), 45.85 (CHCH=CH2),
44.99 (CCN2), 43.30 (ArCH), 21.92 (CH3Ts). The assignments of the 
1H and 13C
were based on DEPT, COSY, HMQC etc.
FTIR (CDCl3): νmax 3091, 3062, 3035, 2255, 1599, 1493, 1354, 1167, 1092, 831,
663.
HRMS calcd for C28H24ClN3O2SNa [M+Na] 524.1175, found 524.1163.
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4-(5-(4-chlorophenyl)-3,3-dicyano-1-tosyl-4-vinylpiperidin-2-yl)phenyl acetate
13e(cw2099)
colorless oil
Pd(PPh3)4: 96% yield, dr >19:1
1H NMR (400 MHz, CDCl3) δ 7.36 (d, 2H, J =8.2 Hz: arom H), 7.28 (t, 4H, J =8.5
Hz: arom H), 7.02 (m, 6H: arom H), 5.84 (s, 1H: PhCHNTs), 5.50 (m, 1H: CH2=CH),
5.18 (d, 1H, J =10.4 Hz: =CH2), 5.08 (d, 1H, J =17.0 Hz: =CH2), 3.89 (dd, 1H, J
=4.4, 12.9 Hz: CH2NTs), 3.15 (m, 2H: overlapping CH2NTs, ArCH), 3.02 (t, 1H, J
=9.1 Hz: CHCH=CH2), 2.27/2.26 (s, 6H: overlapping CH3(Ts), OCOCH3).
13C NMR (75 MHz, CDCl3) δ 168.67 (OCOCH3), 151.70 (Quat.), 144.32 (Quat),
144.59 (Quat.), 135.81/134.70/134.18 (Quat.), 131.30 (=CH), 130.71-127.34
(Arom.CH), 124.46 (=CH2), 122.40 (Arom.CH), 113.12 (CN), 112.71 (CN), 60.45
(PhCHNTs), 46.93 (CH2), 45.42 (CHCH=CH2), 44.54 (CCN2), 42.87 (ArCH),
21.49/21.17 (overlapping CH3Ts, OCOCH3). The assignments of the 
1H and 13C were
based on DEPT, COSY, HMQC etc.
FTIR (CDCl3): νmax 3090, 3032, 2253, 1751, 1601, 1495, 1348, 1163, 1092, 813.
HRMS calcd for C30H26N3O4SClNa [M+Na] 582.1230, found 582.1223.
N
Ph
Ts
NC CN
OAc
4-(3,3-dicyano-5-phenyl-1-tosyl-4-vinylpiperidin-2-yl)phenyl acetate
13f(cw2033)
colorless oil
Pd(PPh3)4: 76% yield, dr >19:1
1H NMR (400 MHz, CDCl3) δ 7.48 (d, 2H, J =8.8 Hz: arom H), 7.40 (m, 5H: arom
H), 7.18 (d, 2H, J =8.1 Hz: arom H), 7.13 (m, 5H: arom H), 5.94 (s, 1H: PhCHNTs),
5.61 (m, 1H: CH2=CH), 5.22 (dd, 2H, J =10.4, 16.7 Hz: =CH2), 3.99 (dd, 1H, J =4.3,
12.9 Hz: CH 2NTs), 3.31 (dd, 1H, J =11.4, 24.2 Hz: CH 2NTs), 3.20 (m, 2H:
overlapping PhCH, CHCH=CH2), 2.36/2.35 (s, 6H: overlapping CH3Ts, OCOCH3).
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13C NMR (75 MHz, CDCl3) δ 169.09 (OCOCH3), δ 152.07 (Quat.), 144.61 (Quat),
137.74 (Quat.), 135.11 (Quat.), 131.98 (=CH), 131.22-127.74 (Arom.CH), 124.55
(=CH2), 122.76 (Arom.CH), 113.65 (CN), 113.25 (CN), 60.91 (PhCHNTs), 47.71
(CH2), 45.71/43.78 (overlapping PhCH, CHCH=CH2), 45.04 (CCN2), 21.88/21.58
(overlapping CH3Ts, OCOCH3). The assignments of the 
1H and 13C were based on
DEPT, COSY, HMQC etc.
FTIR (CDCl3): νmax 3090, 3065, 3034, 2251, 1767, 1599, 1497, 1354, 1167, 814,
660.
HRMS calcd for C30H27N3O4SNa [M+Na] 548.1620, found 548.1620.
N
Ph
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NC
CN
Ph
Ph
2,5-diphenyl-4-styryl-1-tosylpiperidine-3,3-dicarbonitrile
13g (cw2124)
colorless oil
Pd(PPh3)4: 54% yield, dr = 10:1
1H NMR (400 MHz, CDCl3) δ 7.52-7.08 (19H: arom H), 6.44 (d, 1H, J =15.7 Hz:
=CHPh), 5.96 (s, 1H: CHAr), 5.92 (dd, 1H, J =8.6, 15.7 Hz: =CH), 4.03 (m, 1H:
CH2NTs), 3.38 (3H: overlapping CH2NTs, PhCH , CHCH=CH), 2.37 (s, 3H:
CH3(Ts)).
13C NMR (75 MHz, CDCl3) δ 144.38 (Quat.), 138.74 (=CHPh), 137.85 (Quat.),
135.80 (Quat.), 135.30 (Quat.), 133.98 (Quat.), 130.28-127.10 (Arom.CH), 122.95
(=CH), 113.95 (CN), 113.34 (CN), 61.66 (PhCHNTs), 47.61 (CH2), 45.52 (CCN2),
45.38 (CHCH=CH2), 44.28 (CHPh), 21.93 (CH3(Ts)). The assignments of the 
1H and
13C were based on DEPT, COSY, HMQC etc.
FTIR (CDCl3): νmax 3067, 3032, 2253, 1769, 1599, 1497, 1354, 1165, 974, 814, 758,
663.
HRMS calcd for C34H29N3O2SNa [M+Na] 566.1878, found 566.1874.
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4-(3,3-dicyano-5-phenyl-4-styryl-1-tosylpiperidin-2-yl)phenyl acetate
13h (cw2152)
colorless oil
Pd(PPh3)4: 53% yield, dr >19:1
1H NMR (400 MHz, CDCl3) δ 7.52 (d, 2H, J =8.8 Hz: arom H), 7.39 (d, 2H, J =8.3
Hz: arom H), 7.36 (d, 2H, J =7.6 Hz: arom H),  7.30-7.19 (m, 8H: arom H), 7.14 (t,
4H: arom H), 6.47 (d, 1H, J =15.9 Hz: =CHPh), 5.98 (s, 1H: CHAr), 5.91 (dd, 1H, J
=8.3, 15.7 Hz: =CH), 4.06 (dd, 1H, J =3.8, 12.6 Hz: CH2NTs), 3.36 (m, 3H:
overlapping CH2NTs, PhCH , CHCH=CH), 2.37 (s, 6H: overlapping CH3Ts,
OCOCH3).
13C NMR (75 MHz, CDCl3) δ 169.15 (OCOCH3), δ 152.08 (Quat.), 144.65 (Quat),
138.84 (=CHPh), 137.73 (Quat.), 135.76 (Quat.), 135.08 (Quat.), 131.27-127.12
(Arom.CH), 122.82 (=CH), 113.83 (CN), 113.29 (CN), 61.03 (ArCHNTs), 47.59
(CH2), 45.52 (CHCH=CH2), 45.27 (CCN2), 44.22 (CHPh), 21.92/21.63 (overlapping
CH3Ts, OCOCH3). The assignments of the 
1H and 13C were based on DEPT, COSY,
HMQC etc.
FTIR (CDCl3): νmax 3084, 3061, 3032, 2255, 1769, 1599, 1508, 1354, 1271, 1167,
976, 816, 762, 694.
HRMS calcd for C36H31N3O4SNa [M+Na] 624.1933, found 624.1934.
N
Ph
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CN
CN
Ph
5-benzyl-2-phenyl-1-tosyl-4-vinylpiperidine-3,3-dicarbonitrile
13i (cw2178)
colorless oil
Pd(PPh3)4: 66% yield, dr =8.3:1
1H NMR (400 MHz, CDCl3) δ 7.31 (m, 10H: arom H), 7.08 (m, 4H: arom H), 5.82
(m, 2H: overlapping PhCHNTs, CH2=CH), 5.58 (dd, 2H, J =10.4, 16.9 Hz: =CH2),
3.57 (dd, 1H, J =5.1, 13.9 Hz: CH2NTs), 2.98 (m, 2H: overlapping CH2NTs, CH2Ph),
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2.83 (t, 1H, J =9.1 Hz: CHCH=CH2), 2.38 (m, 4H: overlapping CH3Ts, CH2NTs),
2.12 (m, 1H: CHBn).
13C NMR (75 MHz, CDCl3) δ 144.28 (Quat.), 137.17 (Quat), 135.19 (Quat.), 133.88
(Quat.), 132.03 (=CH), 130.06-127.45 (Arom.CH), 125.16 (=CH2), 113.98 (CN),
113.47 (CN), 61.22 (PhCHNTs), 46.78/44.63 (overlapping CHCH=CH2,  CCN2),
44.68 (CH2NTs), 37.42/37.26 (overlapping PhCH2, BnCH), 21.95 (CH3Ts). The
assignments of the 1H and 13C were based on DEPT, COSY, HMQC etc.
FTIR (CDCl3): νmax 3055, 3030, 2252, 1599, 1495, 1354, 1169, 814, 762, 663.
HRMS calcd for C28H26N3O2S [M+NH4] 499.2168, found 499.2163.
N
Ph
Ts
NC
CN
2-phenyl-1-tosyl-4-vinylpiperidine-3,3-dicarbonitrile
13j (cw2157)
colorless oil
Pd(PPh3)4: 85% yield, dr =1:3
1H NMR (400 MHz, CDCl3) δ 7.37 (m, 5H: arom H), δ 7.31 (d, 2H,  J =7.6 Hz: arom
H), 7.07 (d, 2H, J =8.1 Hz: arom H), 5.86 (m, 1H: CH2=CH), 5.80 (s, 1H: PhCH),
5.41 (d, 1H, J = 10.4 Hz: CH=CH(H)Z),  5.35 (d, 1H, J = 16.9 Hz: CH=CH(H)E),
3.94 (m, 1H: CH2NTs), 3.40 (m, 1H: CH2NTs), 3.02 (m, 1H: CHCH=CH2), 2.35 (s,
3H: CH3Ts), 2.03 (m, 1H: CH2).
13C NMR (75 MHz, CDCl3) δ 144.35 (Quat.), 135.26 (Quat.), 133.96 (Quat.), 133.79
(=CH), 130.15-127.82 (Arom.CH), 122.24 (=CH2), 113.59 (CN), 113.43 (CN), 61.55
(CHPh), 44.40 (CCN2), 40.99 (CH2NTs), 40.42 (CHCH=CH2), 26.55 (CH2), 21.91
(CH3Ts). The assignments of the 
1H and 13C were based on DEPT, COSY, HMQC
etc.
FTIR (CDCl3): νmax 3059, 3036, 2254, 1599, 1495, 1350, 1165, 814, 760, 663.
HRMS calcd for C22H21N3O2SNa [M+Na] 414.1252, found 414.1246.
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2-phenyl-1-tosyl-4-vinylpiperidine-3,3-dicarbonitrile
13j (cw2157)
colorless oil
Pd(PPh3)4: 85% yield, dr =1:3
1H NMR (400 MHz, CDCl3) δ 7.38 (m, 5H: arom H), δ 7.30 (d, 2H,  J =6.8 Hz: arom
H), 7.20 (d, 2H, J =8.1 Hz: arom H), 5.88 (m, 1H: CH2=CH), 5.45 (d, 1H, J = 10.1
Hz: CH=CH(H)Z),  5.41 (d, 1H, J = 16.7 Hz: CH=CH(H)E), 4.73 (s, 1H: PhCH), 4.03
(m, 1H: CH2NTs), 3.48 (m, 1H: CH2NTs), 2.68 (m, 1H: CHCH=CH2), 2.43 (s, 3H:
CH3Ts), 2.23 (m, 1H: CH2), 2.01 (m, 1H: CH2).
13C NMR (75 MHz, CDCl3) δ  144.72 (Quat.), 135.71(Arom.CH), 133.76 (Quat.),
133.32 (=CH), 130.27-127.99 (Arom.CH), 122.27 (=CH2), 114.18 (CN), 112.56
(CN), 66.19 (CHPh), 47.08 (CHCH=CH2), 46.42 (CCN2), 44.20 (CH2NTs), 26.47
(CH2), 21.98 (CH3Ts). The assignments of the 
1H and 13C were based on DEPT,
COSY, HMQC etc.
N
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4-(3,3-dicyano-1-tosyl-4-vinylpiperidin-2-yl)phenyl acetate
13k (cw2163)
colorless oil
Pd(PPh3)4: 99% yield, dr =1:2.8
1H NMR (400 MHz, CDCl3) δ 7.37 (m, 4H: arom H), δ 7.23 (d, 2H,  J =8.3 Hz: arom
H), 7.01 (d, 2H, J =8.8 Hz: arom H), 5.86 (m, 1H: CH2=CH), 5.44(d, 1H, J = 9.3 Hz:
CH=CH(H)Z),  5.42 (d, 1H, J = 16.2 Hz: CH=CH(H)E), 4.71 (s, 1H: ArCH), 4.06 (m,
1H: CH2NTs), 3.47 (m, 1H: CH2NTs), 2.70 (m, 1H: CHCH=CH2), 2.42 (s, 3H:
CH3Ts), 2.33 (s, 3H: CH3CO2), 2.23 (m, 1H: CH2), 2.02 (m, 1H: CH2).
13C NMR (75 MHz, CDCl3) δ 169.13 (OCOCH3), δ 152.13 (Quat.), 144.84 (Quat),
135.79 (Quat.), 133.26 (=CH), 130.90-127.92 (Arom.CH), 122.35 (=CH2), 121.94
(Arom. CH), 113.99 (CN), 112.48 (CN), 65.81 (CHAr), 47.22 (CHCH=CH2), 46.40
(CCN2), 44.28 (CH2NTs), 26.55 (CH2), 21.63 (overlapping CH3Ts, CH3CO2). The
assignments of the 1H and 13C were based on DEPT, COSY, HMQC etc.
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FTIR (CDCl3): νmax 3063, 2253, 1762, 1597, 1508, 1354, 1169, 816.
HRMS calcd for C24H23N3O4SNa [M+Na] 472.1307, found 472.1305.
N
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4-(3,3-dicyano-1-tosyl-4-vinylpiperidin-2-yl)phenyl acetate
13k (cw2163)
colorless oil
Pd(PPh3)4: 99% yield, dr =1:2.8
1H NMR (400 MHz, CDCl3) δ 7.42 (d, 2H,  J =8.1 Hz: arom H), δ 7.39 (d, 2H,  J
=8.8 Hz: arom H), 7.13 (d, 2H, J =8.3 Hz: arom H), 7.06 (d, 2H, J =8.6 Hz: arom H),
5.85 (m, 1H: CH2=CH), 5.82 (s, 1H: ArCH), 5.42 (d, 1H, J = 10.4 Hz: CH=CH(H)Z),
5.39 (d, 1H, J = 16.9 Hz: CH=CH(H)E), 3.95 (td, 1H, J =3.5, 12.9 Hz: CH2NTs), 3.34
(m, 1H: CH2NTs), 2.95 (q, 1H, J =7.6, 16.2 Hz: CHCH=CH2), 2.36 (s, 3H: CH3Ts),
2.32 (s, 3H: CH3CO2), 2.02 (m, 1H: CH2).
13C NMR (75 MHz, CDCl3) δ 169.14 (OCOCH3), δ 151.98 (Quat.), 144.60 (Quat),
135.08 (Quat.), 133.64 (=CH), 131.31-127.78 (Arom.CH), 122.60 (Arom. CH),
122.35 (=CH2), 113.42 (CN), 113.36 (CN), 60.90 (CHAr), 44.43 (CCN2), 40.90
(CH2NTs), 40.43 (CHCH=CH2), 26.54 (CH2), 21.90/21.58 (overlapping CH3Ts,
CH3CO2). The assignments of the 
1H and 13C were based on DEPT, COSY, HMQC
etc.
FTIR (CDCl3): νmax 3062, 2253, 1769, 1599, 1508, 1350, 1165, 816.
HRMS calcd for C24H23N3O4SNa [M+Na] 472.1307, found 472.1294.
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4-methyl-2-phenyl-1-tosyl-4-vinylpiperidine-3,3-dicarbonitrile
13l (cw2200)
colorless oil
Pd(PPh3)4: 99% yield, dr =1:2
1H NMR (400 MHz, CDCl3) δ 7.32 (m, 8H: arom H), 7.23 (m, 3H: arom H), 7.15 (m,
3H: arom H), 6.12 (dd, 1H, J =10.9, 17.2 Hz: CH2=CH, major isomer), 5.86 (dd,
0.5H, J =10.9, 17.2 Hz: CH2=CH, minor isomer), 5.49 (dd, 2H, J =10.9, 17.4 Hz:
=CH2, major isomer), 5.28 (dd, 1H, J =14.4, 17.2 Hz: =CH2, minor isomer),  5.15 (s,
0.5H: PhCH , minor isomer), 4.95 (s, 1H: PhCH, major isomer), 3.95 (m, 1.5H:
CH2NTs), 3.75 (m, 1.5H: CH2NTs), 2.40 (s, 4.5H: CH3Ts), 2.28 (m, 1.5H: CH2),
2.02 (m, 1.5H: CH2), 1.48 (s,1.5H: CH3, minor isomer), 1.41 (s, 3H: CH3, major
isomer).
13C NMR (75 MHz, CDCl3) δ 144.31 (Quat.), 138.97 (=CH, minor isomer), 137.38
(=CH, major isomer), 136.47 (Quat.), 136.08 (Quat.), 133.70 (Quat.), 133.48 (Quat.),
129.84-127.81 (Arom. CH), 120.09 (=CH2, major isomer), 118.12 (=CH2, minor
isomer), 113.84 (CN), 113.57 (CN), 62.50, 61.85 (CHPh), 50.82, 50.34 (CCN2),
43.35, 42.72 (Quat.), 41.66, 41.37 (CH2NTs), 31.71, 31.42 (CH2), 25.14, 23.39
(CH3), 21.97 (CH3Ts). The assignments of the 
1H and 13C were based on DEPT,
COSY, HMQC etc.
FTIR (CDCl3): νmax 3060, 2250, 1597, 1496, 1384, 1161, 814, 661.
HRMS calcd for C23H24N3O2S [M+H] 406.1598, found 406.1563.
N
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4-(3,3-dicyano-4-methyl-1-tosyl-4-vinylpiperidin-2-yl)phenyl acetate
13m (cw2205)
colorless oil
Pd(PPh3)4: 99% yield, dr =1:2
1H NMR (400 MHz, CDCl3) δ 7.30 (m, 4H: arom H), 7.16 (d, 2H, J =8.1 Hz: arom
H), 6.94 (d, 2H, J =8.6 Hz: arom H), 6.12 (dd, 1H, J =10.9, 17.2 Hz: CH2=CH), 5.51
(dd, 2H, J =10.9, 17.4 Hz: =CH2), 4.94 (s, 1H: ArCH), 3.95 (m, 1H: CH2NTs), 3.77
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(m, 1H: CH2NTs), 2.40 (s, 3H: CH3Ts), 2.31 (s, 3H: CH3CO2), 2.29 (m, 1H: CH2),
2.03 (m, 1H: CH2), 1.42 (s,3H: CH3).
13C NMR (75 MHz, CDCl3) δ 169.10 (OCOCH3), δ 151.92 (Quat.), 144.44 (Quat),
133.18 (=C H), 136.55 (Quat.), 130.75 (Arom.CH), 130.01 (Arom.CH),
127.69(Arom.CH),130.01 (Arom. CH), 120.24 (=CH2), 113.78 (CN), 113.38 (CN),
62.03 (CHAr), 50.75 (CCN2), 43.42 (Quat.), 41.55 (CH2NTs), 31.71 (CH2), 25.35
(CH3Ts), 21.95, 21.61 (overlapping CH3, CH3CO2). The assignments of the 
1H and
13C were based on DEPT, COSY, HMQC etc.
FTIR (CDCl3): νmax 3056, 2252, 1763, 1599, 1510, 1369, 1163, 814, 760.
HRMS calcd for C25H29N4O4S [M+NH4] 481.1909, found 481.1890.
N
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CN
CNPh
2,4-diphenyl-1-tosyl-4-vinylpiperidine-3,3-dicarbonitrile
13n (cw2227)
White solid
Pd(PPh3)4: 87% yield, dr =1:>19
1H NMR (400 MHz, CDCl3) δ 7.62-7.12 (m, 14H: arom H), 6.45 (dd, J =11.1, 17.4
Hz, 1H: CH2=CH), 5.72 (dd, 1H, J =3.0, 11.1 Hz: =CH2), 5.39 (dd, 1H, J =2.8, 17.4
Hz: =CH2), 4.67 (s, 1H: PhCH), 4.26 (m, 1H: CH2NTs), 3.61 (m, 1H: CH2NTs), 3.01
(app t, 1H: CH2), 2.58 (app d, 1H: CH2), 2.42 (s, 3H: CH3Ts).
13C NMR (75 MHz, CDCl3) δ 144.33 (Quat.), 140.58 (Quat), 136.65 (=CH), 136.17
(Quat.), 132.49 (Quat.), 130.90-127.97 (Arom.CH), 121.89 (=CH2), 113.56 (CN),
113.26 (CN), 65.18 (PhCHNTs), 52.41/50.56 (overlapping CCN2, CH(Ph)CH=CH2),
43.44 (CH2NTs), 30.70 (CH2), 21.98 (CH3(Ts)). The assignments of the 
1H and 13C
were based on DEPT, COSY, HMQC etc.
FTIR (CDCl3): νmax 3094, 3065, 3038, 2253, 1597, 1495, 1350, 1161, 814, 777, 660.
HRMS calcd for C28H25N3O2SNa [M+Na] 490.1565, found 490.1560.
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(E)-N-(5-(4-(2,2-dicyanovinyl)phenoxy)-2-phenylpent-3-enyl)-4-
methylbenzenesulfonamide
14g (cw2031)
colorless oil
Pd(PPh3)4: 90% NMR yield, dr: 1:1
1H NMR (400 MHz, CDCl3) δ ppm 7.03-7.95 (m, 26H: arom H), 5.97 (m, 2 H:
=CH), 5.75 (td, 1H, J=15.7, 5.3 Hz: =CHCH2), 5.53 (m, 1H: =CH), 5.36 (d, 2H,
J=5.6 Hz: OCH2), 4.62 (d, 2H, J=5.6 Hz: OCH2), 3.87 (m, 2H: CHPh), 3.51 (br. s.,
2H: NHTs), 3.28 (m, 2H: CH2NHTs), 3.12 (m, 2H: CH2NHTs), 2.46 (s, 3H: CH3Ts),
2.43 (s, 3H: CH3Ts).
N
Ts
Ph
3-phenyl-1-tosyl-1,2,3,6-tetrahydropyridine
15b (cw2048)
White solid
Pd(PPh3)4: 99% combined yield(15b/15f)
1H NMR (400 MHz, CDCl3) δ ppm 7.70 (d, 2H, J=8.1 Hz: arom H), 7.21 - 7.34 (m,
5H: arom H), 7.04 (d, 2H, J=8.1 Hz: arom H), 5.68 (m, 1H: =CHCH2), 5.41 (m, 1H:
CH=), 4.68 (m, 1H: TsNCH2), 3.40 (m, 1H: CH2CH=), 3.20 (dt, 1H, J=12.6, 6.9 Hz:
TsNCH2), 3.08 (m, 1H: CH2CH=), 2.63 (td, 1H, J=13.3, 8.3 Hz: CHPh), 2.44 (s, 3H:
CH3).
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(rac)-3,3-dimethyl-7-phenyl-8-tosyl-11-vinyl-2,4-
dioxa-8-azaspiro[5.5]undecane-1,5-dione
15c (cw2176)
White solid
Pd(PPh3)4: 38% combined yield(15c/15d), dr: 2:1
1H NMR (400 MHz, CDCl3) δ ppm 7.46 (d, 2H, J=8.2Hz: arom H), 7.20 - 7.30 (m,
7H: arom H), 5.50 (m, 1H: CH=), 5.12 (dd, 2H, J=17.1 Hz: CH2=), 4.80 (s, 1H:
CHPh), 4.39 (m, 1H: diastereotopic CH2NTs), 3.19 (m, 1H: diastereotopic CH2NTs),
2.72 (m, 1H: CH), 2.44 (s, 3H: CH3Ts), 2.35 (m, 1H: diastereotopic CH2), 1.81 (ddd,
1H, J=13.8, 5.1, 1.7 Hz: diastereotopic CH2), 1.50 (s, 3H: CH3), 0.71 (s, 3H: CH3).
13C NMR (100 MHz, CDCl3) δ ppm 168.6 (OC=O), 163.5 (OC=O), 144.2 (Quat.
Arom.C), 136.3 (Quat. Arom.C), 135.2 (=CH), 134.9 (Quat. Arom.C), 130.3
(Arom.CH), 129.9 (Arom.CH), 129.3 (Arom.CH), 128.6 (Arom.CH), 128.4
(Arom.CH), 120.9 (=CH2), 106.8 (C(CH3)2), 66.3 (CHPh), 61.2 (C(CO2R)2), 48.9
(CH), 46.4 (CH2NTs), 30.1 (CH3), 29.1 (CH3), 25.8 (CH2), 22.0 (CH3(Ts)). The
assignments of the 1H and 13C were based on DEPT, COSY, HMQC etc.
FTIR (CDCl3): νmax 3053, 2988, 1780, 1749, 1359, 1164, 941.
HRMS calcd for C25H27NO6SNa [M+Na] 492.1457, found 492.1451.
N
Ph
Ts
O
O
O
O
(rac)-3,3-dimethyl-7-phenyl-8-tosyl-11-vinyl-2,4-dioxa-8-
azaspiro[5.5]undecane-1,5-dione
15d (cw2176)
White solid
1H NMR (400 MHz, CDCl3) δ ppm  7.33 (m, 5H: arom H), 7.25 (m, 2H: arom H),
7.05 (d, 2H, J=8.0 Hz: arom H), 5.68 (dt, 1H, J=10.2, 8.6 Hz: CH=), 5.59 (s, 1H:
CHPh), 5.27 (dd, 1H, J=17.2, 0.8 Hz: CH2=CH(E)), 5.19 (dd, 1H, J=10.3, 0.9 Hz:
CH2=CH(Z)), 3.83 (dd, 1H, J=5.7 Hz: diastereotopic CH2NTs), 3.63 (m, 1H: CH),
3.40 (td, 1H, J=13.3, 3.7 Hz: diastereotopic CH2NTs), 2.33 (s, 3H: CH3Ts), 2.72 (m,
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1H: diastereotopic CH2), 1.90 (s, 3H: CH3), 1.83 (m, 1H: diastereotopic CH2), 1.66
(s, 3H: CH3).
13C NMR (100 MHz, CDCl3) δ ppm 165.1 (OC=O), 164.6 (OC=O), 143.2 (Quat.
Arom.C), 136.3 (=CH), 135.8 (Quat. Arom.C), 134.9 (Quat. Arom.C), 129.9
(Arom.CH), 129.5 (Arom.CH), 129.1 (Arom.CH), 128.6 (Arom.CH), 127.4
(Arom.CH), 120.5 (=CH2), 105.7 (C(CH3)2), 61.4 (CHPh), 58.5 (C(CO2R)2), 39.9
(CH2NTs),  38.3 (CH), 30.7 (CH3), 28.4 (CH3), 25.7 (CH2), 21.5 (CH3(Ts)). The
assignments of the 1H and 13C were based on DEPT, COSY, HMQC etc.
FTIR (CDCl3): νmax 3053, 2988, 1780, 1749, 1359, 1164.
HRMS calcd for C25H27NO6SNa [M+Na] 492.1457, found 492.1451.
N
Ts
OMe
3-(4-methoxyphenyl)-1-tosyl-1,2,3,6-tetrahydropyridine
15e (cw2141)
Colorless oil
Pd(PPh3)4: 80% combined yield
1H NMR (400 MHz, CDCl3) δ ppm 7.70 (d, 2H, J=8.1 Hz: arom H), 7.35 (d, 2H,
J=7.6 Hz: arom H), 7.09 (d, 2H, J=7.6 Hz: arom H), 6.98 (d, 2H, J=8.3 Hz: arom H),
5.65 (dd, 1H, J=15.8, 8.0 Hz: =CHCH2), 5.04 (dd, 1H, J=8.6, 1.8 Hz: CH=), 4.64 (m,
1H: TsNCH2), 3.79 (s, 3H: OCH3), 3.34  (m, 1H: CH2CH=), 3.15(dd, 1H, J=12.8, 6.2
Hz: TsNCH2), 3.10 (m, 1H: CH2CH=), 2.68 (m, 1H: CHPh), 2.47 (s, 3H: CH3).
N
Ph
Ts
O
O
O
O
Ph
(rac)-3,3-dimethyl-7,10-diphenyl-8-tosyl-11-vinyl-
2,4-dioxa-8-azaspiro[5.5]undecane-1,5-dione
15f (cw2048)
White solid
Pd(PPh3)4: 99% combined yield(15b/15f)
1H NMR (400 MHz, CDCl3) δ ppm 7.46 (dd, 2H, J=7.3, 1.0 Hz: arom H), 7.26 (d,
2H, J=8.1 Hz: arom H), 7.34 (m, 8H: arom H), 7.00 (ddd, 2H, J=7.9, 1.4, 0.7 Hz:
arom H), 5.68 (s, 1H: CHPh(NTs)), 5.53 (m, 1H: CH=), 5.02 (m, 2H: CH2=), 4.09
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(m, 1H: CHPh), 3.90 (m, 2H: overlapping diastereotopic CH2NTs and CHCH=), 3.38
(t, 1H, J=13.0 Hz: diastereotopic CH2NTs), 2.30 (s, 3H: CH3Ts), 1.92 (s, 3H: CH3),
1.67 (s, 3H: CH3).
13C NMR (100 MHz, CDCl3) δ ppm 165.5 (OC=O), 165.2 (OC=O), 143.6 (Quat.
Arom.C), 140.4 (Quat. Arom.C), 136.2 (Quat. Arom.C), 135.2 (=CH), 135.1 (Quat.
Arom.C ), 130.0 (Arom.CH), 129.7 (Arom.C H), 129.6 (Arom.C H), 129.3
(Arom.CH), 129.2 (Arom.CH), 128.7 (Arom.CH), 127.9 (Arom.CH), 127.6
(Arom.CH), 123.1 (=CH2), 106.3 (C(CH3)2), 62.1 (CHPh(NTs)), 60.1 (C(CO2R)2),
46.6 (CH2), 44.0 (CHCH=), 42.4 (CHPh), 31.2 (CH3), 28.8 (CH3), 21.8 (CH3(Ts)).
The assignments of the 1H and 13C were based on DEPT, COSY, HMQC etc.
O
O
NTs
H CN
5-oxo-1-tosyl-4-vinyl-2,3,4,4a,5,10b-hexahydro-1H-chromeno[4,3-b]pyridine-4a-carbonitrile
16a (cw2169)
colorless oil
Pd(PPh3)4: 49% yield, dr =  >19:1
1H NMR (400 MHz, CDCl3) δ 7.98 (d, J = 8.3, 2H: arom H), 7.61 (d, J = 7.8, 1H:
arom H), 7.39 (m, 4H: arom H), 7.16 (d, J =8.1, 1H: arom H), 6.12 (s, 1H, J =8.3 Hz:
TsNCH), 5.76 (m, 1H: =CH),  5.25(d, 1H, J = 10.1 Hz: CH=CH(H)Z),  5.12 (d, 1H, J
= 16.9 Hz: CH=CH(H)E), 3.62 (broad d, 1H, J =13.6 Hz: CH2NTs), 3.10 (td, 1H, J
=3.8, 13.6 Hz: CH2NTs), 2.48 (m, 4H: overlapping CHCH=CH2, CH3), 1.63 (m, 2H:
CH2).
13C NMR (75 MHz, CDCl3) δ 161.3 (OCOCH3), 149.6 (Quat.), 145.1 (Quat.), 136.3
(Quat.), 133.8 (=CH), 131.4-126.9 (Arom. CH), 121.0 (=CH2), 117.7 (Arom. CH),
115.5 (CN), 55.8 (TsNCH), 51.5 (CCN), 40.7 (CHCH=CH2), 39.7 (TsNCH2), 27.8
(CH2), 22.1 (CH3). The assignments of the 
1H and 13C were based on DEPT, COSY,
HMQC, NOESY etc. The absolute configuration was assigned, based on the X-ray
structure.
FTIR (CDCl3): νmax  3086, 2252, 1772, 1589, 1487, 1354, 1194, 816.
HRMS calcd for C22H20N2O4SNa [M+Na] 431.1041, found 431.1032.
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4-methyl-5-oxo-1-tosyl-4-vinyl-2,3,4,4a,5,10b-hexahydro-1H-chromeno[4,3-b]pyridine-4a-carbonitrile
16b (cw2)
colorless oil
Pd(PPh3)4: 88% yield, dr =  1:1
1H NMR (400 MHz, CDCl3) δ 7.99-6.98 (14H: arom H), 6.10 (m, 3H: overlapping
=CH, TsNCH), 5.23 (d, 2H, J = 10.9 Hz: CH=CH(H)Z),  5.23 (m, 1H: =CH),  5.06
(d, 1H, J = 17.2 Hz: CH=CH(H)E), 4.98 (d, 1H, J = 17.2 Hz: CH=CH(H)E), 4.74 (d,
2H, J = 10.9 Hz: CH=CH(H)Z), 3.69-3.20 (4H: overlapping CH2NTs), 2.47 (s, 6H:
CH3(Ts)), 1.90-1.57 (3H: overlapping CH2), 1.39 (4H: overlapping CH2, CH3), 0.79
(s, 3H: CH3(Ts)).
13C NMR (75 MHz, CDCl3) δ 161.0/160.7 (OCOCH3), 149.6 (Quat.), 144.6 (Quat.),
141.0/134.7 (=CH), 136.0 (Quat.), 130.8-126.0 (Arom. CH), 119.4/119.2 (CN), 117.0
(Arom. CH), 116.6/116.3 (=CH2), 54.9/54.8 (TsNCH), 54.0/52.6 (CCN), 41.3/40.6
(CCH=CH2), 36.6 (TsNCH2), 33.5/32.9 (CH2), 25.6/19.2 (CH3), 21.7 (CH3(Ts)). The
assignments of the 1H and 13C were based on DEPT, COSY, HMQC etc.
FTIR (CDCl3): νmax 3092, 3061, 2253, 1761, 1591, 1489, 1331, 1161, 816.
HRMS calcd for C23H26N3O4S [M+NH4] 440.1644, found 440.1643.
NHTs
N-(2-(cyclohexa-1,3-dienyl)ethyl)-4-methylbenzenesulfonamide
17b (cw2128)
colorless oil
Pd(PPh3)4: 89% NMR yield
1H NMR (400 MHz, CDCl3) δ ppm 7.75 (d, 2 H, J=8.3 Hz: arom H), 7.32 (d, 2 H,
J=8.6 Hz: arom H), 5.82 (m, 1 H: =CHCH2), 5.65 (d, 1 H, J=9.6 Hz: CH=), 5.47 (br.
s., 1 H: CH=C(Quat.)), 4.46 (s, 1 H: NHTs), 3.02 (q, 2 H, J=6.1 Hz: CH2NHTs), 2.45
(s, 3 H, overlapping CH2), 2.16 (t, 3 H, J=6.7 Hz: overlapping CH2), 2.08 (s, 3 H:
CH3).
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2-phenyl-1-tosyl-4-vinylazetidine
17d (cw2219)
colorless oil
Pd(PPh3)4: 92% NMR yield yield
1H NMR (400 MHz, CDCl3) δ 7.68 (d, J = 8.3 Hz, 2H: arom H), 7.42 (d, J = 7.1 Hz,
2H: arom H) 7.33 (m, 5H: arom H), 6.06 (m, 1H: =CH),  5.38 (d, 1H, J = 17.2 Hz:
CH=CH(H)E), 5.25 (d, 1H, J = 10.4 Hz: CH=CH (H)Z), 4.81 (t, 1H, J =8.3 Hz:
PhCH), 4.41 (q, J =8.1, 4.9 Hz, 1H: CHCH=CH2), 2.61 (d t, J =8.3, 10.9 Hz, 1H:
CH2), 2.45(s, 3H: CH3), 1.99(d t, J =8.3, 10.9 Hz, 1H: CH2). More information about
this compound is available in Chapter 2 of this thesis.
N
Ph
Bz
Bn
CN
CN
1-benzoyl-5-benzyl-2-phenyl-4-vinylpiperidine-3,3-dicarbonitrile
20b (cw2179)
White solid
Pd(PPh3)4: 36% yield, dr 3.9:1
1H NMR (400 MHz, CDCl3) δ ppm 7.49 (m, 10H: arom H), 7.18 (t, 3H, J=3.1 Hz:
arom H), 6.80 (m, 2H, m: arom H), 6.07 (dt, 1H, J=16.7, 10.0 Hz: CH2=CH), 5.92 (s,
1H: PhCHNBz), 5.70 (d, 1H, J=10.2 Hz: CH=CH(E)), 5.61 (d, 1H, J=16.7 Hz:
CH=CH(Z)), 4.03 (dd, 1H, J=14.6, 2.9 Hz: CH2NTs), 3.59 (dd, 1H, J=14.7, 5.1 Hz:
CH2NTs), 3.38 (dd, 1H, J=9.7, 5.7 Hz: CHCH=CH2), 2.79 (d, 1H, J=13.4 Hz:
diastereotopic CH2Ph), 2.53 (m, 2H: overlapping CHBn, diastereotopic CH2Ph).
13C NMR (100 MHz, CDCl3) δ ppm 172.9 (CO), 138.9 (Quat. Arom.C), 134.6 (Quat.
Arom.C), 131.4 (Quat. Arom.C), 130.4 (=CH), 129.9 (Arom.CH), 129.7 (Arom.CH),
129.4 (Arom.CH), 129.3 (Arom.CH), 129.0 (Arom.CH), 128.1 (Arom.CH), 127.7
(Arom.CH), 127.0 (Arom.CH), 126.9 (Arom.CH), 125.7 ((=CH2), 114.9 (CN), 114.2
(CN), 58.9 (PhCHNTs), 48.4 (CHCH=CH2), 44.1 (CH2NTs), 43.0 (CCN2), 39.1
(BnCH), 35.8 (CH2Ph). The assignments of the 
1H and 13C were based on DEPT,
COSY, HMQC etc.
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5-benzyl-2-phenyl-6-vinyl-5,6-dihydro-4H-1,3-oxazine
20c (cw2179)
White solid
Pd(PPh3)4: 39% yield, dr 2.2:1
1H NMR (400 MHz, CDCl3) Major diastereoisomer: δ ppm 8.00 (m, 2 H: arom H,
overlapping minor/major isomers), 7.44 (m, 3 H: arom H, overlapping minor/major
isomers), 7.33 (m, 2 H: arom H, overlapping minor/major isomers), 7.26 (m, 3 H:
arom H, overlapping minor/major isomers), 6.00 (m,1 H,  overlapping minor/major
isomer: CH=), 5.40 (m, 2 H: =CH2), 4.60 (t, 1 H, J=5.9 Hz: OCH), 3.59 (dd, 1 H, d,
J=16.8, 4.9 Hz: CH2N), 3.37 (td, 1 H, J=16.6, 8.1 Hz: CH2N), 2.94 (dd, 1 H, J=13.6,
6.3 Hz: CH2Ph), 2.58 (m, 1 H: CH2Ph), 2.08 (m, 1 H: CHBn).
Minor diastereoisomer: δ  ppm 8.00 (m, 2 H: arom H, overlapping minor/major
isomers), 7.44 (m, 3 H: arom H, overlapping minor/major isomers), 7.33 (m, 2 H:
arom H, overlapping minor/major isomers), 7.26 (m, 3 H: arom H, overlapping
minor/major isomers), 6.00 (m,1 H, overlapping minor/major isomer: CH=), 5.40 (m,
2 H: =CH2), 4.87 (t, 1 H, J=3.7 Hz: OCH), 3.59 (dd, 1 H, d, J=16.8, 4.9 Hz: CH2N),
3.37 (td, 1 H, J=16.6, 8.1 Hz: CH2N), 2.68 - 2.73 (m, 1 H: CH2Ph), 2.58 (m, 1 H:
CH2Ph), 2.43 (m, 1 H: CHBn).
NH
O
Ph
Bn
N-(2-benzylpenta-2,4-dienyl)benzamide
20d (cw2186)
colorless oil
Pd(PPh3)4: 90% NMR yield, dr =1.7:1
1H NMR (400 MHz, CDCl3) Major diastereoisomer: δ ppm 7.72 (m, 3H: arom H),
7.53 (m, 4H: arom H), 6.98 - 7.19 (m, 3 H: arom H), 6.66 (m, 1H: CH=), 6.01 (d, 1H,
J=11.1 Hz: BnC=CH), 5.68 (br. s., 1H: NH), 5.15 (m, 2H; =CH2), 3.99 (d, 2H, J=5.6
Hz: CH2NH), 3.42 (s, 2H: CH2Ph).
Minor diastereoisomer: δ ppm 7.72 (m, 3H: arom H), 7.53 (m, 4H: arom H), 6.98 -
7.19 (m, 3 H: arom H), 6.77 (m, 1H: CH=), 6.14 (d, 1H, J=11.1 Hz: BnC=CH), 5.68
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(br. s., 1H: NH), 5.15 (m, 2 H; =CH2), 4.18 (d, 2H, J=5.6 Hz: CH2N), 3.99 (s, 2H:
CH2Ph).
N N
O
Ts
Ph
Ts
5-phenyl-1,3-ditosyl-4-vinyltetrahydropyrimidin-2(1H)-one
21b (cw2104)
colorless oil
Pd(PPh3)4: 98% yield, dr =3.1:1
1H NMR (400 MHz, CDCl3) δ ppm 7.85 (dd, 2H, J=8.4, 2.0 Hz: arom H), 7.77 (d,
2H, J=8.3 Hz: arom H), 7.36 (dd, 4H, J=8.6, 0.6 Hz: arom H), 7.20 (dd, 4H, J=7.6,
0.7 Hz: arom H), 7.12 (d, 2H, J=5.0 Hz: arom H), 5.68 (m, 1H: CH2=CH), 5.40 (dd,
2H, J=10.6, 1.8 Hz: CH=CH(H)Z), 5.31 (m, 1H: CHNTs), 5.18 (dd, 1H, J=17.1, 1.9
Hz: CH=CH(H)E), 4.35 (dt, 1H, J=12.7, 1.9 Hz: diastereotopic CH2NTs), 4.07 (dd,
1H, J=12.7, 5.3 Hz: diastereotopic CH2NTs), 3.53 (m, 1H: PhCH.), 2.49 (s, 3H:
CH3Ts), 2.41 (s, 3H: CH3Ts).
N N
O
Ts Ts
4-methyl-1,3-ditosyl-4-vinyltetrahydropyrimidin-2(1H)-one
21e (cw2270)
colorless oil
Pd(PPh3)4: 72% yield
1H NMR (400 MHz, CDCl3) δ ppm 7.79 (dd, 4H, J=14.0, 8.3 Hz: arom H), 7.23 (t,
4H, J=9.0 Hz: arom H), 6.13 (dd, 1H, J=17.4, 10.8 Hz: CH2=CH), 5.32 (d, 1H,
J=10.6 Hz: CH=CH(H)Z), 5.24 (d, 1H, J=17.4 Hz: CH=CH(H)E), 3.89 (dd, 2H,
J=7.1, 3.9 Hz: CH2NTs), 3.83 (d, 2H, J=7.8, 4.0 Hz: CH2NTs), 2.44 (s, 3H: CH3Ts),
2.43 (s, 3H: CH3Ts), 2.03 (m, 2H: CH2), 1.91 (s, 3H: CH3).
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1,3-ditosyl-4-vinyltetrahydropyrimidin-2(1H)-one
21g (cw2266/267)
colorless oil
Pd(PPh3)4: 70% NMR yield
Pd2(dba)3/Trost ligand: 85% NMR yield
1H NMR (400 MHz, CDCl3) δ ppm 7.83 (m, 4H: arom H), 7.27 (dd, 4H, J=5.2, 2.8
Hz: arom H), 5.29 (dd, 1H, J=10.5, 1.5 Hz: CH=CH(H)Z), 5.25 (m, 1H: CH), 5.01
(dd, 1H, J=17.1, 1.7 Hz: CH=CH(H)E), 4.03 (m, 1H: diastereotopic CH2NTs), 3.69
(m, 1H: diastereotopic CH2NTs), 2.44 (s, 6H: CH3Ts), 2.15 (m, 2H: CH2).
13C NMR (125 MHz, CDCl3) δ ppm 157.0 (CO), 144.9 (Quat. Arom.C), 135.6 (Quat.
Arom.C), 134.1 (=CH), 129.2 (Arom.CH), 129.1 (Arom.CH), 118.6 (=CH2), 56.2
(CHCH=CH2), 42.3 (CH2NTs), 26.8 (CH2), 22.7 (CH2NTs).
CONH2
CN
1-cyanocyclohexanecarboxamide
O
H
O P
Pt
P P
H
OH
Cat. B
23d (cw3030)
White solid
Cat. B: 90% yield
1H NMR (400 MHz, CDCl3) δ ppm 6.42 (br. s., 2H: CONH2), 2.03 (m, 2H: CH2),
1.82 (m, 5H: CH2), 1.62 (m, 2H: CH2), 1.26 (m, 1H: CH2).
13C NMR (100 MHz, CDCl3) δ ppm 171.1 (CONH2), 121.1 (CN), 46.2 (Quat. C),
33.0 (CH2), 24.6 (CH2), 22.6 (CH2).
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2-benzyl-3-cyano-1-tosyl-4-vinylpiperidine-3-carboxamide
24d (cw3052)
White solid
Cat. B: 95% yield, dr =2.5:1
1H NMR (400 MHz, CDCl3) δ ppm 7.85 (m, 7H: arom H), 7.20 (m, 3H: arom H),
7.10 (d, 2H, J=8.1 Hz: arom H), 7.02 (d, 2H, J=8.0 Hz: arom H), 6.38 (br. s., 1H:
CONH2), 5.77 (m, 1H: =CH), 5.63 (s, 1H: PhCHNTs), 5.44 (m, 2H: =CH2), 3.52 (dd,
1H, J=13.3, 5.1 Hz: diastereotopic CH2NTs), 3.24 (dd, 1H, J=11.7, 8.7 Hz:
diastereotopic CH2NTs), 3.11 (dd, 1H, J=14.0, 3.4 Hz: diastereotopic CH2Ph), 3.00
(t, 1H, J=12.6 Hz: CHCH=CH2), 2.42 (m, 1H: diastereotopic CH2Ph), 2.35 (3, 3H:
CH3Ts), 2.17 (m, 1H: CHBn).
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General procedure for synthesizing starting vinyl benzoxazinanones:
Vinyl benzoxazinanones were prepared as reported in Chapter 2 of this thesis.
General procedure for asymmetric cycloadditions:
In a Schlenk tube under argon, Pd2(dba)3 (0.05 mmol), Trost ligand (0.11
mmol), vinyl benzoxazinanone 1 (1 mmol) and the benzylidene malononitrile (1
mmol) were dissolved in 5 mL of methylene chloride. The resulting yellow solution
was stirred at ambient temperature under Ar until the reaction completion was
indicated by TLC (generally 4-6 hrs). Following solvent evaporation under reduced
pressure, the crude product was purified via flash chromatography (SiO2, 5:1 Hexane:
Ethyl acetate).
N Ph
Ts
CN
CN
(2S,4S)-2-phenyl-1-tosyl-4-vinyl-1,2-dihydroquinoline-3,3(4H)-dicarbonitrile
33a (cw3194)
white solid
Pd(PPh3)4: 98% yield, dr =  8.9:1
Pd/Trost ligand: 97% yield, 89% ee (S,S), dr =  19:1
87% yield, 97% ee (S,S), dr =  50:1 after a single recrystallization
1H NMR (400 MHz, CDCl3) δ ppm 7.89 (1 H, dd, J=8.0, 1.0 Hz: Ar CH), 7.51 - 7.67
(4 H, m: Ar CH), 7.39 - 7.51 (5 H, m: Ar CH), 7.29 (2 H, d, J=7.8 Hz: Ar CH), 7.17
(1 H, d, J=7.7 Hz: Ar CH), 5.91 (1 H, dt, J=16.8, 9.8 Hz: CH=CH2), 5.77 (1 H, s:
CHPh), 5.61 (1 H, dd, J=10.1, 1.0 Hz: CH=CH(H)cis), 5.09 (1 H, d, J=16.8 Hz:
CH=CH(H)trans), 2.56 (1 H, d, J=9.7 Hz: CHCH=), 2.47 (3 H, s: CH3Ts).
13C NMR (75 MHz, CDCl3) δ ppm 145.1 (quat. Ar C), 136.7 (quat. Ar C), 135.1
(quat. Ar C), 134.5 (quat. Ar C), 131.6 (quat. Ar C), 130.2 (Ar CH), 130.0 (Ar CH),
129.6 (Ar CH), 129.3 (CH=CH2), 129.2 (Ar CH), 128.6 (Ar CH), 128.2 (Ar CH),
127.3 (Ar CH), 127.0 (Ar CH), 126.8 (Ar CH), 125.0 (=CH2), 113.9 (CN), 111.2
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(CN), 65.8 (CHPh), 50.0 (CCN2), 49.1 (CHCH=), 21.6 (CH3Ts). The assignments of
the 1H and 13C were based on DEPT, COSY, HMQC etc.
FTIR (CDCl3): νmax 3053, 2986, 2305, 1597, 1483, 1421, 1262, 895.
HRMS calcd for C26H21N3O2SNa [M+Na] 462.1252, found 462.1251.
Separated enantiomers on a Diacel Chiralpak AD-H HPLC column (96%
Hexane/IPA, 1.0 mL/min), tr (major) = 22.8 min, tr (minor) = 32.1 min.
N
Ts
CN
CN
NO2
MeO
(2S,4S)-6-methoxy-2-(4-nitrophenyl)-1-tosyl-4-vinyl-1,2-dihydroquinoline-3,3(4H)-dicarbonitrile
33b (cw4155)
white solid
Pd/Trost ligand: 91% yield, 99% ee (S,S), dr =  25:1
1H NMR (400 MHz, CDCl3) δ ppm 7.89 (1 H, dd, J=8.0, 1.0 Hz: Ar CH), 7.51 - 7.67
(4 H, m: Ar CH), 7.39 - 7.51 (5 H, m: Ar CH), 7.29 (2 H, d, J=7.8 Hz: Ar CH), 7.17
(1 H, d, J=7.7 Hz: Ar CH), 5.91 (1 H, dt, J=16.8, 9.8 Hz: CH=CH2), 5.77 (1 H, s:
CHPh), 5.61 (1 H, dd, J=10.1, 1.0 Hz: CH=CH(H)cis), 5.09 (1 H, d, J=16.8 Hz:
CH=CH(H)trans), 2.56 (1 H, d, J=9.7 Hz: CHCH=), 2.47 (3 H, s: CH3Ts).
13C NMR (75 MHz, CDCl3) δ ppm 159.5 (quat. Ar C), 148.5 (quat. Ar C), 145.5
(quat. Ar C), 143.5 (quat. Ar C), 133.7 (quat. Ar C), 132.8 (quat. Ar C), 130.2 (Ar
CH), 128.7 (CH=), 128.3 (Ar CH), 127.4 (Ar CH), 126.6 (Ar CH), 125.6 (=CH2),
124.4 (Ar CH), 114.7 (Ar CH), 113.4 (CN), 113.2 (Ar CH), 110.8 (CN), 65.1
(CHAr), 55.7 (OCH3), 49.1 (CHCH=), 48.9 (CCN2), 21.7 (CH3Ts). The assignments
of the 1H and 13C were based on DEPT, COSY, HMQC etc.
FTIR (CDCl3): νmax 3053, 2927, 2303, 1608, 1529, 1350, 1263, 1169, 893.
HRMS calcd for C27H22N4O5SNa [M+Na] 537.1209, found 537.1207.
Separated enantiomers on Diacel Chiralpak OD-H HPLC column (90% Hexane/IPA,
1.0 mL/min), tr (minor) = 24.9 min, tr (major) = 28.5 min.
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(2S,4S)-6-methyl-2-(4-nitrophenyl)-1-tosyl-4-vinyl-1,2-dihydroquinoline-3,3(4H)-dicarbonitrile
33c (cw4165)
white solid
Pd/Trost ligand: 90% yield, 99% ee (S,S), dr >99:1
1H NMR (400 MHz, CDCl3) δ ppm  8.31 (2 H, d, J=8.7 Hz: Ar CH), 7.69 - 7.85 (3
H, m: Ar CH), 7.36 - 7.49 (3 H, m: Ar CH), 7.29 - 7.36 (2 H, m, J=8.0 Hz: Ar CH),
6.94 (1 H, s: Ar CH), 5.86 (1 H, dt, J=16.8, 9.8 Hz: CH=CH2), 5.76 (1 H, s: CHAr),
5.61 (1 H, d, J=10.0 Hz: CH=CH(H)cis), 5.06 (1 H, d, J=16.7 Hz: CH=CH(H)trans),
2.47 (3 H, s: CH3Ts), 2.38 - 2.45 (4 H, m: overlapping CH3, CHCH=).
13C NMR (75 MHz, CDCl3) δ ppm 148.4 (quat. Ar C), 145.4 (quat. Ar C), 143.5
(quat. Ar C), 138.9 (quat. Ar C), 133.8 (quat. Ar C), 131.6 (quat. Ar C), 131.1 (Ar
CH), 130.8 (quat. Ar C), 130.1 (Ar CH), 128.9 (CH=CH2), 128.3 (Ar CH), 128.2 (Ar
CH), 127.3 (Ar CH), 127.2 (Ar CH), 125.3 (=CH2), 124.4 (Ar CH), 113.4 (CN),
110.8 (CN), 65.0 (CHAr), 49.1 (CCN2), 49.0 (CHCH=), 21.6 (CH3Ts), 21.4 (CH3).
The assignments of the 1H and 13C were based on DEPT, COSY, HMQC etc.
FTIR (CDCl3): νmax 3053, 2986, 2305, 1528, 1352, 1269, 1259, 895, 818.
HRMS calcd for C27H22N4O4SNa [M+Na] 521.1259, found 521.1262.
Separated enantiomers on Diacel Chiralpak OD-H HPLC column (90% Hexane/IPA,
1.0 mL/min), tr (minor) = 16.6 min, tr (major) = 20.1 min.
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(2S,4S)-2-(4-nitrophenyl)-1-tosyl-4-vinyl-1,2-dihydroquinoline-3,3(4H)-dicarbonitrile
33d (cw4116)
white solid
Pd/Trost ligand: 78% yield, 96% ee (S,S), dr >99:1
1H NMR (400 MHz, CDCl3) δ ppm 8.32 (2 H, d, J=7.5 Hz: Ar CH), 7.92 (1 H, d,
J=8.0 Hz: Ar CH), 7.75 (2 H, d, J=7.5 Hz: Ar CH), 7.60 (1 H, t, J=7.7 Hz), 7.42 -
7.47 (1 H, m: Ar CH), 7.40 (2 H, d, J=7.9 Hz: Ar CH), 7.31 (2 H, d, J=7.6 Hz: Ar
CH), 7.17 (1 H, d, J=7.6 Hz: Ar CH), 5.87 (1 H, ddd, J=17.0, 10.0, 9.8 Hz: CH=),
5.78 (1 H, s: CHAr), 5.63 (1 H, d, J=10.0 Hz: CH=CHcis), 5.09 (1 H, d, J=16.7 Hz:
CH=CHtrans), 2.47 (4 H, s: overlapping CH3Ts, CHCH=).
13C NMR (75 MHz, CDCl3) δ ppm 148.6 (quat. Ar C), 145.6 (quat. Ar C), 143.4
(quat. Ar C), 134.4 (quat. Ar C), 133.8 (quat. Ar C), 131.1 (quat. Ar C), 130.6 (Ar
CH), 130.2 (Ar CH), 128.8 (=CH), 128.7 (Ar CH), 128.6 (Ar CH), 128.3 (Ar CH),
127.3 (Ar CH), 126.9 (Ar CH), 125.5 (=CH2), 124.5 (Ar CH), 113.4 (CN), 110.8
(CN), 65.1 (CHAr), 49.2 (C(CN)2), 49.1 (CHCH=), 21.7 (CH3Ts). The assignments
of the 1H and 13C were based on DEPT, COSY, HMQC etc.
FTIR (CDCl3): νmax 3053, 2952, 2854, 2337, 1529, 1350, 1327, 1171, 910.
HRMS calcd for C26H20N4O4SNa [M+Na] 507.1103, found 507.1097.
Separated enantiomers on Diacel Chiralpak OD-H HPLC column (90% Hexane/IPA,
1.0 mL/min), tr (minor) = 20.6 min, tr (major) = 25.0 min.
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methyl 4-((2S,4S)-3,3-dicyano-6-methoxy-1-tosyl-4-vinyl-1,2,3,4-tetrahydroquinolin-2-yl)benzoate
33e (cw4187)
white solid
Pd/Trost ligand: 99% yield, 92% ee (S,S), dr =25:1
1H NMR (400 MHz, CDCl3) δ ppm 8.11 (2 H, d, J=8.3 Hz: Ar CH), 7.80 (1 H, d,
J=8.8 Hz: Ar CH), 7.62 (2 H, d, J=8.4 Hz: Ar CH), 7.41 (2 H, d, J=8.2 Hz: Ar CH),
7.28 - 7.38 (2 H, m, J=8.2 Hz: Ar CH), 7.06 (1 H, dd, J=8.8, 2.7 Hz: Ar CH), 6.64 (1
H, d, J=2.5 Hz: Ar CH), 5.83 (1 H, dt, J=16.8, 9.8 Hz: CH=CH2), 5.74 (1 H, s:
C H Ar), 5.58 (1 H, d, J=10.1 Hz: CH=CH(H)cis), 5.01 (1 H, d, J=16.8 Hz:
CH=CH(H)trans), 3.93 (3 H, s: CO2CH3), 3.85 (3 H, s: OCH3), 2.46 (3 H, s: CH3Ts),
2.36 (1 H, d, J=9.6 Hz: CHCH=).
13C NMR (75 MHz, CDCl3) δ ppm 166.3 (CO2CH3), 159.4 (quat. Ar C), 145.2 (quat.
Ar C), 141.4 (quat. Ar C), 134.1 (quat. Ar C), 133.1 (quat. Ar C), 131.3 (quat. Ar C),
130.5 (Ar CH), 130.2 (Ar CH), 130.1 (Ar CH), 128.9 (CH=CH2), 127.4 (Ar CH),
127.1 (Ar CH), 127.0 (quat. Ar C), 125.4 (=CH2), 114.6 (Ar CH), 113.7 (CN), 113.1
(Ar CH), 111.0 (CN), 65.4 (CHAr), 55.7 (OCH3), 52.3 (CO2CH3), 49.3 (CCN2), 49.1
(CHCH=), 21.6 (CH3Ts). The assignments of the 
1H and 13C were based on DEPT,
COSY, HMQC etc.
FTIR (CDCl3): νmax 3055, 2953, 2928, 2305, 1725, 1593, 1495, 1360, 1169, 916.
HRMS calcd for C29H25N3O5SNa [M+Na] 550.1413, , found 550.1410.
Separated enantiomers on Diacel Chiralpak AD-H HPLC column (90% Hexane/IPA,
1.0 mL/min), tr (major) = 31.0 min, tr (minor) = 54.0 min.
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CO2Me
methyl 4-((2S,4S)-3,3-dicyano-6-methyl-1-tosyl-4-vinyl-1,2,3,4-tetrahydroquinolin-2-yl)benzoate
33f (cw4099)
white solid
Pd/Trost ligand: 97% yield, 98% ee (S,S), dr =37:1
1H NMR (400 MHz, CDCl3) δ ppm 8.10 (2 H, d, J=8.4 Hz: Ar CH), 7.74 (1 H, d,
J=8.1 Hz: Ar CH), 7.60 (2 H, d, J=8.4 Hz: Ar CH), 7.40 (2 H, d, J=8.3 Hz: Ar CH),
7.35 (1 H, d, J=8.1 Hz: Ar CH), 7.28 (2 H, d, J=8.4 Hz: Ar CH), 6.92 (1 H, s: Ar
CH), 5.86 (1 H, dt, J=16.8, 9.8 Hz: CH=CH2), 5.75 (1 H, s: CHAr), 5.58 (1 H, d,
J=10.0 Hz: CH=CH(H)cis), 5.04 (1 H, d, J=16.7 Hz: CH=CH(H)trans), 3.91 (3 H, s:
CO2CH3), 2.44 (4 H, s: overlapping CH3Ts, CHCH=), 2.39 (3 H, s: CH3).
13C NMR (75 MHz, CDCl3) δ ppm 166.3 (CO2CH3), 145.2 (quat. Ar C), 141.5 (quat.
Ar C), 138.7 (quat. Ar C), 134.2 (quat. Ar C), 132.0 (quat. Ar C), 131.3 (quat. Ar C),
131.1 (quat. Ar C), 131.0 (Ar CH), 130.5 (Ar CH), 130.1 (Ar CH), 129.9 (Ar CH),
129.2 (CH=CH2), 128.4 (Ar CH), 127.3 (Ar CH), 127.1 (Ar CH), 125.1 (=CH2),
113.8 (CN), 111.1 (CN), 65.4 (CHAr), 52.4 (CO2CH3), 49.5 (CCN2), 49.1
(CHCH=),21.6 (CH3Ts), 21.4 (CH3). The assignments of the 
1H and 13C were based
on DEPT, COSY, HMQC etc.
FTIR (CDCl3): νmax 3053, 2955, 2359, 1722, 1493, 1437, 1366, 1283, 1171, 918
HRMS calcd for C29H29N4O4S [M+NH4] 529.1909, found 529.1904.
Separated enantiomers on Diacel Chiralpak AD-H HPLC column (90% Hexane/IPA,
1.0 mL/min), tr (major) = 26.5 min, tr (minor) = 38.5 min.
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methyl 4-((2S,4S)-3,3-dicyano-1-tosyl-4-vinyl-1,2,3,4-tetrahydroquinolin-2-yl)benzoate
33g (cw4090)
white solid
Pd/Trost ligand: 76% yield, 96% ee (S,S), dr =25:1
1H NMR (400 MHz, CDCl3) δ ppm 8.10 (2 H, d, J=8.46 Hz: Ar CH), 7.89 (1 H, d,
J=7.96 Hz: Ar CH), 7.61 (2 H, d, J=8.40 Hz: Ar CH), 7.56 (1 H, t, J=7.77 Hz: Ar
CH), 7.35 - 7.51 (3 H, m: Ar CH), 7.27 (2 H, d, J=7.64 Hz: Ar CH), 7.14 (1 H, d,
J=7.64 Hz: Ar CH), 5.86 (1 H, dt, J=16.75, 9.84 Hz: CH=CH2), 5.77 (1 H, s: CHAr),
5.59 (1 H, d, J=10.04 Hz: CH=CH(H)cis), 5.07 (1 H, d, J=16.74 Hz: CH=CH(H)trans),
3.91 (3 H, s: OCH3), 2.50 (1 H, d, J=9.60 Hz: CHCH=), 2.43 (3 H, s: CH3Ts).
13C NMR (75 MHz, CDCl3) δ ppm 166.3 (CO2Me), 145.3 (quat. Ar), 141.3 (quat.
Ar), 134.8 (quat. Ar C), 134.1 (quat. Ar C), 131.4 (quat. Ar C), 131.3 (quat. Ar C),
130.5 (Ar CH), 130.4 (Ar CH), 130.1 (Ar CH), 129.1 (CH=CH2), 128.6 (Ar CH),
128.4 (Ar CH), 127.3 (Ar CH), 127.2 (Ar CH), 126.8 (Ar CH), 125.3 (=CH2), 113.7
(CN), 111.0 (CN), 65.4 (CHPh), 52.4 (OCH3), 49.5 (CCN2), 49.1 (CHCH=), 21.6
(CH3Ts). The assignments of the 
1H and 13C were based on DEPT, COSY, HMQC
etc.
FTIR (CDCl3): νmax 3065, 2953, 2928, 2350, 1724, 1367, 1283, 862.
HRMS calcd for C28H23N3O4SNa [M+Na] 520.1307, found 520.1307.
Separated enantiomers on Diacel Chiralpak AD-H HPLC column (96% Hexane/IPA,
1.0 mL/min), tr (major) = 67.0 min, tr (minor) = 123.6 min.
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(2S,4S)-6-methoxy-1-tosyl-2-(2-(trifluoromethyl)phenyl)-4-vinyl-1,2-
dihydroquinoline-3,3(4H)-dicarbonitrile
33h (cw4192)
white solid
Pd/Trost ligand: 97% yield, 86% ee (S,S), dr =29:1
1H NMR (400 MHz, CDCl3) δ ppm 7.76 (2 H, dd, J=14.0, 8.2 Hz: Ar CH), 7.52 -
7.64 (2 H, m: Ar CH), 7.42 - 7.52 (3 H, m: Ar CH), 7.35 (2 H, d, J=7.8 Hz: Ar CH),
7.10 (1 H, dd, J=8.8, 2.8 Hz: Ar CH), 6.72 (1 H, s: Ar CH), 6.30 (1 H, s: CHAr), 5.90
(1 H, ddd, J=17.0, 9.8, 9.6 Hz: CH=CH2), 5.61 (1 H, dd, J=10.0, 0.6 Hz:
CH=CH(H)cis), 4.99 (1 H, d, J=16.7 Hz: CH=CH(H)trans), 3.89 (3 H, s: OCH3), 2.49 (3
H, s: CH3Ts), 2.30 (1 H, d, J=9.5 Hz: CHCH=).
13C NMR (75 MHz, CDCl3) δ ppm 159.5 (quat. Ar C), 145.2 (quat. Ar C), 135.3
(quat. Ar C), 134.3 (quat. Ar C), 132.9 (quat. Ar C), 132.3 (Ar CH), 130.5 (Ar CH),
130.3 (Ar CH), 129.8 (Ar CH), 128.9 (CH=CH2), 128.0 (quat. Ar C), 127.9 (quat. Ar
C), 127.7 (Ar CH), 127.3 (Ar CH), 127.2 (Ar CH), 125.5 (=CH2), 114.8 (Ar CH),
113.0 (Ar CH), 112.6 (CN), 111.6 (CN), 111.6 (CN), 59.8 (CHAr), 55.7 (OCH3), 49.9
(CHCH=), 49.2 (CCN2), 21.6 (CH3Ts). (Note: CF3 carbon is not found). The
assignments of the 1H and 13C were based on DEPT, COSY, HMQC etc.
FTIR (CDCl3): νmax 3053, 2986, 2300, 1495, 1421, 1311, 1271, 895.
HRMS calcd for C28H22F3N3O3SNa [M+Na] 560.1232, found 560.1232.
Separated enantiomers on Diacel Chiralpak AD-H HPLC column (96% Hexane/IPA,
1.0 mL/min), tr (major) = 16.4 min, tr (minor) = 26.4 min.
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(2S,4S)-6-methyl-1-tosyl-2-(2-(trif luoromethyl)phenyl)-4-vinyl-1,2-
dihydroquinoline-3,3(4H)-dicarbonitrile
33i (cw4098)
white solid
Pd/Trost ligand: 85% yield, 98% ee (S,S), dr >99:1
1H NMR (400 MHz, CDCl3) δ ppm 7.75 (1 H, d, J=8.1 Hz: Ar CH), 7.68 (1 H, d,
J=8.1 Hz: Ar CH), 7.49 - 7.59 (2 H, m: Ar CH), 7.41 - 7.47 (3 H, m: Ar CH), 7.38 (1
H, d, J=8.1 Hz: Ar CH), 7.32 (2 H, d, J=8.5 Hz: Ar CH), 6.99 (1 H, s: Ar CH), 6.30
(1 H, s: CHAr), 5.91 (1 H, dt, J=16.8, 9.8 Hz: CH=CH2), 5.59 (1 H, d, J=10.1 Hz:
CH=CH(H)cis), 5.00 (1 H, d, J=16.8 Hz: CH=CH(H)trans), 2.47 (3 H, s: CH3Ts), 2.44
(3 H, s: CH3), 2.35 (1 H, d, J=9.6 Hz: CHCH=).
13C NMR (75 MHz, CDCl3) δ ppm 145.1 (quat. Ar C), 138.8 (quat. Ar C), 135.3
(quat. Ar C), 134.5 (quat. Ar C), 133.0 (quat. Ar C), 132.3 (Ar CH), 131.1 (quat. Ar
C), 131.0 (Ar CH), 130.5 (Ar CH), 130.2 (Ar CH), 129.7 (Ar CH), 129.2 (CH=CH),
128.8 (Ar CH), 128.0 (Ar CH), 127.4 (Ar CH), 127.2 (Ar CH), 125.6 (quat. Ar C),
125.2 (=CH2), 112.6 (CN), 111.7 (CN), 59.8 (CHAr), 49.8 (CHCH=), 49.4 (CCN2),
21.6 (CH3Ts), 21.5 (CH3). (Note: CF3 carbon is not found). The assignments of the 
1H
and 13C were based on DEPT, COSY, HMQC etc.
FTIR (CDCl3): νmax 3053, 2925, 2350, 1493, 1310, 1175, 912.
HRMS calcd for C28H26F3N4O2S [M+NH4] 539.1729, found 539.1719.
Separated enantiomers on Diacel Chiralpak AD-H HPLC column (98% Hexane/IPA,
1.0 mL/min), tr (major) = 15.3 min, tr (minor) = 20.9 min.
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(2S,4S)-1-tosyl-2-(2-(trifluoromethyl)phenyl)-4-vinyl-1,2-
dihydroquinoline-3,3(4H)-dicarbonitrile
33j (cw4097)
white solid
Pd/Trost ligand: 78% yield, 89% ee (S,S), dr =36:1
1H NMR (400 MHz, CDCl3) δ ppm 7.81 (1 H, dd, J=8.1, 1.0 Hz: Ar CH), 7.76 (1 H,
d, J=7.1 Hz: Ar CH), 7.51 - 7.68 (3 H, m: Ar CH), 7.43 (4 H, dd, J=10.3, 8.0 Hz: Ar
CH), 7.32 (2 H, d, J=8.3 Hz: Ar CH), 7.20 (1 H, d, J=7.7 Hz: Ar CH), 6.31 (1 H, s:
CHAr), 5.91 (1 H, dt, J=16.8, 9.8 Hz: CH=),5.59 (1 H, d, J=10.0 Hz: CH=CHcis),
5.02 (1 H, d, J=16.8 Hz: CH=CHtrans), 2.46 (3 H, s: CH3Ts), 2.41 (1 H, d, J=9.6 Hz:
CHCH=).
13C NMR (75 MHz, CDCl3) δ ppm 145.3 (quat. Ar C), 135.7 (quat. Ar C), 135.2
(quat. Ar C), 134.4 (quat. Ar C), 132.3 (Ar CH), 131.4 (quat. Ar C), 130.5 (Ar CH),
130.4 (Ar CH), 130.2 (Ar CH), 129.8 (Ar CH), 129.0 (=CH), 128.5 (Ar CH), 127.8
(Ar CH), 127.3 (Ar CH), 127.2 (Ar CH), 127.1 (quat. Ar C), 126.9 (Ar CH), 125.4
(=CH2), 112.5 (CN), 111.6 (CN), 59.8 (CHAr), 49.9 (CHCH=),49.4 (C(CN)2), 21.6
(CH3Ts). (Note: CF3 carbon is not found). The assignments of the 
1H and 13C were
based on DEPT, COSY, HMQC etc.
FTIR (CDCl3): νmax 3053, 2926, 2338, 1599, 1485, 1371, 1312, 1175, 1132, 818.
HRMS calcd for C27H20F3N3O2SNa [M+Na] 530.1126, found 530.1132.
Separated enantiomers on Diacel Chiralpak AD-H HPLC column (96% Hexane/IPA,
1.0 mL/min), tr (major) = 13.7 min, tr (minor) = 16.9 min.
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(2S,4S)-6-methoxy-1-tosyl-2-(4-(trifluoromethyl)phenyl)-4-vinyl-
1,2-dihydroquinoline-3,3(4H)-dicarbonitrile
33k (cw4188)
white solid
Pd/Trost ligand: 93% yield, 84% ee (S,S), dr =37:1
1H NMR (400 MHz, CDCl3) δ ppm 7.82 (2 H, d, J=8.8 Hz: Ar CH), 7.72 (3 H, t,
J=8.0 Hz: Ar CH), 7.42 (2 H, d, J=8.3 Hz: Ar CH), 7.30 - 7.39 (2 H, m: Ar CH), 7.08
(1 H, dd, J=8.8, 2.8 Hz: Ar CH), 6.67 (1 H, s: Ar CH), 5.86 (1 H, dt, J=16.7, 9.8 Hz:
CH=CH2), 5.74 (1 H, s: CHAr), 5.61 (1 H, d, J=10.0 Hz: CH=CH(H)cis), 5.04 (1 H, d,
J=16.8 Hz: CH=CH(H)trans), 3.87 (3 H, s: OCH3), 2.48 (3 H, s: CH3Ts), 2.39 (1 H, d,
J=9.2 Hz: CHCH=).
13C NMR (75 MHz, CDCl3) δ ppm 159.4 (quat. Ar C), 145.3 (quat. Ar C), 140.6
(quat. Ar C), 133.9 (quat. Ar C), 133.0 (quat. Ar C), 131.5 (quat. Ar C), 130.1 (Ar
CH), 128.9 (CH=CH2), 127.6 (Ar CH), 127.4 (Ar CH), 126.9 (quat. Ar C), 126.3 (Ar
CH), 126.2 (Ar CH), 125.4 (=CH2), 114.6 (Ar CH), 113.6 (CN), 113.2 (Ar CH),
110.9 (CN), 65.3 (CHAr), 55.7 (OCH3), 49.2 (CCN2), 49.1 (CHCH=), 21.6 (CH3Ts).
Note: CF3 carbon is not found. The assignments of the 
1H and 13C were based on
DEPT, COSY, HMQC etc.
FTIR (CDCl3): νmax 3055, 2962, 2928, 2330, 1607, 1495, 1325, 1271, 1171, 914.
HRMS calcd for C28H22F3N3O3SNa [M+Na] 560.1232, , found 560.1231.
Separated enantiomers on Diacel Chiralpak AD-H HPLC column (90% Hexane/IPA,
1.0 mL/min), tr (major) = 10.0 min, tr (minor) = 18.9 min.
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(2S,4S)-6-methyl-1-tosyl-2-(4-(trifluoromethyl)phenyl)-4-
vinyl-1,2-dihydroquinoline-3,3(4H)-dicarbonitrile
33l (cw4199)
white solid
Pd/Trost ligand: 88% yield, 86% ee (S,S), dr =56:1
1H NMR (400 MHz, CDCl3) δ ppm  7.75 (1 H, d, J=8.1 Hz: Ar CH), 7.60 - 7.73 (4
H, m: Ar CH), 7.40 (2 H, d, J=8.3 Hz: Ar CH), 7.36 (1 H, dd, J=7.8, 0.9 Hz: Ar CH),
7.29 (2 H, d, J=8.0 Hz: Ar CH), 6.93 (1 H, s: Ar CH), 5.87 (1 H, dt, J=16.8, 9.8 Hz:
CH=CH2), 5.73 (1 H, s: CHAr), 5.60 (1 H, d, J=10.1 Hz: CH=CH(H)cis), 5.05 (1 H, d,
J=16.8 Hz: CH=CH(H)trans), 2.43 - 2.53 (4 H, m: overlapping CH3Ts, CHCH=), 2.40
(3 H, s: CH3).
13C NMR (75 MHz, CDCl3) δ ppm 145.3 (quat. Ar C), 140.7 (quat. Ar C), 140.6
(quat. Ar C), 138.8 (quat. Ar C), 134.1 (quat. Ar C), 131.9 (quat. Ar C), 131.1 (Ar
CH), 130.1 (Ar CH), 129.8 (quat. Ar C), 129.2 (CH=CH2), 128.4 (Ar CH), 127.6 (Ar
CH), 127.4 (Ar CH), 127.3 (Ar CH), 126.2 (Ar CH), 125.2 (=CH2), 113.7 (CN),
111.0 (CN), 65.3 (CHAr), 49.4 (CCN2), 49.1 (CHCH=), 21.6 (CH3Ts), 21.4 (CH3).
(Note: CF3 carbon is not found). The assignments of the 
1H and 13C were based on
DEPT, COSY, HMQC etc.
FTIR (CDCl3): νmax 3053, 2925, 2305, 1597, 1493, 1325, 1171, 1132.
HRMS calcd for C28H22N3O2SNa [M+Na] 544.1283, found 544.1286.
Separated enantiomers on Diacel Chiralpak AD-H HPLC column (96% Hexane/IPA,
1.0 mL/min), tr (major) = 13.3 min, tr (minor) = 23.3 min.
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(2S,4S)-1-tosyl-2-(4-(trifluoromethyl)phenyl)-4-vinyl-
1,2-dihydroquinoline-3,3(4H)-dicarbonitrile
33m (cw4111)
white solid
Pd/Trost ligand: 90% yield, 91% ee (S,S), dr =45:1
1H NMR (400 MHz, CDCl3) δ ppm  7.91 (1 H, dd, J=8.0, 0.9 Hz: Ar CH), 7.70 (4 H,
q, J=8.5 Hz: Ar CH), 7.58 (1 H, t, J=7.8 Hz: Ar CH), 7.37 - 7.50 (3 H, m: Ar CH),
7.29 (2 H, d, J=8.0 Hz: Ar CH), 7.17 (1 H, d, J=7.7 Hz: Ar CH), 5.89 (1 H, dt,
J=16.8, 9.8 Hz: CH=), 5.76 (1 H, s: CHAr), 5.62 (1 H, d, J=10.0 Hz: CH=CHcis), 5.10
(1 H, d, J=16.8 Hz: CH=CHtrans), 2.52 (1 H, d, J=9.6 Hz: CHCH=), 2.45 (3 H, s:
CH3Ts).
13C NMR (75 MHz, CDCl3) δ ppm 145.4 (quat. Ar C), 140.5 (quat. Ar C), 134.7
(quat. Ar C), 134.0 (quat. Ar C), 131.3 (quat. Ar C), 130.4 (Ar CH), 130.1 (Ar CH),
129.0 (=CH), 128.5 (Ar CH), 128.5 (Ar CH), 127.7 (Ar CH), 127.3 (Ar CH), 126.8
(overlapping Ar CH, quat. Ar C), 126.3 (Ar CH), 125.3(=CH2), 113.5 (CN), 110.9
(CN), 65.3 (CHAr), 49.4 (C(CN)2), 49.2 (CHCH=), 21.6 (CH3Ts). (Note: CF3 carbon
is not found). The assignments of the 1H and 13C were based on DEPT, COSY,
HMQC etc.
FTIR (CDCl3): νmax 3053, 2927, 2337, 1367, 1327, 1170, 1132, 852.
HRMS calcd for C27H24F3N4O2S [M+NH4] 525.1572, found 525.1586.
Separated enantiomers on Diacel Chiralpak AD-H HPLC column (98% Hexane/IPA,
1.0 mL/min), tr (major) = 19.6 min, tr (minor) = 24.2 min.
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4-((2S,4S)-3,3-dicyano-6-methoxy-1-tosyl-4-vinyl-1,2,3,4-tetrahydroquinolin-2-yl)phenyl acetate
33n (cw4185)
white solid
Pd/Trost ligand: 90% yield, 80% ee (S,S), dr =50:1
1H NMR (400 MHz, CDCl3) δ ppm 7.75 (1 H, d, J=8.8 Hz: Ar CH), 7.53 (2 H, d,
J=8.5 Hz: Ar CH), 7.40 (2 H, d, J=8.0 Hz: Ar CH), 7.30 (2 H, d, J=8.0 Hz: Ar CH),
7.18 (2 H, d, J=8.5 Hz: Ar CH), 7.04 (1 H, dd, J=8.7, 2.7 Hz: Ar CH), 6.65 (1 H, br.
s.: Ar CH), 5.85 (1 H, dt, J=16.8, 9.7 Hz: CH=CH2), 5.71 (1 H, s: CHAr), 5.57 (1 H,
d, J=10.0 Hz: CH=CH(H)cis), 5.01 (1 H, d, J=16.7 Hz: CH=CH(H)trans), 3.85 (3 H, s:
OCH3), 2.46 (3 H, s: CH 3Ts), 2.39 (1 H, d, J=9.5 Hz: CHCH=), 2.30 (3 H, s:
OCOCH3).
13C NMR (75 MHz, CDCl3) δ  ppm 168.9 (OCOCH3), 159.3 (quat. Ar C), 151.5
(quat. Ar C), 145.1 (quat. Ar C), 134.2 (quat. Ar C), 134.1 (quat. Ar C), 133.3 (quat.
Ar C), 130.2 (Ar CH), 130.0 (Ar CH), 129.1 (CH=CH2), 128.2 (Ar CH), 127.4 (Ar
CH), 127.1 (quat. Ar C), 125.2 (=CH2), 122.3 (Ar CH), 114.5 (Ar CH), 113.9 (CN),
113.1 (Ar C H), 111.1 (C N), 65.3 (CHAr), 55.7 (OCH3), 49.6 (CCN 2), 49.1
(CHCH=),21.6 (CH3Ts), 21.2 (OCOCH3). The assignments of the 
1H and 13C were
based on DEPT, COSY, HMQC etc.
FTIR (CDCl3): νmax 3053, 2928, 2303, 1767, 1607, 1495, 1367, 1263, 1169, 912.
HRMS calcd for C29H29N4O5S [M+NH4] 545.1859, , found 545.1860.
Separated enantiomers on Diacel Chiralpak AD-H HPLC column (90% Hexane/IPA,
1.0 mL/min), tr (major) = 18.8 min, tr (minor) = 35.6 min.
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4-((2S,4S)-3,3-dicyano-6-methyl-1-tosyl-4-vinyl-1,2,3,4-tetrahydroquinolin-2-yl)phenyl acetate
33o (cw3274)
white solid
Pd/Trost ligand: 73% yield, 90% ee (S,S), dr =70:1
1H NMR (400 MHz, CDCl3) δ ppm 7.68 (1 H, d, J=8.1 Hz: Ar CH), 7.50 (2 H, d,
J=8.7 Hz: Ar CH), 7.38 (2 H, d, J=8.3 Hz: Ar CH), 7.32 (1 H, d, J=8.1 Hz: Ar CH),
7.26 (2 H, d, J=8.5 Hz: Ar CH), 7.15 (2 H, d, J=8.6 Hz: Ar CH), 6.91 (1 H, s: Ar
CH), 5.86 (1 H, dt, J=16.8, 9.9 Hz: CH=CH2), 5.71 (1 H, s: CHAr), 5.56 (1 H, d,
J=10.0 Hz: CH=CH(H)cis), 5.04 (1 H, d, J=16.8 Hz: CH=CH(H)trans), 2.48 (1 H, d,
J=9.7 Hz: CHCH=), 2.43 (3 H, s: CH3Ts), 2.38 (3 H, s: CH 3), 2.28 (3 H, s:
OCOCH3).
13C NMR (75 MHz, CDCl3) δ  ppm 168.9 (OCOCH3), 151.5 (quat. Ar C), 145.1
(quat. Ar C), 138.6 (quat. Ar C), 134.4 (quat. Ar C), 134.1 (quat. Ar C), 132.2 (quat.
Ar C), 131.3 (quat. Ar C), 130.9 (Ar CH), 130.0 (Ar CH), 129.4 (CH=CH2), 128.4
(Ar CH), 128.3 (Ar CH), 127.4 (Ar CH), 124.9 (=CH2), 123.0 (Ar CH), 122.3 (Ar
CH), 113.9 (CN), 111.2 (CN), 65.2 (CHAr), 49.8 (CCN2), 49.1 (CHCH=),21.6
(CH3Ts), 21.4 (CH3), 21.2 (OCOCH3). The assignments of the 
1H and 13C were based
on DEPT, COSY, HMQC etc.
FTIR (CDCl3): νmax 3053, 2986, 2305, 1769, 1597, 1506, 1493, 1369, 1203, 1171,
914.
HRMS calcd for C29H25N3O4SNa [M+Na] 534.1463, found 534.1458.
Separated enantiomers on Diacel Chiralpak AD-H HPLC column (96% Hexane/IPA,
1.0 mL/min), tr (major) = 28.5 min, tr (minor) = 51.4 min.
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4-((2S,4S)-3,3-dicyano-1-tosyl-4-vinyl-1,2,3,4-tetrahydroquinolin-2-yl)phenyl acetate
33p (cw3268)
white solid
Pd/Trost ligand: 52% yield, 91% ee (S,S), dr =92:1
1H NMR (400 MHz, CDCl3) δ ppm 7.52 (1 H, d, J=7.8 Hz: Ar CH), 7.52 (2 H, d,
J=8.6 Hz: Ar CH), 7.38 - 7.41 (3 H, m: Ar CH), 7.28 (2 H, d, J=6.1 Hz: Ar CH), 7.18
(2 H, d, J=8.8 Hz: Ar CH), 7.15 (1 H, d, J=7.8 Hz: Ar CH), 5.87 (1 H, dt, J=16.8, 9.8
Hz: CH=CH2), 5.74 (1 H, s: CHAr), 5.58 (1 H, d, J=10.0 Hz: CH=CH(H)cis), 5.07 (1
H, d, J=16.7 Hz: CH=CH(H)trans), 2.55 (1 H, d, J=9.6 Hz: CHCH=), 2.42 (3 H, s:
CH3Ts), 2.28 (3 H, s: CH3).
13C NMR (75 MHz, CDCl3) δ ppm 168.8 (OCOMe), 151.5 (quat. Ar C), 145.2 (quat.
Ar C, s), 134.9 (quat. Ar C), 134.4 (quat. Ar C), 134.0 (quat. Ar C), 131.6 (quat. Ar
C), 130.2 (Ar CH), 130.0 (Ar CH), 129.2 (CH=CH2), 128.6 (Ar CH), 128.5 (Ar CH),
128.3 (Ar CH), 127.3 (Ar CH), 126.8 (Ar CH), 125.1 (=CH2), 122.3 (Ar CH), 113.8
(CN), 111.1 (CN), 65.3 (CHPh), 49.9 (CCN2), 49.1 (CHCH=), 21.6 (CH3Ts), 21.2
(CH3). The assignments of the 
1H and 13C were based on DEPT, COSY, HMQC etc.
FTIR (CDCl3): νmax 3053, 2350, 1769, 1597, 1369, 1204, 1171, 914.
HRMS calcd for C28H27N4O4S [M+NH4] 515.1753, found 515.1752.
Separated enantiomers on Diacel Chiralpak AD-H HPLC column (96% Hexane/IPA,
1.0 mL/min), tr (major) = 35.4 min, tr (minor) = 76.4 min.
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4-((2S,4S)-3,3-dicyano-6-fluoro-1-tosyl-4-vinyl-1,2,3,4-
tetrahydroquinolin-2-yl)phenyl acetate
33q (cw4003)
white solid
Pd/Trost ligand: 60% yield, 87% ee (S,S), dr >99:1
1H NMR (400 MHz, CDCl3) δ ppm 7.74 (1 H, dd, J=8.8, 4.8 Hz: Ar CH), 7.42 (2 H,
d, J=8.8 Hz: Ar CH), 7.32 (2 H, d, J=8.1 Hz: Ar CH), 7.22 (2 H, d, J=8.3 Hz: Ar
CH), 7.14 (3 H, m: Ar CH), 6.80 (1 H, dd, J=8.3, 2.8 Hz: Ar CH), 5.82 (1 H, dt,
J=16.8, 9.8 Hz: CH=CH2), 5.73 (1 H, s: CH Ar), 5.61 (1 H, d, J=10.1 Hz:
CH=CH(H)cis), 5.08 (1 H, d, J=16.8 Hz: CH=CH(H)trans), 2.50 (1 H, d, J=9.5 Hz:
CHCH=), 2.44 (3 H, s: CH3Ts), 2.29 (3 H, s: OCOCH3).
13C NMR (75 MHz, CDCl3) δ ppm 168.9 (OCOCH3), 165.7 (quat. Ar C), 155.3
(quat. Ar C), 151.6 (quat. Ar C), 145.5 (quat. Ar C), 134.1 (quat. Ar C), 133.7 (quat.
Ar C), 132.4 (Ar CH), 130.8 (quat. Ar C), 130.2 (Ar CH), 128.5 (CH=CH2), 128.2
(Ar CH), 127.4 (Ar CH), 125.8 (=CH2), 122.4 (Ar CH), 117.1 (Ar CH), 114.2 (Ar
CH), 113.5 (CN), 110.9 (CN), 65.3 (CHAr), 49.6 (CCN2), 48.9 (CHCH=), 21.6
(CH3Ts), 21.2 (OCOCH3). The assignments of the 
1H and 13C were based on DEPT,
COSY, HMQC etc.
FTIR (CDCl3): νmax 3062, 2926, 2359, 1713_1487, 1352, 1167, 874.
HRMS calcd for C28H22FN3O4S [M+] 515.1315, found 515.1340.
Separated enantiomers on Diacel Chiralpak AD-H HPLC column (96% Hexane/IPA,
1.0 mL/min), tr (major) = 46.3 min, tr (minor) = 99.7 min.
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(2S,4S)-6-methoxy-2-phenyl-1-tosyl-4-vinyl-1,2-dihydroquinoline-3,3(4H)-dicarbonitrile
33r (cw4184)
white solid
Pd/Trost ligand: 92% yield, 86% ee (S,S), dr =54:1
1H NMR (400 MHz, CDCl3) δ ppm 7.79 (1 H, d, J=8.8 Hz: Ar CH), 7.54 (2 H, d,
J=7.1 Hz: Ar CH), 7.42 (5 H, d, J=5.3 Hz: Ar CH), 7.30 (1 H, d, J=8.2 Hz: Ar CH),
7.05 (1 H, dd, J=8.8, 2.8 Hz: Ar CH), 6.65 (1 H, d, J=2.7 Hz: Ar CH), 5.85 (1 H, dt,
J=16.9, 9.8 Hz: CH=CH2), 5.73 (1 H, s: CH Ar), 5.57 (1 H, d, J=10.1 Hz:
CH=CH(H)cis), 5.01 (1 H, d, J=16.8 Hz: CH=CH(H)trans), 3.84 (3 H, s: OCH3), 2.46 (3
H, s: CH3Ts), 2.38 (1 H, d, J=9.5 Hz: CHCH=).
13C NMR (75 MHz, CDCl3) δ ppm 159.3 (quat. Ar C), 145.0 (quat. Ar C), 136.8
(quat. Ar C), 134.3 (quat. Ar C), 133.3 (quat. Ar C), 130.2 (Ar CH), 130.0 (Ar CH),
129.6 (Ar CH), 129.2 (overlapping CH=CH2, Ar CH), 127.4 (Ar CH), 127.3 (quat. Ar
C), 127.0 (Ar CH), 125.1 (=CH2), 114.5 (Ar CH), 114.0 (CN), 113.0 (Ar CH), 111.2
(CN), 65.7 (CHAr), 55.7 (OCH3), 49.7 (CCN2), 49.1 (CHCH=), 21.6 (CH3Ts). The
assignments of the 1H and 13C were based on DEPT, COSY, HMQC etc.
FTIR (CDCl3): νmax 3053, 2927, 2320, 1599, 1495, 1364, 1271, 1169, 914.
HRMS calcd for C27H23N3O3SNa [M+Na] 492.1358, found 492.1357.
Separated enantiomers on Diacel Chiralpak AD-H HPLC column (90% Hexane/IPA,
1.0 mL/min), tr (major) = 13.6 min, tr (minor) = 32.3 min.
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(2S,4S)-6-methyl-2-phenyl-1-tosyl-4-vinyl-1,2-dihydroquinoline-3,3(4H)-dicarbonitrile
33s (cw3265)
white solid
Pd/Trost ligand: 77% yield, 92% ee (S,S), dr >99:1
1H NMR (400 MHz, CDCl3) δ ppm 7.75 (1 H, d, J=8.1 Hz: Ar CH), 7.53 (2 H, dd,
J=7.7, 1.6 Hz: Ar CH), 7.39 - 7.48 (4 H, m: Ar CH), 7.35 (1 H, d, J=8.0 Hz: Ar CH),
7.28 (2 H, d, J=8.0 Hz: Ar CH), 6.94 (1 H, s: Ar CH), 5.89 (1 H, dt, J=16.8, 9.9 Hz:
CH=CH2), 5.75 (1 H, s: CHPh), 5.58 (1 H, dd, J=10.1, 0.9 Hz: CH=CH(H)cis), 5.05 (1
H, d, J=16.8 Hz: CH=CH(H)trans), 2.48 (1 H, d, J=9.7 Hz: CHCH=), 2.45 (3 H, s:
CH3Ts), 2.40 (3 H, s: CH3).
13C NMR (75 MHz, CDCl3) δ ppm 145.0 (quat. Ar C), 138.5 (quat. Ar C), 136.8
(quat. Ar C), 134.6 (quat. Ar C), 132.4 (quat. Ar C), 131.3 (quat. Ar C), 130.9 (Ar
CH), 130.0 (Ar CH), 129.6 (Ar CH), 129.4 (CH=CH2), 129.2 (Ar CH), 128.5 (Ar
CH), 127.3 (Ar CH), 127.3 (Ar CH), 127.0 (Ar CH), 124.8 (=CH2), 114.0 (CN),
111.3 (CN), 65.7 (CHAr), 50.0 (CCN2), 49.1 (CHCH=), 21.6 (CH3Ts), 21.4 (CH3).
The assignments of the 1H and 13C were based on DEPT, COSY, HMQC etc.
FTIR (CDCl3): νmax 3053, 2920, 2302, 1597, 1493, 1366, 1171.
HRMS calcd for C27H23N3O2SNa [M+Na] 476.1409, found 476.1408.
Separated enantiomers on Diacel Chiralpak AD-H HPLC column (96% Hexane/IPA,
1.0 mL/min), tr (major) = 19.6 min, tr (minor) = 30.3 min.
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(2S,4S)-6-fluoro-2-phenyl-1-tosyl-4-vinyl-1,2-dihydroquinoline-3,3(4H)-dicarbonitrile
33t (cw3299)
white solid
Pd/Trost ligand: 75% yield, 87% ee (S,S), dr =87:1
1H NMR (400 MHz, CDCl3) δ ppm 7.78 (1 H, dd, J=8.8, 4.9 Hz: Ar CH), 7.42 (2 H,
dd, J=7.8, 1.8 Hz: Ar CH), 7.37 (5 H, m: Ar CH), 7.23 (2 H, d, J=8.1 Hz: Ar CH),
7.15 - 7.20 (1 H, m: Ar CH), 6.87 (1 H, dd, J=8.4, 2.8 Hz: Ar CH), 5.83 (1 H, dt,
J=16.8, 9.8 Hz: CH=CH2), 5.74 (1 H, s: CH Ph), 5.61 (1 H, d, J=10.1 Hz:
CH=CH(H)cis), 5.06 (1 H, d, J=16.8 Hz: CH=CH(H)trans), 2.40 - 2.60 (4 H, m:
overlapping CH3Ts, CHCH=).
13C NMR (75 MHz, CDCl3) δ ppm 160.5 (quat. Ar C), 145.3 (quat. Ar C), 136.4
(quat. Ar C), 134.3 (quat. Ar C), 131.0 (quat. Ar C), 131.0 (quat. Ar C), 130.1 (Ar
CH), 129.7 (Ar CH), 129.2 (Ar CH), 128.6 (CH=), 127.8 (Ar CH), 127.3 (Ar CH),
126.9 (Ar CH), 125.7 ((=CH2), 117.1 (Ar CH), 114.4 (Ar CH), 113.7 (CN), 111.0
(CN), 65.8 (CHAr), 49.7 (CCN2), 49.0 (CHCH=), 21.6 (CH3Ts). The assignments of
the 1H and 13C were based on DEPT, COSY, HMQC etc.
FTIR (CDCl3): νmax 3053, 2986, 2305, 1489, 1367, 1271, 914.
HRMS calcd for C26H24FN4O2S [M+NH4] 475.1604, found 475.1600.
Separated enantiomers on Diacel Chiralpak AD-H HPLC column (90% Hexane/IPA,
1.0 mL/min), tr (major) = 14.0 min, tr (minor) = 29.5 min.
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37b:37c=1.5:1
37b:37c=4:1(NMR reaction)
(Z)-2',2'-dimethyl-2-phenyl-1-tosyl-2,4-dihydro-1H-spiro[benzo[b]azocine-3,5'-[1,3]dioxane]-4',6'-dione
2,2-dimethyl-2'-phenyl-1'-tosyl-4'-vinyl-2',4'-dihydro-1'H-spiro[[1,3]dioxane-5,3'-quinoline]-4,6-dione
37b (cw3267)
Pd(PPh3)4: 63% combined yield
1H NMR (400 MHz, CDCl3) compound 37b: δ ppm 7.00-7.48 (overlapping Ar CH),
6.53 (s, 1H: CHPh), 6.21 (d, 1H, J=15.7 Hz: =CH), 5.72 (dt, 1H, J=15.6, 7.8 Hz:
=CHCH2), 2.65 (d, 2H, J=7.6 Hz: CH2), 2.26 (s, 3H: CH3Ts), 1.65 (s, 3H: CH3), 1.43
(s, 3H: CH3).
Compound 37c: 7.00-7.48 (overlapping Ar CH), 6.06 (s, 1H: CHPh), 5.44 (m, 1H:
CH=CH2), 4.69 (d, 1H, J=15.9 Hz: CH=CH(H)trans).
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37e:37f= 6.3:1Me Me
(Z)-2',2',8-trimethyl-2-phenyl-1-tosyl-2,4-dihydro-1H-spiro[benzo[b]azocine-3,5'-[1,3]dioxane]-4',6'-dione
2,2,6'-trimethyl-2'-phenyl-1'-tosyl-4'-vinyl-2',4'-dihydro-1'H-spiro[[1,3]dioxane-5,3'-quinoline]-4,6-dione
37e (cw3276)
Pd(PPh3)4: 85% NMR yield
1H NMR (400 MHz, CDCl3) compound 37e: δ ppm 7.03-7.57 (overlapping Ar CH),
6.56 (s, 1H: CHPh), 6.33 (d, 1H, J=15.6 Hz: =CH), 5.85 (dt, 1H, J=15.6, 7.8 Hz:
=CHCH2), 2.77 (dd, 2H, J=7.6, 1.1 Hz: CH2), 2.40 (s, 3H: CH3Ts), 2.28 (s, 3H: CH3),
1.80 (s, 3H: CH3), 1.58 (s, 3H: CH3).
Compound 37f: 7.03-7.57 (overlapping Ar CH), 6.19 (s, 1H: CHPh), 5.59 (dt, 1H,
J=16.9, 10.1 Hz: CH=CH2), 4.81 (d, 1H, J=17.7 Hz: CH=CH(H)trans).
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37h:37i= 2.4:1F F
(Z)-8-fluoro-2 ',2 '-d imethy l-2-phenyl -1-tos yl- 2,4-d ihydro-1H -sp i ro [benzo[b ]azocine-3,5' -[1,3 ]dioxane]-4 ',6 '-d ione
6 '-fluor o-2,2-d imethyl -2' -phenyl -1' -tos yl -4' -viny l-2 ',4 '-d ihy dr o- 1'H -sp ir o[[1 ,3 ]d ioxane-5,3 '-qu inol ine]-4 ,6-d ione
37h (cw4011)
Pd(PPh3)4: 70% NMR yield
1H NMR (400 MHz, CDCl3) compound 37h: δ ppm 7.06-7.49 (overlapping Ar CH),
6.72 (s, 1H: CHPh), 6.34 (d, 1H, J=15.6 Hz: =CH), 5.88 (t, 1H, J=15.7, 7.5 Hz:
=CHCH2), 2.76 (d, 2H, J=7.8 Hz: CH2), 2.42 (s, 3H: CH3Ts), 1.80 (s, 3H: CH3), 1.60
(s, 3H: CH3).
Compound 37i: δ ppm 7.06-7.49 (overlapping Ar CH), 6.19 (s, 1H: CHPh), 5.53 (dt,
1H, J=16.8, 10.1 Hz: CH=CH2), 5.38 (d, 1H, J=10.0 Hz: CH=CH(H)cis), 4.84 (d, 1H,
J=16.8 Hz: CH=CH(H)trans), 2.66 (s, 3H: CH3), 2.43 (s, 3H: CH3Ts), 1.51 (s, 3H:
CH3).
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38b:38c=7:1
(higher Conc.of reactants)
6-oxo-12-tosyl-7-vinyl-6a,7,12,12a-tetrahydro-6H-chromeno[4,3-b]quinoline-6a-carbonitrile
1-tosyl-1,2-dihydroquinoline
38b (cw3256/3260)
Pd(PPh3)4: 85% NMR yield
1H NMR (400 MHz, CDCl3) compound 38b: δ ppm 7.04-7.34 (overlapping Ar CH),
6.34 (s, 1H: CHNTs), 5.23 (m, 1H: CH=CH2), 5.16 (d, 1H, J=9.8 Hz: CH=CH(H)cis),
5.05 (d, 1H, J=16.4 Hz: CH=CH(H)trans), 3.47 (d, 1H, J=8.8 Hz: CHCH=), 2.43 (s,
3H: CH3Ts).
Compound 38c: δ ppm 7.04-7.34 (overlapping Ar CH), 6.04 (d, 1H, J=9.4 Hz: CH=),
5.61 (dt, 1H, J=9.5, 4.2 Hz: =CHCH2), 5.38 (d, 1H, J=10.0 Hz: CH=CH(H)cis), 4.84
(d, 1H, J=16.8 Hz: CH=CH(H)trans), 4.43 (dd, 2H, J=4.1, 1.7 Hz: CH2NTs), 2.35 (s,
3H: CH3Ts).
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38d:38e=6:1
Me Me
9-methyl-6-oxo-12-tosyl-7-vinyl-6a,7,12,12a-tetrahydro-6H-chromeno[4,3-b]quinoline-6a-carbonitrile
6-methyl-1-tosyl-1,2-dihydroquinoline
38d (cw3275)
Pd(PPh3)4: 80% NMR yield
1H NMR (400 MHz, CDCl3) compound 38d: δ ppm  6.98-7.34 (overlapping Ar CH),
6.28 (s, 1H: CHNTs), 5.28 (dd, 1 H, J=16.4, 9.5 Hz: CH=CH2), 5.17 (d, 1H, J=9.9
Hz: CH=CH(H)cis), 5.03 (d, 1H, J=15.9 Hz: CH=CH(H)trans), 3.36 (d, 1H, J=9.2 Hz:
CHCH=), 2.43 (s, 3H: CH3Ts), 2.24 (s, 3H: CH3).
Compound 38e: δ ppm 6.98-7.34 (overlapping Ar CH), 5.99 (1 H, d, J=9.3 Hz: =CH),
5.57 (1 H, dt, J=9.6, 4.17 Hz: =CHCH2), 4.39 (2 H, dd, J=4.0, 1.6 Hz: CH2), 2.35 (3
H, s: overlapping CH3Ts, CH3), 2.31 (3 H, s: overlapping CH3Ts, CH3).
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2-phenyl-3-(phenylsulfonyl)-1-tosyl-4-vinyl-1,2,3,4-tetrahydroquinoline-3-carbonitrile
39c (cw4046)
white solid
Pd(PPh3)4:: 80% NMR yield, dr >19:1
1H NMR (400 MHz, CDCl3) δ ppm 6.06-7.76 (overlapping Ar CH), 6.07 (s, 1H:
CHPh), 5.92 (1H, ddd, J=17.0, 10.0, 9.7 Hz: CH=CH2), 5.38 (d, 1H, J=10.2 Hz:
CH=CH(H)cis), 4.86(1H, d, J=17.2 Hz: CH=CH(H)trans), 3.18 (1H, d, J=9.3 Hz:
CHCH=), 2.43 (3H, s: CH3Ts).
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6-methyl-2-phenyl-3-(phenylsulfonyl)-1-tosyl-4-vinyl-1,2,3,4-tetrahydroquinoline-3-carbonitrile
39d (cw4047)
white solid
Pd(PPh3)4:: 75% yield, dr >19:1
1H NMR (400 MHz, CDCl3) δ  ppm 7.99 (2H, d, J=8.5 Hz: Ar CH), 7.74 (1H, t,
J=7.5 Hz: Ar CH), 7.55 (4H, m: Ar CH), 7.46 (1H, d, J=8.0 Hz: Ar CH), 7.23 (3H, m:
Ar CH), 7.15 (1H, t, J=7.4 Hz: Ar CH), 6.99 (3H, d, J=7.7 Hz: Ar CH), 6.50 (2H, d,
J=8.1 Hz: Ar CH), 5.98 (3 H, m: overlapping CH=CH2, CHPh), 5.38 (dd, 1H, J=10.1,
1.4 Hz: CH=CH(H)cis), 4.79 (1 H, d, J=16.8 Hz: CH=CH(H)trans), 3.12 (1 H, d, J=9.3
Hz: CHCH=), 2.42 (3 H, s: overlapping CH3, CH3Ts), 2.39 (3 H, s: overlapping CH3,
CH3Ts). The assignments of the 
1H was based on COSY.
N Ph
Ts
CN
CN
Me
2-phenyl-4-(prop-1-en-2-yl)-1-tosyl-1,2-dihydroquinoline-3,3(4H)-dicarbonitrile
40b (cw3270)
Pd(PPh3)4: 55% NMR yield
1H NMR (400 MHz, CDCl3) δ ppm 7.12-7.49 (overlapping Ar CH), 5.62 (1H, s: Ar
CH), 5.36 (1 H, s: =CH2), 5.34 (1 H, s: =CH2), 2.43 (3H, s: CH3Ts), 1.74 (3H, s:
CH3).
N
Ts
CN
CN
Me
4-(3,3-dicyano-4-(prop-1-en-2-yl)-1-tosyl-1,2,3,4-tetrahydroquinolin-2-yl)phenyl acetate
OAc
40c (cw3255)
Pd(PPh3)4: 67% NMR yield
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1H NMR (400 MHz, CDCl3) δ ppm 7.12-7.42 (overlapping Ar CH), 5.62 (1H, s: Ar
CH), 5.36 (1 H, s: =CH2), 5.34 (1 H, s: =CH2), 2.35 (6H: overlapping CH3Ts and
CH3OAc), 1.66 (3H, s: CH3).
N
SO2
Ph
CN
CN
O2N
1-(4-nitrophenylsulfonyl)-2-phenyl-4-vinyl-1,2-dihydroquinoline-3,3(4H)-dicarbonitrile
41b (cw4055)
Pd(PPh3)4: 92% NMR yield
1H NMR (400 MHz, CDCl3) δ ppm 6.97-8.26 (overlapping Ar CH), 5.95 (1H, ddd,
J=16.6, 10.0, 9.8 Hz: CH=CH2), 5.86 (1 H, s: CHPh), 5.69 (1 H, d, J=10.2 Hz:
CH=CH(H)cis), 5.33 (1H, d, J=16.80 Hz: CH=CH(H)trans), 3.02 (1H, d, J=9.5 Hz:
CHCH=).
NH
N
Ts
N-(2-((dimethylamino)methyl)phenyl)-4-methylbenzenesulfonamide
42b (cw4180)
Pd(PPh3)4: 62% yield
1H NMR (400 MHz, CDCl3) δ ppm 7.68 (2H, m d, J=8.3 Hz: Ar CH (Ts)), 7.54 (1H,
d, J=7.5 Hz: Ar CH), 7.20 - 7.33 (3H, m: overlapping Ar CH), 6.98 (2H, dddd,
J=14.3, 7.5, 6.7, 0.7 Hz: Ar CH), 3.12 (2H, s: CH2), 2.39 (3H, s: CH3Ts), 2.19 (6H, s:
CH3).
13C NMR (75 MHz, CDCl3) δ ppm 143.34 (quat. Ar C), 138.00 (quat. Ar C), 129.5
(Ar CH), 129.5 (Ar CH), 128.5 (Ar CH), 127.4 (quat. Ar C), 126.8 (Ar CH), 124.0
(Ar CH), 121.3 (Ar CH), 63.0 (CH2), 44.5 (CH3), 21.6 (CH3Ts).
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NH
Ts
N
4-methyl-N-(2-(1-(pyrrolidin-1-yl)allyl)phenyl)benzenesulfonamide
43b (cw3204)
White solid
Pd(PPh3)4: 97% yield
1H NMR (400 MHz, CDCl3) δ ppm 11.89 (1H, br. s.: NHTs), 7.85 (2H, d, J=8.1 Hz:
arom H), 7.58 (1H, d, J=8.1 Hz: arom H), 7.32 (2H, d, J=8.0 Hz: arom H), 7.23 (1H,
t, J=7.7 Hz: arom H), 7.04 (1H, m: arom H), 6.99 (1H, d, J=7.3 Hz: arom H), 5.88
(1H, dt, J=16.9, 9.5 Hz: CHCH=CH2), 5.14 (1H, d, J=16.9 Hz: CH=CH(H)trans), 5.02
(1H, d, J=10.0 Hz: CH=CH(H)cis), 3.75 (1H, d, J=8.9 Hz: CHCH=CH2), 2.61 (2H, m:
NCH2), 2.49 (2H, m: NCH2), 2.45 (3H, s: CH3Ts), 1.91 (4H, m: CH2).
13C NMR (100 MHz, CDCl3) δ ppm 143.4 (quat. Ar C), 137.8 (quat. Ar C), 137.1
(quat. Ar C), 136.5 (CH=CH2), 129.5 (Ar CH), 128.8 (Ar CH), 128.7 (quat. Ar C),
128.2 (Ar CH), 127.0 (Ar CH), 123.1 (Ar CH), 118.1 (Ar CH), 117.2 (=CH2), 74.3
(CHCH=CH2), 51.8 (CH2N), 23.6 (CH2), 21.5 (CH3Ts).
NH
Ts
N
4-methyl-N-(2-(1-(piperidin-1-yl)allyl)phenyl)benzenesulfonamide
43b (cw3167)
Colorless oil
Pd(PPh3)4: 36% yield, 99% NMR yield
1H NMR (400 MHz, CDCl3) δ ppm 12.11 (1H, br. s.: NHTs), 7.72 (2H, d, J=8.3 Hz:
arom H), 7.42 (1H, dd, J=8.1, 1.2 Hz: arom H), 7.21 (2H, d, J=8.0 Hz: arom H), 7.13
(1H, td, J=7.5, 2.0 Hz: arom H), 6.92 (2H, m: arom H), 5.71 (1H, dt, J=16.9, 9.9 Hz:
CHCH=CH2), 5.05 (1H, dd, J=10.1, 1.6 Hz: CH=CH(H)cis), 5.00 (1H, dd, J=16.9, 1.5
Hz: CH=CH(H)trans), 3.57 (1H, d, J=9.7 Hz: CHCH=CH2), 2.40 (3H, s: CH2), 2.35
(3H, s: CH3Ts), 1.62 (5H, br. s.: CH2), 1.45 (2H, br. s.: CH2).
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NH
Ts
NHBn
N-(2-(1-(benzylamino)allyl)phenyl)-4-methylbenzenesulfonamide
45c (cw3227)
Colorless oil
Pd(PPh3)4: 95% NMR yield
1H NMR (400 MHz, CDCl3)  δ ppm 7.46 (2H, d, J=8.3 Hz: arom H), 7.38 (1H, d,
J=8.2 Hz: arom H), 7.18 (8H, m: arom H), 6.85 (2H, m: arom H), 5.64 (1H, ddd,
J=17.2, 10.1, 7.4 Hz: CH=CH2), 4.90 (2H, m: =CH2), 4.00 (1H, d, J=7.6 Hz:
CHCH=CH2), 3.69 (2H, s: NH), 3.52 (2H, m: CH2), 2.21 (3H, s: CH3Ts).
N
N
O
Ts
Ts
1,3-ditosyl-4-vinyl-3,4-dihydroquinazolin-2(1H)-one
5c (cw3227)
Colorless oil
Pd(PPh3)4: 95% NMR yield
White solid
Pd(PPh3)4: 55% yield
Pd/Trost ligand: 24% ee
1H NMR (400 MHz, CDCl3) δ ppm 8.07 (2H, d, J=8.4 Hz: Ar CH), 7.94 (2H, d,
J=8.4 Hz: Ar CH), 7.28 (8H, m: Ar CH), 5.95 (1H, d, J=5.6 Hz: CHCH=), 5.83 (1H,
td, J=11.0, 5.1 Hz: CH=CH2), 5.18 (1H, dd, J=10.3, 1.4 Hz: CH=CH(H)cis), 5.08 (1H,
dd, J=16.9, 1.5 Hz: CH=CH(H)trans), 2.46 (6H, s: CH3Ts).
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X-ray Crystallography Data for 16a
O
O
NTs
H CN
16a (cw2169)
16a was synthesized by the standard decarboxylative olefin insertion reaction from
vinyl oxazinanone. The colorless crystal was formed in a solvent mixture of
dichloromethane and hexane.
Crystal Structure Data:
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Comments   The asymmetric unit contains one crystallographically-independent
C22H20N2O4S molecule. All thermal vibration ellipsoids are drawn at the 50%
probability level.
Brief Experimental Description to be Included as Text or as a Footnote at Time
of Publication
Colorless crystals of C22H20N2O4S are, at 100(2) K, triclinic, space group P1(Ci
1 – No.
2)2 with a  = 7.7457(6) Å, b = 8.3807(6) Å, c = 15.163(1) Å, α = 85.166(2)°, β =
89.549(2)°, γ = 74.976(1)°, V = 947.2(1) Å3 and Z = 2 molecules {dcalcd = 1.432
g/cm3; µa(MoKα) = 0.204mm
-1}. A full hemisphere of diffracted intensities (1850 10-
second frames with an ω scan width of 0.30°) was measured for a single-domain
specimen using graphite-monochromated MoK_ radiation (λ  = 0.71073 Å) on a
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Bruker SMART APEX CCD Single Crystal Diffraction System.3 X-rays were
provided by a fine-focus sealed x-ray tube operated at 50kV and 30mA. Lattice
constants were determined with the Bruker SAINT software package using peak
centers for 5305 reflections. A total of 11612 integrated reflection intensities having
2θ((MoKα)< 61.00° were produced using the Bruker program SAINT;4 5684 of these
were unique and gave Rint = 0.046 with a coverage which was 98.5% complete. The
data were corrected for variable absorption effects using Gaussian face-indexed
absorption corrections; the transmission factors ranged from 0.932 to 0.983. The
Bruker software package SHELXTL Version 6.10 was used to solve the structure
using “direct methods” techniques. All stages of weighted full-matrix least-squares
refinement were conducted using Fo
2 data with the SHELXTL software package.5 All
hydrogen atoms were located from difference Fourier syntheses and included in the
structural model as individual isotropic atoms whose parameters were allowed to vary
in least-squares refinement cycles.
The final structural model incorporated anisotropic thermal parameters for all
nonhydrogen atoms and isotropic thermal parameters for all hydrogen atoms. A total
of 342 parameters were refined using no restraints, 5684 data and weights of w =
1/[σ
2
(F
2
) + (0.0790 P)
2
], where P = [Fo
2
 + 2Fc
2
] / 3. Final agreement factors at
convergence are: R1(unweighted, based on F) = 0.046 for 4539 independent
absorption-corrected reflections having 2θ(MoKα )< 61.00° and I>2σ (I);
R1(unweighted, based on F) = 0.058 and wR2(weighted, based on F
2) = 0.126 for all
5684 independent absorption-corrected reflections having 2θ(MoKα)< 61.00°. The
largest shift/s.u. was 0.001 in the final refinement cycle. The final difference map had
maxima and minima of 0.79 and -0.51 e-/Å
3
, respectively.
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Table 1. Crystal data and structure refinement for C22H20N2O4S.
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Empirical formula C22H20N2O4S
Formula weight 408.46
Temperature 100(2) K
Wavelength 0.71073 Å
Crystal system Triclinic
Space group P1(Ci
1 – No. 2)
Unit cell dimensions a = 7.7457(6) Å α =
85.166(2)°.
b = 8.3807(6) Å _ = 89.549(2)°.
c = 15.163(1) Å γ = 74.976
(1)°.
Volume 947.2(1) Å3
Z 2
Density (calculated) 1.432 Mg/m
3
Absorption coefficient 0.204 mm
-1
F(000) 428
Crystal size 0.45 x 0.24 x 0.10 mm
3
Theta range for data collection 2.53° to 30.50°.
Index ranges -11 ≤ h ≤ 11, -11 ≤ k ≤ 11, -21 ≤ l ≤ 21
Reflections collected 11612
Independent reflections 5684 [Rint = 0.046]
Completeness to theta = 30.50° 98.5 %
Absorption correction Integration
Max. and min. transmission 0.983 and 0.932
Refinement method Full-matrix least-squares on F
2
Data / restraints / parameters 5684 / 0 / 342
Goodness-of-fit on F
2
1.037
Final R indices [I>2sigma(I)] R1 = 0.046, wR2 = 0.119
R indices (all data) R1 = 0.058, wR2 = 0.126
Largest diff. peak and hole 0.79 and -0.51 e.Å
-3
----------
R1 = S ||Fo| - |Fc|| / S |Fo|
wR2 = { S [w(Fo2 - Fc2)2] / S [w(Fo 2)2] }1/2
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Table 2. Atomic coordinates (x 10
4
) and equivalent isotropic displacement parameters
(Å
2
x 10
3
) for C22H20N2O4S.  U (eq) is defined as one third of the trace of the
orthogonalized Uij tensor.
_____________________________________________________________________
x y z U(eq)
_____________________________________________________________________
S -911(1) 3890(1) 3489(1) 15(1)
O(1) -58(1) 7711(1) 419(1) 23(1)
O(2) 1672(1) 5603(1) -199(1) 23(1)
O(3) -1533(1) 4816(1) 4237(1) 20(1)
O(4) -2197(1) 3546(1) 2910(1) 21(1)
N(1) 337(1) 4818(1) 2869(1) 14(1)
N(2) 2715(2) 2108(2) 1252(1) 27(1)
C(1) 1030(2) 6165(2) 467(1) 19(1)
C(2) 1460(2) 5286(2) 1389(1) 17(1)
C(3) 2895(2) 6035(2) 1820(1) 20(1)
C(4) 3368(2) 5157(2) 2750(1) 19(1)
C(5) 1701(2) 5416(2) 3313(1) 16(1)
C(6) -226(2) 5539(2) 1975(1) 14(1)
C(7) -1171(2) 7375(2) 1915(1) 16(1)
C(8) -1029(2) 8361(2) 1152(1) 19(1)
C(9) -1879(2) 10035(2) 1038(1) 25(1)
C(10) -2929(2) 10762(2) 1711(1) 27(1)
C(11) -3137(2) 9814(2) 2476(1) 25(1)
C(12) -2249(2) 8134(2) 2581(1) 20(1)
C(13) 622(2) 2035(2) 3892(1) 16(1)
C(14) 1053(2) 1745(2) 4786(1) 20(1)
C(15) 2267(2) 270(2) 5090(1) 22(1)
C(16) 3078(2) -901(2) 4512(1) 20(1)
C(17) 2638(2) -563(2) 3614(1) 23(1)
C(18) 1396(2) 880(2) 3299(1) 21(1)
C(19) 4467(2) 6003(2) 1233(1) 24(1)
C(20) 4851(2) 7358(2) 883(1) 28(1)
C(21) 2181(2) 3499(2) 1301(1) 20(1)
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C(22) 4369(2) -2504(2) 4853(1) 27(1)
_____________________________________________________________________
Table 3. Bond lengths [Å] for C22H20N2O4S.
_____________________________________________________________________
S-O(4) 1.4326(10)
S-O(3) 1.4369(9)
S-N(1) 1.6352(11)
S-C(13) 1.7595(14)
O(1)-C(1) 1.3463(17)
O(1)-C(8) 1.4051(16)
O(2)-C(1) 1.2000(16)
N(1)-C(6) 1.4583(16)
N(1)-C(5) 1.4705(15)
N(2)-C(21) 1.1400(19)
C(1)-C(2) 1.5211(18)
C(2)-C(21) 1.4733(19)
C(2)-C(6) 1.5525(17)
C(2)-C(3) 1.5807(18)
C(3)-C(19) 1.4993(19)
C(3)-C(4) 1.5344(19)
C(3)-H(3) 1.02(2)
C(4)-C(5) 1.5206(18)
C(4)-H(4A) 0.988(16)
C(4)-H(4B) 0.922(17)
C(5)-H(5A) 0.975(16)
C(5)-H(5B) 1.002(16)
C(6)-C(7) 1.5182(18)
C(6)-H(6) 0.915(16)
C(7)-C(8) 1.3843(19)
C(7)-C(12) 1.3937(17)
C(8)-C(9) 1.384(2)
C(9)-C(10) 1.381(2)
C(9)-H(9) 0.96(2)
C(10)-C(11) 1.382(2)
C(10)-H(10) 0.98(2)
C(11)-C(12) 1.3944(19)
C(11)-H(11) 0.973(18)
C(12)-H(12) 0.941(17)
C(13)-C(14) 1.3851(18)
C(13)-C(18) 1.3940(17)
C(14)-C(15) 1.390(2)
C(14)-H(14) 0.934(16)
C(15)-C(16) 1.3932(19)
C(15)-H(15) 0.968(16)
C(16)-C(17) 1.395(2)
C(16)-C(22) 1.505(2)
C(17)-C(18) 1.387(2)
C(17)-H(17) 0.972(18)
C(18)-H(18) 0.941(18)
C(19)-C(20) 1.316(2)
C(19)-H(19) 1.04(2)
C(20)-H(20A) 0.892(13)
C(20)-H(20B) 0.96(2)
C(22)-H(22A) 0.91(2)
C(22)-H(22B) 0.90(2)
C(22)-H(22C) 1.01(2)
_____________________________________________________________________
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Table 4. Bond angles [°] for C22H20N2O4S.
_____________________________________________________________________
O(4)-S-O(3) 118.87(6)
O(4)-S-N(1) 106.60(6)
O(3)-S-N(1) 110.07(6)
O(4)-S-C(13) 110.21(6)
O(3)-S-C(13) 107.32(6)
N(1)-S-C(13) 102.58(6)
C(1)-O(1)-C(8) 121.81(11)
C(6)-N(1)-C(5) 117.69(10)
C(6)-N(1)-S 121.40(8)
C(5)-N(1)-S 117.72(8)
O(2)-C(1)-O(1) 119.13(12)
O(2)-C(1)-C(2) 124.11(13)
O(1)-C(1)-C(2) 116.62(11)
C(21)-C(2)-C(1) 108.30(10)
C(21)-C(2)-C(6) 108.84(11)
C(1)-C(2)-C(6) 111.77(10)
C(21)-C(2)-C(3) 111.01(11)
C(1)-C(2)-C(3) 107.20(11)
C(6)-C(2)-C(3) 109.71(10)
C(19)-C(3)-C(4) 114.73(12)
C(19)-C(3)-C(2) 112.15(11)
C(4)-C(3)-C(2) 108.34(11)
C(19)-C(3)-H(3) 92.5(11)
C(4)-C(3)-H(3) 116.0(11)
C(2)-C(3)-H(3) 112.6(11)
C(5)-C(4)-C(3) 110.01(11)
C(5)-C(4)-H(4A) 112.0(9)
C(3)-C(4)-H(4A) 106.5(10)
C(5)-C(4)-H(4B) 108.2(10)
C(3)-C(4)-H(4B) 112.8(10)
H(4A)-C(4)-H(4B) 107.4(14)
N(1)-C(5)-C(4) 109.35(10)
N(1)-C(5)-H(5A) 107.6(9)
C(4)-C(5)-H(5A) 112.8(9)
N(1)-C(5)-H(5B) 108.2(9)
C(4)-C(5)-H(5B) 111.0(9)
H(5A)-C(5)-H(5B) 107.8(12)
N(1)-C(6)-C(7) 114.34(10)
N(1)-C(6)-C(2) 108.12(10)
C(7)-C(6)-C(2) 108.54(10)
N(1)-C(6)-H(6) 106.9(10)
C(7)-C(6)-H(6) 109.4(10)
C(2)-C(6)-H(6) 109.4(9)
C(8)-C(7)-C(12) 117.11(12)
C(8)-C(7)-C(6) 119.47(11)
C(12)-C(7)-C(6) 123.37(12)
C(9)-C(8)-C(7) 122.99(13)
C(9)-C(8)-O(1) 114.93(12)
C(7)-C(8)-O(1) 122.04(12)
C(10)-C(9)-C(8) 118.81(14)
C(10)-C(9)-H(9) 123.2(12)
C(8)-C(9)-H(9) 117.9(12)
C(9)-C(10)-C(11) 120.05(14)
C(9)-C(10)-H(10) 116.4(11)
C(11)-C(10)-H(10) 123.5(11)
C(10)-C(11)-C(12) 120.12(13)
C(10)-C(11)-H(11) 118.1(12)
C(12)-C(11)-H(11) 121.8(12)
C(7)-C(12)-C(11) 120.89(13)
C(7)-C(12)-H(12) 119.6(10)
C(11)-C(12)-H(12) 119.5(10)
C(14)-C(13)-C(18) 121.02(13)
C(14)-C(13)-S 119.96(10)
C(18)-C(13)-S 119.02(10)
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C(13)-C(14)-C(15) 118.94(12)
C(13)-C(14)-H(14) 121.9(10)
C(15)-C(14)-H(14) 119.1(10)
C(14)-C(15)-C(16) 121.44(13)
C(14)-C(15)-H(15) 118.1(10)
C(16)-C(15)-H(15) 120.4(10)
C(15)-C(16)-C(17) 118.28(13)
C(15)-C(16)-C(22) 120.80(13)
C(17)-C(16)-C(22) 120.90(13)
C(18)-C(17)-C(16) 121.32(13)
C(18)-C(17)-H(17) 120.0(11)
C(16)-C(17)-H(17) 118.6(11)
C(17)-C(18)-C(13) 118.96(13)
C(17)-C(18)-H(18) 118.5(11)
C(13)-C(18)-H(18) 122.4(11)
C(20)-C(19)-C(3) 122.85(15)
C(20)-C(19)-H(19) 118.5(12)
C(3)-C(19)-H(19) 118.6(12)
C(19)-C(20)-H(20A) 112.0(9)
C(19)-C(20)-H(20B) 121.0(13)
H(20A)-C(20)-H(20B) 127.0(15)
N(2)-C(21)-C(2) 178.11(14)
C(16)-C(22)-H(22A) 110.9(13)
C(16)-C(22)-H(22B) 110.7(13)
H(22A)-C(22)-H(22B) 107.7(17)
C(16)-C(22)-H(22C) 110.2(12)
H(22A)-C(22)-H(22C) 111.4(17)
H(22B)-C(22)-H(22C) 105.8(16)
_____________________________________________________________________
Table 5. Anisotropic displacement parameters (Å
2
x 10
3
) for C22H20N2O4S. The
anisotropic displacement factor exponent takes the form:  -2π
2
[h2 a*
2
U11 + ...  + 2 h k
a* b* U12 ]
_____________________________________________________________________
U11 U22 U33 U23 U13 U12
_____________________________________________________________________
S 14(1) 15(1) 17(1) -1(1) 2(1) -4(1)
O(1) 21(1) 26(1) 19(1) 4(1) 2(1) -4(1)
O(2) 23(1) 32(1) 17(1) -3(1) 3(1) -12(1)
O(3) 20(1) 19(1) 19(1) -2(1) 5(1) -2(1)
O(4) 17(1) 23(1) 24(1) -1(1) 0(1) -9(1)
N(1) 14(1) 16(1) 14(1) 0(1) 0(1) -7(1)
N(2) 26(1) 27(1) 25(1) -5(1) 1(1) -1(1)
C(1) 16(1) 25(1) 18(1) 0(1) 1(1) -10(1)
C(2) 14(1) 22(1) 15(1) -2(1) 1(1) -6(1)
C(3) 17(1) 26(1) 20(1) -2(1) 0(1) -9(1)
C(4) 14(1) 24(1) 20(1) -2(1) -1(1) -5(1)
C(5) 15(1) 20(1) 15(1) -2(1) -1(1) -6(1)
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C(6) 13(1) 16(1) 14(1) -2(1) 0(1) -4(1)
C(7) 13(1) 16(1) 19(1) -1(1) -2(1) -4(1)
C(8) 14(1) 21(1) 21(1) 1(1) -1(1) -5(1)
C(9) 23(1) 22(1) 29(1) 8(1) -5(1) -6(1)
C(10) 23(1) 17(1) 38(1) 0(1) -8(1) 0(1)
C(11) 23(1) 22(1) 28(1) -7(1) -4(1) 2(1)
C(12) 18(1) 20(1) 20(1) -2(1) -1(1) -2(1)
C(13) 17(1) 13(1) 18(1) 0(1) 2(1) -5(1)
C(14) 22(1) 19(1) 18(1) -3(1) 2(1) -4(1)
C(15) 23(1) 22(1) 20(1) 0(1) -3(1) -5(1)
C(16) 16(1) 16(1) 28(1) 1(1) 1(1) -5(1)
C(17) 27(1) 15(1) 26(1) -3(1) 8(1) -4(1)
C(18) 30(1) 16(1) 18(1) -1(1) 3(1) -5(1)
C(19) 17(1) 28(1) 25(1) -4(1) 2(1) -5(1)
C(20) 24(1) 36(1) 26(1) 1(1) -1(1) -14(1)
C(21) 17(1) 26(1) 16(1) -2(1) 1(1) -3(1)
C(22) 22(1) 20(1) 35(1) 4(1) 1(1) -1(1)
_____________________________________________________________________
Table 6. Hydrogen coordinates ( x 10
4
) and isotropic displacement parameters (Å
2
x
10
3  ) for C22H20N2O4S.
_____________________________________________________________________
x y z U(eq)
_____________________________________________________________________
H(3) 2530(30) 7290(30) 1782(13) 41(5)
H(4A) 4280(20) 5630(20) 2998(10) 22(4)
H(4B) 3860(20) 4030(20) 2742(11) 22(4)
H(5A) 1930(20) 4820(20) 3899(10) 18(4)
H(5B) 1190(20) 6620(20) 3395(10) 17(4)
H(6) -980(20) 4960(20) 1773(10) 14(4)
H(9) -1660(20) 10650(30) 504(13) 38(5)
H(10) -3500(30) 11950(30) 1607(13) 40(5)
H(11) -3900(20) 10360(20) 2936(12) 34(5)
H(12) -2390(20) 7500(20) 3106(11) 25(4)
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H(14) 570(20) 2520(20) 5189(11) 22(4)
H(15) 2520(20) 60(20) 5719(11) 21(4)
H(17) 3190(20) -1380(20) 3209(11) 33(5)
H(18) 1180(20) 1080(20) 2685(12) 32(5)
H(19) 5240(30) 4870(30) 1064(14) 46(6)
H(20A) 4111(17) 8273(18) 1064(8) 3(3)
H(20B) 5850(30) 7300(30) 500(13) 42(5)
H(22A) 4850(30) -2400(30) 5387(14) 42(6)
H(22B) 5280(30) -2800(30) 4473(13) 41(5)
H(22C) 3760(30) -3430(30) 4891(13) 40(5)
Table 7. Torsion angles [°] for C22H20N2O4S.
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O(4)-S-N(1)-C(6) 16.46(11)
O(3)-S-N(1)-C(6) -113.73(10)
C(13)-S-N(1)-C(6) 132.31(10)
O(4)-S-N(1)-C(5) 175.84(9)
O(3)-S-N(1)-C(5) 45.65(11)
C(13)-S-N(1)-C(5) -68.32(10)
C(8)-O(1)-C(1)-O(2) 171.75(12)
C(8)-O(1)-C(1)-C(2) -12.31(17)
O(2)-C(1)-C(2)-C(21) -21.10(17)
O(1)-C(1)-C(2)-C(21) 163.19(11)
O(2)-C(1)-C(2)-C(6) -140.99(13)
O(1)-C(1)-C(2)-C(6) 43.30(15)
O(2)-C(1)-C(2)-C(3) 98.75(15)
O(1)-C(1)-C(2)-C(3) -76.96(13)
C(21)-C(2)-C(3)-C(19) 66.25(15)
C(1)-C(2)-C(3)-C(19) -51.85(15)
C(6)-C(2)-C(3)-C(19) -173.41(12)
C(21)-C(2)-C(3)-C(4) -61.40(13)
C(1)-C(2)-C(3)-C(4) -179.50(10)
C(6)-C(2)-C(3)-C(4) 58.94(14)
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C(19)-C(3)-C(4)-C(5) 174.37(12)
C(2)-C(3)-C(4)-C(5) -59.47(14)
C(6)-N(1)-C(5)-C(4) -57.25(14)
S-N(1)-C(5)-C(4) 142.60(10)
C(3)-C(4)-C(5)-N(1) 56.64(14)
C(5)-N(1)-C(6)-C(7) -64.72(13)
S-N(1)-C(6)-C(7) 94.65(12)
C(5)-N(1)-C(6)-C(2) 56.29(13)
S-N(1)-C(6)-C(2) -144.33(9)
C(21)-C(2)-C(6)-N(1) 66.62(13)
C(1)-C(2)-C(6)-N(1) -173.81(10)
C(3)-C(2)-C(6)-N(1) -55.03(13)
C(21)-C(2)-C(6)-C(7) -168.83(10)
C(1)-C(2)-C(6)-C(7) -49.26(13)
C(3)-C(2)-C(6)-C(7) 69.52(13)
N(1)-C(6)-C(7)-C(8) 149.76(11)
C(2)-C(6)-C(7)-C(8) 28.98(15)
N(1)-C(6)-C(7)-C(12) -32.74(17)
C(2)-C(6)-C(7)-C(12) -153.52(12)
C(12)-C(7)-C(8)-C(9) 1.0(2)
C(6)-C(7)-C(8)-C(9) 178.64(12)
C(12)-C(7)-C(8)-O(1) -176.55(11)
C(6)-C(7)-C(8)-O(1) 1.10(19)
C(1)-O(1)-C(8)-C(9) 170.98(12)
C(1)-O(1)-C(8)-C(7) -11.29(19)
C(7)-C(8)-C(9)-C(10) -0.5(2)
O(1)-C(8)-C(9)-C(10) 177.17(12)
C(8)-C(9)-C(10)-C(11) -0.9(2)
C(9)-C(10)-C(11)-C(12) 1.8(2)
C(8)-C(7)-C(12)-C(11) -0.1(2)
C(6)-C(7)-C(12)-C(11) -177.63(12)
C(10)-C(11)-C(12)-C(7) -1.3(2)
O(4)-S-C(13)-C(14) -133.00(11)
O(3)-S-C(13)-C(14) -2.17(13)
260 
N(1)-S-C(13)-C(14) 113.80(11)
O(4)-S-C(13)-C(18) 47.45(12)
O(3)-S-C(13)-C(18) 178.27(10)
N(1)-S-C(13)-C(18) -65.76(11)
C(18)-C(13)-C(14)-C(15) -0.5(2)
S-C(13)-C(14)-C(15) 179.98(10)
C(13)-C(14)-C(15)-C(16) 1.2(2)
C(14)-C(15)-C(16)-C(17) -0.2(2)
C(14)-C(15)-C(16)-C(22) -179.04(13)
C(15)-C(16)-C(17)-C(18) -1.5(2)
C(22)-C(16)-C(17)-C(18) 177.37(13)
C(16)-C(17)-C(18)-C(13) 2.1(2)
C(14)-C(13)-C(18)-C(17) -1.1(2)
S-C(13)-C(18)-C(17) 178.41(10)
C(4)-C(3)-C(19)-C(20) -121.00(16)
C(2)-C(3)-C(19)-C(20) 114.83(16)
C(1)-C(2)-C(21)-N(2) -142(5)
C(6)-C(2)-C(21)-N(2) -20(5)
C(3)-C(2)-C(21)-N(2) 101(5)
________________________________________________________________
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N
Ts
Ph
CN
CNPh
13n (cw2227)
13n was synthesized by the standard decarboxylative olefin insertion reaction from
vinyl oxazinanone. The colorless crystal was formed in a solvent mixture of
dichloromethane and hexane.
Crystal Structure Data:
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Comments   
The asymmetric unit contains one crystallographically-independent C28H25N3O2S
molecule. All thermal vibration ellipsoids are drawn at the 50% probability level.
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Brief Experimental Description to be Included as Text or as a Footnote at Time
of Publication
Colorless crystals of C28H25N3O2S are, at 100(2) K, monoclinic, space group P21/c –
C2h
5 (No. 14)2 with a = 12.781(1) Å, b  = 14.997(1) Å, c = 13.507(1) Å, β =
114.749(1)°, V = 2351.1(2) Å3 and Z = 4 molecules {dcalcd = 1.321 g/cm
3; µa(MoKα)
= 0.169 mm-1}. A full hemisphere of diffracted intensities (1850 10-second frames
with an ω scan width of 0.30°) was measured for a single-domain specimen using
graphite-monochromated  MoK_ radiation (λ = 0.71073 Å) on a Bruker SMART
APEX CCD Single Crystal Diffraction System.3 X-rays were provided by a fine-
focus sealed x-ray tube operated at 50kV and 30mA.  Lattice constants were
determined with the Bruker SAINT software package using peak centers for 3098
reflections. A total of 28640 integrated reflection intensities having 2θ((MoKα)<
61.07° were produced using the Bruker program SAINT;4 7181 of these were unique
and gave Rint = 0.069 with a coverage which was 99.8% complete. The data were
corrected empirically for variable absorption effects using 893 equivalent reflections;
the relative transmission factors ranged from 0.951 to 1.000. The Bruker software
package SHELXTL Version 6.10 was used to solve the structure using “direct
methods” techniques. All stages of weighted full-matrix least-squares refinement
were conducted using Fo
2 data with the SHELXTL software package.5 All hydrogen
atoms were located from difference Fourier syntheses and included in the structural
model as individual isotropic atoms whose parameters were allowed to vary in least-
squares refinement cycles.
The final structural model incorporated anisotropic thermal parameters for all
nonhydrogen atoms and isotropic thermal parameters for all hydrogen atoms. A total
of 407 parameters were refined using no restraints, 7181 data and weights of w =
1/[σ
2
(F
2
) + (0.0302 P)
2
], where P = [Fo
2
 + 2Fc
2
] / 3. Final agreement factors at
convergence are: R1(unweighted, based on F) = 0.049 for 4498 independent
absorption-corrected reflections having 2θ(MoKα )< 61.07° and I>2σ (I);
R1(unweighted, based on F) = 0.086 and wR2(weighted, based on F
2) = 0.091 for all
7181 independent absorption-corrected reflections having 2θ(MoKα)< 61.07°. The
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largest shift/s.u. was 0.000 in the final refinement cycle. The final difference map had
maxima and minima of 0.46 and -0.46 e-/Å
3
, respectively.
Table 1.  Crystal Data and Structure Refinement for C28H25N3O2S.
Empirical formula C28H25N3O2S
Formula weight 467.57
Temperature 100(2) K
Wavelength 0.71073 Å
Crystal system Monoclinic
Space group P21/c – C2h
5 (No. 14)
Unit cell dimensions a = 12.7805(7) Å α = 90.000°
b = 14.9966(9) Å _ =
114.749(1)°
c = 13.5072(8) Å γ = 90.000°
Volume 2351.1(2) Å
3
Z 4
Density (calculated) 1.321 Mg/m
3
Absorption coefficient 0.169 mm
-1
F(000) 984
Crystal size 0.28 x 0.24 x 0.08 mm
3
Theta range for data collection 2.72° to 30.54°
Index ranges -18 ≤ h ≤ 18, -21 ≤ k ≤ 21, -19 ≤ l ≤19
Reflections collected 28640
Independent reflections 7181 [Rint = 0.069]
Completeness to theta = 30.54° 99.8 %
Absorption correction Empirical
Max. and min. transmission 0.728 and 0.692
Refinement method Full-matrix least-squares on F
2
Data / restraints / parameters 7181 / 0 / 407
Goodness-of-fit on F
2
0.852
Final R indices [I>2sigma(I)] R1 = 0.049, wR2 = 0.083
R indices (all data) R1 = 0.086, wR2 = 0.091
Largest diff. peak and hole 0.459 and -0.464 e-/Å
3
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----------
R1 = ||Fo| - |Fc|| / |Fo|
wR2 = { [w(Fo2 - Fc2)2] /  [w(Fo 2)2] }1/2
Table 2. Atomic coordinates (x 10
4
) and equivalent isotropic displacement parameters
(Å
2
x 10
3
) for C28H25N3O2S. U (eq) is defined as one third of the trace of the
orthogonalized Uij tensor.
_____________________________________________________________________
x y z U(eq)
_____________________________________________________________________
S 2742(1) 1008(1) 5313(1) 18(1)
O(1) 3440(1) 1777(1) 5758(1) 22(1)
O(2) 2597(1) 369(1) 6034(1) 22(1)
N(1) 1399(1) 1345(1) 4486(1) 16(1)
N(2) -869(1) 3066(1) 4150(1) 26(1)
N(3) -206(1) 3343(1) 1382(1) 23(1)
C(1) 650(1) 539(1) 4065(1) 19(1)
C(2) -598(1) 779(1) 3421(1) 18(1)
C(3) -801(1) 1371(1) 2434(1) 15(1)
C(4) -28(1) 2226(1) 2940(1) 15(1)
C(5) 1294(1) 1981(1) 3607(1) 16(1)
C(6) -374(1) 953(1) 1641(1) 18(1)
C(7) -257(2) 100(1) 1501(2) 25(1)
C(8) -481(1) 2700(1) 3644(1) 18(1)
C(9) -119(1) 2860(1) 2062(1) 16(1)
C(11) 1982(1) 2836(1) 3983(1) 17(1)
C(12) 2045(1) 3302(1) 4898(1) 20(1)
C(13) 2616(1) 4111(1) 5173(2) 24(1)
C(14) 3117(1) 4469(1) 4530(2) 25(1)
C(15) 3050(1) 4021(1) 3617(1) 24(1)
C(16) 2493(1) 3201(1) 3347(1) 20(1)
C(21) -2079(1) 1627(1) 1817(1) 17(1)
C(22) -2862(2) 1516(1) 2275(2) 24(1)
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C(23) -4019(2) 1715(1) 1691(2) 29(1)
C(24) -4426(2) 2027(1) 637(2) 26(1)
C(25) -3662(2) 2145(1) 168(2) 24(1)
C(26) -2503(1) 1944(1) 746(1) 20(1)
C(31) 3253(1) 450(1) 4459(1) 17(1)
C(32) 3877(2) 911(1) 4004(1) 23(1)
C(33) 4207(2) 480(1) 3271(2) 27(1)
C(34) 3896(1) -395(1) 2963(1) 24(1)
C(35) 3271(2) -850(1) 3436(1) 24(1)
C(36) 2961(1) -443(1) 4190(1) 21(1)
C(37) 4219(2) -854(2) 2144(2) 34(1)
Table 3. Bond lengths [Å] for C28H25N3O2S.
_____________________________________________________________________
S-O(1) 1.4280(11)
S-O(2) 1.4326(11)
S-N(1) 1.6866(13)
S-C(31) 1.7563(16)
N(1)-C(5) 1.4838(19)
N(1)-C(1) 1.499(2)
N(2)-C(8) 1.1404(19)
N(3)-C(9) 1.1391(19)
C(1)-C(2) 1.506(2)
C(1)-H(1A) 0.966(16)
C(1)-H(1B) 0.954(16)
C(2)-C(3) 1.531(2)
C(2)-H(2A) 0.973(16)
C(2)-H(2B) 0.952(15)
C(3)-C(6) 1.526(2)
C(3)-C(21) 1.539(2)
C(3)-C(4) 1.588(2)
C(4)-C(8) 1.485(2)
C(4)-C(9) 1.486(2)
C(4)-C(5) 1.589(2)
C(5)-C(11) 1.517(2)
C(5)-H(5) 0.975(15)
C(6)-C(7) 1.312(2)
C(6)-H(6) 0.938(16)
C(7)-H(7A) 0.994(17)
C(7)-H(7B) 0.995(17)
C(11)-C(16) 1.391(2)
C(11)-C(12) 1.392(2)
C(12)-C(13) 1.385(2)
C(12)-H(12) 0.941(15)
C(13)-C(14) 1.384(2)
C(13)-H(13) 0.978(16)
C(14)-C(15) 1.376(2)
C(14)-H(14) 0.912(17)
C(15)-C(16) 1.391(2)
C(15)-H(15) 0.924(16)
C(16)-H(16) 0.953(16)
C(21)-C(22) 1.390(2)
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C(21)-C(26) 1.399(2)
C(22)-C(23) 1.386(2)
C(22)-H(22) 0.947(16)
C(23)-C(24) 1.377(3)
C(23)-H(23) 0.933(17)
C(24)-C(25) 1.381(2)
C(24)-H(24) 0.963(16)
C(25)-C(26) 1.388(2)
C(25)-H(25) 0.956(17)
C(26)-H(26) 0.951(15)
C(31)-C(32) 1.380(2)
C(31)-C(36) 1.396(2)
C(32)-C(33) 1.387(2)
C(32)-H(32) 0.922(16)
C(33)-C(34) 1.383(2)
C(33)-H(33) 0.925(17)
C(34)-C(35) 1.393(2)
C(34)-C(37) 1.501(2)
C(35)-C(36) 1.380(2)
C(35)-H(35) 0.945(17)
C(36)-H(36) 0.968(16)
C(37)-H(37A) 0.990(19)
C(37)-H(37B) 0.997(19)
C(37)-H(37C) 0.98(2)
_____________________________________________________________________
Table 4. Bond angles [°] for C28H25N3O2S.
_____________________________________________________________________
O(1)-S-O(2) 119.31(7)
O(1)-S-N(1) 108.61(6)
O(2)-S-N(1) 105.37(7)
O(1)-S-C(31) 108.86(7)
O(2)-S-C(31) 108.53(7)
N(1)-S-C(31) 105.26(7)
C(5)-N(1)-C(1) 112.65(12)
C(5)-N(1)-S 116.68(10)
C(1)-N(1)-S 108.69(10)
N(1)-C(1)-C(2) 112.31(13)
N(1)-C(1)-H(1A) 111.5(10)
C(2)-C(1)-H(1A) 109.2(10)
N(1)-C(1)-H(1B) 104.4(10)
C(2)-C(1)-H(1B) 110.5(10)
H(1A)-C(1)-H(1B) 108.9(13)
C(1)-C(2)-C(3) 113.20(14)
C(1)-C(2)-H(2A) 109.3(9)
C(3)-C(2)-H(2A) 108.1(9)
C(1)-C(2)-H(2B) 108.5(9)
C(3)-C(2)-H(2B) 109.8(9)
H(2A)-C(2)-H(2B) 107.8(13)
C(6)-C(3)-C(2) 113.13(13)
C(6)-C(3)-C(21) 109.44(12)
C(2)-C(3)-C(21) 111.76(13)
C(6)-C(3)-C(4) 107.01(12)
C(2)-C(3)-C(4) 104.18(12)
C(21)-C(3)-C(4) 111.13(12)
C(8)-C(4)-C(9) 106.43(13)
C(8)-C(4)-C(3) 108.83(12)
C(9)-C(4)-C(3) 110.23(12)
C(8)-C(4)-C(5) 110.78(12)
C(9)-C(4)-C(5) 108.08(12)
C(3)-C(4)-C(5) 112.33(12)
N(1)-C(5)-C(11) 115.41(13)
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N(1)-C(5)-C(4) 108.73(12)
C(11)-C(5)-C(4) 108.88(12)
N(1)-C(5)-H(5) 110.3(9)
C(11)-C(5)-H(5) 109.1(9)
C(4)-C(5)-H(5) 103.7(9)
C(7)-C(6)-C(3) 126.76(17)
C(7)-C(6)-H(6) 117.2(10)
C(3)-C(6)-H(6) 116.1(10)
C(6)-C(7)-H(7A) 120.8(10)
C(6)-C(7)-H(7B) 119.2(10)
H(7A)-C(7)-H(7B) 120.0(14)
N(2)-C(8)-C(4) 177.36(17)
N(3)-C(9)-C(4) 178.99(17)
C(16)-C(11)-C(12) 118.89(15)
C(16)-C(11)-C(5) 118.79(15)
C(12)-C(11)-C(5) 122.13(15)
C(13)-C(12)-C(11) 120.40(17)
C(13)-C(12)-H(12) 120.5(10)
C(11)-C(12)-H(12) 119.1(10)
C(14)-C(13)-C(12) 120.14(17)
C(14)-C(13)-H(13) 122.5(10)
C(12)-C(13)-H(13) 117.3(10)
C(15)-C(14)-C(13) 120.11(17)
C(15)-C(14)-H(14) 119.6(11)
C(13)-C(14)-H(14) 120.2(11)
C(14)-C(15)-C(16) 119.96(17)
C(14)-C(15)-H(15) 121.5(10)
C(16)-C(15)-H(15) 118.5(10)
C(15)-C(16)-C(11) 120.48(17)
C(15)-C(16)-H(16) 119.8(9)
C(11)-C(16)-H(16) 119.8(9)
C(22)-C(21)-C(26) 117.52(15)
C(22)-C(21)-C(3) 121.86(14)
C(26)-C(21)-C(3) 120.56(14)
C(23)-C(22)-C(21) 121.12(17)
C(23)-C(22)-H(22) 117.2(10)
C(21)-C(22)-H(22) 121.6(10)
C(24)-C(23)-C(22) 120.81(18)
C(24)-C(23)-H(23) 117.9(11)
C(22)-C(23)-H(23) 121.3(11)
C(23)-C(24)-C(25) 119.00(17)
C(23)-C(24)-H(24) 119.2(10)
C(25)-C(24)-H(24) 121.8(10)
C(24)-C(25)-C(26) 120.52(17)
C(24)-C(25)-H(25) 122.2(10)
C(26)-C(25)-H(25) 117.2(10)
C(25)-C(26)-C(21) 121.04(17)
C(25)-C(26)-H(26) 119.1(9)
C(21)-C(26)-H(26) 119.8(9)
C(32)-C(31)-C(36) 120.34(16)
C(32)-C(31)-S 119.82(13)
C(36)-C(31)-S 119.72(13)
C(31)-C(32)-C(33) 119.38(17)
C(31)-C(32)-H(32) 119.7(10)
C(33)-C(32)-H(32) 120.9(10)
C(34)-C(33)-C(32) 121.40(17)
C(34)-C(33)-H(33) 118.9(11)
C(32)-C(33)-H(33) 119.6(11)
C(33)-C(34)-C(35) 118.36(16)
C(33)-C(34)-C(37) 121.60(17)
C(35)-C(34)-C(37) 120.04(17)
C(36)-C(35)-C(34) 121.21(17)
C(36)-C(35)-H(35) 120.9(10)
C(34)-C(35)-H(35) 117.9(10)
C(35)-C(36)-C(31) 119.25(16)
C(35)-C(36)-H(36) 119.1(9)
C(31)-C(36)-H(36) 121.6(9)
C(34)-C(37)-H(37A) 108.1(11)
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C(34)-C(37)-H(37B) 113.0(11)
H(37A)-C(37)-H(37B) 106.3(15)
C(34)-C(37)-H(37C) 111.6(12)
H(37A)-C(37)-H(37C) 109.8(16)
H(37B)-C(37)-H(37C) 107.8(16)
_____________________________________________________________________
Table 5. Anisotropic displacement parameters (Å
2
x 10
3
) for C28H25N3O2S. The
anisotropic displacement factor exponent takes the form:  -2π
2
[h2 a*
2
U11 + ...  + 2 h k
a* b* U12]
_____________________________________________________________________
U11 U22 U33 U23 U13 U12
_____________________________________________________________________
S 16(1) 20(1) 14(1) 1(1) 4(1) 0(1)
O(1) 20(1) 23(1) 18(1) -3(1) 1(1) -2(1)
O(2) 23(1) 26(1) 15(1) 7(1) 6(1) 1(1)
N(1) 13(1) 18(1) 14(1) 3(1) 2(1) -1(1)
N(2) 26(1) 29(1) 24(1) -3(1) 12(1) -1(1)
N(3) 25(1) 21(1) 21(1) 1(1) 8(1) -1(1)
C(1) 20(1) 17(1) 19(1) 4(1) 5(1) -2(1)
C(2) 17(1) 16(1) 18(1) 3(1) 6(1) -1(1)
C(3) 15(1) 14(1) 16(1) 0(1) 6(1) -2(1)
C(4) 16(1) 16(1) 13(1) 1(1) 5(1) 0(1)
C(5) 16(1) 18(1) 14(1) 0(1) 6(1) -1(1)
C(6) 16(1) 20(1) 17(1) -1(1) 5(1) 0(1)
C(7) 27(1) 24(1) 22(1) -1(1) 8(1) 0(1)
C(8) 17(1) 18(1) 16(1) 1(1) 5(1) -2(1)
C(9) 15(1) 16(1) 16(1) -4(1) 5(1) -1(1)
C(11) 14(1) 16(1) 16(1) 2(1) 3(1) 0(1)
C(12) 19(1) 21(1) 17(1) 2(1) 5(1) 1(1)
C(13) 22(1) 22(1) 23(1) -3(1) 3(1) 0(1)
C(14) 19(1) 17(1) 29(1) 2(1) 0(1) -3(1)
C(15) 16(1) 26(1) 24(1) 8(1) 4(1) -4(1)
C(16) 16(1) 24(1) 16(1) 2(1) 4(1) -1(1)
C(21) 15(1) 14(1) 19(1) -1(1) 5(1) -1(1)
C(22) 22(1) 25(1) 26(1) 6(1) 10(1) -2(1)
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C(23) 18(1) 29(1) 42(1) 7(1) 15(1) -2(1)
C(24) 15(1) 18(1) 36(1) 1(1) 3(1) 1(1)
C(25) 25(1) 20(1) 19(1) -2(1) 1(1) 2(1)
C(26) 22(1) 18(1) 19(1) -3(1) 7(1) 1(1)
C(31) 15(1) 21(1) 14(1) 1(1) 4(1) 2(1)
C(32) 23(1) 21(1) 25(1) -1(1) 9(1) -3(1)
C(33) 27(1) 31(1) 26(1) 4(1) 16(1) 0(1)
C(34) 23(1) 29(1) 16(1) 3(1) 4(1) 10(1)
C(35) 23(1) 19(1) 24(1) 0(1) 5(1) 4(1)
C(36) 19(1) 20(1) 23(1) 4(1) 8(1) 1(1)
C(37) 38(1) 39(1) 25(1) 2(1) 13(1) 16(1)
Table 6. Hydrogen coordinates (x 10
4
) and isotropic displacement parameters (Å
2
x
10
3
) for C28H25N3O2S.
_____________________________________________________________________
x y z U(eq)
_____________________________________________________________________
H(1A) 905(14) 173(11) 3619(13) 25(5)
H(1B) 747(14) 213(10) 4704(13) 22(5)
H(2A) -879(13) 1095(10) 3891(13) 22(5)
H(2B) -1031(13) 243(10) 3189(12) 16(4)
H(5) 1501(13) 1690(10) 3069(13) 18(4)
H(6) -176(13) 1352(10) 1212(13) 19(5)
H(7A) -426(14) -354(11) 1950(14) 31(5)
H(7B) 23(15) -92(11) 948(14) 35(5)
H(12) 1694(13) 3059(10) 5327(13) 20(5)
H(13) 2661(14) 4402(11) 5838(14) 26(5)
H(14) 3459(15) 5017(11) 4689(14) 28(5)
H(15) 3378(14) 4248(11) 3177(13) 24(5)
H(16) 2466(13) 2885(10) 2725(13) 19(4)
H(22) -2632(13) 1294(10) 2993(13) 18(4)
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H(23) -4549(15) 1633(11) 1994(14) 33(5)
H(24) -5235(14) 2154(10) 246(13) 24(5)
H(25) -3902(14) 2352(11) -564(14) 28(5)
H(26) -1995(13) 2015(10) 400(12) 16(4)
H(32) 4056(14) 1502(11) 4179(13) 22(5)
H(33) 4624(15) 787(11) 2963(14) 33(5)
H(35) 3078(14) -1452(11) 3236(14) 28(5)
H(36) 2528(13) -779(10) 4504(13) 22(5)
H(37A) 4661(16) -427(13) 1908(15) 42(6)
H(37B) 4731(16) -1379(12) 2451(15) 39(6)
H(37C) 3536(18) -1058(13) 1510(18) 59(7)
_____________________________________________________________________
Table 7. Torsion angles [°] for C28H25N3O2S.
_____________________________________________________________________
O(1)-S-N(1)-C(5) 54.31(12)
O(2)-S-N(1)-C(5) -176.76(11)
C(31)-S-N(1)-C(5) -62.14(12)
O(1)-S-N(1)-C(1) -177.01(10)
O(2)-S-N(1)-C(1) -48.09(12)
C(31)-S-N(1)-C(1) 66.53(12)
C(5)-N(1)-C(1)-C(2) -55.70(18)
S-N(1)-C(1)-C(2) 173.41(12)
N(1)-C(1)-C(2)-C(3) 58.95(19)
C(1)-C(2)-C(3)-C(6) 57.68(18)
C(1)-C(2)-C(3)-C(21) -178.25(13)
C(1)-C(2)-C(3)-C(4) -58.17(17)
C(6)-C(3)-C(4)-C(8) 175.03(12)
C(2)-C(3)-C(4)-C(8) -64.91(15)
C(21)-C(3)-C(4)-C(8) 55.60(16)
C(6)-C(3)-C(4)-C(9) 58.66(16)
C(2)-C(3)-C(4)-C(9) 178.72(13)
C(21)-C(3)-C(4)-C(9) -60.77(16)
C(6)-C(3)-C(4)-C(5) -61.93(15)
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C(2)-C(3)-C(4)-C(5) 58.13(16)
C(21)-C(3)-C(4)-C(5) 178.64(12)
C(1)-N(1)-C(5)-C(11) 176.90(13)
S-N(1)-C(5)-C(11) -56.36(16)
C(1)-N(1)-C(5)-C(4) 54.25(16)
S-N(1)-C(5)-C(4) -179.00(10)
C(8)-C(4)-C(5)-N(1) 63.94(16)
C(9)-C(4)-C(5)-N(1) -179.82(12)
C(3)-C(4)-C(5)-N(1) -58.00(16)
C(8)-C(4)-C(5)-C(11) -62.56(16)
C(9)-C(4)-C(5)-C(11) 53.68(16)
C(3)-C(4)-C(5)-C(11) 175.50(12)
C(2)-C(3)-C(6)-C(7) 25.8(2)
C(21)-C(3)-C(6)-C(7) -99.52(19)
C(4)-C(3)-C(6)-C(7) 139.97(17)
C(9)-C(4)-C(8)-N(2) 62(4)
C(3)-C(4)-C(8)-N(2) -57(4)
C(5)-C(4)-C(8)-N(2) 179(100)
C(8)-C(4)-C(9)-N(3) -76(10)
C(3)-C(4)-C(9)-N(3) 42(10)
C(5)-C(4)-C(9)-N(3) 165(10)
N(1)-C(5)-C(11)-C(16) 142.92(14)
C(4)-C(5)-C(11)-C(16) -94.52(17)
N(1)-C(5)-C(11)-C(12) -42.1(2)
C(4)-C(5)-C(11)-C(12) 80.51(18)
C(16)-C(11)-C(12)-C(13) -0.6(2)
C(5)-C(11)-C(12)-C(13) -175.58(15)
C(11)-C(12)-C(13)-C(14) 0.8(2)
C(12)-C(13)-C(14)-C(15) -0.1(3)
C(13)-C(14)-C(15)-C(16) -0.9(3)
C(14)-C(15)-C(16)-C(11) 1.2(2)
C(12)-C(11)-C(16)-C(15) -0.5(2)
C(5)-C(11)-C(16)-C(15) 174.74(14)
C(6)-C(3)-C(21)-C(22) 141.14(16)
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C(2)-C(3)-C(21)-C(22) 15.0(2)
C(4)-C(3)-C(21)-C(22) -100.89(17)
C(6)-C(3)-C(21)-C(26) -35.88(19)
C(2)-C(3)-C(21)-C(26) -161.99(14)
C(4)-C(3)-C(21)-C(26) 82.09(17)
C(26)-C(21)-C(22)-C(23) -0.2(3)
C(3)-C(21)-C(22)-C(23) -177.29(16)
C(21)-C(22)-C(23)-C(24) 0.2(3)
C(22)-C(23)-C(24)-C(25) -0.4(3)
C(23)-C(24)-C(25)-C(26) 0.6(3)
C(24)-C(25)-C(26)-C(21) -0.7(3)
C(22)-C(21)-C(26)-C(25) 0.4(2)
C(3)-C(21)-C(26)-C(25) 177.59(14)
O(1)-S-C(31)-C(32) -23.44(15)
O(2)-S-C(31)-C(32) -154.76(12)
N(1)-S-C(31)-C(32) 92.84(14)
O(1)-S-C(31)-C(36) 160.70(12)
O(2)-S-C(31)-C(36) 29.39(15)
N(1)-S-C(31)-C(36) -83.02(14)
C(36)-C(31)-C(32)-C(33) 0.3(2)
S-C(31)-C(32)-C(33) -175.49(13)
C(31)-C(32)-C(33)-C(34) 1.8(3)
C(32)-C(33)-C(34)-C(35) -2.1(3)
C(32)-C(33)-C(34)-C(37) 178.02(17)
C(33)-C(34)-C(35)-C(36) 0.2(2)
C(37)-C(34)-C(35)-C(36) -179.90(16)
C(34)-C(35)-C(36)-C(31) 1.9(2)
C(32)-C(31)-C(36)-C(35) -2.2(2)
S-C(31)-C(36)-C(35) 173.67(12)
_____________________________________________________________________
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N Ph
Ts
CN
CN
33a (cw3194)
33a was synthesized by the standard asymmetric decarboxylative cycloaddition
reaction from benzoxazinanone. The colorless crystal was formed in ethanol.
Crystal Structure Data:
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Comments
The asymmetric unit contains one C26H21N3O2S molecule.  All displacement
ellipsoids are drawn at the 50% probability level.
Brief Experimental Description to be Included as Text or as a Footnote at Time
of Publication
Colorless crystals of C26H21N3O2S are, at 100(2) K, orthorhombic, space
group P212121 – D2
4 (No. 19)2 with a = 8.4257(6) Å, b = 8.7925(6) Å, c = 30.075(2)
Å, V = 2228.1(3) Å3 and Z = 4 molecules {dcalcd = 1.310 g/cm
3; µa(MoKα) = 0.174
mm-1}. A full hemisphere of diffracted intensities (1850 10-second frames with a ω
scan width of 0.30°) was measured for a single-domain specimen using graphite-
monochromated MoKα radiation (λ= 0.71073 Å) on a Bruker SMART APEX CCD
Single Crystal Diffraction System.3 X-rays were provided by a fine-focus sealed x-ray
tube operated at 50kV and 30mA. Lattice constants were determined with the Bruker
SAINT software package using peak centers for 9106 reflections.  A total of 26648
integrated reflection intensities having 2θ((MoKα) < 60.07° were produced using the
Bruker program SAINT;4 6483 of these were unique and gave Rint = 0.044 with a
coverage which was 99.8% complete. The data were corrected empirically for
variable absorption effects using equivalent reflections; the relative transmission
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factors ranged from 0.902 to 1.000. The Bruker software package SHELXTL was
used to solve the structure using “direct methods” techniques. All stages of weighted
full-matrix least-squares refinement were conducted using Fo
2 data with the
SHELXTL Version 6.10 software package.5
The final structural model incorporated anisotropic thermal parameters for all
nonhydrogen atoms and isotropic thermal parameters for all hydrogen atoms. All
hydrogen atoms were located in a difference Fourier and included in the structural
model as independent isotropic atoms whose parameters were allowed to vary in
least-squares refinement cycles. A total of 373 parameters were refined using no
restraints, 6483 data and weights of w = 1/ [σ
2
(F
2
) + (0.0545 P)
 2
], where P = [Fo
2
 +
2Fc
2
] / 3. Final agreement factors at convergence are:  R1(unweighted, based on F) =
0.042 for 6087 independent absorption-corrected “observed” reflections having
2θ(MoKα)<  60.07° and I>2σ(I); R1(unweighted, based on F) = 0.045 and
wR2(weighted, based on F
2) = 0.094 for all 6483 independent absorption-corrected
reflections having 2θ(MoKα)< 60.07°. The largest shift/s.u. was 0.000 in the final
refinement cycle. The final difference map had maxima and minima of 0.47 and -0.25
e-/Å
3
, respectively. The absolute configuration for the C26H21N3O2S molecule was
reliably determined experimentally using anomalous dispersion of the x-rays; the
“Flack” absolute structure parameter refined to a final value of 0.02(5).
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Table 1. Crystal data and structure refinement for C26H21N3O2S.
Empirical formula C26H21N3O2S
Formula weight 439.52
Temperature 100(2) K
Wavelength 0.71073 Å
Crystal system Orthorhombic
Space group P212121 – D2
4 (No. 19)
Unit cell dimensions a = 8.4257(6) Å α = 90.000°
b = 8.7925(6) Å β = 90.000°
c = 30.075(2) Å γ = 90.000°
Volume 2228.1(3) Å
3
Z 4
Density (calculated) 1.310 Mg/m
3
Absorption coefficient 0.174 mm
-1
F(000) 920
Crystal size 0.42 x 0.24 x 0.12 mm
3
Theta range for data collection 2.41° to 30.03°
Index ranges -11 ≤ h ≤ 11, -12 ≤ k ≤ 12, -42 ≤ l ≤ 41
Reflections collected 26648
Independent reflections 6483 [Rint = 0.044]
Completeness to theta = 30.03° 99.8 %
Absorption correction Semi-empirical from equivalents
Max. and min. transmission 1.000 and 0.902
Refinement method Full-matrix least-squares on F
2
Data / restraints / parameters 6483 / 0 / 373
Goodness-of-fit on F
2
1.048
Final R indices [I>2sigma(I)] R1 = 0.042, wR2 = 0.092
R indices (all data) R1 = 0.045, wR2 = 0.094
Absolute structure parameter 0.02(5)
Largest diff. peak and hole 0.47 and -0.25 e-/Å
3
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-------------------------------
R1 = Σ ||Fo| - |Fc|| / Σ |Fo|
wR2 = { Σ [w(Fo
2
 - Fc
2
)
2
] / Σ [w(Fo
2
)
2
] }
1/2
Table 2. Atomic coordinates (x 10
4
) and equivalent isotropic displacement parameters
(Å
2
x 10
3
) for C26H21N3O2S. U (eq) is defined as one third of the trace of the
orthogonalized Uij tensor.
_____________________________________________________________________
x y z U(eq)
_____________________________________________________________________
S 6959(1) 3949(1) 4246(1) 15(1)
O(1) 5703(1) 4755(1) 4462(1) 20(1)
O(2) 8462(1) 4661(1) 4171(1) 21(1)
N(1) 6253(1) 3479(1) 3744(1) 14(1)
N(2) 1931(2) 131(2) 3935(1) 30(1)
N(3) 3709(2) 1414(2) 2672(1) 26(1)
C(1) 4559(2) 3011(2) 3740(1) 14(1)
C(2) 4341(2) 1380(2) 3526(1) 16(1)
C(3) 5870(2) 391(2) 3609(1) 15(1)
C(4) 7227(2) 1193(2) 3380(1) 15(1)
C(5) 7347(2) 2762(2) 3443(1) 15(1)
C(6) 8525(2) 3606(2) 3237(1) 18(1)
C(7) 9653(2) 2864(2) 2979(1) 21(1)
C(8) 9568(2) 1299(2) 2922(1) 22(1)
C(9) 8340(2) 468(2) 3115(1) 20(1)
C(10) 3535(2) 4249(2) 3542(1) 15(1)
C(11) 3904(2) 4909(2) 3132(1) 17(1)
C(12) 3012(2) 6121(2) 2974(1) 20(1)
C(13) 1761(2) 6697(2) 3224(1) 22(1)
C(14) 1388(2) 6043(2) 3630(1) 21(1)
C(15) 2265(2) 4820(2) 3787(1) 18(1)
C(16) 2959(2) 670(2) 3745(1) 20(1)
C(17) 3995(2) 1426(2) 3043(1) 17(1)
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C(18) 5659(2) -1241(2) 3474(1) 20(1)
C(19) 5901(3) -2365(2) 3750(1) 34(1)
C(20) 7264(2) 2223(2) 4523(1) 16(1)
C(21) 6112(2) 1681(2) 4814(1) 18(1)
C(22) 6308(2) 249(2) 5005(1) 20(1)
C(23) 7627(2) -641(2) 4908(1) 19(1)
C(24) 8770(2) -74(2) 4614(1) 19(1)
C(25) 8603(2) 1348(2) 4422(1) 17(1)
C(26) 7843(2) -2181(2) 5118(1) 26(1)
Table 3. Bond lengths [Å] for C26H21N3O2S.
_____________________________________________________________________
S-O(2) 1.430(1)
S-O(1) 1.430(1)
S-N(1) 1.674(1)
S-C(20) 1.751(2)
N(1)-C(5) 1.438(2)
N(1)-C(1) 1.486(2)
N(2)-C(16) 1.140(2)
N(3)-C(17) 1.142(2)
C(1)-C(10) 1.511(2)
C(1)-C(2) 1.582(2)
C(1)-H(1) 0.95(2)
C(2)-C(16) 1.477(2)
C(2)-C(17) 1.483(2)
C(2)-C(3) 1.574(2)
C(3)-C(18) 1.502(2)
C(3)-C(4) 1.509(2)
C(3)-H(3) 0.96(2)
C(4)-C(9) 1.387(2)
C(4)-C(5) 1.396(2)
C(5)-C(6) 1.386(2)
C(6)-C(7) 1.389(2)
C(6)-H(6) 0.94(2)
C(7)-C(8) 1.389(3)
C(7)-H(7) 0.94(2)
C(8)-C(9) 1.393(2)
C(8)-H(8) 0.96(2)
C(9)-H(9) 0.93(2)
C(10)-C(15) 1.393(2)
C(10)-C(11) 1.399(2)
C(11)-C(12) 1.387(2)
C(11)-H(11) 1.00(2)
C(12)-C(13) 1.391(2)
C(12)-H(12) 0.94(2)
C(13)-C(14) 1.383(2)
C(13)-H(13) 0.92(2)
C(14)-C(15) 1.388(2)
C(14)-H(14) 0.91(2)
C(15)-H(15) 0.95(2)
C(18)-C(19) 1.306(2)
C(18)-H(18) 0.97(2)
C(19)-H(19A) 0.93(2)
C(19)-H(19B) 0.96(3)
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C(20)-C(21) 1.392(2)
C(20)-C(25) 1.399(2)
C(21)-C(22) 1.394(2)
C(21)-H(21) 0.93(2)
C(22)-C(23) 1.390(2)
C(22)-H(22) 0.96(2)
C(23)-C(24) 1.400(2)
C(23)-C(26) 1.504(2)
C(24)-C(25) 1.384(2)
C(24)-H(24) 1.00(2)
C(25)-H(25) 0.90(2)
C(26)-H(26A) 0.94(3)
C(26)-H(26B) 0.88(3)
C(26)-H(26C) 0.93(3)
_____________________________________________________________________
Table 4. Bond angles [°] for C26H21N3O2S.
_____________________________________________________________________
O(2)-S-O(1) 120.6(1)
O(2)-S-N(1) 106.4(1)
O(1)-S-N(1) 105.7(1)
O(2)-S-C(20) 108.9(1)
O(1)-S-C(20) 108.7(1)
N(1)-S-C(20) 105.5(1)
C(5)-N(1)-C(1) 119.3(1)
C(5)-N(1)-S 116.6(1)
C(1)-N(1)-S 114.7(1)
N(1)-C(1)-C(10) 110.7(1)
N(1)-C(1)-C(2) 111.5(1)
C(10)-C(1)-C(2) 115.3(1)
N(1)-C(1)-H(1) 105(1)
C(10)-C(1)-H(1) 109(1)
C(2)-C(1)-H(1) 105(1)
C(16)-C(2)-C(17) 107.1(1)
C(16)-C(2)-C(3) 110.0(1)
C(17)-C(2)-C(3) 109.3(1)
C(16)-C(2)-C(1) 107.0(1)
C(17)-C(2)-C(1) 113.3(1)
C(3)-C(2)-C(1) 110.0(1)
C(18)-C(3)-C(4) 114.5(1)
C(18)-C(3)-C(2) 112.9(1)
C(4)-C(3)-C(2) 106.9(1)
C(18)-C(3)-H(3) 109(1)
C(4)-C(3)-H(3) 111(1)
C(2)-C(3)-H(3) 103(1)
C(9)-C(4)-C(5) 118.9(1)
C(9)-C(4)-C(3) 124.1(1)
C(5)-C(4)-C(3) 117.1(1)
C(6)-C(5)-C(4) 121.4(1)
C(6)-C(5)-N(1) 120.4(1)
C(4)-C(5)-N(1) 118.2(1)
C(5)-C(6)-C(7) 119.2(2)
C(5)-C(6)-H(6) 120(1)
C(7)-C(6)-H(6) 121(1)
C(6)-C(7)-C(8) 120.0(2)
C(6)-C(7)-H(7) 120(1)
C(8)-C(7)-H(7) 120(1)
C(7)-C(8)-C(9) 120.4(2)
C(7)-C(8)-H(8) 119(1)
C(9)-C(8)-H(8) 121(1)
C(4)-C(9)-C(8) 120.1(2)
C(4)-C(9)-H(9) 119(1)
C(8)-C(9)-H(9) 121(1)
C(15)-C(10)-C(11) 119.2(1)
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C(15)-C(10)-C(1) 119.4(1)
C(11)-C(10)-C(1) 121.3(1)
C(12)-C(11)-C(10) 119.9(2)
C(12)-C(11)-H(11) 117(1)
C(10)-C(11)-H(11) 123(1)
C(11)-C(12)-C(13) 120.4(1)
C(11)-C(12)-H(12) 119(1)
C(13)-C(12)-H(12) 120(1)
C(14)-C(13)-C(12) 119.8(2)
C(14)-C(13)-H(13) 123(1)
C(12)-C(13)-H(13) 117(1)
C(13)-C(14)-C(15) 120.1(2)
C(13)-C(14)-H(14) 123(1)
C(15)-C(14)-H(14) 118(1)
C(14)-C(15)-C(10) 120.5(1)
C(14)-C(15)-H(15) 121(1)
C(10)-C(15)-H(15) 119(1)
N(2)-C(16)-C(2) 176.6(2)
N(3)-C(17)-C(2) 177.7(2)
C(19)-C(18)-C(3) 122.2(2)
C(19)-C(18)-H(18) 122(1)
C(3)-C(18)-H(18) 116(1)
C(18)-C(19)-H(19A) 122(1)
C(18)-C(19)-H(19B) 121(2)
H(19A)-C(19)-H(19B) 117(2)
C(21)-C(20)-C(25) 120.7(1)
C(21)-C(20)-S 119.6(1)
C(25)-C(20)-S 119.5(1)
C(20)-C(21)-C(22) 119.1(2)
C(20)-C(21)-H(21) 120(1)
C(22)-C(21)-H(21) 121(1)
C(23)-C(22)-C(21) 121.1(2)
C(23)-C(22)-H(22) 121(1)
C(21)-C(22)-H(22) 118(1)
C(22)-C(23)-C(24) 118.8(2)
C(22)-C(23)-C(26) 121.0(2)
C(24)-C(23)-C(26) 120.2(2)
C(25)-C(24)-C(23) 121.0(2)
C(25)-C(24)-H(24) 120(1)
C(23)-C(24)-H(24) 119(1)
C(24)-C(25)-C(20) 119.3(2)
C(24)-C(25)-H(25) 119(1)
C(20)-C(25)-H(25) 122(1)
C(23)-C(26)-H(26A) 111(2)
C(23)-C(26)-H(26B) 114(2)
H(26A)-C(26)-H(26B) 107(3)
C(23)-C(26)-H(26C) 114(2)
H(26A)-C(26)-H(26C) 103(2)
H(26B)-C(26)-H(26C) 107(3)
_____________________________________________________________________
Table 5. Anisotropic displacement parameters (Å
2
x 10
3
) for C26H21N3O2S. The
anisotropic displacement factor exponent takes the form:  -2π
2
[ h
2
 a*
2
U11 + ...  + 2 h k
a* b* U12 ]
_____________________________________________________________________
U11 U22 U33 U23 U13 U12
_____________________________________________________________________
S 15(1) 16(1) 15(1) -2(1) -2(1) -1(1)
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O(1) 22(1) 19(1) 21(1) -3(1) 0(1) 2(1)
O(2) 20(1) 21(1) 21(1) -1(1) -3(1) -5(1)
N(1) 12(1) 16(1) 14(1) -2(1) -1(1) -2(1)
N(2) 24(1) 26(1) 40(1) -1(1) 10(1) -4(1)
N(3) 20(1) 33(1) 25(1) -5(1) -1(1) 1(1)
C(1) 13(1) 16(1) 14(1) 0(1) 0(1) -2(1)
C(2) 13(1) 16(1) 17(1) -1(1) 1(1) -2(1)
C(3) 14(1) 16(1) 17(1) 1(1) 0(1) -1(1)
C(4) 12(1) 19(1) 16(1) 0(1) -2(1) -1(1)
C(5) 12(1) 20(1) 13(1) 0(1) -2(1) 1(1)
C(6) 15(1) 21(1) 17(1) 1(1) -2(1) -3(1)
C(7) 13(1) 33(1) 18(1) 2(1) 0(1) -5(1)
C(8) 14(1) 33(1) 19(1) -4(1) -1(1) 2(1)
C(9) 16(1) 21(1) 22(1) -3(1) -3(1) 3(1)
C(10) 13(1) 15(1) 17(1) -1(1) -1(1) -1(1)
C(11) 15(1) 20(1) 17(1) -1(1) 1(1) -2(1)
C(12) 18(1) 22(1) 21(1) 4(1) -3(1) -2(1)
C(13) 18(1) 19(1) 29(1) 1(1) -6(1) 0(1)
C(14) 15(1) 21(1) 28(1) -3(1) 1(1) 1(1)
C(15) 14(1) 20(1) 19(1) -1(1) 2(1) -3(1)
C(16) 17(1) 19(1) 24(1) -3(1) 1(1) -1(1)
C(17) 11(1) 18(1) 22(1) -2(1) 1(1) 0(1)
C(18) 19(1) 17(1) 24(1) -3(1) -2(1) -2(1)
C(19) 45(1) 18(1) 38(1) 1(1) -13(1) -4(1)
C(20) 16(1) 17(1) 14(1) -1(1) -3(1) 0(1)
C(21) 16(1) 24(1) 15(1) -1(1) 1(1) 1(1)
C(22) 20(1) 26(1) 15(1) 0(1) 2(1) -2(1)
C(23) 20(1) 20(1) 16(1) -1(1) -4(1) -2(1)
C(24) 15(1) 22(1) 19(1) -3(1) -3(1) 2(1)
C(25) 14(1) 21(1) 17(1) -1(1) -1(1) -1(1)
C(26) 28(1) 21(1) 30(1) 5(1) -2(1) 0(1)
_____________________________________________________________________
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Table 6. Hydrogen coordinates (x 10
4
) and isotropic displacement parameters (Å
2
x
10
3
) for C26H21N3O2S.
_____________________________________________________________________
x y z U(eq)
_____________________________________________________________________
H(1) 4294(19) 2884(19) 4043(5) 7(4)
H(3) 5990(20) 435(19) 3925(6) 11(4)
H(6) 8560(20) 4670(20) 3275(6) 22(5)
H(7) 10490(20) 3420(20) 2851(6) 24(5)
H(8) 10360(20) 800(20) 2747(6) 19(5)
H(9) 8270(20) -580(20) 3073(6) 21(5)
H(11) 4820(20) 4580(20) 2944(6) 16(4)
H(12) 3250(20) 6550(20) 2695(6) 24(5)
H(13) 1220(20) 7510(20) 3110(6) 17(4)
H(14) 550(20) 6360(20) 3796(6) 17(4)
H(15) 2040(20) 4380(20) 4069(7) 26(5)
H(18) 5340(20) -1420(20) 3169(6) 13(4)
H(19A) 5850(20) -3370(20) 3658(6) 27(5)
H(19B) 6180(30) -2180(30) 4054(8) 51(7)
H(21) 5210(30) 2260(30) 4871(6) 31(5)
H(22) 5520(20) -100(20) 5213(6) 29(5)
H(24) 9720(20) -710(20) 4546(6) 18(5)
H(25) 9340(20) 1680(20) 4228(7) 29(5)
H(26A) 7270(40) -2260(40) 5386(10) 81(10)
H(26B) 7540(40) -2940(40) 4948(11) 73(9)
H(26C) 8880(40) -2380(40) 5207(9) 77(10)
_____________________________________________________________________
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Table 7.  Torsion angles [°] for C26H21N3O2S.
________________________________________________________________
O(2)-S-N(1)-C(5) 45.5(1)
O(1)-S-N(1)-C(5) 174.9(1)
C(20)-S-N(1)-C(5) -70.1(1)
O(2)-S-N(1)-C(1) -168.1(1)
O(1)-S-N(1)-C(1) -38.7(1)
C(20)-S-N(1)-C(1) 76.3(1)
C(5)-N(1)-C(1)-C(10) -108.7(1)
S-N(1)-C(1)-C(10) 105.9(1)
C(5)-N(1)-C(1)-C(2) 21.0(2)
S-N(1)-C(1)-C(2) -124.4(1)
N(1)-C(1)-C(2)-C(16) 149.1(1)
C(10)-C(1)-C(2)-C(16) -83.7(2)
N(1)-C(1)-C(2)-C(17) -93.0(2)
C(10)-C(1)-C(2)-C(17) 34.2(2)
N(1)-C(1)-C(2)-C(3) 29.7(2)
C(10)-C(1)-C(2)-C(3) 156.9(1)
C(16)-C(2)-C(3)-C(18) 54.0(2)
C(17)-C(2)-C(3)-C(18) -63.4(2)
C(1)-C(2)-C(3)-C(18) 171.6(1)
C(16)-C(2)-C(3)-C(4) -179.4(1)
C(17)-C(2)-C(3)-C(4) 63.3(2)
C(1)-C(2)-C(3)-C(4) -61.7(1)
C(18)-C(3)-C(4)-C(9) -8.6(2)
C(2)-C(3)-C(4)-C(9) -134.3(1)
C(18)-C(3)-C(4)-C(5) 171.2(1)
C(2)-C(3)-C(4)-C(5) 45.5(2)
C(9)-C(4)-C(5)-C(6) 1.6(2)
C(3)-C(4)-C(5)-C(6) -178.1(1)
C(9)-C(4)-C(5)-N(1) -175.7(1)
C(3)-C(4)-C(5)-N(1) 4.6(2)
C(1)-N(1)-C(5)-C(6) 141.1(1)
S-N(1)-C(5)-C(6) -74.1(2)
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C(1)-N(1)-C(5)-C(4) -41.6(2)
S-N(1)-C(5)-C(4) 103.2(1)
C(4)-C(5)-C(6)-C(7) -3.0(2)
N(1)-C(5)-C(6)-C(7) 174.3(1)
C(5)-C(6)-C(7)-C(8) 1.6(2)
C(6)-C(7)-C(8)-C(9) 1.1(2)
C(5)-C(4)-C(9)-C(8) 1.1(2)
C(3)-C(4)-C(9)-C(8) -179.2(1)
C(7)-C(8)-C(9)-C(4) -2.5(2)
N(1)-C(1)-C(10)-C(15) -124.4(1)
C(2)-C(1)-C(10)-C(15) 108.0(2)
N(1)-C(1)-C(10)-C(11) 50.9(2)
C(2)-C(1)-C(10)-C(11) -76.7(2)
C(15)-C(10)-C(11)-C(12) 0.2(2)
C(1)-C(10)-C(11)-C(12) -175.1(1)
C(10)-C(11)-C(12)-C(13) 0.7(2)
C(11)-C(12)-C(13)-C(14) -1.0(2)
C(12)-C(13)-C(14)-C(15) 0.3(2)
C(13)-C(14)-C(15)-C(10) 0.6(2)
C(11)-C(10)-C(15)-C(14) -0.9(2)
C(1)-C(10)-C(15)-C(14) 174.5(1)
C(17)-C(2)-C(16)-N(2) 180(100)
C(3)-C(2)-C(16)-N(2) 61(3)
C(1)-C(2)-C(16)-N(2) -59(3)
C(16)-C(2)-C(17)-N(3) -43(4)
C(3)-C(2)-C(17)-N(3) 77(4)
C(1)-C(2)-C(17)-N(3) -160(4)
C(4)-C(3)-C(18)-C(19) 113.2(2)
C(2)-C(3)-C(18)-C(19) -124.3(2)
O(2)-S-C(20)-C(21) 149.1(1)
O(1)-S-C(20)-C(21) 15.9(1)
N(1)-S-C(20)-C(21) -97.1(1)
O(2)-S-C(20)-C(25) -36.0(1)
O(1)-S-C(20)-C(25) -169.2(1)
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N(1)-S-C(20)-C(25) 77.9(1)
C(25)-C(20)-C(21)-C(22) -0.1(2)
S-C(20)-C(21)-C(22) 174.8(1)
C(20)-C(21)-C(22)-C(23) -0.2(2)
C(21)-C(22)-C(23)-C(24) 0.1(2)
C(21)-C(22)-C(23)-C(26) 179.4(2)
C(22)-C(23)-C(24)-C(25) 0.2(2)
C(26)-C(23)-C(24)-C(25) -179.1(2)
C(23)-C(24)-C(25)-C(20) -0.5(2)
C(21)-C(20)-C(25)-C(24) 0.4(2)
S-C(20)-C(25)-C(24) -174.5(1)
________________________________________________________________
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Chapter 4 
 
Selenocatalytic α-Halogenation 
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4.1 Importance of Catalytic α-Halogenation of Carbonyl Compounds 
Halogenation reactions have drawn a lot of attention and been extensively studied. 
The reason partially resides in the fact that a large amount of halogenated natural 
products, isolated from terrestrial and marine organisms displayed interesting 
biological and pharmaceutical activities as shown in Scheme 1. For instance, 
thyrsiferyl acetate 1a is known to inhibit protein phosphatase and halomon 1b 
displays antitumor and cytotoxic activities.1-3 Mailione 1c showed interesting 
anthelminthic properties and furanones 1d exhibits anti-fouling properties.4-6  
Cyclized sesquiterpenes 1e, 1f and acetogenins 1g display broad spectrum 
antimicrobial and antiviral activity.7 Halogens are known to be the bioisosteres of a 
wide variety of atoms such as hydrogen and carbon.8 Introducing halogens into the 
drug candidate can potentially enhance both the activity and bioavailability, for 
example chlorination improves the lipophilicity of the medicine. 
Scheme 1 Halogenated marine natural products 
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Secondly, halogenated products are important synthetic intermediates for further 
manipulations, and this trend has been further magnified by those discoveries of 
transition metal-catalyzed coupling reactions such as Suzuki, Stille, Heck, 
Sonogashira etc.9-12 
Traditionally, α-halogenation of carbonyl compounds uses reagents such as HOX 
or X2, which often exhibit poor chemoselectivity and competing side reactions such 
as dihalogenation.13, 14 Catalytic α-halogenation has been introduced into this scenario 
to address such a problem and received much attention lately due to the importance of 
the products as synthetic precursors and pharmaceuticals.15 The majority of these 
methods focus on the catalytic activation of the carbonyl substrate by formation of 
enolates as shown in Scheme 2. α-Halogenations of β-ketoesters 2a with 
N-halosuccinimide were carried out under mild conditions in the presence of a Lewis 
acid catalyst Mg(ClO4)2.16 Enantiomerically enriched products 2f were produced in 
62-90% ee by treatment of β-ketoesters 2d with a fluorination reagent 2d catalyzed by 
a chiral Lewis acid complex 2g.17 Lectka et al. reported a novel catalyst system for 
asymmetric chlorination and bromination. A chiral benzoylquinine catalyst functioned 
as a nucleophile to react with ketenes 2i to give acylammonium enolates, which were 
then halogenated to generate products 2k in decent yield and excellent 
eantioselectivities.18 However, those transformations have drawbacks in terms of 
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substrate scope and reaction yield. For example, in the first two cases, the 
α-substituents of β-ketoesters 2a and 2d are necessary in order to avoid the formation 
of dihalogenated products. The yields of the third reaction were hampered by a 
homodimerization side reactions. 
Scheme 2 Catalytic α-halogenation via enolate intermediates 
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 Catalytic activation of the carbonyl substrate by formation of enamines is shown 
in Scheme 3. Enantiopure amines 3d and 3h were used to catalyze the formation of 
enamine intermediates, followed by chlorination to generate products 3c and 3g in 
good eantioselectivities.8, 19 Alternatively, the catalytic formation of X2 (X = Cl, Br, I) 
from H2O2/NaX,20 or N-halosuccinimides has been a successful approach.21 However, 
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in order to control the selectivity of halogenation, one would like to utilize a catalyst 
that halogenates ketones through reagent-bound halogens rather than freely diffusing 
oxidized halogen species. 
Scheme 3 Catalytic α-halogenation via enamine intermediates 
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4.2 Selenium-Catalyzed Halogenation of Carbonyl Compounds 
Recently, we described the use of phenylselenium chloride as a catalyst for allylic 
halogenation of olefins with N-chlorosuccinimide (NCS) 4b as shown in Scheme 4.22 
In the course of these studies we noted that the reaction was inhibited by NCS. To 
explain the observed inhibition we postulated that the phenylselenyl chloride catalyst 
was in equilibrium with the oxidized PhSe(succinimide)Cl2 4d.23 While 
PhSe(succinimide)Cl2 4d was less active for allylic halogenation, it is known that the 
related PhSeCl3 α-halogenates ketones.24 Therefore we thought that 4d might be a 
useful catalyst for the α-halogenation of ketones with NCS. 
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Scheme 4 Selenocatalytic allylic chlorinations 
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In order to test whether arylselenides can activate NCS toward nucleophilic 
attack, 2-carboxethoxycyclohexanone 5a was treated with 5 mol% PhSeCl and 1.1 
equiv. NCS in CH3CN (Scheme 5). Analysis of the reaction mixture after 10 min. at 
room temperature showed complete conversion to the α-chloro product 6a. A control 
reaction run in the absence of PhSeCl showed < 1% reaction. 
Scheme 5 Catalytic α–chlorination of a β-ketoester 
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We envisioned several possible mechanisms for product formation as shown in 
Scheme 6. First, the β-ketoester could be α-selenylated by PhSeCl to afford 7a.25, 26 
Oxidation of 7a by NCS would give 7b which could reductively eliminate the 
halogenated product (Mechanism A).27 Alternatively, the β-ketoester can be 
α-selenylated by the Se(IV) reagent 4d, providing 7c, which could liberate 6a upon 
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reductive elimination (Mechanism B). Finally, selenation at oxygen would form 7d, 
which could undergo intramolecular nucleophilic attack at the chlorine (Mechanism 
C). While mechanisms A and B differ by the oxidation state of the selenylating agent, 
the latter two mechanisms differ only by whether the α-carbon is electrophilically 
selenylated or chlorinated. 
Scheme 6 Three possible mechanisms for catalytic α–halogenation of β-ketoesters 
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In order to gain some mechanistic insight several reactions utilizing 
stoichiometric PhSeCl were run. First, 5a was treated with PhSeCl in CH3CN. After 
stirring overnight, the selenylated product 7a was isolated and purified by 
chromatography. Treatment of 7a with NCS in CD3CN at room temperature did 
provide halogenated product 6a, however after standing 2.5 hours, the reaction was 
not complete (t1/2 ~ 150 min.). Therefore, pathway A is not kinetically competent with 
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the observed catalysis (t1/2 < 10 min.). Next, product 7a was treated with SO2Cl2 in 
CD3CN, which should provide intermediate 7c.24 Doing so led cleanly to one product, 
tentatively identified as 7c based on 1H NMR spectroscopy. This compound was 
stable for several hours at room temperature, but slowly decomposed overnight to 
give 6a (67 % conversion after 28 h). Once again, this indicates that intermediate 7c 
is not a kinetically competent intermediate. Therefore, it appears that the mechanism 
of catalysis is electrophilic chlorination rather that selenylation. This is important 
because it shows that selenium can be used to enhance the electrophilicity of oxidized 
halogen sources such as NCS.  
With this knowledge in hand, we set out to explore the scope of the catalysis and 
the results are shown in Table 1. Halogenation of β-ketoesters provided monohalo 
adducts exclusively. Importantly, the halogenation could be conducted in the presence 
of olefins (substrate 5g), without competing allylic halogenation.21 Cyclohexanone 5h 
was readily α-halogenated, showing that the β-keto activating group is not required. 
However, a qualitative correlation between the rate of the reaction and the rate of 
enolization is noteworthy. Unfortunately, cyclohexanone 5h was not as selective for 
monochlorination, and a 4:1 mixture of α-chlorocyclohexanone: α,α'-dichloro- 
cyclohexane was obtained. 
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Table 1 PhSeCl catalyzed α-chlorination of ketones in CH3CN 
Substrate Yield %ProductStructure Time
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5f
5i
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10 min
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10 min
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7 hr
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81
63
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87
61a
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79b
 
 
a
 isolated yield of monochlorocyclohexanone b product is vinyl chloride. 
 
We reasoned that the selectivity for monochlorination could be increased if the 
monochlorointermediate was trapped by solvent as a hemiacetal or an acetal (Scheme 
7). Investigating the reaction in methanol showed that cyclohexanone was chlorinated 
by NCS in < 1 h at room temperature and 1H and 13C NMR spectroscopies of the 
reaction mixture showed the presence of 8a with no evidence for dichlorinated 
product. α-Chlorocyclohexanone was liberated in good yield (72 %) upon passage 
through silica gel. Once again, no reaction occurred in the control without PhSeCl.  
Aside from the faster reaction kinetics in methanol, the reaction progress was 
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conveniently monitored by the dissolution of the relatively insoluble NCS. 
Scheme 7 Trapping monochlorocyclohexanone in methanol 
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Importantly, cyclohexanone was also α-brominated to provide 
α-bromocyclohexanone in 86 % yield when NBS replaced NCS.  No reaction was 
observed in the absence of PhSeBr. 
Finally, we investigated the chlorination of an α,β-unsaturated ketone, mesityl 
oxide 5i (Scheme 8). Interestingly, treatment of mesityl oxide with NCS and 5 mol % 
PhSeCl in CH3CN provided good yield of vinyl halide 6i,28 however, switching the 
solvent to MeOH completely reversed the selectivity and only the product of methyl 
halogenation 9i was observed. 
Scheme 8 Regiochemical solvent effect 
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In conclusion, we have demonstrated that phenylselenides are efficient and 
selective catalysts for α-chlorination of ketones. Experiments suggest that the 
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mechanism of the reaction involves oxidative addition of NCS to selenium which 
activates the “chloronium” toward nucleophilic attack by enols/enolates. This 
represents the first example of such an activation of oxidized halogen reagents. 
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Experimental Procedures and Data for Chapter 4 
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General Experimental  
 
THF was dried over sodium metal and distilled under vacuum. Toluene, 
methylene chloride and diethyl ether were dried over activated alumina on a solvent 
system purchased from Innovative Technology, Inc.1 Acetonitrile and 1,4-dioxane 
were dried and stored over activated molecular sieves. Commercially available 
reagents were used without additional purification unless otherwise stated. Products 
were purified on silica gel from Sorbent Technologies (230x400 mesh, 60 Å porosity, 
pH 6.5-7.5). Ruthenium and palladium compounds were obtained from Strem. Thin 
layer chromatography was performed on silica gel 60F254 plates (EM-5715-7, EMD 
chemicals). UV lamp (254 nm) or KMnO4 stain were used for monitoring TLC plates. 
1H and 13C NMR spectra were obtained on a Bruker Avance 400 or Bruker 
Avance 500 DRX spectrometer and referenced to residual protio solvent signals.  
Structural assignments are based on 1H, 13C, DEPT-135, COSY, and HMQC 
spectroscopies and X-ray data. High resolution mass spectrometry was performed on 
an AUTOSPEC-Q tandem hybrid mass spectrometer (VG Analytical Ltd, 
Manchester, UK). High resolution mass spectrometry was performed on a LCT 
Premier (Waters Corp., Milford MA) time of flight mass spectrometer. FTIR spectra 
were acquired on a Shimadzu FTIR-8400S spectrometer. HPLC analysis was 
performed on a Shimadzu SCL-10A VP instrument. 
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Preparation of Starting Materials 
 
Allyl β-ketoesters were synthesized by the DMAP catalyzed coupling reaction 
between commercially available allylic alcohols with diketene, followed by 
purification via flash column chromatography when R1 equals to methyl group. (SiO2, 
7:1 Hexane: Ethyl acetate).2 
O
O OH
R1
R2
R3
O
O
O
R2
R310 mol% DMAP
Et2O, rt+
 
 
To a solution of the allylic alcohol (225 mg, 1.6 mmol) in 10 ml ether under 
argon was added diketene in one protion (1.8 mmol, 1.1 eq.), followed by DMAP 
(17.6 mg, 0.16 mmol, 0.1 eq). The reation mixture was kept stirring until reaction 
completion indicated by TLC (generally 1.5 hr). The reaction was quenched with sat. 
NH4Cl solution, extracted with ether. The organic phase was washed with brined, 
dried over magnesium sulfate and concentrated to give the crude product, which was 
purified by flash column chromatography (SiO2, 10:1 Hexane: Ethyl acetate). All 
other β-ketoesters are commercially available and used without further purification. 
General procedure for Selenocatalytic α-Halogenation: 
 
In a Schlenk tube under argon, PhSeCl (5 mol%, 0.13 mmol) was dissolved in 
3 mL CH3CN. To this orange color solution at room temperature was added β-
ketoesters (2.51 mmol, 1.0 eq.), followed by N-chlorosuccinimide (2.51 mmol, 1.0 
eq.). The addition resulted in an immediate color change from orange to yellow 
(normally in 10 mins) which indicates the reaction completion. In the mean time, the 
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reaction was also monitored by TLC. Following solvent evaporation the crude 
product was purified via flash chromatography (SiO2, 15:1 Hexane: Ethyl acetate). 
 
Spectroscopic Data  
O
OEt
O
Cl
ethyl 1-chloro-2-oxocyclohexanecarboxylate
 
6a(cw1008)3 
colorless oil 
 86% yield 
 
1H NMR (400 MHz, CDCl3) δ 4.30 (q, J = 7.1 Hz, 2H: OCH2), 2.83 (m, 2H: 
ClCCH2), 2.45 (m, 1H: CH2), 2.14 (m, 1H: CH2), 2.01-1.82 (m, 3H: CH2), 1.75(m, 
1H: CH2), 1.31(t, J = 7.1 Hz, 3H: CH3). 
 
13C NMR (75 MHz, CDCl3) δ 199.67 (C=O), 167.22 (OC=O), 73.47 (ClC), 66.82 
(OCH2), 39.60 (C=OCH2), 38.82 (2.83) (CH2), 26.67 (ambiguous CH2), 22.14 
(ambiguous CH2), 13.87(CH3). 
 
O
OEt
O
Cl
ethyl 2-chloro-3-oxobutanoate
 
6b (cw1005)4 
colorless oil 
81% yield 
 
1H NMR (400 MHz, CDCl3) δ 4.76 (s, 1H: ClCH), 4.30 (q, J = 7.1 Hz, 2H: OCH2), 
2.39 (s, 3H: CH3C=O), 1.32 (t, J = 7.1 Hz, 3H: CH3). 
 
13C NMR (75 MHz, CDCl3) δ 199.61 (C=O), 164.92 (OC=O), 63.14 (ClC), 61.31 
(OCH2), 26.21 (O=CCH3), 13.89 (CH3). 
 
 
 
 306 
O
OEt
O
Cl
ethyl 2-chloro-2-methyl-3-oxobutanoate
 
6c (cw1016)5 
colorless oil 
63% yield 
 
1H NMR (400 MHz, CDCl3) δ 4.27 (q, J = 7.1 Hz, 2H: OCH2), 2.37 (s, 3H: 
CH3C=O), 1.82 (s, 3H: CH3CCl), 1.30 (t, J = 7.1 Hz, 3H: CH3). 
 
 
13C NMR (75 MHz, CDCl3) δ 198.80 (C=O), 168.03 (OC=O), 70.72 (ClC), 63.04 
(OCH2), 25.25 (ambiguous CH3), 24.22 (ambiguous CH3), 13.89 (1.30) (CH3). 
 
O
OEt
O
Cl
OH
OEt
O
Cl
ethyl 2-chloro-3-oxopentanoate (E)-ethyl 2-chloro-3-
hydroxypent-2-enoate
7.5:1
 
6d (cw1030)6 
colorless oil 
74% yield 
 
1H NMR (400 MHz, CDCl3) δ 5.29 (s, 1H: ClCH), 4.41 (q, J = 7.1 Hz, 2H: OCH2 of 
the enol isomer), 4.28 (q, J = 7.1 Hz, 2H: OCH2), 2.91 (q, J = 7.1 Hz, 2H: CH2C=O 
of the enol isomer), 2.79 (q, J = 7.1 Hz, 2H: CH2C=O), 1.28 (t, J = 7.1 Hz, 3H: 
ambiguous CH3), 1.07 (t, J = 7.1 Hz, 3H: ambiguous CH3). 
 
13C NMR (75 MHz, CDCl3) δ 200,87 (C=O), 166.97 (OC=O), 64.38 (ClC), 62.79 
(OCH2), 34.25 (2.79) (CH2), 15.18 (ambiguous CH3), 8.90 (ambiguous CH3). 
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O
OMe
O
Cl
OH
OMe
O
Cl
methyl 2-chloro-3-oxobutanoate (E)-methyl 2-chloro-3-
hydroxybut-2-enoate
 
6e (cw1031)7 
colorless oil 
68% yield 
 
1H NMR (400 MHz, CDCl3) δ 12.24 (1H: OH), 4.78 (s, 1H: CHCl), 3.85 (s, 3H, 
ambiguous OCH3), 3.84 (s, 3H, ambiguous OCH3), 2.34 (s, 3H: CH3C=O), 2.18 (s, 
3H: CH3COH).  
 
13C NMR (75 MHz, CDCl3) δ 196.58 (C=O), 172.21 (ambiguous, OC=O), 169.64 
(ambiguous, OC=O), 165.42 (HOC=), 96.74 (=CCl), 61.06 (CCl), 53.76 (ambiguous 
OCH3), 52.69 (ambiguous OCH3), 26.27 (2.34) (CH3), 19.73 (2.18) (CH3). 
 
O
OEt
O
Cl Bn
ethyl 2-benzyl-2-chloro-3-oxobutanoate
 
6f (cw1032)8 
colorless oil 
95% yield 
 
1H NMR (400 MHz, CDCl3) δ 7.25-7.30 (m, 3H: arom H), 7.21 (m, 2H: arom H), 
4.22 (m, 2H: OCH2), 3.53 (dd, J = 14.4, 21.5 Hz, 1H: diastereotopic CH2Ph), 3.44 
(dd, J = 14.4, 21.5 Hz, 1H: diastereotopic CH2Ph), 2.24 (app. d, J = 3.8 Hz, 3H: 
CH3C=O), 1.24 (app. t, J = 7.1 Hz, 3H: CH3). 
 
13C NMR (75 MHz, CDCl3) δ 198.90 (C=O), 167.02 (OC=O), 133.92 (arom. C), 
130.58 (arom. C), 128.18 (arom. C), 127.48 (arom. C), 75.24 (ClC), 63.04 (OCH2), 
42.15 (2.48) (CH2Ph), 26.50 (2.24) (CH3), 13.80 (1.24) (CH3). 
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1:1
O
O O
cinnamyl 2-chloro-3-oxobutanoate
Ph O
OH O
(E)-cinnamyl 2-chloro-3-hydroxybut-2-enoate
Ph
Cl Cl
 
6g (cw1013)9 
colorless oil 
87% yield 
 
1H NMR (400 MHz, CDCl3) δ 12.28 (1H: OH), 7.40 (m, 5H: arom H), 7.32 (m, 5H: 
arom H), 6.72 (dd, 2H: ambiguous CH=), 6.31 (m, 2H; ambiguous CH=), 4.89 (app. t, 
J = 4.57 Hz, 4H: ambiguous CH2O), 4.81 (s, 1H: ClCH), 2.40 (s, 3H: CH3C=O), 2.20 
(s, 3H: CH3COH). 
 
13C NMR (75 MHz, CDCl3) δ 207.36 (C=O), 143.35 (arom. C), 137.49 (arom. C), 
132.76 (CH=), 130.39 (CH=), 129.13 (arom. CH), 128.91 (arom. CH), 128.06 (arom. 
CH), 127.75 (arom. CH), 127.12 (arom. CH), 126.65 (arom. CH), 49.82 (CH2), 44.36 
(CH), 31.20 (CH3). 
 
O
Cl
2-chlorocyclohexanone
 
6h (cw2056)10 
colorless oil 
61% yield 
 
1H NMR (400 MHz, CDCl3) δ 4.37 (q, J = 5.2 Hz, 1H: ClCH), 2.78 (m, 1H: 
diastereotopic ClCCH2), 2.30-2.43 (m, 2H: CH2C=O), 1.97-2.12 (m, 2H: ambiguous 
CH2), 1.88-1.95 (m, 1H: ambiguous CH2), 1.79-1.87 (m, 1H: ambiguous CH2), 1.68-
1.77 (m, 1H: ambiguous CH2).  
 
13C NMR (75 MHz, CDCl3) δ 203.41 (C=O), 62.87 (ClC), 39.41 (C=OCH2), 37.40 
(2.78) (CH2), 27.02 (ambiguous CH2), 22.90 (ambiguous CH2). 
 
O
Cl
O
Cl
3-chloro-4-methylpent-3-en-2-one 1-chloro-4-methylpent-3-en-2-one
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